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Abstract 
The objective of this research was to investigate the synthesis of nitrile oxides and to 
study their reactivity in 1,3-dipolar cycloadditions with formamidines.  
Chapter one looks at the literature surrounding the 1,3-dipolar cycloaddition 
reaction. It explores the generation of 1,3-dipoles (mainly nitrile oxides) and 
dipolarophiles (predominantly amidines). It discusses the potential synthetic uses of 
the 1,3-dipolar cycloadducts. It examines both and inter- and intra-molecular 
cycloaddition reactions. It recognises the use of the 1,3-dipolar cycloadditions as a 
successful method in building natural products and oxadiazolines. The 
decomposition of oxadiazolines as a route to nitriles is also outlined in this chapter. 
Chapter two discusses the results of this research candidate. The preparation of 
nitrile oxide precursors - hydroximoyl halides - is outlined at first. The generation of 
nitrile oxides is then demonstrated, followed by the preparation of furoxans. 
Methods for preparing the reference materials (nitriles and ureas), which result from 
decomposition of oxadiazolines, then follow. The preparation of series of Δ
2
-1,2,4-
oxadiazolines via the 1,3-dipolar cycloaddition reaction is illustrated in this chapter. 
The selectivity of the addition of nitrile oxides to dipolarophiles was tested by 
competition reactions, which are also described in this chapter. NMR techniques 
were used in the study of the kinetics of the 1,3-dipolar cycloadditions used for the 
preparation of a series of Δ
2
-1,2,4-oxadiazolines, which is addressed in this chapter. 
Chapter three charts the experimental procedures followed to gain results which are 
discussed in chapter two. It also outlines all analytical data produced during the 
course of this research. 
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1 1,3-Dipolar cycloadditions  
Houk et al.  described the 1,3-dipolar cycloaddition reaction as a concept, ‘in which a 
formally zwitterionic molecule (the dipole) 1, undergoes 1,3-addition to an alkene or an 
alkyne, (the dipolarophile) 2, to form a five-membered ring heterocycle 3’ (Scheme 1).
[1]
 The 
reaction has been developed into a useful method for five-membered heterocycle synthesis 
since many 1,3-dipolar species are readily available and are reactive towards a wide range of 
dipolarophiles.  
    
                     1   2                         3 
Scheme 1: 1,3-dipolar cycloaddition
[1]
 
In the 1960s, a well-documented discussion arose regarding the actual mechanism of the 1,3-
dipolar cycloaddition reaction.
[2]
 Huisgen favoured a concerted mechanism, whereas Firestone 
and coworkers proposed a stepwise mechanism. Huisgen’s model involved a transition state 
where the 4π-electron system of the 1,3-dipole (e.g. a nitrile oxide) interacts with the π–bond 
of the dipolarophile in a concerted pericyclic transition state (Scheme 2).  
 
          4 
     
5          6 
Scheme 2: Huisgens’s mechanistic model 
Firestone on the other hand proposed that the reaction proceeds via a singlet diradical 
intermediate (Scheme 3). 
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                   4 
                    
        5           6 
Scheme 3: Firestone’s mechanistic model 
On the basis of the stereoselectivity of the 1,3-dipolar cycloaddition reaction, the dispute was 
settled in favour of the concerted mechanism. Therefore, Huisgen’s model is now generally 




1.1 Orbital interactions 
The transition states of the concerted 1,3-dipolar cycloaddition reactions of nitrile oxides are 
controlled by the frontier molecular orbitals of the substrates,
[2h]
 and the regioselectivity of 
1,3-dipolar cycloadditions can be rationalised by frontier orbital theory.
[3]
 Sustmann has 
classified 1,3-dipolar cycloadditions into three types, designated Types I-III, depending on the 
nature of the substituents on the dipole and dipolarophile.
[4]
 In Type I, the LUMO of the 
dipolarophile can interact with the HOMO of the dipole (common for electron-deficient 
dipolarophiles). In Type III, the HOMO of the dipolarophile can interact with the LUMO of 
the dipole (common for electron-rich dipolarophiles), and in Type II the frontier orbital 
energies of the dipole and dipolarophile are very similar and a combination of both modes of 
interaction can occur ( 
Figure 1).  
 
Figure 1: Sustmann’s classification of 1,3-dipolar cycloadditions 
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The allyl anion is a good model for the orbitals of the nitrile oxide as the 1,3-dipole is 
basically a system of three atoms amongst which are distributed four π-electrons. The 
predominant orbital interaction in the 1,3-dipolar cycloaddition reaction is that of the 
HOMOdipole and LUMOdipolarophile (Figure 2). 
 
Figure 2: Predominant molecular orbital interaction in the 1,3-dipolar cycloaddition 
Once the dominant frontier molecular orbital interaction has been identified, the most 
favourable direction of combination is that in which the terminal atoms of each component 
with the largest orbital coefficients interact. This is illustrated in Figure 3 in which state A is 
more stable than state B.  
 
Figure 3: Schematic representation of greater stabilisation of transition state A than B due to different 
coefficient magnitudes 
The frontier orbital coefficients for a large number of dipolarophiles and dipoles have been 
calculated, and these can be used to rationalise the observed regioselectivities of a range of 
1,3-dipolar cycloadditions.
[3,5]
 The effects of the substituents on the magnitudes of coefficients 






Figure 4: Schematic representation of the effects of the substituents on the magnitudes of coefficients of 
the frontier orbitals of dipolarophiles as derived by Houk
[5]
 
Controlling stereoselectivity is an important factor in synthesising novel compounds and in 
developing new synthetic routes to biologically active compounds. The 1,3-dipolar 
cycloaddition reaction is a very useful reaction from this perspective.  
2 1,3-Dipoles 
A 1,3-dipole is a structure with 4π electrons bearing a formal positive and a formal negative 
charge on adjacent atoms. The history of 1,3-dipoles stretches as far back as 1883, when 
Curtius reported the discovery of diazoacetic ester.
[6]
 His colleague Buchner
[7]
 was the first to 
describe a 1,3-dipolar cycloaddition reaction in relation to the reaction of a diazoacetic ester 




1,3-Dipoles vary greatly in stability. Some can be isolated and stored, and are relatively 
stable, others are reactive molecules which are generated and reacted in situ. 1,3-Dipoles can 
be classified into two types; the allyl anion type (so-called because it is isoelectronic with the 
allyl anion) and the propargyl anion type. The allyl anion type is characterised by four 
electrons in three parallel pZ orbitals perpendicular to the plane of the dipole. 1,3-Dipoles of 
the allyl type are bent, while the presence of a double bond orthogonal to the delocalized -
system in the propargyl anion type gives linearity to the dipole (Figure 5). Examples of the 
propargyl type 1,3-dipoles are given in Table 1. 
13 
 
Figure 5: Resonance structures of the propargyl and allyl anion type 1,3-dipoles 
 
Table 1: Examples of linear propargyl anion type 1,3-dipoles 
Type Dipole Structure 
Azide  
Stable if aromatic, alkyl azides can be explosive 
Nitrile Imine  
Generated and used in situ 
Nitrile Oxide  
Generated and used in situ 
Nitrile Ylide 
 
Generated and used in situ 
Diazoalkane  
Relatively stable. Diazomethane (R=R´=H) can be stored as a dilute ethereal solution in a 
freezer for several months. 
 
Examples of 1,3-Dipoles of the allyl type which are bent are shown in Table 2. 
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Table 2: Examples of the non-linear allyl type 1,3-dipoles 
Type Dipole Structure 
Ozone  
Generated and used in situ from dioxygen 
Nitrones 
 
Relatively stable, usually made just before use. 
Azomethine Imides 
 
Generated and used in situ 
Azomethine Ylides 
 
Generated and used in situ 
 
The 1,3-dipole can be represented by two octet-structures, in which the positive charge is 
located on the central atom and the negative charge is distributed over the two terminal atoms, 
and two sextet-structures, wherein two of the four -electrons are localised at the central 
atom. The structures shown in Tables 1 and 2 are octet stabilised 1,3-dipoles. Table 3 gives 
some examples of non-octet stabilized 1,3-dipoles.  
Our research concentrated on the behaviour of nitrile oxides. Hence, a more detailed 
discussion of their properties and reactions follows. 
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Table 3: Examples of the non-octet stabilised 1,3-dipoles
[9]
 
Type Dipole Structure 
Vinyl carbenes 
 
Generated and used in situ 
Iminocarbenes 
 
Generated and used in situ 
Ketocarbenes 
 
Generated and used in situ 
Vinyl nitrenes 
 
Generated and used in situ 
Iminonitrenes 
 
Generated and used in situ 
Ketonitrenes 
 
Generated and used in situ 
2.1 Nitrile oxides 
Nitrile oxides, RCNO, are organic compounds which contain the monovalent functional 
group –CNO bound directly to another atom, which is usually carbon.
[10]
 They are derivatives 
of fulminic acid (R = H), the parent nitrile oxide originally described by Ley in 1899.
[11]
 
Nitrile oxides are reactive species and are typically generated in situ as they are prone to 
dimerisation. 
[2i,12]
 Nitrile oxides are regarded as the 1,3-dipole which has been most 
frequently and widely utilised in synthetic organic chemistry.
[13]
  
2.1.1 Synthetic uses of nitrile oxides 
Mesitonitrile-N-oxide 7 is well-documented in the literature.
[12d,12i,14]
 Most interested parties 
regard it to be a ‘stable’ nitrile oxide and it is widely used because it is less prone to 
dimerisation.
[12a,15]
 Its stability makes it more useful with dipolarophiles which ‘may not 
produce very fast 1,3-dipolar cycloadditions’. Lee et al. noted this in the exploration of the 
16 
cycloadditions of nitrile oxides with 3-methylenequinuclidine 8 in the synthesis of 
spiroisoxazolines 9 (Scheme 4).  
 
               7                 8       9 
Scheme 4: Reagents: (i) Mesitonitrile-N-oxide 7 (0.5 equiv.) at 4°C added over 48 h to 8 (1 equiv.), CH2Cl2, 
20°C, 24 h; (ii) 7 (0.5 equiv.) at 4°C added over 48 h, 20°C, 24 h. Yield 82%
[14a]
 




Nitrile oxides have also been examined as tools in the investigation of the stereoselectivity of 
cycloaddition chemistry. Umano et al. found that the cycloaddition of phenylglyoxylonitrile-
N-oxide 10 to the 7-substituted norbornadiene 11 gave predominantly the endo-isomer, but 





      10                     11     12 
Figure 6: The structures explored by Umano et al.
[16]
 
Bromonitrile-N-oxide 13 hasbeen used in the direct synthesis of the antitumour agent erythro-
α-amino-3-bromo-4,5-dihydroisoxazole-5-acetic acid 14 which also exhibits anti-bacterial and 
anti-fungal behaviour (Figure 7). Hagedorn et al. noted that dimerisation of 13 was 
encountered during their investigation, but the furoxan 15 was easily separated from the 





        13              14      15 
Figure 7: The products of the reaction of bromonitrile-N-oxide 13 
Dichloroformaldoxime 16 has been used as the precursor for chloronitrile-N-oxide 17 in the 




         16            17            18 
Figure 8: Dichloroformaldoxime 16, its nitrile oxide 17 and the product 18 of its cycloaddition 
1,3-Dipolar cycloaddition reactions of nitrile oxides with dipolarophiles can take place in both 
an inter- and intramolecular mode according to Garanti et al., however length of tether 
between reacting components in the intramolecular cycloadditions has an effect on the rate of 
cycloaddition (Scheme 5). While investigating the intramolecular cycloaddition, the chain 
length in 19 varied from n = 1 up to n = 4. Cycloadducts 20 resulting from the cycloaddition 
were obtained in 47% yield when n = 1 and 17% when n = 2. When the chain length was 




19        20 
Scheme 5: Reagents: i) NO2(g), ether, 0 °C
[19]
 
1,3-Cycloaddition reactions of nitrile oxides with alkenes have been widely reported in the 
literature. Houk et al. explored the reactivity in an intramolecular cycloaddition involving a 
nitrile oxide to an alkene and found that the nitrile oxide dimerised to 21 rather than forming 





  21           23         22 
Scheme 6: The reactivity of nitrile oxide 23
[12j]
 
When R was a TMS group, the anticipated cycloadduct was produced. However, in the 
absence of the TMS group, dimerisation to the furoxan was the principal reaction.  
Savage et al. explored the versatility of the nitrile oxide containing a pinacolyl boronate ester 
24 (Figure 9).
[20]
 This allowed for the synthesis of aryl isoxazolines with the boronate ester 
function intact and available for subsequent reaction. Arylboronic acids and esters are used in 
organic synthesis as key intermediates in transition-metal-catalysed carbon-carbon bond 





Figure 9: The structure of the nitrile oxide 24 investigated by Savage et al.  
2.1.2 Nitrile oxide synthesis 
2.1.2.1 From hydroximoyl chlorides 
The procedure for the synthesis (generation) of nitrile oxides was first described by Werner 
and Buss.
[22]
 This was achieved by chlorination of benzaldoxime 25 to give 
benzohydroximoyl chloride 26, followed by dehydrohalogenation with sodium carbonate to 




      25                   26             27 
Scheme 7: Reagents: (i) Cl2(g) or (ii) t-BuN(CN)Cl, DCM, r.t., <1 min; (iii) NEt3
[22]
 
 Chlorination has been carried out using chlorine, but ring chlorination occurs with aryl 
systems that are substituted with electron donating groups.
[23]
 There are alternative 
chlorinating agents, including nitrosyl chloride, N-chlorosuccinimide, t-butyl hypochlorite, 
iodobenzene dichloride (PhICl2), chloramine-T (N-chloro-N-sodio-4-
methylbenzenesulfonamide), 1-chlorobenzotriazole, and hydrogen chloride in DMF/ozone. 
[12c,14d,14g,24]
 Kaushik et al. explored the use of N-tert-butyl-N-chlorocyanamide as a 
chlorinating agent in the production of hydroximoyl chlorides.
[25]
  
This novel chlorination method yielded the hydroximoyl chloride of benzaldoxime within a 
minute of stirring with the reagent in dichloromethane at room temperature. It was reported 
that the hydroximoyl chloride was isolated in ‘virtually quantitative yields’ and with no 
evidence of over chlorination. The presence of electron donating groups, electron 
withdrawing groups or an aromatic ring in the oxime molecular structure did not affect the 
yields/efficiency or the rate of reaction. 
Kanemasa et al. used benzyltrimethylammonioum tetrachloroiodate 28 as a chlorinating agent 




     28             29 
Figure 10: The structure of benzyltrimethylammonium tetrachloroiodate 28 and its salt 29 
The salt 28 is a stable yellow solid which makes it easier to dispense accurately. While 28 is 
not soluble in dichloromethane, the product salt 29 is soluble however, therefore allowing 
easy identification of reaction completion in that solvent. The salt 29 is poorly soluble in 
diethyl ether, which facilitates easy isolation of the hydroximoyl chloride ‘simply by diluting 
the reaction mixture with diethyl ether’.
[26]
 This would only be beneficial when the 
hydroximoyl chloride is soluble in diethyl ether. 
20 
Dehydrohalogenating agents such as amines e.g. triethylamine and tributylamine have been 
used in place of sodium carbonate.
[27]
 Other alternatives include potassium bicarbonate, 
aluminium oxide, Florisil
®
, molecular sieves, hexabutylditin, bis-(tributyltin)oxide, 
tetraphenyltin, tributyltin hydride, silver nitrate and alkali metal fluorides.
[18a,24g,27e,28]
  
Zhu et al. investigated the use of two different bases - triethylamine and sodium bicarbonate-
on the dehydrohalogenation of the hydroximoyl halide 30 in generating the nitrile oxide 31 
(Scheme 8).
[29]
 Sodium bicarbonate decreased the reaction time from 3 days to 1 day as well 
as increasing the yield of the cycloadduct. 
 
        30       31 
Scheme 8: Reagents: (i) Triethylamine, or (ii) Sodium bicarbonate
[29]
 
Kanemasa et al. illustrated the use of organometallics to liberate nitrile oxides from 
hydroximoyl chloride precursors.
[30]
 Using n-BuLi, EtMgBr or Et2Zn at -30 to -50 
o
C in THF 
successfully liberated benzonitrile oxide, which was in turn trapped with methyl acrylate in 
excellent yields (67-91%). 
Other variations for nitrile oxide generation include bromination rather than chlorination 
using N-bromosuccinimide, alkali hypobromite, or sodium bromite with a catalytic quantity 




Tsuge et al. found that chlorination of the oxime 32 with NCS generated two isomers 33 and 
34 (Scheme 9).
[32]
 The yield and isomer ratio of both products from the chlorination reaction 




       32            33                     34 
Scheme 9: Reagents: (i) NCS
[32]
 
However upon treating 32 with N-bromosuccinimide in DMF, whilst the hydroximoyl 
bromide 35 was not isolated successfully, in situ dehydrobromination with triethylamine 
afforded the nitrile oxide 36 (Scheme 10).  
 
        32    35         36 
Scheme 10: Reagents: (i) NBS, (ii) NEt3
[32]
 
Trapping of the nitrile oxide 36 with N-(p-tolyl)maleimide 37 the gave the cycloadduct 38 in 
80% yield (Scheme 11). 
 
     36                   37              38 
Scheme 11: Nitrile oxide 36 was generated in situ and immediately reacted with N-(p-tolyl)maleimide 37 
which gave the cycloadduct 38
[32]
 
Nitrile oxides have been produced through electrolysis of aldoximes in methanol containing 
sodium chloride.
[33]
 Examples of nitrile oxides that can be prepared from their aldoximes by 
this route include the phosphorous-functionalised nitrile oxides, α-(diethylphosphono)-





        39                40          
Figure 11: The structures of nitrile oxides 39 and 40 which were prepared from the corresponding 
aldoximes  
Dibromoformaldoxime 41 gave the nitrile oxide 13 in >95% yield when reacted with 




            41    13 
Scheme 12: Conversion of dibromoformaldoxime 41 to its corresponding nitrile oxide 13 
Faita et al. investigated solid-supported nitrile oxides as stable and valuable reactive 
intermediates.
[36]
 Mounting of nitrile oxides onto a solid phase (SP) support facilitated the 
1,3-dipolar cycloaddition reactions as the well-known tendency of nitrile oxides to undergo 
dimerization reactions is reduced under solid-phase (SP) conditions. The cycloadduct could 
then be easily cleaved from the resin once synthesised. A Wang resin ( ) was employed as 
the solid state support which was first coupled to m- or p-carboxybenzaldehyde which gave 
the resin bound aldehydes 42 (Scheme 13). 
23 
 
           42                         43 
 
       44      45 




These aldehydes were then converted into the corresponding aldoximes 43 followed by the 
hydroximoyl chlorides 44 (Scheme 13). Treatment of 44 with an excess of triethylamine 
yielded the solid supported nitrile oxides 45. As the distance between the reactive sites is 
increased on resins, these nitrile oxides demonstrated added stability. Accordingly, the SP 
approach might also stabilise other 1,3-dipoles which, under classic solution conditions, must 
be generated in situ and immediately trapped with dipolarophiles. This increased stability will 
allow easier handling of 1,3-dipoles, which not only simplifies reaction conditions and 
increases yields, but should also open a route to additional, useful transformations of nitrile 
oxides that would otherwise be prevented. 
Cheng et al. explored the potential of supported solid phase nitrile oxides in the synthesis of 
∆
2
-isoxazolines (Scheme 14) using Wang resin.
[37]
 The reaction of the resin-bound aldehyde 
42 with hydroxylamine in the presence of triethylamine in methanol at room temperature 
affords the desired aldoxime resin 43. The resin-bound aldoxime obtained was suspended in 
THF and treated with an excess of commercially available aqueous bleach solution (Clorox
®
, 
10 eq.) to form the nitrile oxide, which reacted in situ with alkenes in a one pot synthesis to 
furnish the corresponding resin-bound ∆
2
-isoxazolines. Cleavage of the product from the resin 
under standard condition (20% TFA in dichloromethane) afforded the desired ∆
2
-isoxazolines 
46 in good yields (40-94%). 
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  42          43                   46 








2.1.2.2 Nitrile oxides via dehydration of nitro compounds 
An alternative to the dehydrohalogenation of halooximes as a route to generating nitrile 
oxides is the dehydration of primary nitroalkanes.
[38]
 This method was highlighted by 
Mukaiyama
 
in 1960 and has since been referred to as the ‘Mukaiyama method’.
[12a,39]
 The 
nitroalkanes 47 are dehydrated using phenylisocyanate in the presence of a catalytic amount 
of triethylamine (Scheme 15). N,N-Diphenylisourea 48 is the by-product of the reaction of 
phenylisocyanate with nitroalkanes. 
 
     47                                   48 





Phosphorus oxychloride, chloroformate esters (e.g. ethylchloroformate), the Burgess reagent, 
p-toluenesulfonic acid and arylsulfonyl chlorides (benzenesulfonyl chloride) have been used 
as dehydrating agents in the Mukaiyama reaction.
[12b,38c,40]
 Thionyl chloride has also been 
used as a dehydrating agent with nitroacetamides.
[41]
 One of the advantages outlined by Zhang 
et al., was that a one-pot reaction could be employed to synthesise 4,5-dihydroisoxazoles and 
isoxazoles. This process involved the reaction of diethyl nitromethylphosphonate 49 with 
alkenes or 1-alkynes in the presence of phosphorous oxychloride and triethylamine yielding 
50 and 51 respectively (Scheme 16). 
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Examples of nitrile oxides produced by this method include the labile carbapenam 52 and 




        52           53 
Figure 12: The structures of nitrile oxides 52 and 53 
Carreira et al. discussed the transformation of optically active nitroalkanes into chiral 
aldoximes and then into nitriles (Scheme 17).
[43]
 The complete transformation from 
nitroalkane 54 to nitrile 55 involves the use of relatively inexpensive reagents i.e. potassium 
hydroxide, benzylbromide.  
 
    54             55 
Scheme 17: Reagents: (i) BnBr, KOH, nBu4NI, THF; (ii) TFAA or SOCl2, NEt3, THF
[43]
 
The most useful aspect of this synthesis was the formation of the nitrile in good yield (62-
73%) without the loss of optical activity. If, however, an optically active nitrile oxide was 




Scheme 18: Transformation of optically active nitroalkanes into chiral aldoximes and nitriles
[43]
 
Kozikowski et al. used a three step version of this method in converting 56 into the 
isoxazoline alcohols 57 and 58 in the synthesis of the ergot alkaloid, paliclavine 59 (Scheme 
19).
[44]
 Firstly, dipole generation and cycloaddition was achieved by a 
phenylisocyanate/triethylamine treatment, followed by N-acetylation and Dowex W-X8 
assisted cleavage of the tetrahydroyranyl (THP) group to yield 57 and 58. 
 
            56           57        58      59 
Scheme 19: Reagents: (i) PhNCO, N Et3; (ii) Ac2O, DMAP; (iii) Dowex 50 WX8
[44]
 
Paton et al. examined the Mukaiyama method in the generation of glycosyl nitrile oxides such 
as 60.
[12e]
 This involved the reduction of primary aliphatic nitro compounds to aldoximes 
using Sn (II) complexes. The aldoxime was then oxidised with aqueous hypochlorite to the 
nitrile oxide 60 (Figure 13). 
 
    60      61 62 
Figure 13: The structures of nitrile oxides 60 and 61 
While this Sn(II) reduction method proved useful, it is not infallible as the formation of 61 
from allyl alcohol and C-disaccharide precursor 63 from D-glucose-derived alkene 62 
represent examples of isoxazolines which could not be prepared directly from the nitromethyl 
27 
compound by the Mukaiyama method (Scheme 20). Cycloadducts from the derivatives of D-




           60                     62           63 
Scheme 20: Reagents: (i) Ether
[12e]
 
2.1.2.3 Nitrile oxides via oxidation of oximes 
Moriya et al. created an oxidizing system using sodium bromite with a catalytic amount of tri-
butyltin chloride for the preparations of isoxazolines and isoxazoles from aldoximes via 




Scheme 21: Reagents: (i) NaBrO2, Bu3SnCl
[31c]
 
Since sodium bromite had a low reactivity to thedipolarophiles involved, reasonable yields of 
the cycloadducts could be isolated from a variety of alkenes and alkynes. 
Savage et al. achieved conversion of oxime 64 into the nitrile oxide 24 using a hypervalent 
iodine reagent (Scheme 22).
[20]
 The nitrile oxide was trapped in situ by alkene dipolarophiles 
in the synthesis of isoxazolines 65. 
 
      64           24              65 




2.1.2.4 Cycloreversions of furoxans 
The cycloreversion of furoxans has also been used to generate nitrile oxides in situ under 
thermal conditions.
[12p,45]
 Curran and Fenk performed the thermolysis of bis-[2-
[(trimethylsilyl)oxy]prop-2-yl]furoxan (TOP-furoxan) 66 and a clean conversion to the 




              66      68 
 
67 
Scheme 23: Thermolysis of 66 and conversion to the isoxazoline 67
[46]
 
Crosby et al. anticipated that the cycloreversion of furoxan 69 would generate the bis-nitrile 
oxide 70 (Scheme 24).
[45a]
 However, the experimental evidence collected showed that the 
isocyanate 71 rather than the nitrile oxide 70 was produced when 69 was heated. 
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 69        70 
 
71 
Scheme 24: Cycloreversion product of furoxan 69 produced isocyanate 71
[45a]
 
Dibromofuroxan 15 is another furoxan which does not liberate the expected nitrile oxide 13 
upon heating (Scheme 25). Westwood et al. established that bromine gas was liberated and 
cyanogen-bis-N-oxide 72 was formed upon heating 15.
[12o]





 which were attributed to ‘one molecular species’, and assigned to 72, were 
observed for the principal reaction product.   
 
            15     72 
Scheme 25: Reagents: (i) Heat
[12o]
 
2.1.2.5 From stannyl oximes 
A novel method of nitrile oxide production was devised by Nishiyama et al., whereby 
oxidative fragmentation of β-stannyloximes gave nitrile oxides and alkenes simultaneously, 





      73           74        75 
Scheme 26: Reagents: (i) Pb(OAc)4, NaHCO3
[47]
 
Moriya et al. have also explored the production of nitrile oxides from oximes. O-
Tributylstannyl oxides 76 were treated with alkenes to afford the corresponding isoxazolines 




            78        76                77 
Scheme 27: Reagents: (i) (Bu3Sn)2O; (ii) t-BuOCl
[28g,48]
 









High diastereoselectivity was noted when substituents were present on the cyclopropane ring 
yielding products such as 79 and 80 (Figure 14). This result was attributed to the ‘preferred 
approach of the dipole from the less hindered face of the dipolarophile’. The structure 80 was 
supported by the lack of a nuclear Overhauser effect (nOe) on the protons of the isoxazoline 
methylene group and suggested this originated from rapid conformational equilibrium of the 
boat-cyclohexane. This makes sense, because if the structure was the other diastereisomer, 
then an nOe would have been observed with the cyclopropane protons in a rigid 
conformation. 
 
                                                    79                                   80 
Figure 14: Cycloaddition products 79 and 80 
Interestingly, De Sarlo et al. also carried out rearrangements of the spiro-fused compounds 
including 79, and isolated enaminones 81 and pyridones 82 (Figure 15).
[49]
 In some cases, just 
heating the heterocycles resulted in the rearrangement. 
 
        81                82 
Figure 15: Isolated products 81 and 82 
Other examples of spiroheterocycles resulting from cycloaddition of nitrile oxides to 
dipolarophiles includes those highlighted by Howe et al..
[50]
 Aromatic nitrile oxides 83 were 
reacted with N-aryl-3-methylenephthalamides 84 to produce spiroheterocycles 85 in good 
yields (66-78%) (Scheme 29). 
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             83                                84                        85 
Scheme 29: The formation of spiroheterocycles 85 
[50]
 
2.1.3 Nitrile oxide stability 
Nitrile oxides are known in the literature for being prone to dimerisation.
[10,12c,24k,51]
 Lowe et 
al. explored aromatic nitrile oxides and found that the ‘rate of dimerisation depends upon the 
nature of the the substituent on the aromatic ring’.
[52]
 It was recognised that the greater the 
electron donating ability of the substituent on the aromatic ring, the faster the dimerisation. 
Grundmann et al. studied the stability of nitrile oxides in detail.
[12d]
 This work established that 
aromatic nitrile oxides can be kinetically stabilised with sterically hindered groups.
[12d,12r]
 The 
focus of the investigation was on aromatic nitrile oxides bearing substituents at the o,o’-
positions such as methyl, ethyl or methoxyl.  
2,4,6-Trimethylbenzonitrile oxide 7, 2,3,5,6-tetramethylbenzonitrile oxide 86, 2,4,6-
trimethoxybenzonitrile-N-oxide 87, tetramethylterephthalo-bis-nitrile oxide 88 and 
anthracene-9-yl-nitrile oxide 89 were all isolated as ‘well-crystallised solids’ (Figure 16). 
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     7           86         87 
 
              88                          89 
Figure 16: Sterically hindered nitrile oxides 
Grundmann et al. also tried to force the dimerisation of these nitrile oxides by heating them 
above their melting points, or by heating them to reflux in high boiling solvents such as 
xylene. This afforded the corresponding isocyanates rather than the furoxan dimers (Scheme 
30).  
 
Scheme 30: The conversion of nitrile oxides to the corresponding isocyanates 
Moriya et al. also investigated the reactivity of anthracene-9-yl-nitrile oxide 89 by reacting it 




  90 
Figure 17: The structure of isoxazoline 90 
34 
Suzuki et al. also explored the use of o,o’-disubstituted aromatic nitrile oxide 91 as a 
potentially ‘stable’ structure (Figure 18).
[28d]
 This nitrile oxide provided a synthestic route to 
highly functionalised isoxazole derivatives in yields up to 85%. 
 
91 
Figure 18: The structure of nitrile oxide 91 
As discussed earlier in this chapter (refer to section: ‘Nitrile oxides from hydroximoyl 
chlorides’), Faita et al. explored the mounting of nitrile oxides onto a solid phase (SP) 
support.
[36]
 This work found that the well known tendency of nitrile oxides to undergo 
dimerisation reactions is reduced under SP conditions (Scheme 31). It was postulated that, the 
SP approach might also stabilise other 1,3-dipoles which, under classic solution conditions 
have to be generated in situ and immediately trapped by reacting dipolarophiles and found 
that supported nitrile oxides could in fact be stored in a dry and cool place for at least one day.  
 
Scheme 31: Dimerisation of the nitrile oxide to the furoxan 
Preparing more stable nitrile oxides has its benefits also. If dimerisation of the nitrile oxide to 
the furoxan (Scheme 31) is a problem, then using nitrile oxides that are stable as a result of 
steric shielding, such as 2,4,6-trimethylbenzonitrile oxide 7, is attractive.
[53] 
Groundwater et 
al. synthesised a bis-ortho substituted nitrile oxide 92 and postulated that the relatively long 
lifetime of this nitrile oxide 92 could be attributed to resonance stabilisation and steric 
shielding (Figure 19).
[12c]
 The ortho-substituted nitrile oxide 93 also exhibits stability and 




             7    92               93 
Figure 19: The structures of nitrile oxides 7, 92 and 93 
Houk et al. outlined the dimerisation of nitrile oxides leading to three potential products 
(Figure 20).
[12h]
 Firstly, 1,2,5-oxadiazole-2-oxides, more commonly referred to as furoxans, 
are easily formed. Under acidic or basic conditions, Houk et al. observed that nitrile oxides 
can also dimerise to give either 1,2,4-oxadiazole-4-oxidesor symmetric 1,4-dioxa-2,5-diazines 
(Figure 20). 
                                           
1,2,5-oxadiazole-2-oxides                1,2,4-oxadiazole-4-oxides 
          
1,4-dioxa-2,5- diazines 
Figure 20: Dimerisation products of nitrile oxides 
The 1,2,5-oxadiazole-2-oxides structure is the most common product from the dimerisation of 
nitrile oxides and is well documented in the literature.
[12c-e,12h-j,41]
 Physically adding the 
hydroximoyl halide precursor in a more dilute solution can retard dimerisation. Alternatively, 
following Kamimura et al., using a syringe pump to add the solution of the hydroximoyl 
halide can help to slow down the dimerisation process.
[12z]
 Balsamini et al. noted the half-life 
of p-nitrobenzonitrile oxide to be ‘about one month at room temperature in diethyl ether’.
[54]
  
2.1.4 Synthetic uses of 1,3-dipolar cycloadditions 
The construction of multiple fused carbocyclic systems as a synthetic route to steroids was 
investigated by Kozikowski et al..
[55]
 It was envisaged that a [4+2]-cycloaddition process 
followed directly by a [3+2]-cycloaddition would result in the formation of a tetracyclic 
structure which would possess five new stereogenic centres (Scheme 32). 
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       94        95           96 
Scheme 32: Reagents: (i) Heat, (ii) PhNCO, NEt3
[55]
 
The synthetic scheme (Scheme 33) involved intermolecular cycloaddition followed by dipole 
generation and an intramolecular nitrile oxide cycloaddition which provided the cycloadduct 
97 in 83% yield.  
 
               98            99         100 
 
101          97 
Scheme 33: Reagents: (i) Toluene, 110 
o




This served to demonstrate the potential for building natural products of the steroid (e.g. 
cholesterol 102) and anthracycline (e.g. daunomycin 103) type (Figure 21). 
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102      103 
Figure 21: Natural products cholesterol 102 and daunomycin 103 
An intramolecular 1,3-dipolar cycloaddition reaction has been utilised as the key reaction in 
the total synthesis of calicheamicin γ1-a member of the enediyne class of anti-tumour 





Figure 22: Tetronic acid 104 
The cycloaddition reaction of the nitrile oxide 105 derived from 106, which is a derivative 
itself of 104,yields two products 107 and 108 (Scheme 34). Both epimers were isolated in 
65% combined yield and in a ratio of 4:1 in favour of 107. 
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Martin et al. explored the application of nitrile oxide cycloadditions in the synthesis of (+)-
phyllanthocin 109 (Figure 23).
[31e]
 (+)-Phyllanthocin was intially regarded as a potential anti-




Figure 23: (+)-Phyllanthocin 109 
The total synthesis of (+)-phyllanthocin was realised by the recognition of ‘the synthetic 
equivalency of a β–hydroxyketone moiety with an isoxazoline ring’.
[31e]
 This isoxazoline ring 
110 was accessible via [3+2] dipolar cycloaddition of a nitrile oxide (thermally generated in 
situ) with an alkene 111 (Scheme 35).  
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     111         112          110 
Scheme 35: Reagents: (i) Heating to reflux in toluene
[31e]
 
Kurth et al. explored the synthesis of spiroketals, tetrahydrofurans and tetrahydropyrans by 
way of the products of the cycloaddition of triphenylacetonitrile oxide 113 with α,ω-dienes 
114 (Scheme 36).
[57]
 It was envisaged that increasing the chain length of the diene (from 7 to 
8) would give rise to a tetrahydropyran (from 1,6-heptadiene, n = 2) and an oxepane (from 
1,7-octadiene, n = 3). 
 
 113       114               115       116 
Scheme 36: Reagents: (i) Benzene, 25 
o
C; (ii) I2, DCM
[57]
 
More recent work by Kurth et al. explored the same chemistry, but had the nitrile oxide 
moiety resin bound.
[38b]
 Results indicated that carrying out the cycloaddition while the nitrile 
oxide was tethered to a resin allowed for a smaller excess of dipolarophile to be used (2-3 
equivalents versus 8 equivalents in the non-resin bound reaction) with a noted increase in 
yield. It was surmised that the ‘reaction most likely to benefit from the polymer-supported 
protocol is the 1,3-dipolar cycloaddition, in which isoxazoline production by mono-addition 
would be expected to predominate over bis-addition’. 
Another interesting result by Baouid et al. was the reaction of a 1,4-diazepine 117 with 
mesitonitrile-N-oxide (Scheme 37).
[58]
 While the reaction was slow (7 days), it was 
completely peri- and regioselective. The bicyclic monoadduct 118 which was isolated in 95% 
yield, showed that the potential dipolarophilic alkene group [C(6)=C(7)] did not react, even 
when an excess of nitrile oxide was used (2 equiv.). 
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            117                                        118 
Scheme 37: Reagents: (i) Mesitonitrile-N-oxide, ether, r.t.
[58]
 
Zecchi et al. carried out 1,3-dipolar cycloaddition reactions of nitrile oxides with coumarin 
119 as the dipolarophile (Figure 24).
[59]
 It was anticipated that this method could predicate a 
synthetic route to annulated coumarins, a class of compounds which includes several natural 
products such as dicoumarol 120. However, no further developments are evident to date. 
 
              119           120 
Figure 24: Coumarin 119 and dicoumarol 120 
More recent investigations by Bhuyan et al. within this area explored an intramolecular 
cycoladdition within the coumarin structure itself (Scheme 38).
[60]
 The 1,3-dipolar 
cycloaddition reaction was carried out by generating the nitrile oxide from the reaction of 121 
with sodium hypochlorite in presence of triethylamine. The in situ generation dipole 
underwent intramolecular cycloaddition to the uncongugated double bond to afford the 
cycloadduct dihydroisoxazolo[3’,4’:4,5]pyrido[2,3-c]coumarin 122 in 75% yield. 
 
   121           122 
Scheme 38: Reagents: (i) NaOCl, NEt3, dichloromethane
[60]
 
1,3-Dipolar cycloaddition reactions can provide a diverse range of products as confirmed by 
Harrity et al..
[12i,61]
 The 1,3-cycloaddition reaction of nitrile oxides with alkynylboronates 123 
41 
yielded isoxazoleboronic esters 124 and 125 (Scheme 39). The [3+2] cycloaddition reaction 
offered a relatively simple route to isoxazoleboronic esters in appreciable yield (59%) with 
good levels of regiocontrol- 124:125 (77:23). 
 
123    124    125 
Scheme 39: Reagents: (i) Mesitonitrile-N-oxide
[12i,61]
 
Investigations into benzodiazepine derivatives with heterocyclic rings annelated at the ‘a’ [3-
6], ‘c’ [7] or ‘d’ [8] sides of the heptatomic system have gathered interest. Romeo et al. 
investigated fusing the heterocyclic system to the benzodiazepine ring via a 1,3-dipolar 
cycloaddition with a nitrile oxide to give the cycloadduct.
[62]
 The pharmacological acitivity of 
the benzodiazopene appears to be enhanced by the addition of a further heterocyclic ring to 
the benzodiazepine moiety. They successfully extended the 1,3-dipolar cycloaddition strategy 
to develop a pathway to 1,5-benzodiazepines which incorporated a 1,2,4-oxadiazoline nucleus 
fused to the ‘a’ edge of the heptatomic ring. The reactions themselves proceeded smoothly 
with the new heterocycles being isolated in good yields (Scheme 40). 
 








 = Me 
126b R = H, R
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 = Ph, R
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Scheme 40: Reagents: (i) Benzohydroximoyl chloride, NEt3
[62]
 
Cortes et al. further investigated this reaction by fusing the benzodiazepine ring 128 via a 1,3-
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 Paton et al. investigated the use of 
levoglucosenone 130 - a cellulose derived α,β–unsaturated bicyclic ketone-as a dipolarophile 





Figure 25: Levoglucosenone 130 as a dipolarophile 
The reactivity of dipolarophiles varies greatly. Imines have exhibited a low reactivity to 1,3-
dipoles. Pinho e Melo et al. explored the use of 2H-azirine ring systems 131 as a more 
reactive imine type dipolarophile in 1,3-dipolar cycloadditions (Figure 26).
[65e]
 It was 
hypothesised that the inherent strain in the ring system would make 131 much more reactive 
than corresponding alkylimines. Cycloadditions were attempted with diazomethane, however, 
only complex mixtures of compounds were obtained.  
 
        131 
Figure 26: 2H-Azirine ring system used as a dipolarophile 
43 
In summary, the simplicity and efficacy of the 1,3-dipolar cycloaddition reaction allows it to 
be embraced in modern synthetic methods and technologies. It has been explored by Gallardo 
et al. in the generation of liquid crystals with success.
[66]
 Its scope can accommodate a wide 
variety of conditions such as ionic solvents.
[12t]
 In some cases, the 1,3-dipolar cycloadditions 




Amidines are structures in which an amine group is attached to the carbon atom of an imine 




Figure 27: Resonance forms of amidines 
Amidines are stronger bases than amides or amines and are among the strongest neutral 
bases.
[69]
 Two frequently used amidine bases are 1,5-diazabicyclo[3.4.0]nonene-5 (DBN, 132) 
and 1,8-diazabicyclo[5.4.0]undecene-7 (DBU, 133) (Figure 28). These are ‘easier to make, 
more stable, and less volatile than simpler amidines’.  
 
  132                  133  
Figure 28: Amidine bases 
Amidines are important functional groups in modern drug synthesis.
[70]
 Oszczapowicz et al. 
chronicled the ab initio 3-21G optimisation of the molecular structures of fluoro derivatives 
of formamidines and their conjugate acids.
[71]
 It was concluded that substituents at both 
nitrogen atoms would have an influence on the extent of conjugation along the amidine 
functionality. The proposal that electron-withdrawing substituents at the imino nitrogen atom 
would cause an increase in conjugation which would favour the resonance form (b), whereas 
electron-withdrawing substituents at the amino nitrogen would result in a decrease in 
conjugation and would therefore favour resonance form (a). Conversely, electron-donating 




 From this, it was recognised that electron-withdrawing groups at the 
imino nitrogen should lead to an increase in the length of the formal C=N bond and a decrease 
in the length of the formal C-N bond and an overall decrease in basicity. These experimental 
results indicated that the fluoroformamidines studied were weaker bases than formamidines. It 
was also noted that the more basic the amidine, the larger the energy difference between the 
two tautomeric forms, where this property is possible for the amidine structures.  
Hegarty et al. reported the isomerisation about the C-N and C=N bonds of E- and Z-
amidines.
[72]
 Heating the compounds in an inert solvent or treating with acid at room 
temperature resulted in complete isomerisation of 134 to 135 (Scheme 42). 
 
 134             135         136 
                
  137            138 
Scheme 42: Isomerisation of amidines
[72]
 
There are three sites in the amidino group to which substituents can be attached, the two 
nitrogen atoms and the amidino carbon atom.
[68h]
 Substituents at both nitrogen atoms have 
considerable influence on the extent of conjugation. In general, ‘the effects of a substituent at 
any site of the amidino group depends on substitution at the other two sites’.  
Cai and coworkers reported the use of arenesulfonylchlorides as coupling agents with DMF, 






Scheme 43: Reagents: (i) ArSO2Cl, r.t., <10min, 38-95%
[68i,73]
  
Partridge et al. investigated the synthesis of cyclic amidines of the form 1-aryl-2,5-dimethyl-
∆
2




Scheme 44: Reagents: (i) 180-200 
o
C, 12 h, (ii) HCl, (iii) NaOH
[74]
 
Meyers et al. demonstrated the asymmetric synthesis of (+)-ocoteine 139 via chiral 





 139           140     141 
Figure 29: Chiral formamidines 
Chen et al. used trifluoroacetic anhydride (TFAA) as a coupling agent in the synthesis of 
formamidines and regarded the method as a ‘novel, convenient and highly efficient 
synthesis’.
[76]
 This method was in fact established when the intended modification of the 
amino group present in 2-amino-4-phenyl-6-phenylsulfonyl-pyridine-3,5-carbonitrile 142 
didn’t go according to expectation. Treating 142 with sodium hydride in DMF, which is both 
the solvent and a reagent (Scheme 45), followed by the addition of an equivalent of TFAA 
resulted in the formation of N´-(3,5-dicyano-4-phenyl-6-phenylsulfanyl-pyridin-2-yl)-N,N´-
dimethylformamidine 143, instead of the anticipated N-(3,5-dicyano-4-phenyl-6-phenyl-
sulfanyl-pyridin-2-yl)-2,2,2-trifluoroacetamide 144. The amidine 143 was isolated in high 
yield (93-100%).  
46 
 
       142            143 
               
  144 
Scheme 45: Reagents: (i) NaH; (ii) TFAA, DMF
[76]
 
3.1.1.1 Biological activity of amidines 
In the 1920s, Newbery and Webstertested mono-amidines 145 as bactericides against M. 
Tuberculosum (Figure 30).
[77]
 Some of the amidines possessed anti-bacterial properties and 
marked in vitro activity against M. tuberculosum. Infections in the guinea pig were targeted as 
their biological test subjects and it was concluded that mono-amidines were regarded as being 
‘too toxic for the prolonged administration likely to be required to demonstrate activity 
against guinea pig infections’. 
 
145 
Figure 30: Mono-amidine structure 
Further developments in this area in the 1940s explored benzamidines as potential 
chemotherapeutic agents in the treatment of tuberculosis. Partridge found that N-aryl 
benzamidines such as 146 (where n = 2,3,4,5 or 6) showed high activity in vitro, however ‘no 






Figure 31: N-Aryl benzamidines 
Many other research groups explored the activity of various amidines as potential anti-




Bristow explored the potential use of mandelamidines as bronchodilators. Each of the 
compounds were isolated as their hydrochloride salts (147, 148 and 149) (Figure 32). None 







Figure 32: Structure of mandelamidines 
Hill et al. described the substituted amidine, Holocaine
®
 150, as an analgesic (Figure 33).
[81]
 
In this publication, the synthesis of analogs of Holocaine
®
 where the methyl (-CH3) group 
was substituted by ethyl, n-propyl and isobutyl groups were explored in an effort to identify 








































Self et al. explored the role of bis-amidine 151 as potential trypanocidal agents (Figure 34).
[82]
 
The trypanosomes in the blood stream were targetted and were used as a treatment against 
protozoan parasites of the type encountered in malaria infections.  
 
151 
Figure 34: Bis-Amidine 
The homologue 152 showed a maximum activity coinciding with the disappearance of 
trypansomes from the peripheral blood stream (Figure 35). 
 
152 X = CH2 
153 X = O 
154 X = NH 
155 X = S 
Figure 35: The bis-amidine analogues examined as potential trypanocidal agents 
Substitution of a methylene group by oxygen (Structure 153) results in slightly improved 
activity. The aza-analogue 154 shows little change in activity relative to 152. The sulfur 





300 and its active pharmaceutical ingredient (API) is pentamidine 156 (Figure 36). It is used 




Figure 36: Pentamidine 156 
3.1.1.2 Synthetic importance of amidines 
Meyers et al. outlined the reduction of amidines in the generation of tertiary amines.
[83]
 They 
proposed that an amidine can be regarded as ‘generally useful precursor to α-substituted 
amines’. Initially, the reaction proceded from the amidines 157 to 158 and then treatment with 
various electrophiles (E), such as MeI, n-PrI and cyclohexanone, resulted in the formation of 
the amidines 159. Subsequent transformations lead to the N-formyl derivatives 160 and 
amines 161 (Scheme 46). 
 
157        158           159    
 
        161                 160   
Scheme 46: Reagents: (i) 
t
BuLi (1.1 equiv.), THF, -78 °C; (ii) -78 °C, electrophile; (iii) methanol-H2O, 20 
°C, 15 h; (iv) 5 equiv. KOH, 2:1 methanol-H2O, reflux, H
+[83]
 162, 163 
3.2 Synthesis of amidines 
3.2.1 Synthesis from amines  
De Wolfe investigated access to diarylamidines 164 via reaction of triethylorthoformate with 





 162            163            164 
Scheme 47: Reaction of triethylorthoformate with primary amines as a route to diarylamidines 164
[84]
 
Further examination by Taylor et al. prompted the observation that ‘when two moles of 
aromatic amine are present per mole of ortho-ester, an amidine is obtained whether acid is 
present or not’.
[85]
 When the amine was benzylamine, Taylor et al. isolated the amidine free 
base in 68% yield by adding benzylamine to a refluxing solution of triethylorthoformate and 
acetic acid and continuing to reflux for a further 2 h. Distillation followed by a workup which 
included a sodium bicarbonate wash afforded the title compound. 
Sergheraert et al.
[86]
 explored an alternative synthesis of amidines from amines using a 
coupling agent of the type usually employed in peptide synthesis, e.g. bromo-tris-
pyrrolidinophosphonium hexafluorophosphate (PyBroP). Reaction conditions involved one 
equivalent each of amine, PyBroP and di-isopropylethylamine which were reacted together in 
DMF for 5 h at room temperature. Following purification by HPLC or thick-layer 
chromatography, amidine yields of 42-77% were achieved. Other advantages to this method 
of synthesising formamidines includes (i) the mildness of reaction conditions and relatively 
short reaction times, (ii) the use of a commercially available coupling reagent which is easy to 
handle and (iii) the suitability of the reaction for both aliphatic and aromatic amines. 
The reaction of an amine with an amide acetal has also been investigated.
[87]
 Myers et al. 
investigated the use of N,N-dimethylformamide dimethylacetal 165 and observed the 
formation of N-acyl amidines  from amides (Scheme 48). 
 
  165                                         166           167 





3.2.2 Synthesis from nitriles 
Additions of ammonia and amines to nitriles are only feasible for amidine production in the 
case of nitriles activated by electron-withdrawing substituents in the position α- to the C≡N 
bond.
[68g]
 In practice three types of reactions are used. 
51 
3.2.2.1 Addition of metal amides to nitriles  
This type of reaction uses the metal derivatives of ammonia or of amines as nucleophiles. The 
interaction of alkali amide anions with nitriles involves the addition of sodium or potassium 
salts of amines to nitriles (Scheme 49). This generates metallic derivatives which in turn are 




Scheme 49: The interaction of alkali amide anions with nitriles
[77,88]
 
The reaction of amide anions with nitriles is used in the preparation of monosubstituted 
amidines (Scheme 50). In one of the first reported methods, the metallation was brought about 
by the use of sodium metal. Cooper and Partridge studied this process in detail and reported 









During this reaction, care must be taken to ensure in the final hydrolysis step, that the 
metallated amidine is not converted to an amide.
[89]
 The limitation of this process is that it is 
only useful in the formation of unsubstituted amidines.  
Singh et al. identified an alternative to this method of generating a mono-substituted 
amidine.
[90]
 The reaction conditions involved combining equimolar amounts of amine, nitrile 
and sodium hydride in DMSO and stirring the mixture in an icebath for 2-3 h, then at r.t. for 
several hours until reaction is complete (by t.l.c.). The resulting suspension is then poured 
onto ice water and the solid filtered and recrystallised from alcohol. The advantage of this 
method over others, is that it requires relatively mild conditions and produces high yields (85-
89%) of the amidines. 
52 
3.2.2.2 Addition of ammonium salts or amines to nitriles. 
The addition of amines to nitriles is outlined in Scheme 51. 
 
Scheme 51: The addition of amines to nitriles 
For the direct addition of ammonia and free amines to be carried out, the nitrile must be 




    168  
Scheme 52: Direct addition of ammonia and free amines to nitrile in the preparation of amidines
[91]
 
Perfluoroalkyl nitriles (RFC-C≡N, where RF = C3F7 or C2F5) and ethyl cyanotartronate 169 are 





          169           170     171 
Scheme 53: Reagents: (i) Diethyl ether, -17 °C
[91-92]
 
Early studies on the addition of ammonium salts to nitriles by Cornell have been further 
developed by Partridge and Short and Schaefer and Krapcho.
[68b,88,93]
 Partridge and Short 
explored the reaction of molten mixtures of nitriles with ammonium thiocyanate. Whereas 
Schaefer and Krapcho investigated decreasing the temperature and working with the ammonia 
under pressure. Of the ammonium salts surveyed, the hydrochlorides and bromides gave 
excellent yields. 
In the addition of amine hydrochloride salts to nitriles, satisfactory results were rarely 
obtained. The best results obtained in this approach are those illustrated by Cooper and 





            172     173 
Scheme 54: Reagents: (i) HCl, Diethyl ether, 1 month r.t. (ii) Base
[68e,94]
 
The addition of ammonium salts to nitriles is outlined in Scheme 55. 
 
       174    175    176 
Scheme 55: Reagents: (i) NH4Cl, 180 °C, 8 h; (ii) 5N HCl 





177        178      
      
Scheme 56: The formation of 2-substituted benzimidazole
[95]
 
The following is a scheme proposed by Oxley and Short for the reaction of ammonium 
arenesulfonates with nitriles (Scheme 57).
[96]
 This method was successfully applied in the 






Scheme 57: Preparation of mono-arylamidines and cyclic amidines
[96]
 
Another route examined aluminium trichloride as a catalyst. It was anticipated that, ‘catalysts 





          179            180           181    182 
Scheme 58: Reagents: (i) AlCl3, base; (ii) H2O
[97]
 
At the end of the reaction, the complex of the amidine and aluminium chloride was 
decomposed by water and the organic product isolated by recrystallisation. 
The preparation of cyclic amidines from γ-halonitriles was explored by Moriconi et al. with 




      184    183 
Scheme 59: Reagents: (i) excess NH3
[68f]
 
Experimental results outlined by Moriconi et al. support conclusions previously reported in 
the literature, they serve to correct older literature in the area and to expand the general 





Scheme 60: Reagents: (i) autoclave, ethanol, 120 °C, 8h; (ii) aqueous workup
[98]
 
3.2.3 Preparation from amides 
Amidines may be synthesised from amides by condensation with amines in the presence of 
halogenating agents. The coupling can be carried out in a variety of ways. For example, the 
reaction of mono-substituted amides with a halogenating agent results in the formation of an 
imidoyl halide. This imidoyl halide is then reacted with ammonia or with an amine to yield 




                        


















Charette et al. investigated the use of triflic anhydride to activate amides in their conversion 
into amidines (Scheme 63).
[99]
 The protocol involved addition of triflic anhydride to a 
56 
secondary or tertiary amide which would generate the iminium triflate that would be 
converted into the amidine upon addition of the appropriate amine. Poor conversion was 
initially observed, but optimisation of the reaction which involved adding the amine as the 
hydrochloride salt gave amidines in isolable yields of up to 84%. 
 





Further mechanistic investigations outlined in Scheme 64 involved the isolation of 1-
pyridylimidoyl triflate 185 which was isolated after a short reaction time (< 2 h). 
 
      186        185 





3.2.4 Preparation from imidates 
Neilson et al. reviewed the role of imidates in the synthesis of amidines.
[100]
 A number of 
methods of synthesis of amidines from imidates are outlined below. However, the synthesis of 
amidines from imidates has been subject to some criticism as large volumes of anhydrous 
solvents are required to complete the procedure. Also other, more direct synthetic routes to 




3.2.4.1 From imidoesters with ammonia or amines (Pinner synthesis) 
The Pinner synthesis is a two-step reaction.
[68g]
 The first involves transformation of nitriles 
into imido esters that are then converted into amidines. The iminoether hydrochloride is 
produced when the nitrile is treated with gaseous hydrogen chloride in a mixture of anhydrous 
chloroform and an alcohol (Scheme 65). 
 









The salt produced is referred to as the Pinner salt and may react further with a nucleophile 
(Scheme 66).  
 
        




OH, (iii) HCl, (iv) H2O, (v) NH3
[68g]
 
Pinner’s method is used for the preparation of unsubstituted amidines. It is less successful for 
substituted amidines. 
3.2.4.2 Reaction of imidates with ammonia and substituted amines 
Neilson et al. illustrated the reactions of imidates with ammonia and substituted amines in the 
formation of amidines.
[100]
 Firstly, the reactions of imidate salts with alcoholic ammonia 
solutions were explored (Scheme 67). 
 
Scheme 67: Reagents: (i) NH3
[100]
 
Heating imidates with ammonium salts in aqueous alcohol at 50-70 
o






Scheme 68: Reaction of imidates with ammonium salts
[100]
 




3.2.4.3 Reaction of imidates with sulfonamides 
The reaction of imidates with sulfonamides in the preparation of amidines is outlined in 
Scheme 69. 
 
Scheme 69: Reaction of imidates with sulfonamides
[100]
  
3.2.4.4 Reaction of imidates with primary amines 
Imidate salts condense with primary amines to produce monosubstituted amidines (Scheme 
70). 
 
Scheme 70: Condensation of imidate salts with primary amines
[100]
 
3.2.4.5 Reaction of imidates with secondary amines 
Unsymmetrical disubstituted amidines are formed in the reaction of imidate salts with 
secondary amines (Scheme 71). Imidates do not react with tertiary amines to produce 
amidines. 
 
Scheme 71: Preparation of unsymmetrical disubstituted amidines
[100]
 
3.2.5 Preparation from ureas 
Larizza et al. explored the reduction of ureas as a route to formamidines. Such reactions were 
accompanied with the formation of amine side-products (Scheme 72).
[102]
 The standard 
reaction conditions involved refluxing the urea with LiAlH4 in a 1:1 solution of 
59 
benzene:ether. Following an aqueous workup, the aqueous phase was made alkaline with 
potassium carbonate and extracted with diethyl ether. The resulting residue on evaporation 
was purified by distillation. When N-butylureas (R
1
 = nC4H9) were used, the disubstituted N-
butylformamidines were isolated in yields ranging from 28-53%. With phenylureas (R
1
 = Ph), 
N-phenylformamidines yields ranged from 29-62%. Varying the reflux time and urea to 
reducing agent molar ratios aided in reducing the amine side products. As a general 
observation, it was initially noted that the standard conditions were too harsh for phenylureas 
resulting in increased quantities of amine side products. In the case of the 1,1-dialkyl-3-
butylureas, the conditions were too mild as the majority of the reaction material isolated was 
the urea starting material. 
 
Scheme 72: Reagents: (i) LiAlH4, ether : benzene (1:1)
[102]
 191, 192 
3.2.6 Preparation from ynamines 
Kuehne et al. investigated the synthesis of arylsulfonylamidines from ynamines (Scheme 
73).
[103]
 The product N-p-toluene-sulfonyl-N´,N´-diethylphenylacetamidine 193a was isolated 
in 80% yield. 
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2
 = C6H11 
188c R
1
 = CH3,  
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2
 = C6H11 
 190c R
1
 = CH3,  
R
2
 = C6H11 
193a R
1
 = C6H5, R
2
 =  C2H5, R
3
 =  CH3C6H4 
193b R
1
 = n-C5H11, R
2
 =  n-C3H7, R
3
 =  CH3C6H4 
193c R
1
 = n-C5H11, R
2
 =  C2H5, R
3
 =  Ph 
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3.2.7 Preparation of amidines via rearrangement of ∆4-1,2,4-oxadiazolines 
Wagner et al. synthesised ∆
4





-1,2,4-oxadiazolines in turn underwent a rearrangement 
via ring opening and a 1,2-aryl shift from carbon to the adjacent nitrogen to yield 
formamidine derivatives (Scheme 74). The aryl substituents explored in this work were mono-
, di- and tri-methoxyphenyl groups. 
 
              194    
Scheme 74: Reagents: (i) 60 °C, 1 h – 4 d; (ii) 60 °C, 12 h – 70 d
[104]
 
3-Substituted-1,2,4-oxadiazolin-5-ones 195 are described by Coote et al. as being useful 
amidine precursors and masked amidines. Hydrogenation of the oxadiazoline afforded the 




      195         196 
Scheme 75: Reagents: (i) H2, Pd/C, ethyl acetate, AcOH, 20 h (91% yield)
[105]
 
In the same paper, Coote et al. promoted the use of 1,2,4-oxadiazolin-5-ones as masked 
amidines for N-alkylated amidines as they are base stable and would be easily cleaved under 
mild conditions. 
3.2.8 Preparation from gem-dichloroaziridines 
Meilahn et al. established that the aminolysis of gem-dichloroaziridines provided a new and 
convenient synthesis of amidines.
[106]
 This was achieved by dissolving the gem-
dichloroaziridine 197 in the amine (piperidine) and heating the resulting solution slowly to 
100-130 
o
C and maintaining the solution at this temperature for several hours (Scheme 76).  
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             197            198 
Scheme 76: Reagents: (i) Piperidine, 100-130°C
[106]
 
The piperidine hydrochloride is easily removed by filtration or aqueous work-up. 
Crystallisation affords the amidine in yields varying from 36 to 74%. Gem-dichloraziridines 
are easily accessed via the addition of dichlorocarbene (generated by the action of sodium 
methoxide on chloroform) to N-benzylideneaniline. 
3.2.9 Preparation via N-monoarylation of aryl amidines 
Buchwald et al. explored the development of a method for palladium catalysed N-arylation of 
both aryl and alkyl amidines (Scheme 77).
[70]
   
 
Scheme 77: Reagents: (i) Pd2dba3 (0.25 – 2.5 mol%), 199 (1.0 – 10.0 mol%), Cs2CO3, t-butanol
[70]
 
Using a biaryl phosphine ligand 199, the preparation of N-aryl amidines in almost quantitative 
yields was achieved (Figure 37).  
 
199 
Figure 37: Biaryl phosphine ligand 
62 
It was noted that the particle size of the Cs2CO3 was crucial for successful conversion with the 
ligand 199. When the base was ground using a mortar and pestle, the conversion rates 
consistently increased. A range of aryl formamidines could be coupled with a wide variety  of 
aryl bromides, chlorides and triflates in short reaction times (2h). Both bromides and triflates 
were found to be excellent substrates with successful conversion (R
1
 = Me, 84 - 93%) using 




Oxadiazolines are five-membered heterocycles containing one oxygen, two nitrogen and two 
carbon atoms, which can also be described as dihydro-oxadiazoles. Their exact structure is 
denoted by a nomenclature in which the oxygen atom is assigned position-1 on the ring. This 
ring also contains a single π-bond, the location of which is indicated by delta (Δ) notation 
(Figure 38).  
 
                                               Δ
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Δ
3
                        Δ
4 
Figure 38: 1,2,4-Oxadiazolines 200 
4.1 Δ2-1,2,3-Oxadiazolines  
Gilchrist and O’Neill reviewed 1,2,3-oxadiazoles at length.
[107]
 However, literature on Δ
2
-
1,2,3-oxadiazolines is limited. Koepke et al. prepared 4,5-dihydro-3-methyl-1,2,3-
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4.2 Δ2-1,2,4-Oxadizolines  
In 1889, Tiemann reported the first synthesis of a 1,2,4-oxadiazoline derivative via 
cyclocondensation of benzamidoxime with acetaldehyde.
[109]
 A general method for the 
preparation of Δ
2
-1,2,4-oxadiazolines involves the condensation of amidoximes with 
aldehydes or ketones.
[110]
 This reaction is reversible on treatment with aqueous acid. The 
oxadiazolines 202 are hydrolysed to the carbonyl compounds and the amidoximes 203 
(Scheme 79).  
 
      203           204       205        206 
 
          207        202 
Scheme 79: Reagents: (i) neat or H2O or AcOH; (ii) 23 
o
C, reflux, 2 h – 20 d, 30-80%; (iii) H
+
; (iv) –H2O, -
H
+




 = H, 100%
[110]
 208, 209, 210, 211 
Oxadiazolines such as 202 (R
2
 = H) can be methylated or benzylated at N-4 to give 207. 
Simon et al. noted that nitrone 209 rearranged under the influence of heat to form the 




 208              209                 210                 211 
Scheme 80: Reagents: (i) PhCHO, methanol; (ii) Toluene or Ethanol or H2O, 70-95 
o
C, 4-5 h, >90%
[111]
 
Zhu et al. explored sodium bicarbonate and triethylamine as dehydrohalogenating agents in 
the synthesis of ∆
2




 Compared with triethylamine, using sodium bicarbonate reduced the time of 
reaction from 3 days to 1 day in the synthesis of ∆
2
-1,2,4-oxadiazoline 212 (Figure 39). An 






Wang et al. investigated the solid phase synthesis of Δ
2
-1,2,4-oxadiazolines via the 1,3-
dipolar cycloaddition of resin bound nitrile oxide with a variety of imines in a one pot 
reaction(Scheme 81).
[112]
 At first, the Merrifield resin was chosen to initiate the study in a 
one-pot reaction.
[112a]
 However, polyethylene glycol (PEG) was found to be soluble in a 





         213 
Scheme 81: Reagents: (i) Trioctylamine, r.t.; (ii) CH3ONa, CH3OH, r.t.
[112]
 
Orbital control in the 1,3-dipolar cycloaddition of benzonitrile oxide to benzylidene anilines 
was considered by Alcaide et al. (Scheme 82).
[113]
 Benzonitrile oxide was generated in situ by 
the reaction of triethylamine on benzohydroximoyl chloride in the presence of two 






          26 
Scheme 82: (i) Triethylamine, r.t.
[113]
  
Clapp articulated that the best method of synthesising Δ
2
-1,2,4-oxadiazolines was to carry out 
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During the 1960s, benzamidoxime was the reagent of choice for Barrans and co-workers in 






 By removing the hydrogen on the 
N-4 in the Δ
2
-oxadiazoline 216, the anion 217 was generated. This anion was then alkylated 
using methyl iodide to give a 1:1 mixture of 3-phenyl-4,5-dimethyl- Δ
2





              215           216   217         218          219 
Scheme 84: Reagents: (i) MeCHO, Diethyl ether; (ii) NaNH2, NH3(l); (iii) MeI
[115]
 220, 221 
Hull and Farrand refluxed cyanamide with phenylhydroxylamine in acetone with the 
expectation of producing the disubstituted hydroxylamine 222 (Scheme 85).
[116]
 Instead 3-
amino-5,5-dimethyl-2-phenyl-3-oxadiazoline 223 was isolated. 
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               220      221      222               223 
Scheme 85: Reagents: (i) Acetone, hot HCl(aq)
[116]
 
More recently in 2005, Naidu et al. described a one-pot synthesis of Δ
3
-1,2,4-oxadiazolines 
from a nitrile in an aqueous solution.
[117]
 The formation of oxadiazolines 224 in this manner 
involved a sequential double Michael addition of amidoximes to an electron-deficient alkyne 
(Scheme 86). 
 
             225        226          227      224 
Scheme 86: Reagents: (i) MeNHOH.HCl, EtOH/H2O, Na2CO3, 80 
o





demonstrated the cycloaddition of oxazoles 228 with nitrosoarenes 229 in the 




                      228    229          230 




A variety of methods have been employed such as the platinum (IV)-assisted [2+3]-
cycloaddition of nitrones to nitriles (Scheme 88) to yield co-ordinated platinum Δ
4
-1,2,4-
oxadiazolines (X = Cl).
[119]
 These organic ligands can be easily liberated by reaction of the 
(Δ
4
-1,2,4-oxadiazoline)platinum(IV) complexes with a slight excess of pyridine in chloroform 
(Scheme 88). The trans-[PtCl4(pyridine)2] formed which is highly insoluble in CHCl3 and is 
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separated from the mixture by filtration. Evaporation of the solvent allowed isolation of the 
mixture of Δ
4




Scheme 88: Reagents: (i) DMSO, 50 °C overnight; (ii) Py, CHCl3
[119]
 
The 1,3-dipolar cycloaddition of nitriles to nitrones 231 in mild conditions has been 
investigated in the synthesis of Δ
4
-1,2,4-oxadiazolines 232  and the corresponding Δ4-1,2,4-
oxadiazoline complexes have been isolated in 68-83% yield (Scheme 89).
[119b,120]  
 
231      232 







-1,2,4-oxadiazolines have been synthesised by reacting non-aromatic cyclic 
nitrones with alkylnitrile-Pt(II) complexes under mild conditions (Scheme 90).
[121]
 Liberation 
of the heterocycle from the complex has yet to be achieved. 
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           233    
Scheme 90: Reagents: (i) [(EtCN)2Pt(Cl)2], CH2Cl2:EtCN (1:1)
[121]
 
4.4.1 Biological activity of Δ2-1,2,4-oxadiazolines 
Carotti et al. and Monforte et al. recognised ∆
2
-1,2,4-oxadiazolines for their anti-HIV 
activity.
[122]
 Monforte et al. investigated the synthesis and in vitro anti-HIV activity of Δ
2
-
1,2,4-oxadiazoline (234, X = H), whereas Carotti et al. chronicled a library of Δ
2
-1,2,4-






The antitumour acitvity of these substituted ∆
2
-1,2,4-oxadiazolines was investigated by 
Chimirri et al. who found that ‘most of these compounds exhibit a wide range of inhibitory 
activity’ against a range of  human tumour cell lines.
[123]
 
El-Abadelah et al. investigated oxadiazolines with herbicidal action (Scheme 91).
[124]
 This 
investigation sought to increase the herbicidal action of ∆
2
-1,2,4-oxadiazolines. Findings from 
the study showed that introducing a chloroacetyl grouping at the N-4-amino functionality 
could help enhance the herbicidal action of the oxadiazolines. However, when using 
chloroacetyl chloride or chloroacetic anhydride to introduce the chloroacetyl group, the 
oxadiazoline itself underwent a transformation to 1,3,4-oxadiazoles 235. 
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                 235 
Scheme 91: Reagents: (i) ClCH2COCl or (ClCH2CO)2O
[124]
 236 
4.5 Δ2-1,3,4-Oxadiazolines  
Yu et al. explored the preparation of a novel spiroheterocyclic oxadiazoline 237, with a spiral 
junction at C-3 of fructopyranose group (Scheme 92).
[125]
 This was achieved by reacting the 
pyranose derivative 236 with benzoylhydrazine affording the 3-benzoyl hexulopyranose 
oxadiazoline 237. 
 
         236      237 
Scheme 92: Reagents: (i) Methanol, Acetic acid, 60-65 °C, 6 h
[125]
 238 
The drive to synthesise of Δ
2
-1,3,4-oxadiazolines appears to be driven by the potential 
biological activity of the resulting structures. Rollas et al. investigated 3-acetyl-2,5-
disubstituted-2,3-dihydro-1,3,4-oxadiazolines as potential antimicrobial agents and isolated 
the 1,3,4-oxadiazolines (R
1
 = p-NO2Ph, m-NO2Ph, 2,4-dinitrophenyl) 239 from the reaction of 




  238              239 




When the antimicrobial activities of the hydrazones and 1,3,4-oxadiazolines were evaluated 
against Staphylococcus aureus, Eschericha coli, Pseudomonas aeruginosa and Candida 
albicans, it was evident that cyclisation of hydrazones into their corresponding 3-acetyl-1,3,4-
oxadiazolines resulted in a decrease in antimicrobial activity against S. aureus strains.  
Retaining the geometrical features of combrestatin, a natural antimitotic agent, was the aim 
for Zhu et al., who explored the formation of Δ
2
-1,3,4-oxadiazolines such as 240 (R = Ph, p-
NO2Ph, p-Tolyl) (Figure 41).
[127]
 It was envisaged that the oxadiazoline moiety would provide 






Twenty analogues of oxadiazoline 240 were synthesised using the chemistry outlined in 
Scheme 94 and yields reached 86%. 
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             241            242    243 
 
   244                243 
  
240  
Scheme 94: Reagents: (i) EtOH, H2SO4, reflux 8-12 h; (ii) N2H4-H2O (85%), EtOH, reflux 8-12 h; (iii) 
EtOH, water, acetic acid, reflux, 5 h; (iv) (Ac2)O, reflux, 1 h
[127]
     
Incorporation of a pyrazole and an oxadiazoline moiety in a molecule offers the potential ‘to 
develop new organic antibacterial activity compounds’.
[128]
 Yang et al. synthesised a range of 
compounds containing both the pyrazole and oxadiazoline groups (e.g. R
1
 = OCH3 and R
2
 = 
NO2) and found that these bis-heterocyclic compounds 245 displayed better fungicidal 
activity than pyrazole carbohydrazide hydrazone derivatives such as 246 (Figure 42). 
         
245        246 




-1,3,4-oxadiazolines 247 have been shown by Oniga et al. to have good anti-





   247       248 
Figure 43: Compounds with potential anti-inflammatory properties 
Similarly to Carotti et al., and El-Emam et al. investigated the effect of an adamantyl group 
attached to the oxadiazoline moiety on antimicrobial and anti-HIV activity.
[122a,130]
 5-(1-
Adamantyl)-1,3,4-oxadiazoline-2-thione 249 was prepared from adamantane-1-
carbohydrazide in 81% yield and was found to be the most active amongst the compounds 





-1,3,4-Oxadiazoline with biological activity 
4.6 Δ3-1,3,4-Oxadiazolines 
As discussed in the review of 1,3,4-oxadiazolines by Hill, Warkentin et al. synthesised Δ
3
-
1,3,4-oxadiazolines 250 by the reaction of acylhydrazones 251 with lead tetraacetate in the 
appropriate alcohol (Scheme 95).
[131]
 This reaction was carried out in neat ethanol or in 
dichloromethane and oxadiazoline yields ranged between 40-80%. 
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4.7 Decomposition of oxadiazolines 
Thermal cycloreversion of oxadiazolines has been investigated by Warkentin et al., but the 
results are not as clear-cut as hoped.
[132]
 The thermolysis of 2-acetoxy-3-methoxy-5,5-
dimethyl-∆
3
-1,3,4-oxadiazoline 252 was investigated and it was found that two competing 
cycloreversion reactions were taking place (Scheme 96). The first of which (lowest energy 
cycloreversion) gave rise to 2-diazopropane 253 and a mixed anhydride 254. Secondly, 
following the extrusion of nitrogen, evidence for a carbonyl ylide 255 was found in the form 
of acetone and methyl pyruvate. The methyl pyruvate was formed by rearrangement of the 
carbonyl ylide. A computational study [B3PW91/6-311+G(2df, p) level] was used to support 
the results and as a means of understanding more about the cycloreversion process.  
 
                        252                                     253                                      254 
 
255 
Scheme 96: Thermolysis of 252
[132]
 
5 Synthesis of nitriles 
Nitriles are described as compounds containing the cyano group (-C≡N). The most common 
route to nitriles is by the reaction of a cyanide salt with alkyl halides to generate a nitrile 
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group in the molecule (Method A in Scheme 97). This is a nucleophilic substitution reaction 
in which sodium or potassium cyanide are typically used. The cyanide ion can displace a 
variety of leaving groups, in this example, the halide ion. Another feature of this reaction is 
that it is a carbon-carbon bond forming reaction. 
 
Scheme 97: Method A Reagents: (i) NaCN or KCN; Method B
[43]
 Reagents: (i) 1.1 eq. BnBr, 1.05 eq. 
KOH, 5 mol% Bu4NI, THF, r.t., 3 h: (ii) 4.5 eq. SOCl2, 9 eq. NEt3, -20 
o
C, 12 h. Method C
[133]
 Reagents: (i) 
1 eq. MeSO2Cl, graphite (cat.), neat, 100 
o
C, 5-20 min. Method D
[134]
 Reagents: (i) 0.6 eq. TCBDA, 3 eq. 
NEt3, DMF, 25 
o
C, 1-2 h. Method E
[135]
 Reagents: (i) 1.1 eq. NH4HCO3, 1 eq. (Bu4N)2S2O8, 3 mol% 
Cu(HCO2)2.Ni(HCO2)2, 1 eq. KOH, iPrOH/H2O (1:1), 25 
o
C, 1.5-2 h. Method F
[136]
 Reagents: (i) 0.75 eq. 
TCCA, aq. HN3 (15M), 60 
o
C, 1-5 h. Method G
[137]
 Reagents: (i) NH2OH.HCl (1.1 eq.), DMSO, 90 
o
C, 1-2 h 
However, alkyl halides are not the only starting material which can be used in the synthesis of 
nitriles. Nitriles can be accessed from nitroalkanes, oximes, aldehydes, amines and alcohols 
(Routes B to E in Scheme 97).The conversion of oximes and primary nitroalkanes  into 
nitriles is of particular relevance to the subject matter of this thesis (Chapter 2). 
5.1 Nitriles from nitroalkanes (Method B) 
Creedon developed new routes for the synthesis of nitriles and isonitriles.
[138]
 Utilising the 
1,3-dipolar cycloaddition reaction of a nitrile oxide (generated in situ from a nitroalkane) with 
a formamidine, followed by decomposition of the resulting Δ
2
-1,2,4-oxadiazoline to a nitrile 
and urea, formed the basis of a novel route to nitriles from nitro compounds. This research 
was further explored by Levis who investigated the synthesis of nitriles from nitroalkanes via 
heterocyclic intermediates.
[139]
 This body of work examined the possibility of developing a 
cascade reaction involving the decomposition of Δ
2
-1,2,4-oxadiazolines, resulting in nitrile 
and urea products. Following on in this line of research, Hogan examined ∆
2
-1,2,4-
oxadiazolines as a route to nitriles via nitrile elimination from the heterocycle without 




5.2 Nitriles from aldoximes (Method C) 
Shono et al. explored the transformation of aldoximes into nitriles via electrochemical 
means.
[33]
A number of aldoximes (256a-d) were examined with nitrile (257a-d) being 
isolated in appreciable yields (Table 4). 
Table 4: Aldoximes which were examined by Shono et al in the preparation of nitriles 
 
256a-d   257a-d 
Entry Aldoxime R Charge (F/mol) Nitrile Yield (%) 
1 256a CH3(CH2)5- 3.5 257a 83 
2 256b Cyclohexyl- 3.5 257b 71 
3 256c Ph- 4.5 257c 61 
4 256d 2,4,6-(CH3)3Ph 5.0 257d 91 
 
Acetic anhydride is the typical reagent of choice for the dehydration of oximes, however 
many other reagents such as acetyl chloride, thionyl chloride, ethyl chloroformate, 
phosphorous pentoxide, phenyl isocyanate and titanium tetrachloride have been used. 
[141]
 
More recently, Behrouz et al. investigated the use of 8-bromocaffeine 258 in the conversion 
of aldoximes into nitriles with the aim of establishing a mild, rapid and universally applicable 





Figure 45: 8-Bromocaffeine 258 
Conventional heating versus microwave-assisted conditions were explored with DBU as the 
base in DMF. Microwave-assisted reactions gave nitriles in yields of up to 96% (R = p-
nitrophenyl) within 30 sec. 
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5.3 Nitriles from azapropenones 
Mc Nab et al. investigated the pyrolysis of azapropenones 259 as a means of generating 
nitriles and amides (Scheme 98).
[143]
 Azapropenones are thermally stable compounds when X 
= O, S. To overcome this stability effect, harsh reaction conditions (temperatures of 900 
o
C) 
must be employed. Extreme reaction conditions may account for the low yields of nitriles (20-







Scheme 98: Reagents: (i) Heat 
5.4 Nitriles from nitrile oxides[143] 
While investigating the stability of nitrile oxides, Grundmann et al. discovered that reaction 
of the nitrile oxides with trimethylphosphite resulted in almost quantitative reduction of the 
nitrile oxides 2,4,6-trimethylbenzonitrile oxide 7, 2,3,5,6-tetramethylbenzonitrile-N-oxide 86, 
2,4,6-trimethoxybenzonitrile-N-oxide 87, tetramethylterephthalo-bis-nitrile-N-oxide 88 and 
anthracene-9-yl-nitrile-N-oxide 89 to their corresponding nitriles (Figure 46).
[12d]
 
259a X = S, R = Me 260a, d R = Me 261a-b X = S 
259b X = S, R = Ph 260b, e R = Ph 261c-f X = O 
259c X = O, R = H 260c R = H   
259d X = O, R = Me 260f R =  p-Tolyl   
259e X = O, R = Ph     
259f X = O, R = p-Tolyl     
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     7           86         87 
 
               88                           89 
Figure 46: Sterically hindered nitrile oxides 
Methods for the synthesis of nitriles are important in view of the utility of these compounds in 
synthesis - they undergo or facilitate a wide range of useful functional group transformations. 
Issues relating to a novel process for the production of nitriles from heterocyclic precursors 
(1,2,4-oxadiazolines) and chemistry related to the generation of these heterocycles from nitrile 















Results and Discussion 
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The objective of our research was a study of the synthesis and reactivity of nitrile oxides as 
1,3-dipoles in cycloaddition reactions with formamidines. 
This objective was addressed through the synthesis of certain imines - mostly formamidines 
and investigations of their reactions with selected nitrile oxides generated in situ from their 
precursors e.g. hydroximoyl chlorides in the majority of cases. 
Earlier work by Levis explored two methods of generating nitrile oxides.
[139]
 Firstly, they 





       262           263                     27                             264 
Scheme 99: Reagents: (i) NEt3 
The second process involved conversion of an aldehyde into its corresponding oxime, which 





Scheme 100: Reagents: (i) NH2OH.HCl, Base, solvent; (ii) Cl2(g) or NCS, chloroform; (iii) NEt3 
This earlier research work focused on development of a cascade in which production of a 
nitrile from a primary nitroalkane would be achieved through a heterocyclic intermediate 
(Scheme 101) which, without the addition of catalysts or other reagents generates the nitrile 
(Scheme 102). Nitriles are a valuable synthetic precursor in organic chemistry as they 
undergo or facilitate a wide range of useful functional group transformations. 
Scheme 101: Conversion of a primary nitroalkane to a heterocyclic intermediate 
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From this study, it was apparent that nitrile oxides undergo rapid 1,3-dipolar cycloadditions 
with formamidines to give Δ
2
-1,2,4-oxadiazolines. These heterocycles decompose upon 




Scheme 102: Decomposition of Δ
2
-1,2,4-oxadiazolines 
It was anticipated that a reactive Δ
2
-1,2,4-oxadiazoline would decompose rapidly to a nitrile 
and urea. It had been noted by Creedon that the rate of nitrile elimination could be accelerated 
by the presence of electron donating substituents at position -3 and -4 of the five-membered 
ring and the nitrogen substituent at position -5 of the heterocycle.
[138]
 C. Levis hoped to 
develop a new synthetic procedure leading to a room temperature ‘cascade based’ process 
whereby the oxadiazoline intermediate would not be isolated or observed, thus developing a 
new mild and extremely efficient transformation of primary nitroalkanes into nitriles (Scheme 
103). 
 
Scheme 103: Proposed route to nitriles 





 This involved the reaction of a series of nitrile oxides with a selection 
of formamidines. The nitrile oxides chosen for this study contained electron-withdrawing 
substituents, a property which served to increase the stability of the Δ
2
-1,2,4-oxadiazolines, 
i.e. they could be isolated and characterised as crystalline solids (Scheme 104). 
 
      265           266        267 
Scheme 104: Reagents: (i) Ether, room temperature 
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During that research it was observed, that nitrile oxides appeared to react rapidly with 
formamidines at room temperature to give Δ
2
-1,2,4-oxadiazolines such was the case that the 
oxadiazolines were produced quantitatively within minutes of mixing the nitrile oxide 
precursor with a formamidine in the presence of a base. This raised the question: could the 
rates of these formamidine-nitrile oxide cycloadditions approach the limits of diffusion 
controlled processes? Diffusion controlled reactions would be considered to be novel in 
organic transformations as typically, reactions involving the formation of carbon-carbon and 
carbon-nitrogen bonds have significantly higher activation energies than e.g. electron and 
proton transfer reactions. As the formamidine is an electron rich dipolarophile, an inverse 
electron demand reaction mechanism may operate for the cycloaddition process whereby the 
HOMO-LUMO interaction in the transition state could be the opposite of that normally 
encountered for nitrile oxide cycloadditions (see chapter 1, 1,3-Dipolar Cycloadditions: 
orbital interactions). 
Our current research work aims to explore reactivity in the 1,3-dipolar cycloaddition reaction 
of nitrile oxides with formamidines in the synthesis of Δ
2
-1,2,4-oxadiazolines. The nitrile 
oxides chosen to initiate this study are well documented in the literature.
[12i,12m,14a,b,14d-f,14h-
j,23a,24d,31d,35,51a,65d,145]
 The majority are reactive molecules, generated in situ from a precursor. 
A few, however, e.g. p-nitrobenzonitrile oxide 265 and mesitonitrile-N-oxide 7 are stable, 
isolable species, in particular the latter which is stable owing to the substitution pattern of its 
aromatic ring (Figure 47). This property makes it suitable for NMR spectroscopy studies of 
cycloaddition reactions. The early sections of this chapter describe our work on the synthesis 
of nitrile oxide precursors, amidines and reference materials for reaction product 
identification. 
 
            265                 7 
Figure 47: Nitrile oxides 265 and 7 
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1 Preparation of nitrile oxide precursors 
1.1 The nitrile oxides 
The preparation of nitrile oxides, either as reactive intermediates in solution or as isolable 
species has been addressed by numerous research groups.
[22-23,26,28g,30,31c,32,37-38,45a,46-48,146]
 
Many different procedures exist as outlined in chapter 1 of this thesis. The procedure for the 
synthesis of nitrile oxides was first described by Werner and Buss.
[22]
 They generated 
benzonitrile oxide 27 by chlorination of benzaldoxime 25 to give benzohydroximoyl chloride 
26, followed by dehydrohalogenation with sodium carbonate (Scheme 105). This method is 
the most common route to nitrile oxides and the method we employed in our study. The 
oxime was synthesised from the aldehyde using the Fieser method and in all cases one isomer 
was isolated which was assumed to be the E-isomer. 
 
     25           26      27 
Scheme 105: Reagents: (i) Cl2(g), ether, r.t.; (ii) Sodium hydroxide, ether 
Both hydroximoyl chlorides and bromides were investigated during the course of our 
research. A number of halogenating agents such as chlorine, thionyl chloride and oxalyl 
chloride were examined. The chlorination of the oximes via chlorine gas proved to be the 
more robust method. Kaushik et al. explored the use of N-tert-butyl-N-chlorocyanamide 268 




        268          269 
Scheme 106: Reagents: (i) DCM, r.t., <1 min 
This novel chlorination method yielded the hydroximoyl chloride within a minute of stirring 
with the reagent 268 in dichloromethane at room temperature. It was reported that the 
hydroximoyl chloride was isolated in ‘virtually quantitative yields’ and no evidence of over 
chlorination or interference from other substituents was observed. The presence of electron 
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donating groups, electron withdrawing groups or an aromatic ring in the oxime molecular 
structure did not affect the yields/efficiency or the rate of reaction. 
1.1.1 Synthesis of substituted benzohydroximoyl chlorides  
Benzaldoxime 25 was generated by the addition of sodium hydroxide to benzaldehyde, 




270 X = H 25 X = H 
271 p-NO2 272 p-NO2 
273 m-NO2 274 m-NO2 
Scheme 107: Conversion of the aldehyde to the oxime 
Carbon dioxide was then bubbled through the solution resulting in the precipitation of the 
oxime. Following an aqueous work-up and distillation at water aspirator pressure (b.p. 114-
124
o
C @ 25 mmHg), the oxime 25 was isolated in 82% yield. Its boiling point and 




      270                 25      26 
Scheme 108: Reagents: (i) NaOH, NH2OH.HCl, water; (ii) CO2(g); (iii) Cl2(g), chloroform, < -10°C 
The subsequent step involved the reaction of the oxime 25 with chlorine gas to produce 
benzohydroximoyl chloride 26 (Scheme 108). The progress of this reaction is accompanied by 
colour change.
[147]
 This was outlined by Gilchrist as involving transient ‘vinyl nitroso 
compounds’ in solution which ‘have been detected spectroscopically or simply by the 
appearance of a characteristic blue colour in the solution’.
[148]
 On saturation with chlorine, the 
reaction mixture turned a dark orange colour. The product 26 was isolated as a pale cream 
solid in 43% yield following recrystallisation from cold hexane. Its melting point (51
o
C) and 




1.1.1.1 p-Nitrobenzohydroximoyl chloride 
p-Nitrobenzaldoxime 272 was produced by heating a mixture of p-nitrobenzaldehyde, 
hydroxylamine hydrochloride and sodium acetate to reflux in 95% ethanol for 28 h (Scheme 
109). The oxime 272 was isolated as a pale yellow crystalline solid in 78% yield following 
recrystallisation from ethanol/water. Its melting point (130-132
o
C) and spectroscopic 




  271                272       275 
Scheme 109: Reagents: (i) NaOAc, NH2OH.HCl, ethanol, reflux 28 h; (ii) Cl2(g), chloroform, <0°C 
The subsequent step again involved the reaction of the oxime 272 with chlorine gas to 
generate p-nitrobenzohydroximoyl chloride 275. The progress of this reaction was monitored 
by colour change. Upon saturation with chlorine the reaction solution turned a deep 
yellow/orange colour. The product 275 was isolated as a pale yellow crystalline solid in 58% 
yield following recrystallisation from cold chloroform/hexane. Its melting point (124-125
o
C) 
correlated with the literature value (123-124°C).
[145b]
 Its spectroscopic properties (NMR and 
IR) were consistent with the molecular structure involved and agreed with those reported in 
the literature.  
1.1.1.2 m-Nitrobenzohydroximoyl chloride 
m-Nitrobenzaldoxime 274 was similarly prepared from m-nitrobenzaldehyde, hydroxylamine 
hydrochloride and sodium acetate in ethanol (Scheme 110). The oxime 274 was isolated as a 
pale yellow crystalline solid in 95% yield. Its melting point (115-119
o
C) and spectroscopic 




   273                274             276 
Scheme 110: Reagents: (i) NaOAc, NH2OH.HCl, ethanol, reflux 28 h; (ii) Cl2(g), chloroform, < 0°C 
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The chlorination step involved the reaction of the oxime 274 with chlorine gas to generate m-
nitrobenzohydroximoyl chloride 276 (Scheme 110). The progress of this reaction was 
monitored by the usual colour change. On saturation with chlorine the solution turned a deep 
yellow colour. The product 276 was isolated as a yellow crystalline solid in a 61% yield 
following recrystallisation from cold chloroform/hexane. Its melting point (97-99
o
C) and 




1.1.1.3 2,4,6-Trimethylbenzohydroximoyl chloride 
Synthesis of 2,4,6-trimethylbenzohydroximoyl chloride from mesitylene 277 involved three 
sequential steps. Firstly, the acylation of mesitylene via the mesitylene methyl ether 
intermediate 278 in the formation of mesitaldehyde 279, secondly, the condensation of 
mesitaldehyde to form mesitaldoxime 280, and finally, the synthesis of 2,4,6-
trimethylbenzohydroximoyl chloride 281 (Figure 48). 
 
281      280           279       277 
Figure 48: Retrosynthetic analysis of 281    
Mesitaldehyde 279 was prepared by the dropwise additions of titanium tetrachloride and then 
dichloromethyl methyl ether to mesitylene followed by gentle heating (35-40
o
C) of the 
mixture to reflux for 15 min (Scheme 111). Following purification of the crude product by 
distillation at water aspirator pressure (102-112
o
C @ 15 mmHg), mesitaldehyde 279 was 
isolated in 74% yield as a pale yellow oil. The boiling point correlates to that reported in the 
literature.
[145c]
 The spectroscopic properties also agree with those reported in the literature.
[151]
 
The formyl proton signal was observed at δH 10.54 and the signal of the corresponding 
attached carbon of the aldehyde occurred at δC 193.4 ppm.  
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        277            278          279 
Scheme 111: Reagents: (i) TiCl4, (Cl)2CHOMe, DCM, (ii) HCl, water 




         279 
Scheme 112: The proposed mechanism for the formation of mesitaldehyde 279 
Two different methods were employed synthesising mesitaldoxime 280. Initially, following 
Liu et al., the oxime 280 was prepared by adding 50% NaOH (aq.) solution to a stirring 
solution of hydroxylamine hydrochloride in mesitaldehyde 279 (Scheme 113, Method (i)).
[14d]
 
The solution was then stirred overnight. The solution of the oxime anion was acidified with 
conc. hydrochloric acid and the oxime was isolated following an aqueous work-up. The oxime 
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from this process was a pale yellow crystalline solid, isolated in 45% yield following 
recrystallisation from ethyl acetate/hexane. Its melting point (119-123
o
C) was in agreement 
with that reported in the literature.
[24d]
 Its spectroscopic properties correlate with those 
reported in the literature.  
Secondly, mesitaldoxime 280 was prepared by the heating a mixture of mesitaldehyde, 
hydroxylamine hydrochloride and sodium acetate to reflux in ethanol for 24 h (Scheme 113, 
Method (ii)). The oxime 280 was isolated as a white crystalline solid in 65% yield following 
recrystallisation from ethanol/water. Its melting point (119-121
o
C) was slightly lower, but its 





    279       280 
Scheme 113: Reagents: (i) NH2OH.HCl, NaOH, or (ii) NH2OH.HCl, NaOAc, ethanol 
Two methods were employed in the synthesis of 2,4,6-trimethylbenzohydroximoyl chloride 
281. The first involved adding N-chlorosuccinimide to a stirring solution of mesitaldoxime 
280 in DMF (Scheme 114). This was carried out in the presence of HCl gas to help initiate the 
chlorination reaction. The benzohydroximoyl chloride 281 was isolated as a white solid in 
97% yield. Its melting point (66-74.5
o
C) is within the range of the literature data for the 
compound and the spectroscopic properties, IR and 
1
H NMR spectroscopy, agree with those 




   280      281 
Scheme 114: Reagents: (i) NCS, HCl(g), DMF; (ii) Pyridine, Chlorofrom, r.t., NCS 
The second method employed was that outlined by Bode et al., which involved adding 
pyridine to a stirring solution of the oxime in chloroform.
[152]




C and NCS added. The chlorination was complete within 3 h and following an aqueous 
work-up, the hydroximoyl chloride 281 was isolated as a pale yellow solid in 91% yield. Its 
melting point (59-65
o
C) was within the range of the crude literature value outlined by Liu et 
al., however it lies outside the range of the purified value.
[12d,14d]
 This may be attributed to 
isolation of the oxime as a mixture of both syn- and anti-isomers, however the spectroscopic 
data correlated well with the literature and suggested that only one isomer had been isolated. 
1.1.2 Synthesis of dihaloformaldoximes 
1.1.2.1 Dibromoformaldoxime 
Dibromoformaldoxime 41 was generated by adding solid hydroxylamine hydrochloride to a 
stirring solution of glyoxylic acid monohydrate 282 (Scheme 115). Sodium carbonate was 
then added to the solution which resulted after stirring the mixture overnight. 
Dichloromethane was added as a surfactant and the solution was cooled prior to bromine 
addition. The reaction mixture was stirred overnight and an aqueous work-up yielded the 
oxime as a white crystalline solid in 44% yield. Its m.p. (55.5-60
o
C) and carbon-13 NMR 




      41                282         16 
Scheme 115: Reagents: (i) NH2OH.HCl, water, r.t., (ii) NaHCO3, DCM, cooled to 0°C, Br2; (iii) a) 
NH2OH.HCl, b) 1M NaOH(aq), c) 2M H2SO4, d) Extraction with ether., (iv) NCS, chloroform, reflux 
1.1.2.2 Dichloroformaldoxime 
The two-step synthesis employed involved the preparation of glyoxylic acid aldoxime 283 
first. Dichloroformaldoxime 16 was then formed from the decarboxylative halogenation of 
glyoxylic acid aldoxime (Scheme 116). 
 
                282            283            16 
Scheme 116: Reagents: (i) a) NH2OH.HCl, b) 1M NaOH(aq), c) 2M H2SO4, d) extraction with ether.; (ii) 
NCS, chloroform, reflux 
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Glyoxylic acid aldoxime 283 was the selected precursor of dichloroformaldoxime 16 (Scheme 
117). It was initially produced by heating glyoxylic acid monohydrate with hydroxylamine 
hydrochloride to reflux. However, the yield was extremely low at 3%.  
 
     282                283 
Scheme 117: Reagents: (i) NH2OH.HCl, (ii) 1M NaOH(aq), (iii) 2M H2SO4, (iv) extraction with ether 
An alternative method was adapted from the procedure outlined by Wieland in 1910.
[153]
 The 
first attempt at this procedure involved stirring glyoxylic acid with hydroxylamine 
hydrochloride in water, basifying the solution and stirring overnight. The solution was 
acidified with sulphuric acid and the product extracted into ether. This gave the oxime in 5% 
yield with spectroscopic properties that correlate well with the structure. The proposed 
reaction mechanism is outlined in Scheme 118. 
 
    282                  283 
Scheme 118: The proposed reaction mechanism  
A slight modification to the Wieland procedure, by concentrating the reaction mixture prior to 
the extraction into ether, gave the oxime in 78% yield. Its melting point is more indicative of a 
salt (>304
o
C). However, carbon-13 NMR spectroscopic data is consistent with the molecular 
structure (Table 5). As there is no acidification in this method, it is more likely that the 
isolated material is the sodium salt of glyoxylic acid aldoxime. 
Table 5: The 
13






Dichloroformaldoxime 16 was generated following the procedure outlined by Torssell et al. 
by the decarboxylative halogenation of glyoxylic acid aldoxime 283 with N-
chlorosuccinimide (Scheme 119).
[145i]
 The chloro-oxime 16 was isolated and used directly in 
the generation of the nitrile oxide 17 without further analysis or purification.  
 
          282   283            16     17 
Scheme 119: Reagents: (i) a) NH2OH.HCl, b) 1M NaOH(aq), c) 2M H2SO4, d) extraction with ether.; (ii) 
NCS, chloroform, reflux; (iii) NEt3, ether, 0°C  
1.1.3 Synthesis of 1-aroyl-1-chloroformaldoximes 
1.1.3.1 1-Benzoyl-1-chloroformaldoxime  
Kozhevnikov et al. discussed the preparation of 1-benzoyl-1-chloroformaldoxime 286 from 
its corresponding ketone 285 using iso-propyl nitrite, as did Levin et al. and also 
Brachwitz.
[154]
 Alternative syntheses include the nitrosation of β-keto sulfoxides, treatment of 
α-haloketones with alkyl thionitrites under mild conditions.
[12f,155]
 For the most part, the alkyl 
thionitrite route was regarded as a better alternative to the nitrosation route due, ‘both to the 
more facile cleavage of sulphur-nitrogen bond than that of oxygen - nitrogen bond of nitrites 
and also to the better leaving group of the thiolate  (RS 
-
) moiety than alkoxy (RO 
-
) in the 
nitrosation step’.  
Tegeler et al. outlined a procedure for the synthesis of 1-benzoyl-1-chloroformaldoxime 286 




284 X = H 286 X = H 
287 X = CH3                   288 X = CH3 
289 X = CH3O 290 X = CH3O 
Scheme 120: Reagents: (i) Butyl nitrite, HCl(g) 
However, iso-propyl nitrite and butyl nitrite are known heart stimulants and we were reluctant 
to use them from a health and safety point of view.
[156]
 This brought us to the Šunjić et al. 





285 X = H 286 X = H 
291 X = p-Br                  292 X = p-Br 
Scheme 121: Reagents: (i) 15% aq. HCl/ NaNO2, (ii) HNO3, 70
o
C 
1-Benzoyl-1-chloroformaldoxime 286 was successfully synthesised from acetophenone 285 
by the Šunjić method (Scheme 121).
[145d]
 The chloro-oxime 286 was isolated by extraction 
with dichloromethane affording the title compound as a yellow solid in 77% yield. Its melting 
point (128-131
o
C) shows good correlation with the literature value (130-131
o
C) as does the 
NMR spectroscopic analysis (Table 6). The compound was isolated as one isomer, assumed 
to be the E-form. 




C NMR spectroscopic data of 286 
δH(ppm) δC(ppm) 
m-ArH 7.47 3 x ArCH 128.4, 130.7 and 133.8 
p-ArH 7.62 i-ArC- 134.8 
o-ArH 7.97 -C(Cl)=NOH 139.2 
-OH 9.21 -C=O 183.9 
 
1.1.3.2 1-(p-Bromobenzoyl)-1-chloroformaldoxime  
1-(p-Bromobenzoyl)-1-chloroformaldoxime 292 is another example of an α-oximino-α-
haloketone which was produced by modification of the procedure described by Šunjić et al. 
(Scheme 122).
[145d]
 p-Bromoacetophenone 291 (rather than acetophenone) was treated with 
hydrochloric acid, sodium nitrite and nitric acid to yield 1-(p-bromobenzoyl)-1-
chloroformaldoxime 292 as a pale yellow solid in 17% yield, as a single isomer. 
 
    291       292 




The purity of the compound was confirmed by elemental micro analysis which was within 




C NMR spectroscopy resonances of 292 are 
detailed in Table 7. 




C NMR spectroscopic data of 292 
δH (ppm) δC (ppm) 
ArH 7.62 ArC(Br) 129.27 
ArH 7.88 ArCH x 2 131.74 and 132.12 
-OH 8.83 ipso C of Ar 133.42 
 C(Cl)=NOH 139.40 
 C=O 182.60 
 
1.1.4 Synthesis of other hydroximoyl halides 
1.1.4.1 Ethylchloroglyoxalate oxime  
This two-step synthesis was initiated with the preparation of glycine ethyl ester hydrochloride 
294 from glycine 293 (Scheme 123). The product then underwent nitrosation under acidic 
conditions to give the target molecule 295.  
Glycine ethyl ester hydrochloride 294 was prepared by bubbling HCl gas through a stirring 
solution of glycine in ethanol, followed by heating the solution to reflux for 19 h (Scheme 
123). The hydrochloride salt 294 was isolated as a white solid (and used without further 
purification) in 94% yield. Its melting point (120-122
o
C) was lower than that reported in the 




 293        294           295 
Scheme 123: Reagents: (i) HCl(g), ethanol; (ii) HCl, NaNO2 
Ethylchloroglyoxalate oxime 295 was prepared by adding hydrochloric acid and sodium 
nitrite in alternate portions, followed by stirring the solution for 69 h (Scheme 124). The 
hydroximoyl chloride 295 was isolated in 24% yield as a colourless crystalline solid 
following recrystallisation from chloroform/hexane. Its melting point (80-81
o
C) and 
spectroscopic properties correlate to those reported in the literature.
[157]
 The absence of the 
93 
proton NMR resonance for the CH2 group of glycine ethyl ester hydrochloride 294 at 3.81 
ppm in the spectrum for 295 clearly indicates all 294 had been consumed in the conversion. 
 
    294         295 
Scheme 124: Reagents: (i) HCl, NaNO2 
We propose the reaction mechanism as per Scheme 125. 
 
           295 
Scheme 125: Formation of ethylchloroglyoxalate oxime 295 from oxime 294 
Ethylchloroglyoxalate oxime 295 has been shown to possess weak mutagenicity for S. 
typhimurium TA-100 and for mammalian V79 cells by Mirvish et al..
[158]
 We have 
encountered difficulties in handling this oxime 295 as it has caused skin blisters similar to 





The synthesis of p-toluenesulfonylnitromethane 297 was followed by the production of 
diazomethane 298 (Scheme 126). The combination of these gave the simplest route to 1-p-
toluenesulfonyl-1-bromoformaldoxime 299. 
 296     
    297     299 
Scheme 126: Reagents: (i) a) NaOMe, CH2NO2, b) I2, Na2SO3; (ii) a) NaOAc, DCM; b) Br2, DCM, water; 
c) CH2N2(298)/ether; d) Reflux 15 min 
p-Toluenesulfonylnitromethane 297 was prepared by adapting the procedure of Wade et al. 





         296              297 
Scheme 127: Reagents: (i) NaOMe, CH2NO2, (ii) I2, Na2SO3 
The target compound 297 was isolated in 40% yield as a pink/orange solid. Its m.p. (115-
116
o




 Its spectroscopic properties 
reflect all components of the compounds molecular structure (Table 8).  




C NMR spectroscopic data of 297 
δH(ppm) δC(ppm) 
ArCH3 2.50 ArC(CH3) 21.9 
CH2NO2 5.57 CH2NO2 90.4 
o-ArH to SO2 7.44 i-ArCH 147.2 
m-ArH to SO2 7.84 2 x ArCH 128.4 and 130.4 
- p-ArC(CH3) 132.6 
 
Diazomethane 298 was generated from Diazald
®
 following the procedure outlined by O’ 
Leary
[161]
 and used directly as an ethereal solution in the synthesis of 299 (Scheme 128).  
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                298 
 
Scheme 128: Reagents: (i) KOH, (ii) Reflux/distillation 
1-p-Toluenesulfonyl-1-bromoformaldoxime 299 was generated by adapting the procedure of 
Wade et al.
[51b]
 (Scheme 129): p-Toluenesulfonylnitromethane 297 was used in place of 
phenylsulfonylnitromethane. 
 
 297          299 
Scheme 129: Reagents: (i) NaOAc, DCM;  (ii) Br2, DCM, water; (iii) CH2N2/ether; (iv) Reflux 15 min 
Following the bromine addition, the mono-brominated product 300 was identified by proton 
NMR spectroscopic analysis of the reaction product mixture(Figure 49). 
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       300 
Figure 49: The mono-brominated product of p-toluenesulfonylnitromethane 297 
It is anticipated that the sequential bromination and O-methylation of the α–nitrosulfone 297 
affords an unstable nitronic ester 301 which rapidly converts into the bromo oxime 299 
(Figure 50). 
 
     301 
Figure 50: The unstable nitronic ester intermediate 
The bromooxime 299, a known compound, was successfully isolated as a yellow solid in 77% 
yield following recrystallisation from dichloromethane:hexane.
[18b]
 Its spectroscopic data 
agreed well with the structure of the bromooxime, but there is a lack of data in the literature 
for comparison purposes (see Table 9). 




C NMR spectroscopic data of 299 
δH(ppm) δC(ppm) 
ArCH3 2.48 ArC(CH3) 21.8 
o-ArH 7.40 i-ArC 132.6 
m-ArH 7.89 o- & m-ArCH 129.7 & 130.3 
-OH 9.47 p-ArC(CH3) 132.4 
- C=N 146.6 
 
1.1.4.3 Cyanoformohydroximoyl chloride 
The synthesis of cyanoformohydroximoyl chloride 304 involved a number of steps. Intially, 
chloroglyoxime 303 was synthesised, followed by its dehydration to form 
cyanoformohydroximoyl chloride 304 (Scheme 130). 
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302       303     304 
Scheme 130: Reagents: (i) NH2OH.HCl, K2CO3/H2O, r.t.; (ii) 25% NaOH (aq) 0-5
o
C; (iii) 25%H2SO4 (aq); 
(iv) MTBE; (v) SOCl2, ether 
The synthesis of chloroglyoxime 303 proved to be more troublesome than previously 
anticipated. In all, four methods were investigated with three of these an attempt to synthesise 
chloroglyoxime as a one-pot synthesis. We found that a scaled down version of a procedure 
outlined by Burgoon et al. was the most reliable of these methods.
[162]
 
Chloroglyoxime was produced in 20% yield from chloral hydrate 302 and isolated as a white 
solid. Its melting point (154
o
C) was in good correlation with the literature.
[163]
 Spectroscopic, 
proton and carbon NMR data (Table 10), confirm the structure of the compound 303.  




C NMR spectroscopic data of 303 
δH(ppm) δC(ppm) 
-CH=N- 8.33 -CH=N 137.2 
-OH 12.31 N=C(Cl) 142.5 
-OH 12.52 - 
 
1.1.4.3.1 Synthesis of chloral oxime  
One alternative route involved the preparation of chloral oxime 305 first, as it was the obvious 
precursor, which in turn was used as a reagent in the second step of the two-step synthesis of 
chloroglyoxime 303 (Scheme 131). Chloral oxime 305 was prepared utilising a modification 
of a method outlined by Tiemann et al..
[164]
 Anhydrous chloral 306, hydroxylamine 
hydrochloride and calcium chloride were combined in water and stirred together firstly at 
room temperature, then at 50
o
C for 1 h. Distillation at water aspirator pressure afforded the 
oxime in 96% yield.  
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    306     305 
Scheme 131: Reagents: (i) NH2OH.HCl, CaCl2, H2O 
There is a dearth of data for compound 305 in the scientific literature with the boiling point as 
the only means to correlate data. The proton NMR spectrum clearly identified the hydrogens 
attached to the carbon of the oxime and the –OH group. Coupled to this information is the 
carbon spectrum which accounts for both carbons in the molecule (Table 11).  




C NMR spectroscopic data of 305 
δH(ppm) δC(ppm) 
-CH=N- 7.82 -CH=N 103.4 
-OH 9.05 -C(Cl)3 149.8 
 
The procedure that we used was not in full conformity with that outlined in the literature.
[164]
 
The absence of an aqueous work-up, accounts for other products being present in the reaction 
mixture. Tiemann et al. distilled off any excess chloral following the aqueous work-up. 
Therefore, the additional peaks observed in the NMR spectrum implied that some of the 
reaction product was contaminated with chloral. There was a discrepancy in the boiling point 
of the reaction mixture (b.p. 41-44.5°C @20mmHg) when compared to the literature value 
(b.p. 82-83°C@14mmHg). The omission of the aqueous work up may account for this. 
Chloral oxime 305 was then used as an intermediate in the preparation of chloroglyoxime 303 
(Scheme 132). This method involved heating chloral oxime, hydroxylamine hydrochloride 
and sodium acetate to reflux in ethanol for 26h. However, this method yielded an 
unidentifiable product and the earlier route to chloroglyoxime 303 was examined. 
 
   305                  303 
Scheme 132: Reagents: (i) NH2OH.HCl, NaOAc, 95% ethanol, 26 h reflux; (ii) 2M NaOH, H2O; (iii) pH3 
with glacial acetic acid; (iv) ether 
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Cyanoformohydroximoyl chloride 304 was synthesised following the procedure outlined by 
Kozikowski et al. (Scheme 133).
[157]
 Chloroglyoxime 303 and an excess of thionyl chloride 
were refluxed together in ether. Distillation at water aspirator pressure (b.p. 48-50
o
C @ 15 
mmHg) followed by precipitation of cyanoformhydroximoyl chloride from the distillate by 
the addition of hexane, yielded the target compound in 31% yield.  
 
   303                304 
Scheme 133: Reagents: (i) SOCl2, ether 
Carbon-13 NMR spectroscopy identified the two carbon atoms in the structure (Table 12). 
Table 12: The 
13





The IR spectrum of 304 also supports the structure. A strong broad signal at 3234 cm
-1
 was 
assigned to the –OH stretch. Characteristic nitrile and imine stretches were observed at 2243 
and 1624 cm
-1
 respectively. The ESI
+
 mass spectrum in negative ion mode confirmed the 
molecular mass of the compound (M
-
, 103, 100%). 
1.2 Generation of nitrile oxides 
Nitrile oxides are liberated from their hydroximoyl halide precursor by the addition of a base. 
The IR spectra of a number of nitrile oxides were reported by Wakefield et al, who identified 
absorption bands at 2295 cm
-1
 and 1370 cm
-1
 as ‘characteristic of the triple bond and the N-
oxide linkages of the nitrile oxide group’.
[165]
 Wakefield et al. chose aqueous sodium 
carbonate as the base for dehydrohalogenation of the hydroximoyl chloride precursor to 
liberate 3,5-dichlorobenzonitrile-N-oxide. The nitrile oxide was reacted immediately with a 
dipolarophile, therefore it was not isolated or characterised (other than to note that the IR 
spectrum did not have a typical for CNO absorption).  
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1.2.1 p-Nitrobenzonitrile-N-oxide 
The first method that we employed to generate a nitrile oxide in solution utilised NMR 
spectroscopy as the analytical method. Combining a solution of the hydroximoyl chloride 275 
in chloroform-d with a solution of triethylamine in the same solvent allowed for quick 
transferral of the solution into an NMR spectroscopy tube. The triethylammonium 
hydrochloride produced in the reaction is soluble in chloroform-d, therefore facilitating 
efficient analysis.  
 
       275    265 
Scheme 134: Reagents: (i) NEt3, ethanol, < 0 °C 
Evidence for the nitrile oxide 265 was observed in the proton and carbon-13 NMR spectra of 
the solution - characteristic signals are shown in Table 13. The signals for o–Ar-C and m-Ar-
C shifted from 8.05 and 8.31 ppm in the hydroximoyl chloride to 7.73 and 8.31 ppm in the 
nitrile oxide. The absence of the broad singlet in the proton NMR spectrum of the nitrile 
oxide at 13.01 ppm (-OH of hydroximoyl chloride) confirms that the hydroximoyl chloride 
was consumed.  




C NMR spectroscopic data of 265 
δH(ppm) δC(ppm) 
ArH 7.73 C≡N 119.6 
ArH 8.31 ArCH 123.4 and 132.1 
 
For a preparatory scale preparation of p-nitrobenzonitrile oxide 265, ethanol was used in place 
of chloroform as per the procedure outlined by Eloy et al. (Scheme 134). The nitrile oxide 
was generated as an isolable, relatively stable solid and was isolated in 91% yield as a pale 
yellow solid.
[145l]
 Its melting point (92-93 
o
C) compares well with the literature value. The 
spectra of the crystalline nitrile oxide followed those observed for the compound in solution.  
Balsamini et al. note that the half-life of p-nitrobenzonitrile oxide is one month at room 
temperature in ether.
[54]
 According to our experience, the lifetime of the compound is ca. 15 h 
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in chloroform-d at room temperature. It is considerably more stable when stored as a solid in a 
freezer (up to 303 days). 
1.2.2 Mesitonitrile-N-oxide 
Mesitonitrile-N-oxide 7 was produced by adding a solution of the hydroximoyl precursor 281 
to a stirring solution of triethylamine in ether (Scheme 135). The use of ether as the solvent 
facilitates the ease of removing the triethylamine hydrochloride precipitate that forms during 
dehydrohalogenation of the hydroximoyl chloride. Stirring the solution at room temperature 
for 2 h gave the nitrile oxide 7 in excellent yield following isolation of the triethylammonium 
chloride precipitate by filtration. While the melting point of crude 281 was ten degrees lower 
than the literature melting point, the solid did melt over a narrow range which is indicative of 
a relatively pure compound.
[14d]
 The spectroscopic properties obtained correlate well with the 
literature, with the δC of the nitrile carbon observed at 141.7 ppm.
[14i]
 The stability of this 
nitrile oxide in deuterated chloroform is 15 days.  
 
   281               7 
Scheme 135: Reagents: (i) NEt3, ether 
1.2.3 Bromoformonitrile-N-oxide 
Bromoformonitrile-N-oxide 13 was initially generated by the addition of the hydroximoyl 
bromide 41 to a stirring solution of triethylamine in ether (Scheme 136). The nitrile oxide 13 
was isolated as a white solid in 51% yield following evaporation of the filtrate. A shift of δC 
from 99.2 ppm in the bromooxime to 97.6 ppm in the nitrile oxide supports the formation of 
13.  
 
41               13 
Scheme 136: Reagents: (i) NEt3, ether 
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The reaction solvent can also play a part in the dehydrohalogenation of 41. Herdewijn et al. 
found difficulty in generating the nitrile oxide of dibromoformaldoxime 41 when the reaction 
was carried out in THF.
[145f]
 They used wet ethyl acetate and sodium bicarbonate to generate 
the nitrile oxide, as did Sala et al..
[166]
 Other than characterisation of the cycloaddition 
products, no other evidence for the generation of the bromonitrile oxide is provided by these 
researchers. 
1.2.4 p-Toluenesulfonylformonitrile-N-oxide  
The benefit of generating a benzenesulfonyl substituent on the heterocycle cycloadduct, is that 
it was ‘easily substituted by a variety of nucleophiles’.
[167]
 Wade et al. explored this benefit by 
using benzenesulfonylnitrile oxide to generate the benzenesulfonyl substituent on the 
heterocycle. They attributed the high reactivity of benzenesulfonylnitrile oxide to synergistic 
electronic and steric factors: electron attracting substituents are known to increase the 
reactivity of other 1,3 dipoles toward alkenes and presumably this is one function of the 




Successful dehydrobromination of 1-p-toluenesulfonyl-1-bromoformaldoxime 299 proved to 
be more challenging than originally anticipated (Scheme 137).  
 
299              307 
Scheme 137: Reagents: (i) Base, ether 
The literature discusses the dehydrohalogenation challenge in relation to 
dibromoformaldoxime 41 and benzenesulfonyl-1-bromoformaldoxime 308.
[51b,145e,f]
 Wade et 
al. used potassium carbonate and sodium carbonate to release the nitrile oxide from 
dibromoformaldoxime 41 and benzenesulfonyl-1-bromoformaldoxime 308 (Figure 51). 
Wigerinck et al. used sodium bicarbonate to produce bromonitrile oxide from 41. 
Extrapolating from this, we used a range of bases in the attempt at forming the nitrile oxide 
307: potassium hydrogen carbonate, potassium carbonate, DBU, triethylamine and potassium 
t-butoxide. The bases were screened using the same procedure on a 1 mmol scale: the base 
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was added to 1-p-toluenesulfonyl-1-bromoformaldoxime 299 in chloroform at room 
temperature.  
 
                41           308         299 
Figure 51: Hydroximoyl halides that proved difficult to dehydrohalogenate 
Chloroform was chosen as the NMR spectroscopic analysis was carried out in CDCl3 and this 
avoided masking of NMR signals in the NMR spectrum. The resulting solution was stirred for 
five minutes and the putative nitrile oxide was isolated following an aqueous wash. The 
results of the screening process are summarised in Table 14. 






      
299                   307                      309 
3 KHCO3 Predominantly 299 with a trace of 307 and 309 evident 
4 K2CO3 299 0% : 307 54% : 309 46% 
5 DBU Mixture of unidentifiable compounds 
6 NEt3 Mostly 309 
7 KO
t
Bu Mostly 299 with a trace of 309 
 
Potassium carbonate and triethylamine were selected as the best bases to use for the 
dehydrohalogenation of the bromooxime 299. We did note, however, that in any intended 
future cycloaddition reactions that the dipolarophile would have to be present in the reaction 
mixture prior to the addition of base to ensure that the nitrile oxide could be efficiently 
trapped to give an optimum yield and minimise the formation of the furoxan 309 (Figure 52).  
                                                 
1
 For methods 1-7, please see section 5.1.4 in Chapter 3. 
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   309 
Figure 52: Structure of 3,4-bis-(p-toluenesulphonyl)-furoxan 309 
Figure 53 shows the proton NMR spectra correlating to these screening reactions:  
 
Figure 53: The 
1
H NMR spectroscopic analysis using different bases to generate nitrile oxide 307 
The scale of the reaction was increased to 3.0 mmol and triethylamine was used as the base 
(Method 2). Ether was the solvent used as the triethylamine hydrobromide precipitate was 
easily removed by filtration. Following ten minutes stirring at room temperature, 
1
H NMR 
spectroscopic analysis showed that not all of the hydroximoyl bromide 299 was fully 
dehydrohalogenated, but 299, the nitrile oxide 307 and furoxan 309 were evident in a ratio of 




Figure 54: The nitrile oxide 307 
Dipole generation was followed by NMR spectroscopy in chloroform-d on a 0.07 mmol scale 
(Method 1). Triethylamine was selected as the base. 
1
H NMR spectroscopic analysis showed 
that total dehydrohalogenation had taken place, under these conditions, within ten minutes of 
adding the base to the halide in the NMR spectroscopy tube. In addition to triethylamine 
hydrobromide, formation of the nitrile oxide 307 and the furoxan 309 was evident from the 
spectra.  
1.3 Preparation of furoxans 
To definitively assign the peaks in the 
1
H NMR spectra of the nitrile oxides prepared, 
reference samples of their dimers (furoxans) were prepared. The preparation of 3,4-
disubstituted 1,2,5-oxadiazole-2-oxides (furoxans) is typically achieved via dimerisation of 
nitrile oxides.
[12h,12k,l,12n,12p,165]
 Harris et al. discussed an alternative from nitroacetamides.
[41]
 
During an attempt to convert N-methyl nitroacetamide 310 into its iminochloride, it was 
treated at room temperature with phosphorous oxychloride. The furoxan 311 was isolated as 
the only reaction product (Scheme 138). 
 
       310                 311 
Scheme 138: Conversion of N-methyl nitroacetamide 310 into its iminochloride  
As outlined above, the first method of preparing p-nitrobenzonitrile-N-oxide 265 involved its 
generation from p-nitrobenzohydroximoyl chloride 275 in CDCl3 in an NMR spectroscopy 
tube. This solution was monitored over time to view the formation of the furoxan 312 
(Scheme 139). Dimerisation of the nitrile oxide in solution was complete in CDCl3 within 15 
h at room temperature and its 
1
H NMR spectroscopic analysis was in agreement with that 
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reported by Krishnamurthy et al..
[12l]
 Ben Hadda et al. have determined the single crystal X-




265            312 
Scheme 139: Dimerisation of nitrile oxide 265 to the corresponding furoxan 312  
A synthetic scale reaction was the second method employed in generating the nitrile oxide 
265. The dehydrohalogenation of the hydroximoyl chloride 275 precursor was carried out in 
ether with triethylamine as the base (Scheme 140). A sample of p-nitrobenzonitrile-N-oxide 
265 was dissolved in CDCl3 and monitored by 
1
H NMR spectroscopy. Within 1.25 h in 
solution, dimerization to the furoxan began to take place. This experiment confirmed that 
within 17.75 h, the nitrile oxide component of the NMR spectroscopy sample had completely 
dimerised. The spectra showed a complete absence of the δH signals at 7.73 and 8.31 ppm for 
nitrile oxide 265.  
 
         275    265 
Scheme 140: The conversion of 275 to 265 
The nitrile oxide sample, a pale yellow solid, was stored in a freezer over time and was 
analysed periodically (refer to previous section p-nitrobenzonitrile-N-oxide). A fresh sample 
was analysed in each case, in a chloroform-d solution, and it was found that the nitrile oxide 
could be stored without any decomposition at -23 
o
C for 303 days (analysis was stopped at 
this point, so technically it may be stored for longer than this time!).  
1.3.1 Dimesitylfuroxan  
Evidence for the furoxan 313 of mesitonitrile-N-oxide 7 was collected during an experiment 
using NMR spectroscopy (Scheme 141). The solution of mesitonitrile-N-oxide 7 in 
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chloroform-d at r.t. was monitored over time for dimerization and dimerisation was complete 
within 15 days. Mesitonitrile-N-oxide 7 is regarded as a kinetically stable nitrile oxide
[12a,15]
 
and proved to be more stable than all other nitrile oxides encountered during the course of this 
research. 
 
7                     313  
Scheme 141: Dimerisation of nitrile oxide 7 to the corresponding furoxan 313 
Dimesitylfuroxan-N-oxide was not observed by Grundmann et al..
[12d]
 Their ‘attempts to force 
the dimerization to furoxans by heating the nitrile oxides above their melting point or by 
refluxing them in a high boiling solvent, such as xylene or decalin, have resulted in a clean 
rearrangement to the corresponding isocyanates with no furoxan formation’. The 
spectroscopic data for dimesitylfuroxan-N-oxide 313 has not appeared in the literature. 
1.3.2 Dibromofuroxan  
Spectroscopic signals of dibromofuroxan 15 were observed when a solution of 13 was 
allowed to stand in chloroform-d at r.t. for 7 days (Scheme 142). The initial 
13
C NMR 
spectrum, shows the nitrile oxide peak at δC 99.1 ppm as a sharp singlet. In the next spectrum 
(t = 17.75 h), the original sharp singlet at 99.1 ppm appears to broaden. In subsequent spectra 
(t = 144 h), the peak at 99.1 ppm has completely disappeared and in its place are two single 
peaks at 97.9 and 98.0 ppm (Figure 55), therefore, indicating the change from nitrile oxide 
(having one single C signal) to the furoxan (having two C signals). The shift in ppm also 
indicates the change of environment of the C signals. 
 
     13           15 
Scheme 142: Dimerisation of bromonitrile oxide 13 to dibromofuroxan 15 
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Hagedorn et al. reported the isolation of dibromofuroxan 15 by ether extraction.
17]
 As no solid 
precipitate was seen while the furoxan was in solution, chloroform could also be an example 
of a solvent in which the furoxan is soluble. Sennewald et al. reported the formation of the 




Figure 55: A time series of the 
13
C NMR spectroscopic analysis (CDCl3, 600MHz) illustrating the 
dimerisation of bromonitrile oxide 13 to dibromofuroxan 15 
1.3.3 3,4-Dibenzoylfuroxan 
Generation of the furoxan 314 was carried out by adding triethylamine to a stirring solution of 
286 in ether at room temperature (Scheme 143). The solution was stirred overnight and the 
dimer 314 was isolated as a yellow crystalline solid in 78% yield. 
 
          286     314 
Scheme 143: Reagents: (i) NEt3, ether 
Its melting point (77.5-80.5 
o
C) correlated with the literature value.
[12f]
 Boyer et al. reported 
the infrared ‘vibrations’ at 1620, 1475, 1330, 1188, 1030, 930 and 850 cm 
-1
 in 1955, which 
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parallels the research by Engberts et al. and correlates with the experimental data we obtained 
for 314. 
[12v,12x]
 The molecular ion species was observed at m/z = 295 under ESI
+
 conditions 








C NMR spectroscopic data of 314 
δH(ppm) δC(ppm) 
ArH 4H, m 7.55 4 x ArCH 129.1, 129.2, 129.7 and 130.6 
ArH 2H, m 7.70 2 x p-ArCH 128.5 and 130.2 
ArH 2H, m 7.86 2 x i-ArCH 135.2 and 135.5 
ArH 2H, m 8.20 2 x C=N 154.3 and 170.7 
- 2 x C=O 180.4 and 181.8 
 
1.3.4 3,4-Diethoxycarbonylfuroxan 
The furoxan 315 was produced by reacting its hydroximoyl halide precursor 295 with 
triethylamine as the base (Scheme 144). The reaction mixture was stirred at room temperature 
for 1 h and the solution was filtered to remove the triethylammoniun chloride precipitate. On 
evaporation of the solvent, no product was isolated, indicating that the furoxan 315 had in fact 
precipitated from the ether with the amine hydrochloride. Dissolving the solid in 
dichloromethane and washing the resulting solution with water served to separate the 
triethylammonium chloride from the furoxan 315. The latter was isolated as a yellow oil in 




     295      315 
Scheme 144: Reagents: (i) NEt3, ether 
The spectroscopic properties of the compound we isolated correlate well with the structure 
(Table 16) and those outlined in the literature.
[12n,12v,170]
 While Trogu et al. recorded two 
signals in the region of 13.5 ppm in the carbon-13 NMR spectroscopy, we observed these 











C NMR spectroscopic data of 315 
δH(ppm) δC(ppm) 
2 x CH3 1.42 2 x CH3 8.6 and 13.9 
2 x CH2 4.48 2 x CH2 43.8 and 63.6 
- 2 x C=N 106.7 and 148.4 
- 2 x C=O 155.1 and 156.7 
 
1.3.5 3,4-bis-(p-Toluenesulfonyl)-furoxan 
The furoxan 309 was generated by reacting its hydroximoyl halide precursor 299 with 
triethylamine as the base (Scheme 145). 
 
299                309 
Scheme 145: Reagents: (i) Triethylamine, ether 
The resulting solution was stirred overnight at room temperature and following filtration, the 
furoxan 309 was isolated in 29% yield as an orange solid. Its melting point (155-158 
o
C) did 
not correlate well with the literature data for the product (181-183 °C), however the infrared 





proton NMR spectroscopic data for the furoxan 309 sample is consistent with its molecular 
structure (Table 17).  




C NMR spectroscopic data of 309 
δH(ppm) δC(ppm) 
2 x ArCH3 2.49 3 x ArCH3 21.4, 21.5 and 22.0 
ArH 7.42 8 x ArCH 126.0, 126.5, 129.1, 129.3, 129.7, 130.3 and 130.5 
ArH 7.80 C=N 147.5 
ArH 7.96 - 
ArH 8.04 - 
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Subsequent carbon-13 spectroscopic analysis, which was collected two years after initial 
NMR spectroscopy analysis, suggests that the product was a mixture of 309 and the 
asymmetric 1,2,4-oxadiazole-4-oxide 316 (Figure 56). 
 
     309     316 
Figure 56: Symmetric furoxan 309 and asymmetric 1,2,4-oxadiazole-4-oxide 316  317, 
2 Reference compounds 
2.1.1 N-Benzylformamide 
N´-Benzylformimidoylmorpholine 318 was degrading during the cycloaddition reaction and 
was believed to be forming N-benzylformamide 319 (Scheme 146).  
 
      318          319 
Scheme 146: Degradation of 318 to 319 
For the purpose of comparison, amide 319 was prepared by heating benzylamine to reflux in 
neat ethyl formate (Scheme 147). N-Benzylformamide 319 was isolated in 83% yield as a 
white solid following recrystallization from toluene. The melting point (63-65 
o
C) was in 
excellent correlation with the literature, as was the spectroscopic data. 
1
H NMR spectroscopic 
evidence for both rotamers was observed with a ratio of minor:major (1:5).
[171]
 Its molecular 







      317       319 
Scheme 147: Reagents: (i) Ethyl formate 
2.2 Reference material for bromonitrile oxide cycloadditions 
Scheme 148 illustrates the typical 1,3-dipolar cycloaddition reaction with 
dibromoformaldoxime 41 as the nitrile oxide precursor of 13. This reaction was carried out 
with a number of dipolarophiles.  
 
              41                  13 
Scheme 148: 1,3-Dipolar cycloaddition reaction with dibromoformaldoxime 41 as the nitrile oxide 
precursor of 13 with a dipolarophile to form the Δ
2
-1,2,4-oxadiazoline  
Our initial work failed to isolate the Δ
2
-1,2,4-oxadiazoline. Following previous studies by 
Hogan with related structures, the decomposition products were anticipated to be a nitrile and 




Scheme 149: The expected decomposition products of a Δ
2
-1,2,4-oxadiazoline 
However, in the case of the bromonitrile oxide, our work established that this did not occur. 
Instead, an amide was isolated, leading to the belief that a different mechanistic pathway was 
operative (Scheme 150). A process proceeding through an imidoyl nitrene that would 
rearrange to a carbodi-imide was envisaged.  
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Scheme 150: The putative mechanistic pathway for the 3-bromo-Δ
2
-1,2,4-oxadiazoline 
In view of the plan to conduct cycloadditions of 13 with various amidines, we prepared 
several N-benzoyl amides as reference compounds. 320, 321 
2.2.1 N-Benzoylmorpholine 
The amide 322 was synthesised by addition of an ethereal solution of morpholine 321 to 
benzoyl chloride 320 (also in ether) in the presence of triethylamine (Scheme 151). N-
Benzoylmorpholine 322 was isolated as a white crystalline solid in 42% yield following 
dilution in hexane. Its melting point (67-69 
o
C) was a few degress lower than that observed in 




     320      321                322 
Scheme 151: Reagents: (i) NEt3, ether 
The infrared spectrum was in excellent accord with that reported by Ohshima et al., as is the 
NMR spectroscopic data (Table 18). One discrepancy between the carbon-13 data we 
obtained and those reported by Ohshima et al., was the clear signal we observed at δC 42.5 
ppm for the carbons attached to the nitrogen of the morpholine group. There was not any 











C NMR spectroscopic data of 322  323 
δH(ppm) δC(ppm) 
N(CH2)4O 3.60 N(CH2)2 42.5 
ArH 7.41 O(CH2)2 66.9 
- m-ArCH 127.1 
- o-ArCH 128.6 
- p-ArCH 129.9 
- ipso C of Ar 135.3 
- C=O 170.5 
 
2.2.2 N-Benzoylpiperidine 
The amide 324 was prepared by the reaction of benzoyl chloride 320 with piperidine 323 in 
the presence of triethylamine (Scheme 152). Ether was the reaction solvent. N-
Benzoylpiperidine 324 was isolated in 79% yield as yellow oil.  
 
     320                   323    324 
Scheme 152: Reagents: (i) NEt3, ether 





infrared spectra supports the structure and is in agreement with that reported by Ohshima et 
al..
[172]
 The spectroscopic data was also in good agreement with the literature, except for the 
carbon spectra of the piperidine ring in particular. Hirsch et al. described the observed signals 
as 45.8 (α- to N), 26.1 (β- to N), 24.5 (γ- to N).
[173]
 On the other hand, Ohshima et al. 
chronicled the piperidine ring as being represented by four signals: 48.66, 42.97, 26.08 and 
24.58 ppm. The carbon spectra of the amide we synthesised showed five signals for the 
piperidine ring-one for each carbon 48.8, 43.1, 26.6, 25.6 and 24.6 ppm. 325, 326 
2.2.3 N-(p-Chlorobenzoyl) morpholine 
The amide 327 was prepared from p-chlorobenzoic acid 325 in two steps via the acid chloride 




           325    326 
Scheme 153: Reagents: (i) Thionyl chloride, dichloromethane 
Conversion to the pale yellow acid chloride 326 was confirmed by the loss of the IR 
absorption at 1677 cm
-1
and the observation of the acid chloride peak at 1776 cm
-1
. The 
compound was used directly in the next step without further purification. 
The amide 327 was generated by the combination of the acid chloride 326 with morpholine in 
the presence of triethylamine, in ether (Scheme 154). N-(p-Chlorobenzoyl) morpholine 327 
was isolated as a white solid in 77% yield (over two steps). 
 
          326                    321        327 
Scheme 154: Reagents: (i) NEt3, ether 
 Its melting point (73-74 
o
C) was within the range of that reported in the literature.
[174]
 The 
proton and carbon spectroscopic data was in good agreement with that reported by Shen et al. 







2.2.4 Phenylcyanamide  
The products from certain cycloaddition reactions did not follow the nitrile-urea route, but 
instead produced an amide plus another material. A sharp peak observed at ~2220 cm
-1
 in the 
IR spectra suggested a cumulene (N=C=N) or nitrile type structure. We synthesised 
phenylcyanamide from potassium phenylcyanamide in an effort to ascertain if it could be the 
other reaction product. 
Thioureas may be prepared by the Meckler synthesis, which is based on the condensation of 
amine hydrogen halides with potassium thiocyanate (Scheme 155).
[175]
 This route is useful in 
the synthesis of primary thioureas and symmetrical N,N´-disubstituted thioureas. 
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      328    329        330 
 
  331    332    333 
Scheme 155: (i) Ammonia, dichloromethane; (ii) Iodomethane, acetone; (iii) Ammonia, IPA; (iv) 
potassium hydroxide, DIW, IPA; (v) 2 M HCl 
Initially, α-phenylisothiourea 329 was synthesised using the method of Batey et al..
[176]
 This 
was achieved by adding phenylisothiocyanate to a stirring solution of ammonia in 
dichloromethane. An aqueous work-up followed with the phenylisothiourea being extracted 
into dichloromethane. Recrystallisation from dichloromethane-hexane afforded α-
phenylisothiourea 329 in 63% yield and its m.p. (154-155 
o




Methyl-N-phenylcarbamidothioate hydroiodide 330 was then generated following Cohen’s 
procedure by adding iodomethane to a stirring solution of phenylisothiourea in acetone.
[178]
 
Washing the solid residue with ether afforded the product as a pale cream solid in 95% yield. 
Its m.p. (145-145.5 
o





 The methyl-N-phenylcarbamidothioate hydroiodide 330 was then reacted with 
ammonia and gave N-phenyl-S-methylisothiourea 331 in 82% yield. Its m.p. (63-65 
o
C) and 
spectroscopic data agreed with the literature (72 
o
C). Potassium phenylcyanamide 332 was 
generated from 331 by the procedure of Schultz et al.. This involved addition of potassium 
hydroxide to N-phenyl-S-methylisothiourea 331. The resulting solution was heated at reflux 
and the product precipitated from solution as a white solid. Recrystallisation from acetone 
afforded the salt as a white solid in 42% yield. Its m.p. (328 
o
C, decomp.) is in good 
correlation with the literature (345 
o
C). Phenylcyanamide 333 was available
[177]
 by 
neutralisation of 332 with 2 M HCl and isolated as a pale yellow oil in 96% yield. The IR 
spectrum with the characteristic peaks at 3100 cm
-1
 (-NH) and 2229 cm
-1
(C≡N), reflects the 
literature data.  
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One of the reasons we believed phenylcyanamide 333 to be one of the potential conversion 





 The experimental data we report is in agreement with this literature data which was 
outlined by Schultz et al.. However, overlaying of the spectra of phenylcyanamide that we 
isolated with those of the spectra of the oxadiazoline reaction mixture showed that the peaks 
at ~2220 cm
-1
 did not quite correlate with each other. 
2.3 Ureas 
Early studies relating to the field of nitrile oxide-amidine cycloadditions did not permit 
isolation of Δ
2
-1,2,4-oxadiazoline as the heterocycles involved were too unstable. Other 





-1,2,4-oxadiazolines that were being prepared during our research work were 
novel compounds, the anticipated urea decomposition products were generated as a means to 
simplify interpretation of the NMR spectra by way of direct comparison. 
2.3.1 1-Benzyl-3-(N,N-dimethyl)-urea 
Benzylisocyanate 334 was added to a solution of N,N-dimethylamine in toluene at 70-80 
o
C to 
give the crude urea 335 as pale yellow oil (Scheme 156). 
 
   334     335 
Scheme 156: Reagents: (i) N,N-Dimethylamine, toluene 
Recrystallisation of the latter from methanol gave 1-benzyl-3-(N,N-dimethyl)-urea 335 in 
85% yield as a white solid. Its melting point (64-65 
o
C) was lower than that reported by 
Anastassiou et al., but was still within range.
[179]
 The NMR spectroscopic data is outlined in 










C NMR spectroscopic data of 335 
δH(ppm) δC(ppm) 
N(CH3)2 2.92 N(CH3)2 36.3 
PhCH2 4.42 PhCH2 45.1 
NH 4.65 p-ArCH 127.3 
ArH 7.30 2 x ArCH 127.8 and 128.6 
- ipso C of Ar 139.7 
 
2.3.2 N´-Benzylmorpholine-4-carboxamide 
The urea 336 was prepared by the reaction of benzylisocyanate 334 with morpholine in 
toluene at 70-80 
o
C (Scheme 157). 
 
                334           336 
Scheme 157: Reagents: (i) Morpholine, toluene 
N´-Benzylmorpholine-4-carboxamide 336 was isolated in 84% yield as a white crystalline 
solid. Its melting point (129-130 
o
C) was slightly higher than that reported in the literature, 
but the narrow range indicated reasonable purity.
[180]
 The spectroscopic data is in good 
correlation with that of Peterson et al..
[181]






2.3.3 N-Phenyl-1-piperidine carboxamide 
The urea 337 was prepared by the addition of phenylisocyanate 338 to piperidine in toluene 
(Scheme 158). 
 
        338               337 
Scheme 158: Reagents: (i) Piperidine, toluene 
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N-Phenyl-1-piperidine carboxamide 337 was isolated as a white solid in 90% yield. Its 
melting point (166-168 
o
C) is in excellent agreement with the literature, as is the 
spectroscopic data.
[182]






3 Preparation of dipolarophiles 
3.1 Formamidines 
There are three sites in the amidine functional group to which substituents can be attached; the 
two nitrogen atoms and the amidine carbon atom.
[68h]
 Substituents at both nitrogen atoms have 
considerable influence on the extent of conjugation. In general, the impact ‘of a substituent at 
any site of the amidino group depends on substitution at the other two sites’.  
Choosing formamidines as the dipolarophile in the 1,3-dipolar cycloaddition with nitrile 
oxides to form Δ
2
,1,2,4-oxadiazolines enabled exploration of subsitituents at the N4 and C5 
position of the oxadiazoline. The formamidines selected during the course of this research 
investigated the effect on stability of the heterocycle when a phenyl, benzyl or p-chlorophenyl 
substituent was at the N4 position of the oxadiazoline. The formamdines targeted also gave an 
indication as to the effect on stability of the oxadiazoline when an N,N-dimethyl, morpholino 
or piperidino substituent is at the C5 position of the oxadiazoline.  
3.1.1 N,N-Dimethyl-N´-benzylformamidine 
N,N-Dimethyl-N´-benzylformamidine as a dipolarophile in a cycloaddition reaction would 
introduce a benzyl substituent at the N4 position of the resulting oxadiazoline and an N-alkyl 
substituent at the C5 position. N,N-Dimethylformamide dimethyl acetal 165 has already been 
used in the synthesis of amidines.
[87a,183]
 N,N-Dimethyl-N´-benzylformamidine 339 was 
prepared by heating benzylamine with N,N-dimethylformamide dimethyl acetal 165 to reflux 
in methanol for 19 h (Scheme 159). 
 
              317       165        339 
Scheme 159: Reagents: (i) Methanol, reflux 
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The amidine 339 was isolated as a clear yellow oil following bulb to bulb distillation (b.p. 
132-136 
o
C @ 15 mmHg) in 93% yield. Proton NMR spectroscopy exhibited the 
characteristic imine methine proton signal at 7.38ppm indicating that the formamidine had 





Figure 57: The 
13
C NMR spectroscopic data of 339 
3.1.2 N´-Benzylformimidoylmorpholine 
N´-Benzylformimidoylmorpholine 318 as a dipolarophile in a cycloaddition reaction would 
introduce a benzyl substituent at the N4 position of the resulting oxadiazoline and a 
morpholine substituent at the C5 position. The synthesis of this formamidine is a two-step 
process: Firstly, N-formylmorpholine 340 is prepared and secondly, this formamide is 
coupled with benzylamine to yield N´-benzylformimidoylmorpholine 318  
N-Formylmorpholine 340 was prepared by heating a solution of morpholine 321 with formic 
acid to reflux until all water (34.5 ml) was collected in a Dean-Stark trap (Scheme 160). The 
formamide 340 was purified by vacuum distillation (b.p. 112-114 
o
C @25 mmHg) and was 
isolated in 91% yield as a clear oil. 
1
H NMR spectroscopic analysis of the product showed the 




              321    340 
Scheme 160: Reagents: (i) Formic acid, toluene 
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Preparation of N´-benzylformimidoylmorpholine 318 involved a Vilsmeier-type condensation 
of N-formylmorpholine 340 with benzylamine 317 in the presence of phosphorous 
oxychloride (Scheme 161) 
 
             317                  340                 318 
Scheme 161: Reagents: (i) POCl3, benzene. 
The amidine 318 was isolated in 47% yield as a clear yellow oil following bulb-bulb 





N-Phenylformimidoylmorpholine 341 was obtained following the addition of a solution of 
phosphorous oxychloride to a mixture of aniline and N-formylmorpholine 340 (Scheme 162).  
 
              317          340      341 
Scheme 162: Reagents: (i) Formic acid, toluene 
The amidine 341 was isolated in 51% yield as a pale yellow crystalline solid following 
recrystallisation from ether : hexane. The amidine showed the same spectroscopic properties 
as those reported by previous researchers in the group with the imine singlet observed at δH 
7.52 ppm.
[140]
 Further spectroscopic techniques were used to examine this amidine. Sampling 
a solution of the amidine 341 in deuterated chloroform at 300K and at 323K yielded 





C NMR spectroscopic data at two different temperatures of a solution of N-
phenylformimidoylmorpholine 341 to illustrate the sharpening of the NCH2 signal of the morpholine 
group at higher temperature 
More typically, rotation around the single C-N bond is hindered by conjugation of the 
nitrogen lone pair of electrons with the carbonyl group.
[184]
 Taking note of the signal for 
NCH2, it appears as a broad singlet in the carbon spectra at 300K. However, increasing the 
temperature by 23 K shows a sharpening of the signal. At the higher temperature, rotation 
about the C-N bond is faster on the NMR spectroscopy time-scale and therefore, a sharpening 
of the signal occurs. The outcome suggests that 300K is the approximate coalescence 
temperature for the process. 342 
3.1.4 N-Phenylformimidoylpiperidine 
N-Phenylformimidoylpiperidine 343 was synthesised using a two-step approach. N-
formylpiperidine 342 was firstly prepared and this was reacted with aniline to yield the 
amidine 343 (Figure 59). 
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        343        342                 323 
Figure 59: Retrosynthetic analysis of amidine 343 
3.1.4.1 N-Formylpiperidine 
N-Formylpiperidine 342 was isolated in 70% yield following the reflux of a solution of formic 
acid with piperidine 323 in toluene (Scheme 163). The solution was refluxed until water that 
was collected had ceased. 
 
                 323    342 
Scheme 163: Reagents: (i) Formic acid, toluene 
The observed boiling point (74-99 
o
C @ 25 mmHg) was in accord with the literature.
[187]
 The 
spectroscopic properties are in excellent correlation with the literature.
[188]
 The formyl proton 
signal was observed at 8.00 ppm. 
3.1.4.2 N-Phenylformimidoylpiperidine  
The formamidine 343 was produced by combining N-formylpiperidine, phosphorous 
oxychloride and aniline in benzene and heating the resulting solution to reflux for 4 h 
(Scheme 164).  
 
       342             343 
Scheme 164: Reagents: (i) Aniline, phosphorous oxychloride, benzene 
N-Phenylformimidoylpiperidine 343 was isolated in 19% yield following recrystallization 
from chloroform:hexane as a pale yellow solid. The melting point (169-170.5 
o
C) differs with 
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Seefelders who reported that 343 was isolated as an oil (b.p. 134-136 
o
C @ 0.5 mmHg)!
[189]
 
The infrared spectrum was consistent with the molecular structure and its molecular ion 
[M+H]
+
 was observed at m/z = 188 under ESI
+
 conditions. NMR spectroscopic data is 
outlined in Table 20 and is in agreement with the structure of 343. 




C NMR spectroscopic data of 343 
δH(ppm) δC(ppm) 
(CH2)3 1.69 N(CH2)(CH2)3 23.2, 25.1 and 26.3 
N(CH2) 3.83 N(CH2) 48.2 
N(CH2) 4.06 N(CH2) 54.0 
p-ArH 7.17 m-ArCH 119.7 
m-ArH 7.28 p-ArCH 126.3 
o-ArH 7.70 o-ArCH 129.5 
N=CH 8.74 i-ArC 137.3 
- N=CH 150.4 
  
3.1.5 N-(N´-p-Chlorophenylformimidoyl)-morpholine 
The formamidine 345 was prepared by heating a solution of p-chloroaniline 344, morpholine 
and phosphorous oxychloride to reflux in benzene (Scheme 165). 
 
               344    345 
Scheme 165: Reagents: (i) Morpholine, phosphorous oxychloride, benzene 
N-(N´-p-Chlorophenylformimidoyl)-morpholine 345 was isolated in 63% yield as a grey 
crystalline solid following recrystallization from chloroform : hexane. It melted over a narrow 
range (66-67 
o
C) and its infrared spectra showed peaks that correlated to stretches in the 
molecule e.g. imine (C=N, 1632 cm
-1
). Its molecular ion [M+H]
+ 
was observed at m/z = 225 
under ESI
+
 conditions. NMR spectroscopic data is outlined in Table 21. 
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C NMR spectroscopic data of 345 
δH(ppm) δC(ppm) 
N(CH2)2 3.52 N(CH2)2 45.8 
O(CH2)2 3.74 O(CH2)2 66.7 
o-ArH 6.88 2 x ArCH 122.2 and 129.1 
m-ArH 7.21 i-ArC 128.0 
ArH 7.49 ArC(Cl) 150.1 




Two methods were used to prepare N-benzylideneaniline 346 (Scheme 166). As this is a 
dehydration reaction involving an aldehyde and and amine, the water must be absorbed 
(method 1) or separated (method 2) from the reaction solution.  
 
          270           172         346 
Scheme 166: The preparation of N-benzylideneaniline 346 
Benzaldehyde 270 and aniline 172 were used to make the imine with magnesium sulphate as 
the drying agent in the first method and a Dean-Stark apparatus was used to separate the water 
in the second method. Both methods gave the title compound in appreciable yield (89-99%), 
however the Dean-Stark apparatus gave the product in 99% yield. From a purity point of 
view, the melting point (49-50.5 
o
C) is in excellent correlation with the literature.
[190]
 
Spectroscopic data, both IR and proton NMR spectroscopic data correlate well with the 
literature. Details of the carbon-13 spectrum are given in Table 22: 
Table 22: The 
13
C NMR spectroscopic data of 346 
δC(ppm) 
4 x ArCH 120.9, 128.8, 128.8 and 129.2 
2 x p-ArCH 125.9 and 131.4 





3.3.1 N-(N´-Phenylbenzimidoyl)-morpholine  
The synthesis of N-(N´-phenylbenzimidoyl)-morpholine 349 was a three-step process 
involving the preparation of N-benzoylaniline 347, followed by its conversion to the 
corresponding imidoyl chloride, N-phenylbenzimidoyl chloride 348 (Figure 60). The crude 
imidoyl chloride 348 was subsequently combined with morpholine to yield the benzamidine 
N-(N´-phenylbenzimidoyl)-morpholine 349. 
 
 349           348        347        320 
Figure 60: Retrosynthetic analysis of benzamidine 349 
N-Benzoylaniline 347 was prepared by stirring a mixture of benzoyl chloride 320 with aniline 
172 and pyridine in THF overnight at room temperature (Scheme 167).   
 
                     172   320       347 
Scheme 167: Reagents: (i) Pyridine, THF 
The amide was isolated in 85% yield as a grey crystalline solid following recrystallization 
from ethanol. The melting point (166-168 
o
C) and spectroscopic properties of the compound 
agree with those reported in the literature.
[191]
 
Heating N-benzoylaniline 347 with phosphorous pentachloride to reflux in toluene gave N-




                 347              348 
Scheme 168: Reagents: (i) PCl5, toluene 
The freshly prepared imidoyl chloride 348 was combined with two equivalents of morpholine 
in ether and the resulting solution was stirred overnight at room temperature (Scheme 169). 
 
        348        321   349 
Scheme 169: Reagents: (i) Ether 
N-(N´-Phenylbenzimidoyl)-morpholine 349 was isolated in 53% yield (over two steps) as a 
pale orange crystalline solid following recrystallization from hexane. Its melting point (92-93 
o
C) is higher than that reported in the literature (88
 o
C), but as the solid melted over a 
relatively narrow range, we concluded that the amidine 349 had been isolated in a pure 
state.
[192]
 The spectroscopic data correlates excellently with those reported in the literature and 
its molecular ion [M+H]
+






N-(N´-Phenylbenzimidoyl)-piperidine 350 was prepared by combining piperidine with the 
crude imidoyl chloride 348 in ether and stirring the solution overnight (Scheme 170). N-
Phenylbenzimidoyl chloride 348 could be prepared by heating N-benzoylaniline 347 with 
phosphorous pentachloride to reflux in toluene which was used without further purification in 
the next step. The amidine 350 was isolated in 57% yield (two steps) as yellow oil. Rappoport 





   347              348        350 
Scheme 170: Reagents: (i) PCl5, Toluene (ii) piperidine, ether 
The spectroscopic data we obtained is in correlation with the literature, however, our spectra 
showed better resolution of the aromatic proton signals. The parent molecular ion [M+H]
+
 
was observed at m/z = 265. 351, 352, 353 
3.3.3 N-(p-Chlorophenyl)-benzimidoyl morpholine 
N-(p-Chlorophenyl)-benzimidoyl morpholine 353 was synthesised via three steps. Preparation 
of N-benzoyl-p-chloroaniline 351, was followed by its conversion to the corresponding 
imidoyl chloride, N-p-chlorophenyl-benzimidoyl chloride 352 (Figure 61). Coupling of the 
crude imidoyl chloride 352 with morpholine yielded the benzamidine N-(p-chlorophenyl)-
benzimidoyl morpholine 353. 
 
      353         352     351      320 
Figure 61: Retrosynthetic analysis for benzamidine 353 
N-Benzoyl-p-chloroaniline 351 was prepared by a nucleophilic substitution reaction of 
benzoyl chloride 320 with p-chloroaniline 344 (Scheme 171). 
 
            344    320       351 
Scheme 171: Reagents: (i) Pyridine, THF 
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Stirring a solution of the p-chloroaniline with benzoyl chloride 351 and pyridine in THF gave 
the amide in 82% yield following recrystallization with ethanol. Its melting point (190-191.5 
o
C) and spectroscopic data correlates well with the literature.
[194]
  
N-p-Chlorophenylbenzimidoyl chloride 352 was isolated as a low melting yellow/brown solid 
following its conversion from the amide 351 with phosphorous pentachloride in toluene 
(Scheme 172). The imidoyl chloride 352 was used directly in the next step without further 
purification. 
 
   351      352 
Scheme 172: Reagents: (i) PCl5, toluene 
The benzamidine 353 was generated by combining morpholine with N-p-chlorophenyl-
benzimidoyl chloride 352 in ether (Scheme 173).  
 
   352      353 
Scheme 173: Reagents: (i) Morpholine, ether 
The benzamidine 353 was isolated in 49% yield (over two steps) as a yellow crystalline solid. 
Its melting point (98-99 
o
C) is in the same range as the literature melting point (113.5 °C), but 
is more than ten degrees lower.
[192]
 Our spectroscopic data for 353 is in accordance with the 
literature and is outlined in Table 23. The ions of m/z = 301 and m/z = 303 represent the 












C NMR spectroscopic data of 353   
 
3.3.4 N-Phenyl-(p-chlorobenzimidoyl)-morpholine  
N-Phenyl-(p-chlorobenzimidoyl)-morpholine 357 was prepared utilising a four-step synthesis 
from p-chlorobenzoic acid 325 (Figure 62). 
 
               357                   356                       355                      354                       325 
Figure 62: Retrosynthetic analysis of benzamidine 357 
3.3.4.1 p-Chlorobenzoyl chloride 
p-Chlorobenzoic acid was converted into its acid chloride 354 using two different chlorinating 
agents (Scheme 174). Initially, thionyl chloride was used. p-Chlorobenzoyl chloride 354 was 
isolated in 98% yield as a pale yellow solid. Its formation was confirmed by a peak at 1776 
cm
-1
 in its IR spectrum. 
 
             325     354 
Scheme 174: Reagents: (i) Thionyl chloride, dichloromethane, or (ii) Oxalyl chloride, dichloromethane 
The other chlorinating agent employed was oxalyl chloride. IR once again confirmed the 
formation of the acid chloride by the C=O peak at 1776 cm
-1
. Oxalyl chloride, while being a 
δH(ppm) δC(ppm) 
N(CH2)2 3.41 N(CH2)2 46.6 
O(CH2)2 3.74 O(CH2)2 66.8 
ArH of p-substituted Ar 6.47 5 x ArCH 123.9, 128.2, 128.5, 129.0 and 129.0 
ArH of p-substituted Ar 6.96 ipso C of Ar 126.4 
ArH 7.09 ipso C of Ar 132.7 
ArH 7.26 ArC(Cl) 149.5 
- N=C 161.0 
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more expensive reagent than thionyl chloride, proved to be much easier to handle. Thionyl 
chloride is malodorous, is typically used in excess and needs to be removed prior to isolation 
of the product. Oxalyl chloride on the other hand is used in an equimolar ratio to the acid and 
the products of the reaction include gaseous carbon monoxide, carbon dioxide and hydrogen 
chloride.  
3.3.4.2 N-(p-Chlorobenzoyl)-aniline 
The amide 355 was synthesised by reacting the acid chloride with aniline in THF in the 
presence of pyridine (Scheme 175).  
 
  354              355 
Scheme 175: Reagents: (i) Aniline, pyridine, THF 
N-(p-Chlorobenzoyl)-aniline 355 was isolated in 77% yield as a white crystalline solid 
following recrystallization from ethanol. Its melting point (198-199 
o
C) compares well to the 
literature.
[195]
 The infrared spectra showed the characteristic absorptions at 3351 and 1653 cm
-
1
 for the N-H and C=O groups respectively as reported in the literature. The 
13
C NMR 
spectroscopic data correlates well with the literature and the molecular structure itself (Figure 
63).  
 
Figure 63: The 
13
C NMR spectroscopic data of 355 
3.3.4.3 N-Phenyl-(p-chlorobenzimidoyl) chloride 
The imidoyl chloride 356 was prepared by heating the amide 355 with phosphorous 
pentachloride to reflux in toluene (Scheme 176). 
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        355      356 
Scheme 176:Reagents: (i) Phosphorous pentachloride, toluene 
IR spectroscopy was used to monitor the process and reaction completion was determined by 
the appearance of the imine stretch (1654 cm
-1
). The crude product was used directly in the 
next step without further purification. 
The imidoyl chloride 356 was combined with morpholine in the presence of pyridine to give 
the benzamidine 357 in 52% yield (two steps) as a pale yellow crystalline solid (Scheme 177). 
 
   356       357 
Scheme 177: Reagents: (i) Morpholine, ether 
The solid benzamidine 357 melted over a narrow range (138-140 
o
C), indicating its purity. Its 
NMR spectroscopy properties are outlined in Table 24. 




C NMR spectroscopic data of 357 
δH(ppm) δC(ppm) 
N(CH2)2 3.38 4H, bs N(CH2)2 46.7 
O(CH2)2 3.74 4H, m O(CH2)2 66.8 
ArH 6.53 2H, m 5 x ArCH 121.5, 122.5, 128.4, 128.7, 130.5 
p-ArH 6.78 1H, m i-ArC 131.4 
ArH 7.03 4H, m i-ArC 134.8 
ArH 7.21 2H, m ArC(Cl) 150.4 
- N=C 159.5 
 
Its molecular ion [M+H]
+
 was observed at m/z = 301 under ESI
+
 conditions. The infrared 
spectrum showed characteristic absorptions at 3071 (aromatic C-H), 1587 (C=N), 1485 (C-N) 





We undertook the synthesis of a range of Δ
2
-1,2,4-oxadiazolines via the 1,3-dipolar 
cycloaddition of nitrile oxides with amidines (Scheme 178). Previous studies by previous 
members of this research group investigated the development of a cascade process in which 
production of a nitrile from a primary nitroalkane was achieved through a heterocyclic 





               358                 359                 360 
 
            360             257    361 
Scheme 178: The 1,3-dipolar cycloaddition reaction of a nitrile oxide and amidine in the formation of a Δ
2
-
1,2,4-oxadiazoline and its subsequent decomposition to the nitrile and urea 
It was observed by Creedon, that the rate of nitrile elimination could be accelerated by the 
presence of electron donating substituents at position -3 and -4 of the five membered ring and 
by having a nitrogen substituent at position -5 of the heterocycle.
[138] 
The advantages of 
utilising this cascade-based reaction are numerous-waste is minimised, encourages faster 
production of the product and would also be less energy consuming. While initial work 
carried out by Levis illustrated that these heterocyclic intermediates decomposed without 
heating or acid catalysts producing a nitrile and urea, Hogan sought to capture these 
heterocyclic intermediates as stable compounds.
[140]
 
Hogan’s research  investigated the reaction of a series of nitrile oxides with a range of 
formamidines.
[140]
 Following on from this research base, the nitrile oxides chosen for our 
study contain electron-withdrawing substituents, which serves to increase the stability of the 
Δ
2
-1,2,4-oxadiazolines formed. Oxadiazolines need to be synthesised as quickly as 
possible.
[138-139]
 Initially, synthesis included an aqueous work-up (following Hogan’s 
procedure) which gave pure products when the oxadiazoline was stable. However, as the 
134 
amidines that we used contained benzyl- groups in place of phenyl group, the oxadiazoline 
structure was less stable which gave decomposition products rather than the heterocycle. 
Therefore, time was a factor to be considered when planning the synthetic procedure. Stir 
time was the first to be reduced. Initial stir times were often 12 h and this was successful in 
some cases. This lead us to believe that some oxadiazoline preparatory scale reactions could 
take as little time as ten minutes to execute (including product isolation and 
1
H NMR 
spectroscopic analysis).  
During our research it was observed, that nitrile oxides appeared to react rapidly with 
formamidines at room temperature to give Δ
2
-1,2,4-oxadiazolines. Such was the case that the 
oxadiazoline was produced within minutes of stirring the nitrile oxide and formamidine at 
room temperature, thus raising the question, could the reaction rates approach diffusion 
control? 
Solvent effects were also explored. Initial methods involved the use of solvents that were 
immiscible in water. This facilitated the washing out of the triethylamine hydrohalide 
precipitate which formed when the hydroximoyl halides were dehydrohalogented by the base 
in generating the nitrile oxide. Dichloromethane, ethyl acetate and ether were used 
predominantly as solvents which would facilitate an aqueous work-up. Instead of using 
solvents in this sense, it was concluded that a solvent in which the precipitate was insoluble 
would be better because it would allow a physical separation of the solid (via gravity 
filtration). Then, simply concentrating the filtrate would produce the oxadiazoline in a pure 
state.  
Stoichiometric equivalents of the nitrile oxide precursor, dipolarophile and base helped in the 
efficient isolation of the oxadiazoline. [Morrocchi et al. used this method of equimolar 
quantities of nitrile oxide and dipolarophile in their investigations into their reactions of nitrile 
oxides with arylacetylenes. 
[27c]
] This helped to avoid unnecessary removal of side products, 
which would ultimately slow down the isolation of the oxadiazoline and may contribute to 
decomposition processes. 
The reported method of addition varies throughout the literature: Martin et al. favoured the 
addition of the base (1.5 equiv) to the hydroximoyl chloride (1.0 equiv.) and excess alkene 
(either at room temperature or initially at 0 °C and then warm to toom temperature).
[64e]
  
However, intially we investigated the addition of hydroximoyl halide to a stirring, cooled 
solution of the dipolarophile and base. On completion of addition, the solution was warmed to 
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room temperature and stirred for an amount of time. We felt that this approach would help to 
reduce the instance of dimerisation of the nitrile oxide to the furoxan. The idea was that the 
1,3-dipole would be trapped immediately by the dipolarophile. 
Aitken et al. outlined different methods for the 1,3-dipolar cycloaddition of nitrile oxides to 




 Firstly, a solution of triethylamine in 
ether was added dropwise to a cooled (0
o 
C), stirring solution of the hydroximoyl chloride and 
imine in ether. The resulting solution was then warmed to room temperature and stirred for 2 
h. The solution was then filtered and the solvent evaporated in vacuo to yield the product. The 
second procedure added a solution of the hydroximoyl chloride in ether to a stirring solution 
of the imine and triethylamine in ether at 0 
o
C. The solution was then warmed to room 
temperature and stirred for 2 h, filtered and evaporated. The former method could be used in 
the majority of cases, however, in the case of sensitive aliphatic imines such as 362, the latter 
method was preferred (Figure 64). Therefore the order of addition was considered important. 
 
362 
Figure 64: Aliphatic imine 362 
Torssell et al. used solid-phase bases (basic Al2O3 and Florisil
®
) as dehydrohalogenating 
agents.
[28a] 
They reported that this ‘simplified the procedure’ and facilitated the whole 
sequence of reactions being performed in ‘one step’. 
Selecting the correct base to use for dehydrohalogenation of the hydroximoyl chloride is 
important. Katritzky et al. used potassium bicarbonate to neutralise HCl liberated from the 
hydroximoyl chloride.
[24g]
 Zhu et al. explored the use of sodium bicarbonate as well as 
triethylamine as the dehydrohalogenating agent and reported that sodium bicarbonate reduced 
the time of reaction from 3 days to 1 day in the synthesis of ∆
2
-1,2,4-oxadiazoline 212 (Figure 
65).
[29]
 An improved yield as well as facilitating the synthesis of a larger range of 
oxadiazolines was reported. However, a reduction in enantioselectivity was also noted when 







Suzuki et al. suggest that the ‘choice of base’ is ‘critical’ especially in the case of ortho-
disubstituted benzonitrile oxides.
[197]
 Interestingly, 4Ǻ molecular sieves were used as 
promoters for the reaction i.e. the base for dehydrohalogenation of the chorooxime. The 
reaction conditions included propan-2-ol as the solvent and a typical reaction temperature of 
50 
o
C. These conditions were sufficient to generate the ortho-disubstituted benzonitrile oxides 
in situ and complete the cycloaddition in 2-60 h. 
The temperature of 1,3-dipolar cycloaddition reaction is important as a competing reaction 
can occur very quickly. Therefore reducing the temperature of the reaction helps to avoid 
dimerisation of the nitrile oxide.
[27e]
 
The proposed factor contributing to the stability of the Δ
2
-1,2,4-oxadiazoline formed through 
cycloaddition reactions of 1,3-dipoles, from hydroximoyl halide precursors, and amidines is 
believed to be the electron density by way of lone pair repulsions in the heterocycle. The 
oxadiazoline structure is made up of a five membered ring containing one oxygen (O1), two 
nitrogen (N2 and N4) and two carbon (C3 and C5) atoms. Each nitrogen atom contributes one 
pair of lone pair of electrons and the oxygen atom contributes two pairs of lone pairs of 
electrons. The N2-O1 bond (outlined in red in Figure 66) has too much inherent electron 
density by way of lone pair repulsions which can be relieved by cleavage of that linkage.  
 
Figure 66: Inherent electron density by way of lone pair repulsions in the Δ
2
-1,2,4-oxadiazoline structure 
Although the reaction mechanism for thermal, un-catalysed decomposition of the 
oxadiazoline has not been established, several pathways for this process can be considered. 
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Initially, putative cyclo-elimination of a nitrile moiety from the oxadiazoline which in turn 
leads to an amino-oxaziridine intermediate 363 could be explored. Subsequent thermal 
rearrangement of this species under the reaction conditions employed would lead to formation 
of the urea (Scheme 179). 
 
      363 
      
Scheme 179: The potential reaction mechanistic pathway to urea from the oxadiazoline 
An alternative mechanistic pathway would involve a concerted proton shift, from C5 to N4, 
followed by nitrile elimination (Figure 67). Another possibility could involve a related proton 
shift to oxygen leading to the generation of an isourea intermediate. The difficulty with this 
proposal is in identifying a role for the acid catalyst in these mechanisms.  
 
Figure 67: The potential intermediates in the formation of urea 
A process involving equilibration of the oxadiazoline with its zwitterion 364 and subsequent 
elimination of the nitrile from this species cannot be ignored. Neither can a similar route 
involving zwitterion 365 (Scheme 180). 
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                  364 
                     
                   365 
Scheme 180: Proposed mechanistic process involving equilibration of the oxadiazoline with its zwitterion 
364/365 and subsequent elimination of the nitrile from this species 
4.1 1,3-Dipolar cycloaddition reactions with formamidines 
4.1.1 Reactions with N,N-dimethyl-N´-benzylformamidine  
The 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from hydroximoyl halide precursors, 
with N,N-dimethyl-N´-benzylformamidine 339 is outlined in the following section. Scheme 
181 outlines the 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from substituted 
benzohydroximoyl halide precursors, with N,N-dimethyl-N´-benzylformamidine 339: 
 
                  339     
Scheme 181: The 1,3-dipolar cycloaddition reaction of 1,3-dipoles) with N,N-dimethyl-N´-
benzylformamidine 339 
The results of these reactions with a variety of substituted benzohydroximoyl chlorides at an 
addition temperature of less than 10 
o
C and triethylamine as the base are summarised in Table 
25. Entry 1 (Table 25) illustrates the reaction of benzohydroximoyl chloride 26 with amidine 
339 (Scheme 182).  
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        26             339                   366 
Scheme 182: The 1,3-dipolar cycloaddition reaction of benzohydroximoyl chloride 26 with N,N-dimethyl-
N´-benzylformamidine 339 
The benzonitrile 175 and the urea 335 were both observed in the 
1
H NMR spectrum indicating 
that the hetereocycle formed and was subsequently converted (Scheme 183). It was 
impossible to decipher the ratio as there is an overlapping of their characteristic signals in the 
aromatic region. A ratio of 1:1 would be anticipated as there is not any evidence for the 
heterocycle 366. Conclusive evidence for the formation of the oxadiazoline heterocycle would 
be immediately apparent in the 
1
H NMR spectroscopic analysis. The proton attached to the C-
5 of the oxadiazoline (highlighted in red in oxadiazoline 366 in Scheme 183) is typically 
observed in the 6 ppm region which integrates as a 1H singlet.  
 
366     175         335 
Scheme 183: The conversion of oxadiazoline 366 to nitrile 175 and urea 335 
A second attempt at the same conversion (Entry 2) involved a shorter reaction time. The stir 
time was reduced to 1 h and the triethylamine hydrochloride was isolated by filtration, aiding 
the rapid isolation of the oxadiazoline 366 in 50% yield. The characteristic proton NMR 
spectroscopic signal for oxadiazoline formation is of the proton attached to the C5 in the 
oxadiazoline which is typically in the region of 6ppm. For oxadiazoline 366, this proton 
signal was observed at 6.05ppm. This signal coupled to the absence of the precursor peaks 
(amidine δH = 7.38 ppm) indicated that the heterocycle had formed. 
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Table 25: 1,3-Dipolar cycloaddition reaction of 1,3-dipoles with N,N-dimethyl-N´-benzylformamidine 339 
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1 26 H Ether 12 h A 
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   367                          339  
(88:12) 














                                                 
2
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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An attempt to introduce thermal stability into the heterocycle by attaching a more electron-
withdrawing group (R = p-nitrophenyl) is illustrated by entry 3, which shows the production 
of oxadiazoline 367. The formation of oxadiazoline 367 was confirmed by the presence of the 
oxadiazoline proton NMR spectroscopic signal at 6.14 ppm. With a reaction stir time of ten 
minutes followed by an aqueous work-up, it appears that the reaction did not go to 
completion. The oxadiazoline 367 and amidine 339 were isolated as a mixture in a ratio of 88 
: 12. Entry 4 shows the reaction of the same substrates but with a stir time of one hour. In this 
case, the cycloaddition reaction went to completion and the oxadiazoline 367 was isolated in 
19% yield after recrystallisation as a bright yellow solid. However, the parent molecular ion 
was not observed during mass spectral analysis. Incorporating a faster isolation time by 
carrying out a filtration of the triethylamine hydrochloride precipitate in conjunction with a 
                                                 
3
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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ten minute stir time was once again attempted. In this case, the oxadiazoline 367 was 
successfully isolated as a yellow solid in 47% yield (Entry 5). 
We then investigated if the nitro substituent in a meta-position of the aromatic ring would 
influence the reaction outcome. The Hammett σ constants for m-nitro (+0.71) and p-nitro 
(+0.78) substituents on phenyl rings are similar so one would predict that the nitrile oxides 
should react at a similar rate.
[52]
 Entries 6-8 (Table 25) portray the action of m-
nitrobenzohydroximoyl chloride 276 with the formamidine 339. Whether a stir time of ten 
minutes or an hour was employed, the oxadiazoline 368 was isolated, regardless of the 
purification procedure. However, there was a variation in the yield of oxadiazoline. When the 
reaction was carried out in dichloromethane (Entry 6), a yield >100% was attributed to 
dichloromethane present in the sample. Increasing the stir time to one hour resulted in a yield 
of 23% (Entry 7). The formation of the oxadiazoline 368 was confirmed by the presence of 
the oxadiazoline proton signal at 6.14 ppm in the 
1
H NMR spectroscopic analysis.  
The results of the reactions of 2,4,6-trimethylbenzohydroximoyl chloride 281 with 
formamidine 339 is outlined in entries 9-10. The absence of an oxadiazoline peak in the 
1
H 
NMR spectrum following overnight stirring suggests that the oxadiazoline did not form. Since 
the 
1
H NMR spectrum peaks do not correlate to the amidine 339 or the mesitonitrile-N-oxide 
7, the amidine 339 may have hydrolysed to the amide 319 (Scheme 184). Comparison with an 
authentic sample of amide 319 confirms this. 
 
         339           319 
Scheme 184: Hydrolysis of amidine 339 to the amide 319  
Entry 10 shows that the cycloaddition did not take place within 10 min as the amidine (δH = 
7.38 ppm) and nitrile oxide were evident. The dehydrohalogenation did occur as is evident by 
the formation of mesitonitrile-N-oxide 7 which has characteristic proton NMR spectroscopy 
signals at 2.30 and 2.42 ppm. This suggests that the mesitonitrile-N-oxide/amidine 339 
combination is not as reactive as that of the amidine with other nitrile oxides. 
The 1,3-dipolar cycloaddition reaction of 1,3-dipoles from dihaloformaldoxime precursors 
with N,N-dimethyl-N´-benzylformamidine 339 is discussed in this section. To explore the 
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effect of introducing bromine as a substituent at the 3-position of the heterocycle 370, the 
reaction of dibromoformaldoxime 41 with formamidine 339 was attempted (Scheme 185). 
 
         41         339           370 
Scheme 185: The 1,3-dipolar cycloaddition reaction of 1,3-dipoles (from dihaloformaldoxime precursors) 
with N,N-dimethyl-N´-benzylformamidine 339 
Typically, we used in the dehydrohalogenation of the hydroximoyl halide precursors. 
However, in the case of dibromoformaldoxime, Herdewijn et al.
[145f]
 found that the 
bromonitrile oxide 13 could not be generated from dibromoformaldoxime 41, when 
triethylamine was used as the base (Scheme 186). Therefore potassium t-butoxide was used 
initially to generate the nitrile oxide in the synthesis of oxadiazoline 370.  
 
          41      13 
Scheme 186: The conversion of dibromoformaldoxime 41 to bromonitrile oxide 13 
The result of this reaction was the formation of N,N-dimethylformamide 371 and unidentified 
product(s). This suggests that if the heterocycle formed and then degraded, it may have 
proceeded to the nitrile (cyanogen bromide 372) and the urea 335 (Scheme 187) in 
competition with another process (formation of DMF 371, Scheme 188). Cyanogen bromide 
would not be recognisable by 
1




                     370              372         335 
Scheme 187: The heterocycle formation and subsequent degradation may have proceeded to the nitrile 
(cyanogen bromide 372) and the urea 335 
 
        370       371    
Scheme 188: The proposed competing cycloreversion reaction of oxadiazoline 370 
Repeating the reaction with a shorter stir time (10 min) and using triethylamine as the base 
gave similar results. N,N-Dimethylformamide 371 was isolated along with unknown 
product(s). 
The 1,3-dipolar cycloaddition reaction of 1,3-dipoles from 1-aroyl-1-chloroformaldoxime 
precursors with N,N-dimethyl-N´-benzylformamidine 339 involved the reaction of 1-benzoyl-
1-chloroformaldoxime 286 with formamidine 339 in the preparation of oxadiazoline 373 
(Scheme 189). A one hour stir time combined with isolation of the product by filtration gave 
the oxadiazoline in 44% yield as a pale yellow oil whose spectroscopic properties were in 
excellent agreement with the structure. 
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        286                 339         373 




H NMR spectroscopic signal was identified at 6.12 ppm for the proton 
attached to the C-5 of the heterocycle (Table 26). The parent molecular ion was not observed 
in the mass spectral data. However, a methanol adduct of the parent molecular ion 
(M+H
+
+HOMe) was present at 342 amu under ESI conditions. Isolating the oxadiazoline 373 
within 10 min of stirring gave a slight increase in yield to 51%. 




C NMR spectroscopic data of 373 
δH(ppm) δC(ppm) 
N(CH3)2 2.38 N(CH3)2 36.4 
PhCH2 4.29 & 5.08 PhCH2 46.5 
NCHON 6.12 NCHON 107.7 
ArH 7.29 6 x ArCH 127.8, 128.4, 128.7, 130.5 & 134.1 
m-ArH 7.46 ipso C of Ar 136.0 
p-ArH 7.60 ipso C of Ar 136.7 
o-ArH 8.12 C=N 151.4 
- C=O 183.6 
 
Table 27 outlines the 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from other 
hydroximoyl halide precursors, with N,N-dimethyl-N´-benzylformamidine 339: 
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Table 27: The 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from other hydroximoyl halide precursors, 
with N,N-dimethyl-N´-benzylformamidine 339 
 
      295, 299        339                    374, 375  








1 295 EtO2C- -Cl 12 h A 
 
    
374                     315 
(85 : 15) 
2 295 EtO2C- -Cl 1 h B 
 
  
374                   315 
(78 : 22) 
3 295 EtO2C- -Cl 10 min B 
 
    
374                     315 
(32 : 68) 




   47% 
  
Disclosures in the literature by Kozikowski et al.,
[157]
 emphasise the versatility of 
ethylchloroglyoxalate oxime as a dipole precursor (Figure 68). ‘Due to the ready availability 
of chlorooxime 295, we were able to more easily examine the reactivity of 376 with a large 
number of alkenes. Since 376 generally gave higher yields of cycloadducts than did 304 and 
since its immediate precursor is more easily prepared, 376 is clearly the dipole of choice.’ 
[157]
  
                                                 
4
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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       295        376            304 
Figure 68: The structures of nitrile oxides 295, 376 and 304 
The outcome from our reaction of ethylchloroglyoxalate oxime 295 with the formamidine 339 
(Scheme 190) is outlined in Entries 1-3 (Table 27). The oxadiazoline product 374 was isolated 
as a yellow oil following stirring of the reactants overnight. The 
1
H NMR spectroscopic 
analysis of that oil showed the characteristic proton signal for the oxadiazoline was observed 
at 6.08 ppm as well as the presence (15%) of furoxan 315 as illustrated by the characteristic 
signals at 1.42 and 4.48 ppm. Reducing the stir time to 1 h and to 10 min respectively showed 
that oxadiazoline 374 was generated within a shorter reaction time (10 min). However, the 
quantity of furoxan 315 increased as the reaction time became shorter. The rate of addition of 
ethyl chloroglyoxalate oxime 295, although still dropwise, may have been increased during 
the shorter reaction times, accounting for the increase in furoxan 315 (up to 68%).  
 
       295           339           374 
Scheme 190: The 1,3-dipolar cycloaddition reaction of ethylchloroglyoxalate oxime 295 with N,N-
dimethyl-N´-benzylformamidine 339 
The formation of furoxan 315 during 1,3-dipole generation from the hydroximoyl chloride is 
well documented in the literature, with a number of experimental techniques being employed 
to reduce furoxan formation (Scheme 191).
[157,198]
 Dimerisation of the nitrile oxide to the 
furoxan may be reversible under the reaction conditions used. 
148 
 
              376        315 
Scheme 191: The dimerisation of nitrile oxide 376 to furoxan 315 
Entry 4 illustrates the reaction of 1-(p-toluenesulfonyl)-1-bromoformaldoxime 299 with 
amidine 339 in the preparation of the oxadiazoline 375 (Scheme 192).  
 
          299   339     375 
Scheme 192: 1,3-Dipolar cycloaddition reaction of 299 with amidine 339  
Comparison of the 
1
H NMR spectrum of an authentic sample of the urea 335 and literature 
data of the nitrile 377 indicate that the oxadiazoline 375 had been isolated in a mixture with 
nitrile 377 and urea 335 (ratio of 66 : 17 : 17) (Scheme 193).
[199]
 The characteristic proton 
signal for the oxadiazoline was observed at 5.94 ppm indicating the heterocycle had formed. 
 
        375     377        335 
Scheme 193: The cycloreversion of oxadiazoline 375 to the corresponding nitrile 377 and urea 335 
Having the N,N-dimethylamino group at C-5 position on the oxadiazoline ring inhibits our 
ability to isolate the corresponding oxadiazolines. This is potentially due to the fact that the 
Δ
2
-1,2,4-oxadiazoline is a small heterocycle with three electron density rich heteroatoms-
oxygen and nitrogen. The nitrogen on the C-5 of the molecule would also contribute to 
electron pair repulsion, especially at the N-O of the oxadiazoline, and result in an un-
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catalysed decomposition of the oxadiazoline. Electron withdrawing groups would reduce the 
electron density of the N-O bond through inductive effects and thereby stabilise the structures. 
In an effort to stabilise the oxadiazoline structure, introduction of a more electron 
withdrawing morpholine group at C-5 was explored. It was anticipated that the morpholino 
group would yield isolable oxadiazolines. 
4.1.2 Reactions with N-benzylformimidoylmorpholine 
A variety of substituted benzohydroximoyl chlorides were reacted with N-
benzylformimidoylmorpholine 318 at an addition temperature of less than 10 
o
C and 
triethylamine as the base. The results of these reactions are summarised in Table 28.  
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Table 28: The 1,3-dipolar cycloaddition reaction of 1,3-dipoles with N-benzylformimidoylmorpholine 318 
 
                          318     








1 26 H- 12 h A 
           
         175                               336  
                       (1 : 1) 
2 275 p-NO2- 12 h A         
378                               336  
(1 : 1) 




4 275 p-NO2- 10 min B           
378                              336  
(1 : 1) 
5 276 m-NO2- 10 min B             &  Unidentified 
Product(s) 
              336 
6 281 2,4,6-(CH3)3- 12 h A  
336 
0.01% 
7 281 2,4,6-(CH3)3- 10 min B           
379                         336  
(67 : 33) 
 
                                                 
5
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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Entry 1 (Table 28) illustrates the reaction of benzohydroximoyl chloride 26 with N-
benzylformimidoylmorpholine 318 in the attempted synthesis of oxadiazoline 380 (Scheme 
194). 
 
      26                318                  380 
Scheme 194: The reaction of benzohydroximoyl chloride 26 with N-benzylformimidoylmorpholine 318  
The reagents were stirred overnight and an attempt at isolating the oxadiazoline 380 was 
made following an aqueous work-up. However, the nitrile 175 and urea 336 were the only 
products isolated in 42.7% yield and in a 1:1 ratio,indicating that the oxadiazoline 380 had 
decomposed (Scheme 195).  
 
    380                 175         336 
Scheme 195: The conversion of oxadiazoline 380 to nitrile 175 and urea 336 
Their presence was confirmed by comparison of the spectroscopic properties of nitrile 175 
with literature data and comparison of the urea 336 with an authentic sample of the 
compound.
[200]
 The authentic sample of urea 336 was produced through the reaction of 
benzylisocyanate 334 with N-morpholine 321 (Scheme 196). 
 
           334               321               336 
Scheme 196: Reaction of benzylisocyanate 334 with N-morpholine 321 to form urea 336 
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Entries 2-4 chart the results achieved when p-nitrobenzohydroximoyl chloride 275 was 
combined with amidine 318 to prepare a sample of oxadiazoline 381 (Scheme 197). An 
overnight stir of the reaction mixture was employed.  
 
        275       318               381 
Scheme 197: The preparation of oxadiazoline 381 
Subsequent analysis of the product mixture showed that it was composed of a small amount 
of the oxadiazoline 381 combined with the nitrile 378 and urea 336 as the major products. As 
the oxadiazoline was still present, it can be concluded that the oxadiazoline was in the process 
of decomposition (Scheme 198). The characteristic oxadiazoline proton attached to the C-5 in 
the oxadiazoline was observed at 6.08 ppm as a 1H singlet in 
1
H NMR spectrum. The urea 
336 was isolated by crystallisation and its identity confirmed by comparison with an authentic 
sample.  
 
381        378       336 
Scheme 198: The cycloreversion of oxadiazoline 381 to nitrile 378 and urea 336 
The second attempt (Entry 3) at isolating the oxadiazoline involved a ten minute stir time 
followed by an aqueous work-up. The yellow solid that resulted had the same spectroscopic 
properties as the nitrile oxide 265 (Figure 69). 
 
265 
Figure 69: The structure of nitrile oxide 265 
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By introducing filtration of the reaction mixture (Entry 4), it was anticipated that the overall 
isolation time could be reduced. This resulted in a mixture of compounds being isolated 
which on comparison with authentic samples of urea 336, nitrile oxide 265, hydroximoyl 
chloride 275 and amidine 318, illustrated that the urea 336 and nitrile 378 had been isolated. 
Thus indicating that oxadiazoline 381 had decomposed even in ten minutes. 
An attempt to insert a m-nitrophenyl substituent at the C-3 position of the oxadiazoline (R
1
 = 
m-NO2C6H4) is illustrated in entry 5 of Table 28. Entry 5 shows a mixture of products with 
the urea 336 alone being identifiable on comparison with literature data and authentic samples 
(Scheme 199). The IR spectra show that decomposition had occurred with an intense peak at 
3278 cm
-1
 indicating the NH stretch of the urea. This absorption plus an intense peak at 1660 
cm
-1
 identifies the urea. The products were poorly soluble in CDCl3 which may have 
contributed to our difficulty in assigning their molecular structures.  
 
     382      383         336 
Scheme 199: The conversion of oxadiazoline 382 to nitrile 383 and urea 318. 
Entry 6 refers to the reaction of 2,4,6-trimethylbenzohydroximoyl chloride 281 with amidine 
318 in the attempted synthesis of oxadiazoline 384 (Scheme 200). The reaction mixture was 
stirred overnight and following recrystallization from ethyl acetate and hexane, the urea 336 
was isolated in 0.01% yield.  
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     281            318         384 
Scheme 200: The attempted synthesis of oxadiazoline 384 
Reducing the stir time to ten minutes and comparing the spectra with the literature data for the 
nitrile 379 and with an authentic sample of the urea 336 established that a mixture of urea and 
nitrile was formed in a ratio of 33 : 66 (Entry 7) (Scheme 201).
[201]
 The IR spectrum shows a 
broad peak at 3296 cm
-1
 and an intense peak at 1671 cm
-1
 which are indicative of urea. The 
peak at 2291 cm
-1
 could indicate a nitrile group, but is different from that reported by 
Ushijima et al. (2218 cm
-1
) for 2,4,6-trimethylbenzonitrile 379. This discrepancy may be due 
to a different media employed in analysis. Ushijima et al. did not specify the media used for 
their measurements. 
 
    384            379         336 
Scheme 201: The decomposition of oxadiazoline 384 to nitrile 379 and urea 336 
The results of the attempted 1,3-dipolar cycloaddition reactions of 1,3-dipoles from 
dibromoformaldoxime precursor with N-benzyformimidoylmorpholine 318 at an addition 
temperature of less than 10 
o
C is discussed in this section. The reaction of 
dibromoformaldoxime 41 with amidine 318 which would potentially generate oxadiazoline 
385 is outlined Scheme 202. Both experiments were carried out under similar reaction 
conditions. Different bases were used for dehydrohalogenation - triethylamine and potassium 
t-butoxide - both produced the same outcome. 
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         41       318             385 
Scheme 202: The 1,3-dipolar cycloaddition reaction of 41 with N-benzylformimidoylmorpholine 318 
Comparing the reaction mixture with authentic samples of N-formylmorpholine 340 and urea 
336 showed that both compounds were isolated in a ratio of 50 : 50. This result suggests that 
the oxadiazoline is decomposing via two different pathways simultaneously (Scheme 203). 
Infrared spectra of the products of both reactions show a peak at ~2216 cm
-1 
which may 
additionally indicate the presence of a nitrile containing compound.  
 
          340                     385           336 
Scheme 203: The cycloreversion of oxadiazoline 385 via two different routes 
The attempted 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from a 1-aroyl-1-
chloroformaldoxime precursor, with N-benzylformimidoylmorpholine 318 at an addition 
temperature of <10 
o
C to form oxadiazoline 386 is discussed in this section. Scheme 204 
refers to the reaction of 1-benzoyl-1-chloroformaldoxime 286 with amidine 318 in the 
attempted preparation of oxadiazoline 386. 
 
           286           318      386 





H NMR spectrum with an authentic sample of urea 336 and with literature 
data of nitrile 387 show that both compounds were isolated as a mixture, indicating the 




               386                 387       336 
Scheme 205: The cycloreversion of oxadiazoline 386 to form nitrile 387 and urea 336 
The ratio of products was difficult to determine as the characteristic proton NMR 
spectroscopy peaks were overlapping. The IR data confirms the presence of a nitrile (2285 
cm
-1
), however this does not correlate closely with the literature data for the compound 387 
(2230 cm
-1
). The discrepancy between the reference data may be the media used to analyse 
the IR spectrum. A KBr disc was used by Ibrahim et al., whereas we employed a film for IR 
analysis.
[202]
 The broad absorption at 3285 cm
-1
 shows the presence of the NH of the urea. 
This combined with the intense peak at 1660 cm
-1
 confirms that secondary conversion of the 
oxadiazoline into nitrile 387 and urea 336 took place within the ten minute reaction time. 
The 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from other hydroximoyl halide 
precursors, with N-benzylformimidoylmorpholine 318 at an addition temperature of <10 °C is 
outlined in Table 29. 
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Table 29: The 1,3-dipolar cycloaddition reaction of 1,3-dipoles with N-benzylformimidoylmorpholine 318 
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Ethylchloroglyoxalate oxime 295 and amidine 318 were combined to explore potential to 
prepare oxadiazoline 388 (Entries 1-2, Table 29). An overnight stir time (Entry 1), followed 
by recrystallization from ethyl acetate and hexane gave no significant amount of any product 
other than a few crystals of urea 336 (0.01%). Decreasing the stir time to ten minutes (Entry 
2) gave a mixture of products. Comparison of 
1
H NMR spectrum with authentic samples 
                                                 
6
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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established that N-benzylformimidoylmorpholine 318 and 3,4-diethoxycarbonylfuroxan 315 
were present in a ratio of 43 : 57. Filtration of the sample should have removed all of the 
triethylammonium chloride, but it was evident in the 
1
H NMR spectrum. The complete 
consumption of triethylamine and the absence of hydroximoyl chloride peaks in the 
1
H NMR 
spectrum indicate that the hydroximoyl chloride had been successfully converted to the nitrile 
oxide 376 (Figure 70). This nitrile oxide is prone to dimerisation and converted into the 
furoxan before undergoing cycloaddition. Dimerisation of nitrile oxide to 315 is noted in the 




      376         315 
Figure 70: Nitrile oxide 376 and furoxan 315 
This indicates that the amidine 318 may not be as reactive a dipolarophile as amidine 339 for 
example, as results outlined in Table 27 illustrates that nitrile oxide 376 did not have the same 
dimerisation issue when reacted with amidine 339 (Figure 71). Many experimental techniques 
are outlined in the literature as a means to reduce dimerisation of the nitrile oxide during the 
cycloaddition reaction. Some involve using a different base, others include physically adding 




          339                    318 
Figure 71: Amidines 339 and 318 
Entry 3 (Table 29) relates to the reaction of 1-p-toluenesulfonyl-1-bromoformaldoxime 299 
with amidine 318 in the attempted formation of the oxadiazoline 389 (Scheme 206).  
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    299                                  318                                                389 
Scheme 206: The attempted formation of oxadiazoline 389 
With a stir time of ten minutes and the comparison of 
1
H NMR spectrum with those of 
authentic samples of urea 336, nitrile oxide 307, nitrile oxide dimer 309 and with the literature 




        299            307                  309 
Scheme 207: The dehydrohalogenation of 299 
This suggests that while the nitrile oxide 307 dimerised, the oxadiazoline 389 formed but 
decomposed to the nitrile 377 and urea 336 (Scheme 208). The infrared spectra showed peaks 
at 3285 and 1655 cm
-1
 which may correlate to the urea 336 and the peak at 2219 cm
-1
 to the 
nitrile 377. However, the literature data suggests that the IR absorption for C≡N in compound 




. The characteristic proton NMR spectroscopic signal for oxadiazoline 
formation is of the proton attached to the C5 in the oxadiazoline which is typically in the 
region of 6ppm. For oxadiazoline 389, this proton signal was observed at 5.94 ppm. 
                                                 
7
 The difference may be attributed to medium effects in the composition of the mixture examined. 
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                            389                          377        336 
Scheme 208: The cycloreversion of oxadiazoline 389 to nitrile 377 and urea 336 
The reaction of cyanoformohydroximoyl chloride 304 with amidine 318 is outlined in entry 4 
(Scheme 209). Following a 30 min stir time and an aqueous work-up, a mixture of products 
was isolated.  
 
        304        318                        390 
Scheme 209: The synthesis of oxadiazoline 390 
Spectroscopic comparison with authentic samples of amidine 318 and urea 336 established 
that both were present (Scheme 210). The oxadiazoline 390 was also present as confirmed by 
a 
1
H NMR spectroscopy characteristic singlet at 6.08 ppm. Carbon-13 NMR spectroscopy 
confirmed the presence of a nitrile at 107.40 ppm indicating cyanogen 391 (NC-CN) was 
present. It can be concluded that the oxadiazoline 390 was undergoing cycloreversion to the 
nitrile 391 and urea 336 at the time of analysis. 
 
          390        391     336 
Scheme 210: The cycloreversion of oxadiazoline 390 to the nitrile 391 and urea 336 
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4.1.3 Reactions with N-phenylformimidoylmorpholine 
In order to promote formation of a more stable oxadiazoline, we changed from an N-benzyl to 
an N-phenyl amidine. It was anticipated that the addition of a phenyl substituent directly 
attached to the oxadiazoline ring at the N-4 position would further stabilise the oxadiazoline 
formed during the cycloaddition reactions through inductive effects of the aromatic ring. The 
results of these reactions with a variety of substituted benzohydroximoyl chlorides with N-
phenylformimidoylmorpholine 341 at an addition temperature of less than 10 
o
C and 
triethylamine as the base are summarised in Table 30. 
Table 30: The 1,3-dipolar cycloaddition reactions of substituted benzohydroximoyl chlorides with 341 
 
             341 













2 26 H- Ether 1 h B 
 
          & Unidentified 
Products 
             267 






                                                 
8
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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           341       394         7   
(50 : 50) 
 
Entries 1-2 show the reaction of benzohydroximoyl chloride 26 with amidine 341 in the 
preparation of oxadiazoline 267 (Scheme 211). With a ten minute stir time (Entry 1), an 
aqueous work-up and recrystallization from ethyl acetate and hexane, the oxadiazoline was 
isolated as a white solid in 26% yield. The characteristic oxadiazoline proton attached to the 
C-5 in the oxadiazoline was observed at 6.13 ppm as a 1H singlet in its 
1
H NMR spectrum. 
                                                 
9
Method A indicates an aqueous work up, method B indicates isolation by filtration. 
10
Addition temperature increased to 20°C for this entry. 
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    26      341       267 
Scheme 211: The synthesis of oxadiazoline 267 
A study of the conversion of the oxadiazoline 267 into its nitrile 175 and urea 395 products 
(Scheme 212) by time course 
1
H NMR spectroscopic analysis was next undertaken.  
 
267            175       395 
Scheme 212: The conversion of oxadiazoline 267 to nitrile 175 and urea 395 
Figure 72 illustrates that the urea 395 began to form within 24 h of storing the oxadiazoline 
267 in chloroform-d1 at room temperature. Subsequent analysis showed that the oxadiazoline 
267 remained in a small quantity after 46 days at 300 K. 
 
Figure 72: The conversion of oxadiazoline 267 to urea 395 in CDCl3 at 300 K (Scheme 212)
11
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To explore the rate of conversion of the oxadiazoline into urea, proton NMR spectroscopic 
analysis was the tool used. To determine the relative concentration of oxadiazoline and urea in 
the sample analysed, the relative integral of the heterocyclic 5-H proton in oxadiazoline 267 
was integrated as being equivalent to one proton in each proton NMR spectrum obtained over 
the time course of this study. The relative integral of the urea NH proton was then determined 
in comparison to the oxadiazoline 5-H proton signal in the same spectrum (Figure 73). These 
values were combined to give the overall total integration. The concentration of oxadiazoline, 
relative to that at t = 0 days, [oxadiazoline]rel was determined as a percentage of the 
oxadiazoline integration divided by the total integration to facilitate the relative rate constant 
determination. The concentration of urea, relative to that at t = 0 days, [urea]rel was then 
determined as a percentage of the urea integration divided by the total integration. For 
determination of a relative rate constant, krel, the molar concentration was not used, instead the 
relative concentrations, as defined by the relative percent integration of the oxadiazoline and 
urea, denoted [oxadiazoline]rel and [urea]rel in the following discussion. 
          
   267           395 
Figure 73: The proton heterocyclic 5-H proton of 267 and the NH proton of 395 (highlighted in red in each 
structure) used in the determination of concentration for relative rate constant calculation 
The rate law for a first order process is given by the expression shown below, where [A] is the 
molar concentration of the reactant. 
][AkRate   
When integrated, the rate law has the following form: 
0]ln[]ln[ AktA   
[A]0 is the reactant concentration at t = 0. This equation is in the form of a standard equation 
of a line, with ln[A] on the y-axis, the time in seconds t on the x-axis, and ln[A]0 as the 
intercept. The rate constant k can thus be determined from the slope of a plot of: 
t    vs.ln[A]  
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The rate law for a second order process where one reactant is used and is given by the 
expression shown below, where [A] is the molar concentration of the reactant. 
2][AkRate   









This equation is in the form of a standard equation of a line, with 1/[A] on the y-axis, the time 
in seconds t on the x-axis, and 1/[A]0 as the intercept. The rate constant k can thus be 







The oxadiazoline reaction (Table 30, Entry 1) follows first order kinetics, and a relative rate 




) was calculated from the graph of ln[Oxadiazoline 267]rel versus 
time (d) (Figure 74).  
 
Figure 74: Determination of relative rate constant, krel by plotting ln[oxadiazoline]rel vs time (d) with a 
straight line fit  
Plotting the relative oxadiazoline (Figure 74) and urea (Figure 75) concentrations with time 
illustrates that each exhibits slightly differing behaviour. The plot of relative oxadiazoline 
concentration with time portrays a much better correlation to a first order reaction, whereas 
the plot of relative urea concentration with time shows a biphasic property with a first-order 
y = -9E-07x + 4.8677 






















segment later in the process. This difference may be attributed to the practicality of measuring 
a signal that disappears with time (the oxadiazoline), which is usually easier, in contrast to the 
ability to accurately integrate the broad signal of the amide NH that increases with time. 
However, both of the relative rate constants that were determined are of the same order of 
magnitude. 
 
Figure 75: Determination of relative rate constant, krel by plotting ln[urea 395]rel vs time (d) with curve fit 
A second order plot does not give a linear correlation for either the oxadiazoline or urea 
(Figure 76 and Figure 77). 
 















































Figure 77: Second order rate check: 1/[urea 395]rel vs time (d) 
To try to improve the yield of oxadiazoline 267, the stir time of the reaction was extended 
(entry 2, Table 30), which gave a mixture of products. It appears as though another substance 
containing a morpholine group in its molecular structure is present in a 1:1 ratio with 
oxadiazoline 267. The aromatic peaks were also too numerous to correlate to just the 
oxadiazoline alone. However, comparison with the urea 395, amidine 341 and N-
formylmorpholine showed that none of these were present.  
The results of the reaction of p-nitrobenzohydroximoyl chloride 275 and amidine 341 in the 
preparation of oxadiazoline 392 are summarised by entries 3-5 in Table 30 (Scheme 213).  
 
        275        341         392 
Scheme 213: The preparation of oxadiazoline 392 
With a stir time of 1.25 h, an aqueous work-up and recrystallization from ethyl acetate - 
hexane, the oxadiazoline was obtained as a pale yellow crystalline solid in 41% yield (Entry 
3). Its spectroscopic properties were in excellent agreement with the proposed structure. The 
characteristic oxadiazoline proton attached to the C-5 in the oxadiazoline was observed at 
6.19 ppm as a 1H singlet in 
1
H NMR spectrum. Reducing the stir time to ten minutes 
produced the oxadiazoline in just 29% yield (Entry 4). When the oxadiazoline was isolated by 


























with a 1 h stir time (Entry 5). A study of the conversion of the oxadiazoline into its nitrile and 
urea products by time course 
1
H NMR spectroscopic analysis was next undertaken (Scheme 
214).  
 
    392              378       395 
Scheme 214: The decomposition of oxadiazoline 392 to nitrile 378 and urea 395 
The results are shown in Figure 78. It showed that urea 395 began to form within 8 days. 
 
Figure 78: The conversion of oxadiazoline 392 to urea 395 at 300 K in CDCl3
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To explore the rate of conversion of the oxadiazoline to urea, proton NMR spectroscopic 
analysis was the tool used. To determine the relative concentration of oxadiazoline and urea in 
the sample analysed, the relative integral of the heterocylic 5-H proton in oxadiazoline 392 
was integrated as being equivalent to one proton in each proton NMR spectrum obtained over 
the time course of this study. The relative integral of the urea NH proton was then determined 
in comparison to the oxadiazoline 5-H proton in the same spectrum. These values were 
combined to give the overall total integration. The concentration of oxadiazoline, relative to 
that at t = 0 days, [oxadiazoline]rel was determined as a percentage of the oxadiazoline 
integration divided by the total integration, to facilitate the relative rate constant 
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determination. The concentration of urea, relative to that at t = 0 days, [urea]rel was then 
determined as a percentage of the urea integration divided by the total integration. For the 
purpose of relative rate constant determination, the molar concentration was not used, but the 
relative percent integration of the oxadiazoline and urea, denoted [oxadiazoline]rel and [urea]rel 
in the following discussion. Plotting [oxadiazoline 392]rel (Figure 79) and [urea 395]rel (Figure 
80) versus time illustrates that each exhibits slightly differing behaviour. The plot of the 
[oxadiazoline 392]rel with time portrays a much better correlation to a first order reaction, 
whereas the plot of [urea 395]rel with time shows a biphasic property with a first-order 
segment later in the process.  
 
Figure 79: Determination of relative rate constant, krel by plotting ln[oxadiazoline 392]rel vs time (d) 
straight line fit 
 
Figure 80: Determination of relative rate constant, krel by plotting ln[urea 395]rel vs time (d) 
A second order plot does not give a linear correlation for either the oxadiazoline or urea 
(Figure 81 and Figure 82). The decomposition of oxadiazoline 392 was a first order reaction 
y = -4E-07x + 4.8976 




















































) was calculated from the graph of 
ln[Oxadiazoline 392] versus time (d) (Figure 79).  
 
Figure 81: Second order rate check: 1/[oxadiazoline 392]rel vs time (d) 
 
Figure 82: Second order rate check: 1/[urea 395]rel vs time (d) 
The relative rate constant for oxadiazoline 392 decomposition is about half of that for 



















































   267        392 
Figure 83: The comparison of 267 and 392 
Both oxadiazolines benefit from the stabilising effect of aromatic substituents at C3 and N4 of 
the oxadiazoline. However, oxadiazoline 392 contains a para-nitro substituent on the C3 
phenyl ring. The difference in electronegativity between the C3-N and the N-O and N=O 
bonds of the para-nitro group results in electrons from the phenyl ring being pulled towards 
the para-nitro group (Figure 84). This in turn further stabilises the phenyl ring through 
inductive effects which accounts for the rate of decomposition of oxadiazoline 392 taking 
twice as long as the decomposition of oxadiazoline 267. A second order plot does not give a 
linear correlation for either the oxadiazoline or urea (Figure 81 and Figure 82). 
 
Figure 84: The stabilising effect of the para-nitro substituent on the C3 phenyl in oxadiazoline 392 
When m-nitrobenzohydroximoyl chloride 276 and amidine 341 were combined and stirred for 
1 h (Entry 6), the oxadiazoline 393 was isolated in 59% yield as a pale yellow solid (Scheme 
215). Its spectroscopic properties correlate well with its molecular structure. The 
characteristic oxadiazoline proton attached to the C-5 in the oxadiazoline was observed at 
6.19 ppm as a 1H singlet in 
1
H NMR spectrum. 
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                       276               341         393 
Scheme 215: The synthesis of 393 
Entries 7-9 illustrate the results of the reaction of 2,4,6-trimethylbenzohydroximoyl chloride 
281 with amidine 341 in the attempted synthesis of oxadiazoline 393 (Scheme 216). Initially, 
a low temperature reaction (<10 
o
C) with a 1 h stir time was employed (Entry 7). Following 
an aqueous work-up, no characteristic oxadiazoline peak was evident in the 
1
H NMR 
spectrum of the product. Comparison of the NMR spectrum with those of an authentic sample 
of the amidine and nitrile oxide indicated that starting materials were unchanged. This implies 
that mesitonitrile-N-oxide 7 may not react with N-phenylformimidoylmorpholine 341 at <10 
o
C. Stirring the reagents at room temperature for 1 h also returned starting materials (Entry 8). 
Repeating the reaction at room temperature and stirring the reaction mixture overnight yielded 
starting materials also (Entry 9). This suggests that the nitrile oxide 7 does not react at room 
temperature with amidine 341. 
 
              281            7        341       393 
Scheme 216: The attempted synthesis of oxadiazoline 393 
The results of the attempted 1,3-dipolar cycloaddition reactions of 1,3-dipoles from 
dihaloformaldoxime precursors, with N-phenylformimidoylmorpholine 341 at an addition 
temperature of less than 10 
o
C are summarised in Table 31. 
173 
Table 31: The 1,3-dipolar cycloaddition reactions of 1,3-dipoles with N-phenylformimidoylmorpholine 341 
 
            41, 16                         341       396, 397 
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13
 Isolated by aqueous work-up, all other entries isolated by filtration. 
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The reaction of dibromoformaldoxime 41 with amidine 341 was expected to produce 
oxadiazoline 396, as outlined in entries 1-4 of Table 31 (Scheme 217).  
 
        41     341    396 
                                                                            
       340 
Scheme 217: The attempted preparation of oxadiazoline 396 
Both triethylamine and potassium t-butoxide were employed as bases in this reaction. The stir 
time of the reaction varied from ten minutes to 12 h, but the outcome was still the same. N-
Formylmorpholine 340 was observed along with unknown product(s). Its presence was 
confirmed by a spiking experiment and comparison of the spectra with the spectra of the 
authentic sample. The electronegative effect of the bromine group at the C3 position of 
oxadiazoline 396 is not sufficient to stabilise the oxadiazoline formed in the 1,3-dipolar 
cycloaddition reaction. The bromine atom itself contributes electron density, by means of its 
lone pairs of electrons, to the oxadiazoline (Figure 85). This results in too much electron 
density on the periphery of the five-membered ring. The net result is the breaking of the N2-
O1 bond, in an effort to alleviate the inherent electron density of the heterocycle formed.  
 
Figure 85: The distribution of the electron lone pairs in 3-bromo-oxadiazolines 
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Introduction of a chlorine atom at the C3 position of the oxadiazoline (R = X = Cl) was 
attempted by the reaction of dichloroformaldoxime 16 with amidine 341 in the presence of 
triethylamine (Entries 5-6, Table 31) (Scheme 218). Both experimental procedures involved 
stirring the reaction mixture at room temperature and isolating the reaction product by 
filtration. Employing stir times of 10 min to 20 min did not yield the oxadiazoline 397. In 
both cases, the amidine 341 was returned quantitatively. 
 
              16     341      397 
Scheme 218: The attempted preparation of oxadiazoline 397 
The 1,3-dipolar cycloaddition reaction of 1,3-dipoles from 1-aroyl-1-chloroformaldoxime 
precursors with N-phenylformimidoylmorpholine 341 at an addition temperature of less than 
10 
o
C in the synthesis of oxadiazoline 398 is portrayed in Table 32. 
176 
Table 32: The 1,3-dipolar cycloaddition reactions of 1,3-dipoles with N-phenylformimidoylmorpholine 341 
  
 286, 292                 341      398, 399 
Entry Precursor (R) Stir time Product(s) 
1
14





















Introduction of the benzoyl group at the C3 position of the oxadiazoline was achieved by 
reacting 1-benzoyl-1-chloroformaldoxime 286 with amidine 341 (Entries 1-3, Table 32) in the 
presence of triethylamine (Scheme 219). The overall stir times range from 10 min to 1 h 40 
                                                 
14
 Isolated by aqueous work-up, all other entries isolated by filtration. 
177 
min. It was observed that the longer the stir time, the better the yield of the heterocycle (12-
39%).  
 
286     341     398 
Scheme 219: The reaction of 1-benzoyl-1-chloroformaldoxime 286 with amidine 341 
Stirring the reagents for 1 h 40 min gave the oxadiazoline 398 in 39% yield, which was 
isolated as a pale yellow solid. Its melting point (94-95.5 
o
C) shows that it was relatively pure 
following recrystallization from ethyl acetate - hexane. The spectroscopic properties of the 
oxadiazoline are in agreement with its molecular structure. The characteristic oxadiazoline 
proton attached to the C-5 in the oxadiazoline was observed at 6.26 ppm as a 1H singlet in 
1
H 
NMR spectrum. HRMS identified the parent molecular ion mass at 338.1499 amu under ESI 
conditions. A time-course study of the formation of urea 395 from oxadiazoline 398 was next 
undertaken (Scheme 220). 
 
  398          387       395 
Scheme 220: The cycloreversion of oxadiazoline 398 to nitrile 387 and urea 395 
The results are summarised in Figure 86.  
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Figure 86: The conversion of oxadiazoline 398 to urea 395 at 300K in CDCl3
15
 
To explore the rate of conversion of the oxadiazoline to urea, proton NMR spectroscopic 
analysis was again used. To determine the relative concentration of oxadiazoline and urea in 
the sample analysed, the relative integral of the heterocylic 5-H proton in oxadiazoline 398 
was integrated as being equivalent to one proton in each proton NMR spectrum obtained over 
the time course of this study. The relative integral of the urea NH proton was then determined 
in comparison to the oxadiazoline 5-H proton in the same spectrum. These values were 
combined to give the overall total integration. The concentration of oxadiazoline, relative to 
that at t = 0 days, [oxadiazoline]rel was determined as a percentage of the oxadiazoline 
integration divided by the total integration to facilitate the relative rate constant determination. 
The concentration of the urea, relative to that at t = 0 days, [urea]rel was then determined as a 
percentage of the urea integration divided by the total integration. For the purpose of relative 
rate constant determination, the molar concentration was not used, but the relative percent 
integration of the oxadiazoline and urea, denoted [oxadiazoline]rel and [urea]rel in the 
following discussion. 
Plotting [oxadiazoline 398]rel (Figure 87) and [urea 395]rel (Figure 88) versus time illustrates 
that each exhibits slightly differing behaviour. The plot of [oxadiazoline 398]rel with time 
portrays a much better correlation to a first order reaction, whereas the plot of [urea 395]rel 
with time shows a biphasic property with a first-order segment later in the process.  
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Figure 87: The determination of first order relative rate constant of the conversion of oxadiazoline 398 to 
urea 395, by plotting ln [oxadiazoline 398]rel vs time (d) with a straight line fit 
 
Figure 88: The determination of first order relative rate constant of the conversion of oxadiazoline 398 to 
urea 395, by plotting ln [urea]rel vs time (d) 
A second order plot does not give a linear correlation for either the oxadiazoline or urea 
(Figure 89 and Figure 90). The decomposition of oxadiazoline 398 is a first order reaction and 




) was calculated from the graph of ln[oxadiazoline 
398]rel versus time (d) (Figure 87). 
y = -8E-07x + 4.6967 
















































Figure 89: Second order rate check of the conversion of oxadiazoline 398 to urea 395, by plotting 
1/[oxadiazoline 398]rel vs time (d)  
 
Figure 90: Second order rate check of the conversion of oxadiazoline 398 to urea 395, by plotting 1/[urea 
395]rel vs time (d) 
The relative rate constant for the 3-benzoyl compound 398 is about the same as that for the 
corresponding 3-phenyl compound 267 even though the former substituent is more electron 
withdrawing (Figure 91). Interestingly, the 3-ethoxycarbonyl analogue 400 which has a 





















































    398         267            400 
Figure 91: The comparison of 398, 267 and 400  
1-(p-Bromobenzoyl)-1-chlorofomaldoxime 292 as a nitrile oxide precursor was included in 
the study (Scheme 221). It was anticipated that including an electron-withdrawing substituent 
in the para position of the phenyl group would increase the stability of the corresponding 
nitrile oxide, such that its rate of cycloaddition with amidine 341 in the attempted preparation 
of oxadiazoline 399 could be studied by NMR spectroscopy. 
 
                    292       341            399 
Scheme 221: The preparation of oxadiazoline 399 
NMR spectroscopy studies (Entry 4, Table 32) suggest heterocycle formation within 10 
minutes, subsequent isolation gave oxadiazoline 399 as a pale orange solid in 50% yield. Its 
melting point 90-92
o
C confirming that recrystallization from chloroform - hexane gave the 
oxadiazoline in good purity. Its spectroscopic properties were in excellent agreement with the 
molecular structure. The characteristic oxadiazoline proton attached to the C-5 in the 
oxadiazoline was observed at 6.58 ppm as a 1H singlet in 
1
H NMR spectrum. The mass 
spectrum of 399, under ESI conditions showed a typical ion pattern characteristic of a 
compound containing one bromine atom in its molecular structure. Attempted HRMS analysis 
182 
of the molecular ion species produced evidence for the urea 395, i.e. the compound 
decomposed under the MS analysis conditions. 
 
         399          395 
Scheme 222: The decomposition of 399 to 395 
The 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from other hydroximoyl halide 
precursors, with N-phenylformimidoylmorpholine 341 at an addition temperature of <10 °C is 
outlined in Table 33. 
Table 33: The results of the reaction of other hydroximoyl halides with N-phenylformimidoylmorpholine 
341 
 
         295, 299, 304                341             400, 401, 402 
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 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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4 299 Ts- Br- 1 h B 
 
        
      401                    341 
(36 : 64) 













          
402                 341  
(48 : 52) 
 
Ethylchloroglyoxalate oxime 295 and N-phenylformimidoylmorpholine 341 were combined 
(Entries 1-2, Table 33) in an effort to prepare oxadiazoline 400 (Scheme 223). Stirring the 
reagents together for ten minutes at room temperature followed by an aqueous work-up and 
recrystallisation from ethyl acetate and hexane yielded the oxadiazoline (Entry 1) (m.p. 105-
105.5°C) in 10% yield as a white crystalline solid. Increasing the stir time at room 
temperature to 1 h (Entry 2) also increased the yield to 56%.  
                                                 
17
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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          295       341       400 
Scheme 223: The reaction of oxime 295 with amidine 341  
The spectroscopic properties of oxadiazoline 400 were in excellent agreement with the 
molecular structure and the HRMS analysis produced an ion of mass 306.1464 amu (M+1) 
under ESI conditions. The characteristic oxadiazoline proton attached to the C-5 in the 
oxadiazoline was observed at 6.17 ppm as a 1H singlet in its 
1
H NMR spectrum. A 
1
H NMR 
spectroscopy study of the conversion of oxadiazoline 400 (Scheme 224) showed that it took 
ten days at room temperature before a steady rate of decomposition to the urea 395 was 
achieved. 
 
 400                                                     403           395 
Scheme 224: The conversion of oxadiazoline 400 to nitrile 403 and urea 395 
The results are summarised in Figure 92. 
185 
  
Figure 92: The conversion of oxadiazoline 400 to urea 395 in CDCl3 at 300K over time (d)
18
 
To determine the relative concentration of oxadiazoline and urea in the sample analysed, the 
relative integral of the heterocylic 5-H proton in oxadiazoline 400 was integrated as being 
equivalent to one proton in each proton NMR spectrum obtained over the time course of this 
study. The relative integral of the urea NH proton was then determined in comparison to the 
oxadiazoline 5-H proton in the same spectrum. These values were combined to give the 
overall total integration. The concentration of oxadiazoline, relative to that at t =0 days, 
[oxadiazoline]rel was determined as a percentage of the oxadiazoline integration divided by 
the total integration to facilitate the relative rate constant determination. The concentration of 
urea, relative to that at t =0 days, [urea]rel was then determined as a percentage of the urea 
integration divided by the total integration. For the purpose of relative rate constant 
determination, the molar concentration was not used, but the relative percent integration of the 
oxadiazoline and urea, denoted [oxadiazoline 400]rel and [urea 395]rel in the following 
discussion. 
The plot of ln[oxadiazoline 400]rel versus time portrays a good correlation to a first order 
reaction, however, the R
2
 value indicates that the straight line fit is poor (Figure 93). The plot 
of ln[urea 395]rel versus time shows a better correlation to a first-order reaction (Figure 94).  
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 All experimental data and calculations used in the plotting of graphs in this section is 










































































Figure 93: The determination of relative rate constant of the conversion of oxadiazoline 400 to urea 395 by 
plotting ln[oxadiazoline 400]rel vs time (d) with a straight line fit 
 
Figure 94: The determination of relative rate constant of the conversion of oxadiazoline 400 to urea 395 by 
plotting ln[urea 395]rel vs time (d) with a straight line fit 
A second order plot does not give a linear correlation for either the oxadiazoline or urea 
(Figure 95 and Figure 96). The decomposition of oxadiazoline 400 is a first order reaction and 




) was determined from the graph of ln[urea 395]rel 
versus time (d) (Figure 94). 
y = -3E-08x + 4.6525 























y = -4E-07x - 0.598 

























Figure 95: Second order relative rate constant check of the conversion of oxadiazoline 400 to urea 395: 
1/[oxadiazoline 400]rel vs time (d) 
 
Figure 96: Second order relative rate constant checkof the conversion of oxadiazoline 400 to urea 395 by 
plotting 1/[urea 395]rel vs time (d) 
The relative rate constant for 400 decomposition is one tenth of that for the 3-nitrophenyl 
oxadiazoline 392 and thirty times less than that for the 3-phenyl compound 267 (Figure 97).  
 
   400             392       267 








































Resonance delocalisation of the lone pair of electrons on the oxygen of the ester moiety 
provides sufficient stabilisation for oxadiazoline 400 (Figure 98). This factor, coupled to the 
moderate electron-withdrawing effect of the ester group account for oxadiazoline 400 having 
a decomposition rate that is ten times slower than the 3-nitrophenyl-oxadiazoline 392 and 
thirty times slower that the 3-phenyl oxadiazoline 267. 
 
Figure 98: The resonance delocalisation of the ester group which contributes to the increased stability of 
oxadiazoline 400 
Entries 3-5 in Table 33 chart the results of the reaction of 1-p-toluenesulfonyl-1-
bromoformaldoxime 299 with amidine 341 in the preparation of oxadiazoline 401 (Scheme 
225). Reaction stir times varied from ten minutes to one hour. The optimum reaction was 
found to involve a stir time of 32 min, isolation by filtration (Entry 5) and recrystallization 
from ethyl acetate - hexane. This gave the oxadiazoline 401 in 42% yield as a pale yellow 
solid. Its melting point was 70-72 
o
C. The characteristic oxadiazoline proton attached to the 
C-5 in the oxadiazoline was observed at 6.15 ppm as a 1H singlet in its 
1
H NMR spectrum. 
The parent molecular ion was observed at 388 amu under nominal mass spectral conditions. 
The spectroscopic properties of the compound were consistent with its molecular structure.  
 
        299        341        401 
Scheme 225: The reaction of 299 with amidine 341 
The attempted preparation of oxadiazoline 402 is outlined in entry 6 of Table 33. This 
involved the reaction of cyanoformohydroximoyl chloride 304 with amidine 341 in the 
presence of triethylamine (Scheme 226). Following recrystallization from ether - hexane, a 
mixture of the oxadiazoline 402 and amidine 341 was isolated as a yellow solid in a ratio of 
189 
48 : 52. The characteristic oxadiazoline proton attached to the C-5 in the oxadiazoline was 
observed at 6.38 ppm as a 1H singlet in its 
1
H NMR spectrum. The spectroscopic properties 
for the oxadiazoline are in agreement with the molecular structure. The oxadiazoline structure 
was also confirmed by HRMS analysis (M+1) = 259.1189 amu under ESI conditions. 
 
    304         341     402 
Scheme 226: The attempted preparation of oxadiazoline 402  
4.1.4 Reactions of N-phenylformimidoylpiperidine with p-
nitrobenzohydroximoyl chloride 
To investigate the effect of a slightly less electron withdrawing group at the C-5 position of 
the oxadiazoline, a piperidine ring was used in the place of the previously investigated 
morpholine ring. The introduction of a piperidine ring at the C-5 position of the oxadiazoline 
was explored by using N-phenylformimidoylpiperidine 343 as the dipolarophile in the 
formation of oxadiazoline 404 (Scheme 227). Oxadiazoline 404 was formed by the reaction of 
p-nitrobenzohydroximoyl chloride 275 and N-phenylformimidoylpiperidine 343 in the 
presence of base.  
 
275   343     404 
Scheme 227: The reaction of 275 and N-phenylformimidoylpiperidine 343  
The results of this cycloaddition reaction at an addition temperature of <10 °C and isolation 
by filtration are outlined in Table 34. 
190 
Table 34: The effect of different reaction stir times on the reaction outcome 








2 1 h 
 
           
                                      404                      378                 337  
(38 : 31 : 31) 
 
Stirring the reaction mixture for ten minutes gave the oxadiazoline 404 in 62% yield. 
However, drying the solid under high vacuum after recrystallization gave a mixture of results 
suggesting that conversion of the oxadiazoline into the nitrile 378 and the urea 337 occurred 
during the recrystallisation and drying operations. This mixture of products were purified by 
column chromatography and the nitrile 378 and the urea 337 were isolated. Increasing the stir 
time of the 1,3-dipolar cycloaddition reaction to 1 h, yielded the oxadiazoline 404, nitrile 378 
and urea 337 in a ratio of (38 : 31 : 31). The spectroscopic properties pertaining to the 
oxadiazoline 404 were in excellent correlation with the molecular structure. The characteristic 
oxadiazoline proton attached to the C-5 in the oxadiazoline was observed at 6.20 ppm as a 1H 
singlet in 
1
H NMR spectrum. In comparison to the morpholine derivative, the piperidine 
derived oxadiazoline partly decomposed on handling, consistent with earlier observations that 
electron donating groups at C-5 in the heterocyclic ring accelerate the rate of conversion of 
the oxadiazoline into the nitrile and urea products. 
4.1.5 Reactions of N-p-chlorophenylformimidoylmorpholine with p-
nitrobenzohydroximoyl chloride 
In an attempt to positively influence the stability of the oxadiazoline generated by the 1,3-
dipolar cycloaddition of nitrile oxides with formamidines, the type of formamidine explored 
in this study was expanded to include N-p-chlorophenylformimidoylmorpholine 345 (Scheme 
228). The addition of an electron-withdrawing para-chlorine group on the phenyl at the N4 
position of the oxadiazoline ring was anticipated to further stabilise the oxadiazoline formed. 
This study was explored by the reaction of p-nitrobenzohydroximoyl chloride 275 with 
amidine 345 to afford oxadiazoline 405. NMR spectroscopy studies suggest heterocycle 
191 
formation within 10 minutes, subsequent isolation gave oxadiazoline 405 as a pale yellow 
crystalline solid in 3% yield. Stirring the reaction mixture for up to 2 h 10 min (Entry 2) 
resulted in a marginal increase in the isolated yield of the product (3% to 4%). A poor 
recrystallisation is the primary cause of this low yield as the 
1
H NMR spectroscopic data 
indicated that the oxadiazoline 405 was the only product of this reaction as all starting 
materials had been consumed.  
 
       275      345            405 
Scheme 228: The reaction of 275 and N-p-chlorophenylformimidoylmorpholine 345 
The oxadiazoline 405 was isolated as a pale yellow crystalline solid. Its melting point (123-
147 
o
C) was broad. The characteristic oxadiazoline proton attached to the C-5 in the 
oxadiazoline was observed at 6.15 ppm as a 1H singlet in 
1
H NMR spectrum. The NMR 
spectra were assigned with the aid of HSQC and HMBC analysis and the spectroscopic 





 389.1017 a.m.u. and a value of 389.1003 a.m.u was found under ESI 
conditions. The aim was to introduce a moderately electron-withdrawing substituent in the 
amidine so that the rate of reaction with the nitrile oxide with regards to the parent N-phenyl-
morpholino amidine (341) could be sufficiently slowed as to allow the reaction to be studied 
by 
1
H NMR spectroscopy. An NMR spectroscopy tube reaction (outlined in detail further on 
in this chapter – see page 213) showed that after addition of the nitrile oxide 265 solution to 
the amidine, the oxadiazoline 405, amidine 345 and nitrile oxide 265 were present, 9 min after 
the beginning of the reaction (Scheme 229). This supports the reasoning employed in 
including this amidine in the study, i.e. that electron withdrawing substituents on the imino 
nitrogen of the amidine reduces the rate of the cycloaddition. 
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          275     265                   345 
          
                        405 
Scheme 229: The reaction of 275 and N-p-chlorophenylformimidoylmorpholine 345 
4.2 1,3-Dipolar cycloaddition reactions with benzamidines 
The introduction of a phenyl group in place of the hydrogen at the C-5 position of the 
oxadiazoline ring was explored in an effort to observe if it would introduce a positive 
stabilisation effect. 
4.2.1 Reactions with N-(N´-phenylbenzimidoyl)-morpholine 
The result of the reaction of a substituted benzohydroximoyl halide 275 with N-(N´-
phenylbenzimidoyl)-morpholine 349 at an addition temperature of <10°C is summarised in 
Scheme 230. The oxadiazoline was isolated as a yellow crystalline solid after recrystallization 
from chloroform - hexane in 7% yield, its melting point 180-181 
o
C. The spectroscopic 
properties are in excellent agreement with the literature data for the compound. The exact 
mass was calculated for C24H22N4O4 [M+H]
+
 431.1719 a.m.u. and a value of 431.1722 a.m.u 
was found under ESI conditions. 
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   275                    349        406 
Scheme 230: The reaction of p-nitrobenzohydroximoyl chloride 275 with benzamidine 349  
The results of the reaction of a dihaloformaldoxime with N-(N´-phenylbenzimidoyl)-
morpholine 349 at an addition temperature of <10°C are summarised in Table 35. 
Table 35: The reaction of dibromoformaldoxime 41 with N-(N´-phenylbenzimidoyl)-morpholine 349 in the 
presence of different bases  
 
      41      349        407 
Entry Base Stir time Product(s) 
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 0 min stir time refers to the reaction mixture being filtered immediately once the addition of the 
dihalformaldoxime solution had been completed. 
20
 0 min stir time refers to the reaction mixture being filtered immediately once the addition of the 
dihalformaldoxime solution had been completed. 
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The reactions employed to incorporate a bromine substituent at the C-3 position of the 
oxadiazoline are outlined by entries 1-4 in Table 35. The preparation of oxadiazoline 407 was 
attempted by mixing dibromoformaldoxime 41 with the benzamidine 349 in the presence of a 
base; triethylamine and potassium t-butoxide were employed. The stir time of the reactions 
varied from 10 min to 0 min. Entry 1 illustrates the use of triethylamine as the base with a stir 
time of 10 min. The crude reaction product was purified by column chromatography on silica 
gel with ethyl acetate - hexane as eluent. Initially, 20:80 ethyl acetate:hexane was the mobile 
phase, which was gradually increased as elution continued to 60:40 ethyl acetate:hexane. Two 
separate fractions were isolated. The first was a mixture of predominantly N-(N´-
phenylbenzimidoyl)-morpholine 349 and a small quantity of N-benzoylmorpholine 322. The 
second fraction was a mixture of predominantly N-benzoylmorpholine 322 and a small 
quantity of N-(N´-phenylbenzimidoyl)-morpholine 349. This suggests that N-
benzoylmorpholine 322 is a product of the decomposition of the oxadiazoline. As there was 
not any evidence for the oxadiazoline 407, the stir time of the reaction was reduced to aid the 
potential isolation of the heterocycle. Entry 3 shows the results of not stirring the reaction 
mixture and immediately working up the reaction after addition of the reagents. In this case, a 
mixture of N-benzoylmorpholine 322 and unknown product(s) formed. When potassium t-
butoxide was utilised as the (Entries 2 and 4), N-benzoylmorpholine 322 was isolated 
regardless of stir time. This implies that the oxadiazoline could spontaneously undergo 
conversion to the amide and other products once the reagents are mixed together. The other 
products were not isolated nor identified but could be the N-bromocarbodiimide 408 (Scheme 
231), a diazirine 410 or its ring opened isomer, the nitrilimine 411 (Scheme 232) – expected 
to be of short lifetime and likely to convert into a hydrazide through reaction with water. This 
is based on the understanding that bromine has a better migratory aptitude in 1,2-
rearrangements. In addition, an imidazole 414 or an imidazolone 415 could arise through 
cyclisation of a putative imidoyl nitrene intermediate 412 to the ortho-position of the aromatic 
ring (Scheme 233).  
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407    408     322 
      
          409           333 
Scheme 231: Putative route A mechanism of decomposition of oxadiazoline 407 
 
 
       407                           410    322 
                                                              
                        411 
Scheme 232: Putative route B mechanism of decomposition of oxadiazoline 407 
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             407                412         322 
 
                413                 414 
 
                        415 
Scheme 233: Putative route C mechanism of decomposition of oxadiazoline 407 
4.2.2 Reactions with N-(N´-phenylbenzimidoyl)-piperidine 
The interaction of dibromoformaldoxime 41 with N-(N´-phenylbenzimidoyl) - piperidine 350 
in the attempted synthesis of oxadiazoline 416 is displayed in Scheme 234.  
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         41         350   416                 324 
Scheme 234: The reaction of dibromoformaldoxime 41 with N-(N´-phenylbenzimidoyl) - piperidine 350 
The results illustrate that the cycloaddition reaction appears to be followed by a rapid 
conversion yielding the amide 324 in line with the outcome observed from amidine 349, 
regardless of which base - triethylamine or potassium t-butoxide - is used (Figure 99). 
Comparison of the 
1
H NMR spectroscopic data with an authentic sample of amide 324 
confirmed its presence. 
 
349 
Figure 99: Amidine 349 
4.2.3 Reactions with N-(p-chlorophenyl)-benzimidoylmorpholine 
The introduction of a more electron-withdrawing substituent at the N-4 of the oxadiazoline 
ring was explored in an effort to stabilise the oxadiazoline formed in the 1,3-dipolar 
cycloaddition reaction with dibromoformaldoxime 41 as the hydroximoyl halide precursor. 
The reaction of dibromoformaldoxime 41 with N-(p-chlorophenyl)-benzimidoylmorpholine 
353 for the attempted preparation of oxadiazoline 417 is outlined in Scheme 235. 
 
         41        353        417        322 
Scheme 235: The attempted preparation of oxadiazoline 417 
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Irrespective of the base employed, triethylamine or potassium t-butoxide, the spectroscopic 
data obtained from these reaction mixtures demonstrate that N-benzoylmorpholine 322 was 
one of the products of the reaction. Identification of the amide 322 was facilitated by 
comparison with the 1H NMR spectrum of an authentic sample.Other products were not 
isolated nor identified but could, in line with earlier observations be the N-bromocarbodiimide 
408, the diarizine 410 or its ring opened isomer, the nitrile imine 411 (Figure 100). 
                            
              408            410          411 
Figure 100: The potential side products from the reaction of 41 with 353  
4.2.4 Reactions with N-phenyl-(p-chlorobenzimidoyl)-morpholine 
The reaction of dibromoformaldoxime 41 with N-phenyl-(p-chlorobenzimidoyl)-morpholine 
357 as a preparation of oxadiazoline 418 is illustrated in Scheme 236. Introducing an electron-
withdrawing p-chlorophenyl substituent on the amidine 357 could potentially increase the 
thermal stability of the oxadiazoline formed, allowing NMR spectroscopic analysis of the 
conversion products as they formed.  
 
          41  357     418          327 
Scheme 236: The reaction of dibromoformaldoxime 41 with N-phenyl-(p-chlorobenzimidoyl)-morpholine 
357 
Comprison of the 
1
H NMR spectrum of the reaction products with an authentic sample of the 
amide 327 confirmed that it was isolated following the cycloaddition reaction, i.e. a consistent 
outcome pattern for a range of benzamidines with the bromonitrile oxide.  
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4.3 1,3-Dipolar cycloaddition reactions with other dipolarophiles 
4.3.1 1,3-Dipolar cycloaddition reactions with imines 
The 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from hydroximoyl halide precursors, 
with N-benzylideneaniline 346 is outlined in the following section. The results of the 1,3-
dipolar cycloaddition reaction of 1,3-dipoles, from substituted benzohydroximoyl halide 
precursors, with N-benzylideneaniline 346 at an addition temperature of less than 10 
o
C and 
triethylamine as the base are summarised in Table 36. 
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Table 36: The results of the 1,3-dipolar cycloaddition reaction of 1,3-dipoles with N-benzylideneaniline 
346 
 











1 26 H- Ether 12 h B 
 
       
 
419                   346  
(80 : 20) 
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3 276 m-NO2- Ether 16.25 h B 
 
          
 
421                   346  
(78 : 22) 
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  85% 
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Entry 1 in Table 36 shows the synthesis of oxadiazoline 419 from benzohydroximoyl chloride 
26 and imine 346 (Scheme 237). The spectroscopic data of the oxadiazoline 419 correlates to 
that in the literature with the 5-H proton NMR spectroscopy resonance of 419 observed at 
6.54 ppm.
[196]
 Aitken et al. found that the oxadiazoline ‘
1
H signal for the 5-H generally 
appearing as a singlet in the range δH 6.3-6.6 and the 
13
C spectra forming a highly consistent 
pattern with signals for C3 at δC 154-159 and for C5 at δC 90-100’.  
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 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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         26      346           419 
Scheme 237: The synthesis of oxadiazoline 419  
As the 
1
H NMR spectroscopic signals of the oxadiazoline 419 and the imine 346 are both 
evident in the spectra, it may be concluded that stirring the reaction mixture overnight was not 
long enough to bring the cycloaddition to completion. However, the proton NMR 
spectroscopic data of the aromatic signals in the oxadiazoline 419 and imine 346 would mask 
any furoxan 422 (Figure 101) signals which may also account for the reason why the 
cycloaddition did not appear to go to completion within the timeframe examined.  
 
422 
Figure 101: The structure of 3,4-diphenylfuroxan 422 
On comparison with formamidine 341, the imine 346 reacts slower with the 1,3-dipole. This 
could be due to the conjugation of the N=C bond in the formamidine with the lone pair of 
electrons on the nitrogen of the C-N bond of the secondary amine group (Figure 102). 
 
                   341          346 
Figure 102: The structure of imine 346 and amidine 341 
Inserting a p-nitrophenyl substituent into the C-3 position of the oxadiazoline (Entry 2, Table 
36) was achieved by the reaction of p-nitrobenzohydroximoyl chloride 275 with imine 346 
(Scheme 238). Recrystallisation of the product from ethyl acetate - hexane gave the 
oxadiazoline 420 in 60% yield. Its melting point (143-144 
o






275   346      420 
Scheme 238: The reaction of 275 with imine 346 
The formation of the oxadiazoline 420 was confirmed by the presence of the oxadiazoline 
proton signal at 6.55 ppm in the 
1
H NMR spectroscopic analysis. The spectroscopic data 
correlates well with the structure and its assignment was aided by HMBC and HSQC 
experiments (Table 37).  
Table 37: The 
13
C NMR spectroscopic data of 420 
δC (ppm) 
NCHON 101.4 
8 x ArCH 
123.9, 124.6, 126.5, 128.8, 
128.9 and 130.1 
ArC(NO2) 131.8 
ipso C of Ar at C5 of oxadiazoline 138.4 
ipso C of Ar at N4 of oxadiazoline 140.7 
ipso C of Ar at C3 of oxadiazoline 148.9 
NC(p-NO2Ar)=N 153.8 
 
Reactions involving m-nitrobenzohydroximoyl chloride 276 and imine 346 in the preparation 
of oxadiazoline 421 are summarised by Entries 3-9 in Table 36 (Scheme 239). The initial 
reaction protocol involved stirring the reagents for 16.25 h and isolating the reaction product 
by filtration.  
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276           346          421 
Scheme 239: The preparation of oxadiazoline 421 by the reaction of m-nitrobenzohydroximoyl chloride 
276 and imine 346 in the presence of base 
This resulted in a mixture of oxadiazoline 421 and imine 346 following an attempted 
recrystallization from chloroform - hexane. The H-5 oxadiazoline proton NMR spectroscopy 
singlet was observed at 6.56 ppm. The ratio of oxadiazoline to imine illustrates that even after 
16.25 h of stirring the reaction mixture, the cycloaddition did not go to completion. However, 
the proton NMR spectroscopic data of the aromatic signals in the oxadiazoline 421 and imine 
346 would mask any furoxan 423 signals which may also account for the reason why the 
cycloaddition did not appear to go to completion within the timeframe examined (Figure 103).  
 
423 
Figure 103: The structure of furoxan 423 
Whether the oxadiazoline 421 could be formed within ten minutes of stirring the reagents was 
then investigated (Entry 4). Following an aqueous work-up, the compound 421 was isolated 
in 85% yield as a yellow oil. Its spectroscopic data is in excellent correlation with the 
structure. HRMS analysis confirmed the elemental composition of the oxadiazoline. Further 
variation of the reaction stir time, the method of isolation or changing the solvent from 
dichloromethane (Entry 6) to ether (Entry 9) did little to improve the yield or the outcome of 
the cycloaddition. In all cases, evidence for the oxadiazoline 421 was observed, but the 
compound was not isolated. 
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In relation to aromatic nitrile oxides, ‘the rate of dimerization depends on the nature of the 
substituent on the aromatic ring’-Lowe et al.
[52]
 They investigated having a nitro group on the 
aromatic ring of the nitrile oxide and the effect it would exert on the nitrile oxide stability. ‘to 
ascertain the influence of the electrical nature of the nitro group and the effect of its position 
on the addition reaction.’ The Hammett σ constants for m-nitro (+0.71) and p-nitro (+0.78) 
substituents are similar so one would predict that the nitrile oxides should react in a similar 
manner. Our experimental results support this position. 
The results of the 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from a 
dihaloformaldoxime precursor, with N-benzylideneaniline 346 at an addition temperature of 
less than 10 
o
C are summarised in Table 38. 
Table 38: The 1,3-dipolar cycloaddition reactions of dibromoformaldoxime 41 with N-benzylideneaniline 
346  
 
          41            346        424 
Entry Base
 
Stir time Product(s) 
1 
t
BuOK 15 h                
                                 424                 346            270 
(14 : 69 : 17). 
2 NEt3 0 min
23
                
                                424                 346              270 
(3 : 88 : 9) 
 
                                                 
23
 0 min stir time refers to the reaction mixture being filtered immediately once the addition of the 
dihalformaldoxime solution had been completed. 
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Entry Base Stir time Product(s) 
3 NEt3 0 min
24
                
                                424                346              270 
(3 : 90 : 7) 
4 NEt3 1 h              
                                424                 346             270 
(2 : 93 : 5) 
5 NEt3 6 h              
                                424                346             270 
(2 : 84 : 14) 
6 NEt3 19.5 h              
                                424                 346            270 
(2 : 75 : 23) 
 
The initial reaction conditions used potassium t-butoxide and a stir time of 15 h (Entry 1, 
Table 38). NMR spectroscopic analysis of the reaction mixture showed the presence of 
oxadiazoline 424, imine 346 and aldehyde 270 in the ratio of 14 : 69 : 17. Comparison of the 
NMR spectra with the literature data confirmed the presence of benzaldehyde.
[205]
 The mass 
spectral analysis confirmed the presence of bromine in the heterocycle. The stir time of the 
reaction did not appear to have a significant effect on the formation of the oxadiazoline 424. 
Increasing that variable from 0 min to 19.5 h did not directly impact the yield of oxadiazoline 
formed (Entry 6, Table 38). The amount of benzaldehyde present increased as the stir time 
was increased. Benzaldehyde can be a contaminant in the imine sample, being carried through 
in the imine synthesis. However, NMR spectroscopic analysis carried out prior to the 
cycloaddition reaction showed that only a very small trace of benzaldehyde was present in the 
imine sample. This raised the question of whether the benzaldehyde is a product of the 
cycloaddition reaction or originates from hydrolysis of the imine. An attempt to isolate a 
sample of the oxadiazoline 424 by column chromatography was unsuccessful. Thus, the 
thermal stability of the oxadiazoline 424 is called into question. The use of triethylamine 
versus potassium t-butoxide shows that potassium t-butoxide gave the oxadiazoline 424 in a 
greater yield than all of the reactions involving triethylamine. The formation of the 
                                                 
24
 0 min stir time refers to the reaction mixture being filtered immediately once the addition of the 
dihalformaldoxime solution had been completed. 
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oxadiazoline 424 was confirmed by the presence of the oxadiazoline proton signal at 6.50 
ppm in the 
1
H NMR spectroscopic analysis. 
Clearly, bromine as a substituent at the 3-position of the putative cycloadducts derived from a 
range of amidines induces a significant change in the reactivity of the heterocycle. Following 
the putative reaction mechanism discussed earlier in this chapter, route A indicates that 
phenylcyanamide 333 could have formed from the attempted synthesis of oxadiazoline 396 
(Scheme 240). 
 
             396           408       340 
                           
                               409       333 
Scheme 240: Putative route A mechanism of decomposition of oxadiazoline 396 
Table 39 summarises the results of the cycloaddition reactions with dibromoformaldoxime 
and interestingly, an amide decomposition product rather than a urea is evident for a range of 
compounds.  
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1 370 PhCH2- -N(CH3)2 H 371 Not observed 
2 385 PhCH2- Morpholino- H 340 Not observed 
3 396 Ph- Morpholino- H 340 333 
4 407 Ph- Morpholino- Ph 322 Not observed 
5 414 Ph- Piperidino- Ph 324 Not observed 
6 417 p-ClC6H4- Morpholino- Ph 322 Not observed 
7 418 Ph- Morpholino- p-ClC6H4- 327 Not observed 
8 424 Ph- Ph- H 270 Not observed 
 
Decomposition to a mixture of nitrile and urea involving a hydrogen atom migration is 
superseded by a cyanamide/heterocumulene and amide route, a process that we have 
described earlier in this thesis as the imidoyl nitrene route (Scheme 232). This route seems to 
prevail regardless of hydrogen or an aryl group as a substituent at the C-5 position of the 
oxadiazoline intermediate. 
The results of the 1,3-dipolar cycloaddition reaction of 1,3-dipoles, from a 1-aroyl-1-
chloroformaldoxime precursor, with N-benzylideneaniline 346 at an addition temperature of 
less than 10 
o
C are summarised in Table 40. 
                                                 
25
 The term ‘Not observed’ is used when an absorption corresponding to the cyano group in phenylcyanamide is 
not observed. 
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Table 40: The 1,3-dipolar cycloaddition reaction of 1,3-dipoleswith N-benzylideneaniline 346 
 
   286            346     425 






1 3 h A 
 
          
                                        425                        347 
(50 : 50) 
2 15 h B 
 
                     
                    425                   346                  347              270  
(38 : 48 : ?
27
 : 14) 
 
The reaction of 1-benzoyl-1-chloroformaldoxime 286 with imine 346 is outlined in entries 1-2 
in Table 40. Utilising a 3 h stir time and recrystallisation from ethyl acetate - hexane yielded a 
1 : 1 mixture of the oxadiazoline 425 and amide 347 (Entry 1). The formation of the 
oxadiazoline 425 was confirmed by the presence of the oxadiazoline proton signal at 6.61 
ppm in the 
1
H NMR spectroscopic analysis. The amide (benzanilide) 347 may have originated 
from the oxadiazoline 425 through the imidoyl nitrene pathway – see Scheme 233. The 
presence of the benzoyl group at the C-3 position of the oxadiazoline, combined with phenyl 
groups at N4 and C5 should serve to stabilise the ring structure. However, detection of an 
amide product conflicts with this expectation. Increasing the stir time to 15 h, gave a crude 
reaction mixture of products - oxadiazoline 425, imine 346, amide 347 and aldehyde 270 in a 
ratio of 37 : 48 : ?
28
 : 14 (Entry 2, Table 40). With both results, an argument for the presence 
of the nitrile exists. If conversion is taking place, then the nitrile 387 and amide 347 will be 
present in equal quantities (Scheme 241). Al-Awadi et al. describe benzoyl cyanide 387 as 
showing a 3H proton NMR spectroscopy multiplet at 7.25-7.83 ppm and a 2H proton NMR 
                                                 
26
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
27
 ? indicates that amide 347 was unquantifiable in 
1
H NMR spectrum. 
28
 ? indicates that amide 347 was unquantifiable in 
1
H NMR spectrum. 
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spectroscopy multiplet at 8.00-8.67 ppm.
[202]
 The proton NMR spectrum of the product 
mixture from reaction of 286 with 346 showed extra peaks in the aromatic region of which 
signals at 7.47 and 7.87 ppm could be representative of the nitrile. It is worth noting that the 
1,3-dipolar cycloaddition reaction appears to take longer for completion when an imine is the 
dipolarophile. 
 
         425    387    347 
Scheme 241: The cycloreversion of oxadiazoline 425 
Table 41 outlines the 1,3-dipolar cycloaddition reaction of ethylchloroglyoxalate oxime 295 
with N-benzylideneaniline 346 at an addition temperature of less than 10°C. 
Table 41: The effect of varying the stir time and isolation method in the 1,3-dipolar cycloaddition reaction 
of 295 with 346 
 
          295     346         426 






1 10 min A 
 
                                315                346             426 
(31 : 63 : 6) 
2 3 h A 
  
                                315             346            426  
(31 : 63 : 6) 
 
                                                 
29
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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                              315                  346            426  





2.5 h, then 20 
o
C 12 h 
B 
  
                                315                346            426  
(25 : 50 : 25) 
 
Whether the reagents were stirred together for 10 min or 3 h (Entries 1 and 2), the reaction 
outcome was the same; the oxadiazoline 426, furoxan 315 and imine 346 were isolated as a 
mixture in a ratio of 6 : 31 : 63 (Scheme 242). 
 
             295           376         346         426        
           
            315 
Scheme 242: The attempted synthesis of oxadiazoline 426 
Changing the rate of addition was believed to benefit the formation of oxadiazoline 426 if the 
nitrile oxide 376 was tending towards dimerisation rather than adding to the dipolarophile. 
Kamimura et al. used a syringe pump to add the nitrile oxide precursor slowly to a solution of 
dipolarophile (over 12 h) to avoid dimerization of the nitrile oxide.
[12z]
 Incorporating the use 
of a syringe pump for addition of a solution of ethylchloroglyoxalate oxime 295 in ether 
served to add the hydroximoyl halide solution at a rate of 0.793 mL/h. This did increase the 
                                                 
30
 Method A indicates an aqueous work up, method B indicates isolation by filtration. 
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yield of oxadiazoline 426 formed, but the ratio of oxadiazoline : furoxan : imine was 
relatively unchanged (Entry 3, Table 41). Kozikowski et al. noted the use of a syringe pump 
during the 1,3-dipolar cycloaddition reaction of ethylchloroglyoxalate oxime 295 to an 
alkene.
[157]
 They added the base via syringe pump rather than the hydroximoyl halide. When 
we added the base via syringe pump to a stirring solution of ethylchloroglyoxalate oxime 295 
and imine 346, the overall proportion of oxadiazoline 426 improved to a ratio of 1 : 1 : 2 
relative to the imine and dimer (Entry 4, Table 41). The key proton NMR spectroscopy 
signals for imine (8.45 ppm), oxadiazoline (6.50 ppm) and furoxan (4.45 ppm) were used to 
identify the compounds. 
The 1,3-dipolar cycloaddition reaction of 1-p-toluenesulfonyl-1-bromoformaldoxime 299 
with imine 346 in the presence of triethylamine at an addition temperature of less than 10°C 
was next undertaken (Scheme 243).The reaction mixture was stirred overnight and a mixture 
of products was isolated. The oxadiazoline 427, imine 346, amide 347, aldehyde 270 and 
furoxan 309 were isolated as a mixture in a ratio of 4 : 29 : ?
31
 : 44 : 23. The formation of the 
oxadiazoline 427 was confirmed by the presence of the oxadiazoline proton signal at 6.56 
ppm in the 
1
H NMR spectroscopic analysis.  
 
         299    307            346   427 
           
              309 
Scheme 243: The attempted synthesis of oxadiazoline 427 
                                                 
31
? indicates that amide 347 was unquantifiable in 
1
H NMR spectrum.  
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In relation to the 1,3-dipolar cycloaddition reaction of benzenesulfonylnitrile oxide with 
alkenes, Wade et al. stated that triethylamine could be used as the base, ‘but only with the 
more reactive alkenes’.
[51b]
 They found that the major product of the reaction of 
benzenesulfonylnitrile oxide with an alkene was the nitrile oxide dimer. 
4.3.2 1,3-Dipolar cycloaddition reactions with an alkene 
The reaction of p-nitrobenzohydroximoyl chloride 275 with trans-stilbene 428 in the presence 
of triethylamine at an addition temperature of less than 10°C was next undertaken (Scheme 
244). The 
1
H NMR spectrum for the crude reaction mixture showed evidence for the 
isoxazoline 429 and trans-stillbene 428. Recrystallisation from chloroform - hexane gave the 
isoxazoline as an orange solid in 13% yield. Further purification by column chromatography 
was unsuccessful as the compound degraded to unknown products. 
 
               275          428    429 
Scheme 244: The attempted synthesis of isoxazoline 429 
4.4 NMR spectroscopy tube experiments 
In the expectation that a nitrile oxide was relatively stable and its kinetics for reaction with 
amidines could be measured, we examined the progress of the 1,3-dipolar cycloaddition 
reaction in an NMR spectroscopy tube in CDCl3. Initially, the nitrile oxide was generated in 
situ by reaction of a base with the hydroximoyl halide precursor. This gave rise to a partial 
precipitate of triethylamine hydrochloride with accompanying evidence for the triethylamine 
hydrochloride salt in the proton NMR spectrum. One way to avoid the extra signals in the 
NMR spectroscopic analysis was to use freshly generated nitrile oxide and to add this to the 
amidine. In some cases this was very beneficial as it gave a clear indication of the conversion 
to the oxadiazoline. However, in other cases the nitrile oxide proved to be too reactive and 
favoured the formation of the corresponding furoxan.  
Time was initially a factor to be considered in carrying out NMR spectroscopy tube reactions. 
We wanted to establish the timeframe in which the oxadiazoline was being produced. 
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Previous work carried out by D. Hogan suggested that the oxadiazoline was forming within 
minutes of stirring the starting materials in synthetic scale reactions.
[140]
 
The NMR spectroscopy reactions were set up so that a nitrile oxide formation check would 
take place first. This involved establishing that dehydrohalogenation had taken place and a 
check to see if dimerisation of the nitrile oxide had occurred prior its combination with the 
dipolarophile. A portion of the combined solution was then submitted for 
1
H NMR 
spectroscopic analysis. Typically, the 
1
H NMR spectroscopic analysis procedure took as little 
as seven minutes before a spectra was available to view. Subsequent NMR spectra were 
measured in order to follow the reaction as it progressed to oxadiazoline and in some cases 
until secondary reactions had occurred. 
The NMR spectroscopy tube reaction of p-nitrobenzohydroximoyl chloride 275 with amidine 
339 (Figure 105) was examined first (Scheme 245). The aim of the experiment was to 
ascertain the rate of formation of oxadiazoline 367.  
 
  275                  339    367 
Scheme 245: The reaction of p-nitrobenzohydroximoyl chloride 275 with amidine 339 
The 
1
H NMR spectroscopic analysis of the first experiment (Figure 105-i) shows immediate 
conversion of the hydroximoyl chloride 275 to the nitrile oxide 265 in the presence of 
triethylamine (Figure 104). On mixing with the dipolarophile 339 (Figure 105-ii), the 





Figure 104: Nitrile oxide 265 
The reaction was monitored at intervals and decomposition of the oxadiazoline began within 
21 h (Figure 105-iv) to form the corresponding nitrile 378 and urea 335 (Scheme 246). 
 
                             367                  378      335 
Scheme 246: The decomposition of the oxadiazoline 367 to form the nitrile 378 and urea 335 
 
Figure 105: The 
1
H NMR spectroscopy tube reaction of p-nitrobenzohydroximoyl chloride 275 with 
amidine 339 in CDCl3 at 300K over 27 h 
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The reaction of 2,4,6-trimethylbenzohydroximoyl chloride 281 with amidine 339 was 
monitored by 
1
H NMR spectroscopy (Scheme 247).  
 
  281                             339       369 
Scheme 247: The reaction of 2,4,6-trimethylbenzohydroximoyl chloride 281 with amidine 339  
Following the addition of reagents, the reaction was monitored over 17 h. It showed that the 
cycloaddition reaction did not take place within 17 h of combining the reactants as indicated 
by the presence of mesitonitrile-N-oxide 7 (2.30 and 2.42 ppm) and N,N-dimethyl-N´-
benzylformamidine 339 (7.38 ppm). A second attempt at promoting formation of 
oxadiazoline was carried out by the reaction of mesitonitrile-N-oxide 7 with the amidine 339 
over a longer period of reaction time (Scheme 248).
 1
H NMR spectroscopic analysis 
suggested that the nitrile oxide 7 and amidine 339 did not undergo any cycloaddition reaction; 
the furoxan 313 was observed to have formed after 65 h. The amidine 339 appears to have 
degraded over this time. 
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              7                   339                         369 
    
                         313 
Scheme 248: The conversion of mesitonitrile-N-oxide 7 to dimesitylfuroxan 313 
The NMR spectroscopy tube experiments involving the interaction of hydroximoyl halides 
with N-benzylformimidoylmorpholine 318 were examined (Scheme 249). p-
Nitrobenzohydroximoyl chloride 275 and N-benzyl amidine 318 were reacted together with 





              275                318                                           381 
Scheme 249: The reaction of p-nitrobenzohydroximoyl chloride 275 and N-benzyl amidine 318 
The oxadiazoline 381 formed quantitatively on mixing of reactants. Following 4.75 h, 
conversion of oxadiazoline 381 to the nitrile 378 and urea 336 began to occur  and they were 
produced in a 50:50 ratio (Scheme 250). Comparison with an authentic sample of the urea 336 
218 
and with literature data of the nitrile confirmed their identity. The transformation was 




381        378       336 
Scheme 250: The cycloreversion of oxadiazoline 381 to nitrile 378 and urea 336 
Monitoring the reaction of mesitonitrile-N-oxide 7 with amidine 318 showed that the 
oxadiazoline 384 did not form and that the nitrile oxide dimerised to furoxan 313 in the 
presence of 318 (Scheme 251). The reaction was monitored for 360.8 h. 
 
                          7    318             384 
        
             313 
Scheme 251: The reaction of mesitonitrile-N-oxide 7 with amidine 318 
The NMR spectroscopy tube experiments involving the interaction of hydroximoyl halides 
with N-phenylformimidoylmorpholine 341 were examined (Scheme 252). The NMR 
spectroscopy tube reaction of p-nitrobenzohydroximoyl chloride 275 with amidine 341 for the 
intended generation of oxadiazoline 392 showed that on reacting hydroximoyl chloride 275 
219 
with triethylamine, the chloride was converted completely to p-nitrobenzonitrile-N-oxide 265. 
Spectra recorded subsequently illustrate that while some amidine 341 is still present, all of the 
nitrile oxide has been consumed within 7 min to form oxadiazoline 392. 
 
                  275                        265                                        341 
 
       392 
Scheme 252: The reaction of p-nitrobenzohydroximoyl chloride 275 with amidine 341 for the intended 
generation of oxadiazoline  
When pregenerated p-nitrobenzonitrile-N-oxide 265 was used, the oxadiazoline 392 was 
formed immediately. The reaction solution was monitored over 44 days for conversion to the 
nitrile 378 and urea 395, but neither was evident in this timeframe (Scheme 253). 
 
 392           378             395 
Scheme 253: The cycloreversion of oxadiazoline 392 to nitrile 378 and urea 395 
Upon reacting mesitonitrile-N-oxide 7 with amidine 341 for the attempted preparation of 
oxadiazoline 394, NMR spectroscopic analysis showed that the sample contained the amidine 
341 (7.51 ppm) and nitrile oxide 7 (2.30, 2.42 and 6.91 ppm) in a 1:1 ratio (Scheme 254). 
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Subsequent NMR spectroscopic analysis carried out over 360 h (15 days) showed no change 
to the result. 
 
         7           341     394 




H NMR spectroscopy check of the reaction of 1-benzoyl-1-chloroformaldoxime 286 
with triethylamine established that a 50 : 50 ratio of nitrile oxide 10 and furoxan 314 was 
present (Scheme 255).  
 
  286      10             314 
Scheme 255: The dehydrohalogenation of 286 
Reaction of this solution with amidine 341 gave furoxan 314, amidine 341 and oxadiazoline 
398 in a ratio of 23 : 58 : 19 (Scheme 256). This shows that within 8 min of mixing the dipole 
and dipolarophile, the oxadiazoline 398 was formed. Spiking the reaction mixture with an 
authentic sample of the oxadiazoline 398 confirmed its presence.  
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     10              341     398 
     
     314 
Scheme 256: The reaction of  with amidine 341 
The NMR spectroscopy tube reaction of 1-(p-bromobenzoyl)-1-chloroformaldoxime 292 and 
amidine 341 illustrated that dehydrohalogenation of the hydroximoyl halide precursor gave a 
mixture of nitrile oxide 430 and furoxan 431 (Scheme 257).  
 
          292           430         431 
Scheme 257: The dehydrohalogenation of 292 
Combining this solution with the amidine produced a mixture of furoxan 431 and amidine 341 




                          430               341        399 
         
              431 
Scheme 258: The reaction of nitrile oxide 430 with amidine 341  
The 
1
H NMR spectroscopic data showed that nitrile oxide 376 had dimerised prior to the 
addition of amidine 341 in the synthesis of oxadiazoline 400 (Scheme 259). Subsequent NMR 
spectra showed that the dimer 315 and amidine 341 were present in equal quantities. 
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             376       341             400        
            
           315 
Scheme 259: The attempted synthesis of oxadiazoline 400 
The combination of 1-(p-toluenesulfonyl)-1-bromoformaldoxime 299 with triethylamine gave 
a mixture of the nitrile oxide 307 and furoxan 309 (Scheme 260). (The ratio could not be 
established).  
 
                  299                  307                   309 
Scheme 260: The dehydrohalogenation of 299 
When this solution was combined with amidine 341, 
1
H NMR spectroscopic analysis 
demonstrated that the furoxan 309 and amidine 341 were present in a ratio of 29 : 71 (Scheme 
261). This indicates that nitrile oxide 307 favours dimerisation over cycloaddition and is too 
reactive to be pregenerated in situ prior to the addition of the dipolarophile.  
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           307                341          401 
     
            309 
Scheme 261: The attempted synthesis of oxadiazoline 401 
When the nitrile oxide 265 had been generated from p-nitrobenzohydroximoyl chloride 275 
and combined with the amidine 343, the oxadiazoline 404 was formed quantitatively (Scheme 
262). 
 
                275                  265              343 
                  
         404 
Scheme 262: The combination of nitrile oxide 265 with amidine 343 in the preparation of oxadiazoline 404 
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Subsequent proton NMR spectroscopic analysis (Figure 106) illustrated that conversion of 
oxadiazoline 404 to the nitrile 378 and urea 337 had occurred within 20.4 h after mixing the 
1,3-dipole and dipolarophile (Scheme 263).  
 
      404          378    337 
Scheme 263: The conversion of the oxadiazoline 404 to the nitrile 378 and urea 337 
 
Figure 106: The NMR spectroscopic analysis of the reaction of p-nitrobenzohydroximoyl chloride 275 
with amidine 343 in the presence of triethylamine as the base in CDCl3 at 300K 
The NMR spectroscopy tube dehydrohalogenation reaction of p-nitrobenzohydroximoyl 
chloride 275 with triethylamine and subsequent reaction with amidine 345 in the attempted 
preparation of oxadiazoline 405 was examined (Scheme 264). After addition of the nitrile 
oxide 265 solution to the amidine 345, the oxadiazoline 405, amidine 345 and nitrile oxide 
265 were present (9 min after the addition of the dipolarophile) in a ratio of 58 : 24 : 18. 
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Within 1.1 h of mixing the reagents, the nitrile oxide 265 was completely consumed and the 
oxadiazoline 405 was formed.  
         
275         265            345 
                
                 405 
Scheme 264: The synthesis of oxadiazoline 405 
The relative rate constant of the reaction was evaluated by plotting 1/[amidine] (M
-1
) versus 






at 300K (Figure 107). Thus, 
while the reaction of amidine 345 is still rapid, the presence of a moderately electron 
withdrawing substituent (Cl), is sufficient to slow the rate of reaction to a level where the 
oxadiazoline can be observed within a shorter period. 
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Figure 107: The determination of the second order relative rate constant, k, for the reaction of amidine 
345 and nitrile oxide 265 by plotting 1/[amidine 345] against time (mins) 
The initial step in the NMR spectroscopy tube reaction in the formation of oxadiazoline 406 
involved the conversion of p-nitrobenzohydroximoyl chloride 275 to the nitrile oxide 265 
(Scheme 265). Figure 106-i showed 100% conversion to nitrile oxide 265. Addition of the 
resulting solution to amidine 349 (Figure 106-ii) showed that all of the nitrile oxide was 
consumed within 9 min in the formation of oxadiazoline 406. 
 
  275        265                 349 
        
           406 
Scheme 265: The preparation of oxadiazoline 406 
y = 0.0042x + 23.6 






















The presence of a small amount (<20%) of amidine 349 is probably due to stoichiometric 
differences (there is 0.07 μmol more of amidine than nitrile oxide). The result of this 
experiment demonstrated that the 1,3-dipolar cycloaddition took place within 9 min of mixing 
the reagents. This is still a fast rate of reaction given that the dipolarophile was a 
benzamidine, i.e. the additional phenyl group would be expected to exert a steric effect on the 
reaction rate. The reaction of p-nitrobenzohydroximoyl chloride 275 with imine 346 in the 
presence of triethylamine was also carried out as an NMR spectroscopy tube reaction 
(Scheme 266). The result of which, is that the full conversion to the oxadiazoline 420 was 
observed within 27 h.  
 
           275                  346              420 
Scheme 266: The reaction of p-nitrobenzohydroximoyl chloride 275 with imine 346 in the presence of 
triethylamine 
Following on from that cycloaddition, mesitonitrile-N-oxide 7 was reacted with imine 346 in 
a similar manner (Scheme 267). After 16.25 days, the imine 346 and furoxan 313 were 




     281           346       432 
           
                313 
Scheme 267: The reaction of 2,4,6-trimethylbenzohydroximoyl 281 with imine 346 in the attempted 
synthesis of oxadiazoline 432 
The first spectra of the NMR spectroscopy tube reaction of p-nitrobenzohydroximoyl chloride 
275 and triethylamine showed 100% conversion of hydroximoyl chloride 275 to the nitrile 
oxide 265. Following the addition of the alkene 428, 
1
H NMR spectroscopic analysis was 
immediately carried out (Scheme 268). 
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        275    265       428 
               
           429 
Scheme 268: The reaction of hydroximoyl chloride 275 with alkene 428  
This demonstrated that the 1,3-dipolar cycloaddition had not commenced immediately as both 
nitrile oxide 265 and alkene 428 were present. Twenty minutes after the combination of the 
nitrile oxide and the alkene, the isoxazoline 429 began to form. Subsequent spectra indicated 
that cycloaddition was continuing and the proportion of nitrile oxide 265 and alkene 428 were 
less. However, there is also evidence of the furoxan 312 forming at this point.  
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                 265                428              429 
          
                              312 
Scheme 269: The conversion of 265 with 428 
The NMR spectroscopic analysis indicated that the majority of the isoxazoline 429 was 
formed within 4 h. Monitoring of the reaction continued for a total of 79 h, however the 
proportion of isoxazoline 429 formed did not further increase during this time. The formation 
of the furoxan 312 proved to be a competing reaction preventing complete conversion of the 
alkene 428 to the isoxazoline 429.  
5 Competition reactions 
We investigated selectivity of the formamidines for nitrile oxides by means of competition 
reactions in which a solution of the hydroximoyl halide was added to a solution of 
dipolarophiles and base. To investigate which dipolarophile was more reactive towards the 
nitrile oxide, the hydroximoyl halide solution was added to a mixture of the two 
formamidines to be screened. The ratio of oxadiazolines formed was measured using proton 
NMR spectroscopic analysis (Table 42).  
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Dipolarophiles Products targetted 









367                381  
(50 : 50) 









381                    392  
(84 : 16) 
3    
 







390                402  
(68 : 32) 
 
The product ratio was determined using the characteristic oxadiazoline H-5 proton resonances 
for each product. The shifts used are specified in the Experimental section, with detail for 
each competition experiment. Entry 1 in Table 42 shows that p-nitrobenzonitrile oxide did not 
have a preference for either of the formamidines assessed even though an N,N-dimethyl 
amino group is more electron donating than than a 4-morpholino substituent; the relative rate 
of reaction from the product ratio is (krel) = 1. Entry 2 (Table 42) demonstrates that 
oxadiazoline 392 was successfully produced using this procedure however the oxadiazoline 
381 had undergone conversion to the corresponding nitrile 378 and urea 336 (Scheme 270).  
 
381        378       336 
Scheme 270: The cycloreversion of oxadiazoline 381 to nitrile 378 and urea 336 
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Cyanoformhydroximoyl chloride 304 showed a 2:1 preference for the N-benzyl 318 rather 
than the N-phenyl formimidoyl 341 morpholine (Entry 3, Table 42).We attribute this 
difference to a combination of a reduced steric effect upon changing from N-phenyl to N-
benzyl, coupled with an increased conjugation of the imine group in amidine 341 with the N-
phenyl substituent. 
 
              304          318      341 
Figure 108: The structures of 304, 318 and 341 
In order to identify the amidine for which the nitrile oxide had a preference, the procedure of 
adding equimolar amounts of the two hydroximoyl halides to the dipolarophile being assessed 
was adopted. The results of these competition experiments are summarised in Table 43. 
Table 43: The products targetted  in the reaction of formamidines with a mixture of two hydroximoyl 
halide precursors  
Entry Hydroximoyl Halide Dipolarophiles Products targetted 
1 
   
 







267                      400 
(59 : 41) 









392                   400 
(63 : 37) 
3    
 







398                      400 
(60 : 40) 
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Entry Hydroximoyl Halide Dipolarophiles Products targetted 
4    
 







392                     398 
(54 : 46) 
5   
 
 







420                 426 
(89 : 11) 
 
This method of assessment gave similar results across the board, as illustrated by the 
oxadiazoline ratios in Table 43. While it appears that the ethoxycarbonylnitrile-N-oxide 376 is 
less reactive than the other nitrile oxides presented in Table 43, a more realistic conclusion is 
that this nitrile oxide dimerised to furoxan 315 in competition with the amidine (Scheme 271). 
Therefore, the product ratios for Entries 1-3 suggest that the ethoxycarbonylnitrile-N-oxide 
376 is marginally less reactive that the other nitrile oxide competitors. This conclusion could 
be invalid if the rate of dimerisation of the former nitrile oxide exceeds that for the 
cycloaddition process. If an allowance is made for this possibility, then it is reasonable to 
conclude that there is no difference in selectivity for reaction of amidine 341 with the nitrile 
oxides studied.  
 
                376         315 
Scheme 271: The dimerisation of nitrile oxide 376 to furoxan 315 
Likewise, the results (Entry 4) suggest little difference between p-nitrobenzonitrile oxide 265 
and benzoylformonitrile-N-oxide 10 for amidine 341 even though the former 1,3-dipole is 
more stable (isolable) (Figure 109). 
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   265     10       341 
Figure 109: The structures of 265, 10 and 341 
Substitution of the 4-morpholine group with a phenyl ring (amidine 341 vs imine 346) 
produces a more significant result in the cycloaddition selectivity experiment – compare 
Entries 2 and 5. It is clear that in this case, p-nitrobenzonitrile oxide 265 exhibits a significant 
preference for imine 346. The competing dimerisation of ethoxycarbonylnitrile-N-oxide 376 
would not be entirely sufficient to explain the product ratio observed. A favourable secondary 
interaction in the transition state for cycloaddition of the imine with p-nitrobenzonitrile oxide 
265 could originate from a π-stacking interaction between the N-phenyl group of 346 and the 
p-nitrophenyl ring of the 1,3-dipole 265 (Figure 110). 
 
346 
Figure 110: Imine 346 
6 Conclusions 
The objective of our research was to investigate the synthesis & reactivity of nitrile oxides 
and their 1,3-dipolar cycloadditions of nitrile oxides with formamidines.  
In our experience, methods described in the literature for generation of the nitrile oxide 
precursors are reliable on a small to medium scale. The preparation of the precursor of 
cyanoformonitrile oxide  : CN(Cl)C=N-OH, is also reliable if conducted in accordance with 
the description of Tieman et al. but is either impractical or unreliable for the other published 
methods that we attempted.
[164]
 We attributed the lack of success to a combination of poorly 
documented procedures for the precursor in one case, confusion about the use of chloral 
hydrate or anhydrous chloral in another and our view, an incorrect documentation of the 
procedure in the case of the Kozikowski route. We have no explanation for our lack of 
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success in the preparation of dichloroformaldoxime. Most of the yields and spectral analysis 
conform with those outlined in the literature. NMR spectroscopic analysis was a useful tool to 
monitor the generation of stable nitrile oxides. Carrying out the dehydrohalogenation reaction 
on an NMR spectroscopy scale enabled us to not only see the spectra of the 1,3-dipole 
immediately, but also to note its rates of reaction. In the case of p-nitrobenzonitrile oxide, the 
nitrile oxide was seen immediately upon addition of the base and the lifetime of the 
compound was ca. 15 h in chloroform-d at room temperature. This gave us valuable 
information on the likely reactivity of this nitrile oxide in 1,3-dipolar cycloaddition reactions 
and confirmed that generating the nitrile oxide in situ is the best option. Triethylamine was 
the best choice of base for a prompt dehydrohalogenation reaction.  
The choice of base for the liberation of the nitrile oxide from the hydroximoyl halide 
precursor was important for other systems however. Experiments involving 1-p-
toluenesulfonyl-1-bromoformaldoxime showed that bulkier bases such as DBU or milder 
bases such as potassium bicarbonate were not suitable to generate the nitrile oxide 
quantitatively from the hydroximoyl halide. In principal, one could influence the rate of 
cycloaddition of this nitrile oxide by selecting potassium carbonate ahead of triethylamine. 
Experiments carried out under the same reaction conditions with the former yielded a mixture 
of the nitrile oxide and its dimer (furoxan), whereas triethylamine gave the latter exclusively. 
If the rate of cycloaddition reaction was anticipated to be slow i.e. a less reactive 
dipolarophile involved, then potassium carbonate instead of triethylamine could help to 
reduce the rate of the competing dimerisation reaction. However, the more typical reaction 
procedure would be involve control of the addition of the hydroximoyl halide solution to a 
solution or a mixture of the base and dipolarophile. 
The furoxan of p-nitrobenzonitrile-N-oxide was the quickest to form (complete within 15 h), 
with the dimer of mesitonitrile-N-oxide, being the slowest (complete within 15 days). Mid-
way in the range was dibromofuroxan, which was observed in a solution of bromonitrile-N-
oxide in chloroform-d by 
13






Quite a number of nitrile oxides were generated in the course of this research. This facilitated 
a comparison of various substituents at the C-3 position of the oxadiazoline (Figure 111). A p-
nitrophenyl- substituent at this position consistently yielded the corresponding oxadiazoline, 
regardless of the dipolarophile used. Mesitonitrile-N-oxide 7 gave the poorest cycloaddition 
result as it tended not to undergo the 1,3-dipolar cycloaddition reaction with the 
dipolarophiles explored. The propensity of ethoxycarboxynitrile oxide  to self-dimerisation 
proved to be an ever-present competing reaction. The only cycloaddition of that dipole that 
did not yield a furoxan by-product was the reaction involving N-
phenylformimidoylmorpholine as the dipolarophile. 
The 1,3-dipolar cycloaddition reaction with dibromoformaldoxime as the nitrile oxide 
precursor was carried out with a number of dipolarophiles. All attempts failed to isolate the 
Δ
2
-1,2,4-oxadiazoline from that compound. The anticipated decomposition products were a 
nitrile and a urea. However, an amide was isolated leading to the belief that a different 
mechanistic pathway was in operation for the 3-bromo compounds. Infrared spectra of the 
reaction mixtures isolated invariably showed a peak at ~2216 cm
-1 
which we believed 
indicated the presence of a nitrile or a heterocumulene. The IR absorption that we observed 
for the reaction product mixture is consistent with the presence of phenylcyanamide-
comparison with spectra of an authentic sample of the compound, synthesised independently. 
A literature search for compounds with a similar intense peak at ~2220 cm
-1
, revealed that 
dibromofuroxan 15 is a furoxan which does not liberate the bromonitrile oxide upon heating. 
Westwood et al. established that bromine gas was liberated and cyanogen bis-N-oxide 72 was 
formed (Scheme 272). They observed an IR absorption of 2227 and 1259 cm
-1
 which 




              15     72 
Scheme 272: The conversion of furoxan15 to yield cyanogen-bis-N-oxide 72 
The potential stabilising effect of the subsituent at the C-3 position of the oxadiazoline is 
evident by comparing the degradation data of oxadiazolines 267 (R
1
 = Ph, Figure 72), 392 (R
1
 
= p-NO2Ph, Figure 78), 398 (R
1
 = PhC(O), Figure 86) and 400 (R
1
 = EtO2C-, Figure 92) 
(Figure 112). Oxadiazoline 400 was the slowest to initiate degradation to N-
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phenylmorpholine-4-carboxamide and ethoxycarbonylformonitrile taking ten days to reach a 
steady state of conversion. After 136 days, ~50% of the oxadiazoline still remained. 
 
267    392    398    400 
Figure 112: The structures of oxadiazolines 267, 392, 398 and 400 
The data yielded from the cycloaddition reactions with amidines 341 and 318 as the 
dipolarophiles allowed a direct comparison the effect of a phenyl or benzyl substituent at R
2
 
of the oxadiazoline (Figure 113).  
 
         341            318 
Figure 113: The amidines 341 and 318 
The benzyl group at R
2
 tended to yield more reactive oxadiazolines that were difficult to 
isolate. The similarity in reactivity of a phenyl, benzyl or p-chlorophenyl substituent at the 4-
position of the heterocycle was also examined. NMR spectroscopy tube experiments 
facilitated this and established that each of the oxadiazolines 267, 380 and 405 were formed 
quantitatively on mixing of the reagents (Figure 114). 
 
                    267            380     405 
Figure 114: The oxadiazolines 267, 380 and 405 
239 
Introduction of a more electron releasing N,N-dimethyl amino subsituent on C5 of the 
oxadiazoline affected our ability to isolate the corresponding oxadiazolines (Figure 111). 
With a morpholine group at C-5 position, isolation of the oxadiazoline was dependent on the 
substituent R
2
. In the case of cycloadditions with amidine 343, short reaction times of up to 
ten minutes allowed for exclusive isolation of oxadiazoline in the case of oxadiazoline 404 
(Figure 115). Reaction times extending beyond ten minutes yielded a mixture of oxadiazoline, 
nitrile and urea.  
 
   343             404               346 
Figure 115: The compounds 343, 404 and 346 
When a comparison is made with the imine 346 as the dipolarophile, the reaction times are 
much slower. Therefore, an additional nitrogen substituent does impact the cycloaddition 
reaction rate and subsequent conversion of the oxadiazoline into nitrile plus urea. This 
outcome clearly demonstrates that the nature of the N-substituent (electron donating to 
moderately electron withdrawing) in the imine group of the amidine has little influence on the 
reactivity of the amidines towards p-nitrobenzonitrile oxide (see also the competition reaction 
data in Table 42 and Entry 4 in Table 43: the latter for comparison of reactivity of two nitrile 
oxides possessing electron withdrawing groups in their molecular structures). This conclusion 
does not however provide any evidence for a diffusion controlled rate of cycloaddition since 
an order or reactivity beyond what is measurable through preparative, millimole scale 
reactions over a short timescale. Further work on this issue would require use of a kinetics 
technique in the realm of stopped-flow methodology using either UV-visible or NMR 










Chapter 3  
Experimental 
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1 General procedures 
Solvents were distilled prior to use: hexane and ethyl acetate were distilled from phosphorous 
pentoxide. Dichloromethane was also distilled from phosphorous pentoxide, and when needed 
in an anhydrous state, it was redistilled from calcium hydride and stored over activated 4Å 
molecular sieves. THF was distilled from sodium in the presence of benzophenone. Pyridine 
was distilled from sodium hydroxide and was subsequently distilled from calcium hydride. 
Triethylamine was distilled from calcium hydride. DMSO was distilled from calcium hydride 
under reduced pressure and stored over activated 4Å molecular sieves. Dry solvents were 
obtained by standard procedure.
[207]
 Infrared (IR) spectra were recorded on a Perkin-Elmer 
Paragon 1000 and Perkin Elmer Spectrum One. Liquid samples were examined as thin films 
interspersed between sodium chloride plates. IR spectra of solids were measured as KBr discs. 
1
H NMR spectra were recorded on a Bruker AVANCE 300, Bruker AVANCE 400, Bruker 
AVANCE 500 and Bruker AVANCE 600 spectrometers. 
13
C NMR spectra were recorded on 
a Bruker AVANCE 300, 500 and 600 instruments at 75, 125 and 150MHz respectively. All 
spectra were recorded at 20°C in deuterated chloroform (CDCl3) using tetramethylsilane 
(TMS) as an internal standard unless otherwise stated.  Chemical shifts (δH and δC) are 
reported in parts per million (ppm) relative to TMS and coupling constants are expressed in 
Hertz (Hz). Splitting patterns in 
1
H spectra are designated as s (singlet), bs (broad singlet), bd 
(broad doublet), bt (broad triplet), d (doublet), t (triplet), q (quartet), dd (doublet of doublets), 
dt (doublet of triplets), ddd (doublet of doublet of doublets), ddt (doublet of doublet of 
triplets), ABq (AB quartet) and (m) multiplet. 
Organic solutions were dried using anhydrous magnesium sulphate (MgSO4). Thin layer 
chromatography (TLC) was performed on precoated silica gel (Merck HF254) plates and 
compounds were visualised under ultraviolet light. Column “wet flash” chromatography was 
performed using FLUKA high-purity grade silica gel with a pore size of 60 Å, a 220-440 
mesh particle size and 35-75 μm particle size (catalogue number 60738). Bulb to bulb 
distillations were carried out on a Buchi GKR-50 Kugelröhr apparatus and the oven 
temperature is given as the boiling point of the substrate. 
Chlorine gas was generated by the dropwise addition of conc. HCl to solid KMnO4. HCl gas 
was removed by bubbling the gas through water. The chlorine gas was dried by bubbling 
through H2SO4. 
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HCl gas was generated by the dropwise addition of conc. H2SO4 on solid ammonium chloride 
and dried by its passage through conc. H2SO4 in a train of Dreschel bottles. 
In cases where a synthesis proved successful, the same procedure was executed in the 
preparation of families of compounds, e.g. the method used in the preparation of 1-benzoyl-1-
chloroformaldoxime was used in the preparation of 1-(p-bromobenzoyl)-1-
chloroformaldoxime from the related starting material. 
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BnBr: Benzyl bromide 
n-BuLi : n-Butyl lithium 
tBuOCl: t-Butyl hypochlorite 
Bu3SnCl: Tri-n-butyltin chloride 
(Bu3Sn)2O: Bis-Tributyltin oxide 
(Bu4N)2S2O8: Tetrabutylammonium Peroxydisulphate 
nBu4NI: Tetra-n-butylammonium iodide 
Cs2CO3: Caesium carbonate 
Cu(CHCO2)2.Ni(HCO2)2: 
DBU: 1,8-Diazabicyclo [5.4.0]-undec-7-ene 
DCM: Dichloromethane 




EtMgBr: Ethylmagnesium bromide  
EWG: Electron-withdrawing group 
Et2Zn : Diethylzinc 
FMO: Frontier molecular orbital 
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F/mol: Faraday/mole 
HOMO: Highest occupied molecular orbital 
HPLC: High performance liquid chromatography 
LAH: Lithium aluminium hydride 
LUMO: Lowest unoccupied molecular orbital 
MEM: β-Methoxyethoxymethyl ether 
MeSO2Cl: Methanesulfonyl chloride 
Mes: Mesityl group 
MW: Microwave irradiation 
NaBrO2: Sodium bromite 
NaHCO3: Sodium bicarbonate 
NBS: N-Bromosuccinimide 
NCS: N-Chlorosuccinimide 
NH2OH.HCl: Hydroxylamine hydrochloride 
NOE: nuclear Overhauser effect 
Pd2dba3: Tris(dibenzylideneacetone)dipalladium (0) 
Pb(OAc)4: Lead tetraacetate 
PCl5: Phosphorous pentachloride 
PhI(OAc)2: Diacetoxyiodobenzene 
PyBroP: Bromo-tris-pyrrolidinophosphonium hexafluorophosphate 
rt: Room temperature 
SOCl2: Thionyl chloride 
TCBDA: N,N,N',N'-Tetrachlorobenzene-1,3-disulfonamide 
245 
TCCA: Trichloroisocyanuric acid 
TEOF: Triethyl orthoformate 
TFAA: Trifluoroacetic anhydride 
p-TSA: p-Toluenesulfonic acid 
THF: Tetrahydrofuran 
t.l.c.: Thin layer chromatography 




3 Appendix 2: Compound reference guide 
Compound 
number 

































275 p-Nitrobenzohydroximoyl chloride 
 
4.1.4 









281 2,4,6-Trimethylbenzohydroximoyl chloride 
 
4.1.9 
















Compound name Compound structure Section 















304 Cyanoformohydroximoyl chloride 
 
4.4.8 
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4 Preparation of nitrile oxide precursors 
4.1 Synthesis of substituted benzohydroximoyl chlorides 
4.1.1 Benzaldoxime[208] 25 
A solution of sodium hydroxide (44.1 g, 1.1 mol) in water (120 mL) 
was added dropwise via a pressure-equalising addition funnel to a 
stirring benzaldehyde (63.7 g, 0.6 mol). Addition took 2 hr 30 min, 
and a pale white gloopy solution resulted. Hydroxylamine 
hydrochloride (41.9 g, 0.6 mol) was added to the stirring solution. The pale yellow solution 
which resulted was stirred at room temperature for 1.5 h and sufficient water was added to 
reform the clear solution (~80 mL). The solution was stirred overnight. CO2(g) was bubbled 
through the stirring solution (for 135 min) until a thick oily emulsion formed.  Water (500 
mL) was added and the mixture was extracted with ether (200 mL first, then 2 x 80 mL). 
The combined organic extracts were dried and the solvent removed in vacuo. Sample was 
purified by distillation and the oxime (59.73 g, 82%) was isolated as clear oil, b.p. 114-124 
o
C @ 15 mmHg, (Lit. b.p. 122-124 
o
C @ 12 mmHg). νmax (film): 3306, 1632, 1494, 1446, 
1304, 1210 cm
-1
; δH: 7.37 (3H, m, m- & p-ArH), 7.57 (2H, m, o-ArH), 8.17 (1H, s, 
CH=N), 9.32 (1H, bs, OH). 
4.1.2 Benzohydroximoyl chloride[145b] 26 
Chlorine gas was bubbled through a cooled (<0 
o
C, salt/ice water), 
stirring solution of benzaldoxime (12.16 g, 0.1 mol) in chloroform 
(150 mL) - a CaCl2 guard tube was fitted to the reaction flask. The 
temperature was maintained at -10 
o
C and the chlorine gas caused 
the solution to go from clear through yellow, dark yellow/green, dark green, dark 
blue/green, blue, bright green, yellow/green, yellow, yellow/orange and finally to a dark 
orange indicating saturation with chlorine. The flask was stoppered, sealed and left in a 
freezer overnight. Excess chlorine was evaporated in a nitrogen stream (5 h). The solvent 
was removed in vacuo and the resulting dark red/orange residue was diluted with hexane 
(~20 mL) and placed in a freezer. The resultant solid was isolated by vacuum filtration to 
give the hydroximoyl chloride (6.73 g, 43%) as a pale cream solid, m.p. 51 
o
C (Lit. 48-50 
o
C). νmax (KBr): 1628, 1491, 1238 cm
-1
; δH: 7.42 (3H, m, m- & p-Ar-CH), 7.85 (2H, m, o-
Ar-CH), 8.04 (1H, s, OH). δC: 127.6, 128.9 and 131.13 (3 x ArCH), 132.82 (ipso C of Ar), 
140.5 (C=N). 
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4.1.3 p-Nitrobenzaldoxime[209] 272 
p-Nitrobenzaldehyde (37.95 g, 0.25 mol), hydroxylamine 
hydrochloride (17.47 g, 0.25 mol) and sodium acetate (41.01 
g, 0.50 mol) were heated under reflux for 28 h in 95% ethanol 
(600 mL). The solvent was evaporated and the resulting 
yellow residue was dissolved in 2 M NaOH (600 mL) and the solution was stirred 
overnight. Water (1000 mL) was then added and a bright orange solution resulted. It was 
then filtered to give a bright orange solution of the oxime anion. Glacial acetic acid (~60 
mL) was added which resulted in the precipitation of the pale yellow oxime. The crude 
oxime was isolated by filtration and recrystallised from ethanol/water to yield the pale 
yellow crystalline oxime (32.49 g, 78%). m.p. 130-132 
o
C (Lit. m.p. 126-127 
o
C), νmax 
(KBr): 3304, 1605, 1537, 1350, 1216, 1107 cm
-1
; δH(DMSO-d6): 7.81 (2H, d, J = 9.00, o-
ArH), 8.20 (2H, d, J = 9.00, m-ArH), 8.26 (1H, s, CH=N), 11.86 (1H, bs, OH). 
4.1.4 p-Nitrobenzohydroximoyl chloride[145b] 275 
Chlorine gas was bubbled through a cooled (<0 
o
C, 
salt/icebath), stirring solution of p-nitrobenzaldoxime (16.68 g, 
0.10 mol) in chloroform (500 mL). The solution changed 
colour from yellow, through green, blue and on to orange and 
finally yellow. Nitrogen gas was bubbled through the reaction mixture for 4 h to remove 
excess chlorine gas. The solvent was removed in vacuo and the crude chloro-oxime was 
recrystallised from chloroform/hexane. The hydroximoyl chloride (11.62 g, 58%) was 





C), νmax (KBr): 3271, 3111, 1599, 1522, 1353, 1335 cm
-1
; δH (DMSO-d6): 8.05 (2H, 
d, J = 8.78, o-ArH), 8.31 (2H, d, J = 8.78, m-ArH), 13.01 (1H, bs, OH). 
4.1.5 m-Nitrobenzaldoxime[209]32 274 
m-Nitrobenzaldehyde (33.31 g, 0.22 mol), hydroxylamine 
hydrochloride (15.31 g, 0.22 mol), and sodium acetate (36.1 g, 0.4 
mol) were heated under reflux for 28 h in 96% ethanol (600 mL). 
The solvent was evaporated and the resulting yellow residue was 
dissolved in 2 M NaOH (600 mL) and water (1000 mL). The 
solution was filtered, leaving a dark yellow solution of the oxime which was acidified with 








glacial acetic acid (~100 mL) resulting in the precipitation of the oxime. The solid oxime 
was isolated by filtration, washed with water and recrystallised from ethanol/water to yield 
the oxime (34.75 g, 95%) as a pale yellow crystalline solid, m.p. 115-119 
o





 νmax (KBr): 3294, 3069, 1536, 1466, 1350 cm
-1
; δH(DMSO-d6): 7.69 (1H, t, J = 
7.95, m-ArH), 8.04 (1H, d, J = 7.80, o-ArH), 8.20 (1H, m, p-ArH), 8.32 (1H, m, o-ArH), 
8.41 (1H, s, CH=N), 11.68 (1H, s, OH); δC: 120.8, 123.6, 130.3, 132.3 (4 x ArCH), 134.9 
(ipso C of Ar), 146.6 (C-NO2), 148.1 (CH=NOH). 
4.1.6 m-Nitrobenzohydroximoyl chloride[145b] 276 
Chlorine gas was bubbled through a cooled (<0 
o
C, salt/ice-bath), 
mechanically stirred solution of m-nitrobenzaldoxime (4.21 g, 25 
mmol) in chloroform (200 mL). The reaction mixture went from 
yellow-green-green with precipitate to green/blue to light green and 
finally yellow. The solution was stirred at room temperature 
overnight. Nitrogen gas was bubbled through the resulting solution to remove excess 
chlorine (8 h) in the solution. The solvent was removed in vacuo to give a pale yellow 
solid. Recrystallisation from chloroform:hexane to yield the hydroximoyl chloride (3.09 g, 
61%) as a yellow crystalline solid, m.p. 97-99 
o
C (Lit. 99-100 
o
C). νmax (KBr): 3306, 3082, 
1698, 1526, 1354 cm
-1
; δH(DMSO-d6): 7.87 (1H, t, J = 8.06, o-ArH), 8.31 (1H, m, o-ArH), 
8.42 (1H, m, p-ArH), 8.59 (1H, t, J = 1.97, m-ArH), 12.94 (1H, bs, OH). δC: 121.3, 125.3, 
131.0 and 132.9 (4 x ArCH), 134.0 (ipso C of Ar), 134.4 (C-NO2), 148.3 [C(Cl)=NOH]. 
4.1.7 Mesitaldehyde[145c] 279 
A solution of mesitylene (72.09 g, 0.60 mol) in dry 
dichloromethane (375 mL) was cooled (<10 
o
C, water/ice bath) and 
TiCl4 (105 mL, 0.96 mol) was added over a period of 3 min. On 
addition, the solution changed from yellow to orange to 
brown/orange. While the solution was stirred and cooled, dichloromethylmethyl ether 
(57.54 g, 0.50 mol) was added dropwise over a 25 min period. The reaction commenced 
(as indicated by the evolution of gas-HCl) when the first drop of the chloro ether was 
added. Bubbles were noted in the solution and the solution became red/brown in colour. 
After the reaction was complete, the solution was stirred for 5 min in the water/ice-bath. 
The solution was stirred without cooling for 30 min, then heated to 35-40 
o
C and stirred for 
15 min at this temperature. The solution began to reflux. Once the 15 min had elapsed, the 
solution was cooled and the deep red solution was transferred to a 1 L separation funnel 
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which contained ~0.5 kg ice. On addition to the ice, effervescence and a colour change 
from deep red to white/clear solution were observed. The phases were separated. The 
aqueous layer was washed with dichloromethane (50 mL) and the organic extracts were 
combined. Nitrogen gas was used to retard the auto oxidation of the aldehyde in place of 
hydroquinone. The organic extracts were washed with water (3 x 75 mL), dried and the 
solvent was evaporated in vacuo to yield the aldehyde (54.94 g, 74%) as a pale yellow 
liquid, b.p. 102-112 
o
C @ 15 mmHg (Lit. 113-115 
o
C @ 11 mmHg); νmax (film): 2922, 
1689, 1609, 1437, 1378 cm
-1
; δH: 2.30 (3H, s, p-ArCH3), 2.56 [6H, s, o-Ar(CH3)2], 6.88 
(2H, s, ArH), 10.54 (1H, s, CHO); δC: 21.5 and 21.8 (2 x ArCH3), 128.9 (p-ArC-CH3), 
130.9 (ArCH), 141.9 [o-ArC-(CH3)2], 144.3 (C-CHO), 193.4 (CHO).  




Hydroxylamine hydrochloride (9.36 g, 0.14 mol) was added to 
a cooled (<10 
o
C, water/ ice-bath), stirring solution of 
mesitaldehyde (18.04 g, 0.12 mol) in water (32 mL), 95% 
ethanol (32 mL) and ice (60 mL). 50% Sodium hydroxide 
solution (25 mL) was added dropwise to the stirring solution of mesitaldehyde and 
hydroxylamine hydrochloride. Ice (~20 mL) was added to maintain the temperature 
between 25-30 
o
C. The solution was stirred overnight (19 h). The resulting pale creamy 
yellow solid was dissolved in ether (124 mL). This resulted in a bright orange/brown bi-
phasic mixture. The phases were separated and the organic phase was acidified to pH 6 
with conc. HCl. The aqueous layer was extracted with dichloromethane (123 mL initially, 
then 2 x 50 mL). The organic extracts were washed with water (50 mL), dried and the 
solvent was evaporated in vacuo. The resulting white residue was recrystallised from 1:1 







 νmax (KBr): 3252, 2966, 1610, 1444, 1375, 1297, 
944 cm
-1
; δH: 2.28 (3H, s, p-Ar-CH3), 2.37 [6H, s, o-Ar(CH3)2], 6.88 (2H, s, ArH), 8.34 
(1H, bs, OH), 8.41 (1H, s, CH=N); δC: 20.2 and 21.5 (2 x Ar-CH3), 126.8 (p-ArC-CH3), 
129.7 (ArCH), 137.9 [o-ArC-(CH3)2], 139.3 (ipso C of Ar). 150.2 (CH=N-OH).  




 contained a crude m.p. for mesitaldoxime 280, therefore the recrystallised m.p. in reference 
[24d]







Mesitaldehyde (9.00 g, 0.06 mol), hydroxylamine hydrochloride (4.22 g, 0.06 mol), and 
sodium acetate (12.68 g, 0.16 mol) were heated under reflux in absolute ethanol (166 mL) 
overnight (24 h). The solvent was evaporated in vacuo and the resulting cream coloured 
residue was dissolved in 2 M NaOH (150 mL) and water (250 mL). The solution was 
vacuum filtered to give a grey clear solution of the oxime anion. The filtrate was acidified 
using glacial acetic acid (30 mL) resulting in the precipitation of the cream/white oxime, 
which was recrystallised from 1:3 ethanol/water to yield the oxime (6.4 g, 65%) as a white 






 νmax (KBr): 3249, 2950, 1609, 
1444, 1375, 1297, 944 cm
-1
; δH: 2.28 (3H, s, p-Ar-CH3), 2.37 [6H, s, o-Ar(CH3)2], 6.88 
(2H, s, ArH), 8.03 (1H, bs, OH), 8.41 (1H, s, CH=N); δC: 20.2 and 21.5 (2 x Ar-CH3), 
126.8 (p-ArC-CH3), 129.7 (ArCH), 137. 9 [o-ArC(CH3)2], 139.3 (ipso C of Ar), 150.3 
(CH=N-OH). 




A solution of mesitaldoxime (4.90 g, 30 mmol) in chloroform 
(25 mL) was cooled to 0 
o
C (water/icebath). N-
Chlorosuccinimide (4.01 g, 30 mmol) was added portionwise 






 of the overall 
portion of NCS was added, the solution was monitored for 10 min to see if any temperature 
increase/exotherm took place. As no increase in temperature took place, 10 mL HCl gas 
headspace was bubbled through the solution. Chloroform (25 mL) was also added to aid 
solubility. The remainder of the NCS was then added to the stirring solution while 
maintaining the reaction temperature at 0 
o
C. The solution was stirred for 45 min with 
icebath in place and overnight at room temperature. Completion of the reaction was 
indicated by cessation of the exotherm and by formation of no dark colored ring upon 
application of a small drop of reaction mixture to starch-iodide paper previously moistened 
with distilled water. The reaction mixture was poured onto ice water (~100 mL) and stirred 
until homogenous. The phases were separated and the aqueous phase was extracted with 
chloroform (2 x 50 mL). The organic extracts were combined, dried and concentrated in 




 contained a crude m.p. for mesitaldoxime 280, therefore the recrystallised m.p. in reference 
[24d]
 is cited. 
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vacuo to yield the crude hydroximoyl chloride as a pale yellow oil. The sample was put on 
high vacuum line and the hydroximoyl chloride (5.7 g, 97%) solidified as a white solid, 
m.p. 66-74.5 
o
C (Lit. m.p. 61-69 
o
C); νmax (film): 3294, 2921, 2289, 1707, 1610, 1454, 
1423, 961 cm
-1
; δH: 2.29 [6H, s, ArC-(CH3)2], 2.31 (3H, s, ArC-CH3), 6.90 (2H, s, m-ArH), 




Pyridine (0.2 mL, 2.8 mmol) was added to a stirring solution of mesitaldoxime (4.90 g, 30 
mmol) in chloroform (29 mL) at room temperature. The stirring solution was heated to 40 
o
C and N-chlorosuccinimide (4.41 g, 33 mmol) was added slowly. The resulting pale 
yellow solution was left to stir at 40 
o
C for 3 h. The solution was cooled to room 
temperature and dichloromethane (200 mL, distilled) added. The solution was transferred 
to a separating funnel and washed with water (2 x 100 mL) and brine (1 x 100 mL). The 
organic extract was dried, filtered and solvent evaporated in vacuo to yield the crude 
hydroximoyl chloride as a pale yellow oil. The sample was placed under high vacuum to 
remove residual solvent and the hydroximoyl chloride (5.38 g, 91%) was isolated as a pale 
yellow solid, m.p. 59-65 
o




; νmax (KBr): 3294, 2921, 1706, 1611, 1444, 
1423, 962 cm
-1
; δH: 2.26 [6H, s, o-Ar(CH3)2], 2.28 [3H, s, p-Ar(CH3)], 6.87 (2H, s, m-
ArH), 8.67 (1H, bs, OH). 
4.2 Synthesis of dihaloformaldoximes 
4.2.1 Dibromoformaldoxime 41 
Solid hydroxylamine hydrochloride (13.90 g, 0.20 mol) was added to a 
stirring solution of glyoxylic acid monohydrate (18.42 g, 0.20 mol) in 
water (120 mL) at room temperature and the resulting clear solution was 
stirred overnight (69 h). Sodium bicarbonate (35.30 g, 0.42 mol) was added carefully to the 
stirring solution followed by dichloromethane (120 mL, distilled). The solution was then 
cooled to 0 
o
C (water/icebath) and bromine (14.5 mL, 0.30 mol) was added dropwise via 
pressure-equalising addition funnel at such a rate that the temperature did not exceed 10 
o
C. The pale orange solution was then warmed to room temperature and stirred overnight. 
The phases were separated and the aqueous phase was washed with dichloromethane (190 
mL, distilled), organic extracts combined, dried  and solvent removed in vacuo to yield 
                                                 
35




 is used for the lit. m.p. comparison. 
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crude dibromformaldoxime (17.98 g, 44%) as a white crystalline solid, m.p. 55.5-60 
o
C 




 νmax (KBr): 3172, 1588, 1401, 982, 905 cm
-1
; δC: 99.2 (C=NOH). 
4.2.2 Glyoxylic acid aldoxime 283 
Method 1 
Glyoxylic acid monohydrate (10.18 g, 0.11 mol), hydroxylamine 
hydrochloride (7.68 g, 0.11 mol) and sodium acetate (18.04 g, 0.22 
mol) were heated under reflux for 24 h in 95% ethanol (300 mL). The 
solvent was removed in vacuo and the resulting white residue was dissolved in a mixture 
of 2 M NaOH (300 mL) and water (500 mL). The resulting bright yellow solution of the 
oxime anion was acidified with glacial acetic acid. At pH 4, the oxime had not precipitated 
out so the yellow solution was stirred overnight. The solution was extracted with ether 
(500 mL first, then 2 x 200 mL). The organic extracts were combined, dried  and the 
solvent was evaporated in vacuo to yield the glyoxylic acid aldoxime (0.251 g, 3%) as a 
pale cream solid, m.p. 90-97 
o




 νmax  (KBr): 3199, 1719, 1627, 
1459, 1257 cm
-1
: δH(DMSO-d6): 7.46 (1H, s, CH=N).   
Method 2 
Hydroxylamine hydrochloride (7.57 g, 0.11 mol) was added to a stirring solution of 
glyoxylic acid monohydrate (10.01 g, 0.11 mol) in water (100 mL) and the resulting 
solution was stirred until homogenous. The solution was then basified (alkaline to litmus) 
with 1 M aqueous NaOH solution. This solution was then stirred for 69 h. The solution was 
acidifed with 10% (v/v) aqueous sulphuric acid solution [red to litmus] and the oxime was 
extracted with ether (3 x 100 mL). The combined organic extracts were dried and solvent 
removed in vacuo to yield the oxime (50 mg, 5%) as a pale cream solid, m.p. 107-110 
o
C 




 νmax  (KBr): 3198, 1719, 1459, 1256, 1008 cm
-1
; δH(D2O): 7.58 
(1H, s, CH=N); δC(D2O): 142.9 (CH=N), 165.8 (COOH). 
Method 3 
Hydroxylamine hydrochloride (13.58 g, 0.195 mol) was added to a stirring solution of 
glyoxylic acid monohydrate (18.02 g, 0.196 mol) in water (200 mL) at room temperature. 
Once the clear mixture was homogenous, it was basified (from pH 1) to pH 10 and stirred 
overnight. The solution was concentrated to a quarter of its original volume and some solid 
precipitated. The mixture was extracted with ether (3 x 200 mL) and the combined organic 
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extracts were dried, filtered and solvent was removed in vacuo to yield a white solid. 
Granular salt was added to the aqueous phase and the solution was stirred overnight. The 
aqueous phase was then extracted with ether (3 x 200 mL). A white emulsion formed. The 
combined organic extracts were dried, filtered and the solvent removed in vacuo to yield 
the oxime (13.59 g, 78%) as a white solid, m.p. >304 
o





 νmax  (KBr): 3272, 1701, 1451, 1253, 1026 cm
-1
; δC(D2O): 143.1 (CH=NOH), 
165.9 (COOH). 
4.2.3 Dichloroformaldoxime[145i] 16 
N-Chlorosuccinimide (1.34 g, 10.00 mmol) and glyoxylic acid aldoxime 
(0.46 g, 5.19 mmol) in chloroform (5 mL) were heated under reflux at 70 
o
C until effervescence ceased. The solvent was evaporated in vacuo to 
yield the crude oxime (1.67 g, >100%) as a white solid. The sample was used directly in 
the next step without further purification or analysis. 
4.3 Synthesis of 1-aroyl-1-chloroformaldoximes 
4.3.1 1-Benzoyl-1-chloroformaldoxime[145d] 286 
Acetophenone (22.50 g, 0.19 mol) in water (40 mL) was 
combined with 37% HCl (30 mL, 0.4 mol) at room temperature 
and the solution was stirred. Sodium nitrite (0.50 g, 7.3 mmol) 
was then added portionwise to the stirring solution. The resulting 
reaction mixture was heated to 70 
o
C and conc. nitric acid (12 mL) was added dropwise to 
the stirring solution over 1.8 h. The resulting solution was then stirred for 1.3 h at 70 
o
C. A 
sticky yellow oily residue separated from the mixture which solidified on cooling. This 
solution was left to stand overnight. This solid was isolated by extraction with 
dichloromethane (3 x 100 mL). The combined organic extracts were dried, filtered and 
solvent removed in vacuo to yield the crude chloro-oxime (26.46 g, 77%) as a yellow solid, 
m.p. 128-131 
o
C (Lit. 130-131 
o
C). νmax (KBr): 3277, 1660, 1448, 1392, 1039, 854, 720 
cm
-1
; δH(DMSO-d6): 7.47 (2H, m, m-ArH), 7.62 (1H, m, p-ArH), 7.97 (2H, m, o-ArH), 
9.21 (1H, bs, OH); δC(DMSO-d6): 128.4, 130.7 and 133.8 (3 x ArCH), 134.8 (ipso C of 
Ar), 139.2 [C(Cl)=NOH] and 183.9 (C=O).  
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4.3.2 1-(p-Bromobenzoyl)-1-chloroformaldoxime 292 
Sodium nitrite (0.10 g, 1.51 mmol) was added to a stirring 
solution of 4-bromoacetophenone (7.92 g, 39.78 mmol) and 
conc. HCl (37%, 7.5 mL, 90 mmol) in water (10 mL) at 
room temperature. The solution was stirred and heated to 70
 
o
C. Nitric acid (3 mL, 0.07 mol) in water (5 mL) was added dropwise via pressure-
equalising addition funnel at 70 
o
C. Following addition, the stirring solution was 
maintained at 70 
o
C for 64 h. Chloroform (100 mL) was added to dissolve the yellow 
sticky solid which had separated from the solution. Water (20 mL) was also added as an 
emulsion formed. The solution was transferred to separating funnel and the phases were 
separated. The aqueous phase was extracted with chloroform (1 x 100 mL). The organic 
phase was then washed with water (1 x 50 mL). The organic extracts were dried, filtered 
and concentrated to ~50 mL. Hexane (~100 mL) was added and the solution left to stand 
overnight. The hydroximoyl chloride (1.8 g, 17%) was isolated as a pale yellow solid by 
vacuum filtration, m.p. 125-127 
o
C. Found: C, 37.10; H, 1.96; N, 5.13 C8H5NO2BrCl 
requires C, 36.92; H, 1.94; N, 5.43%; νmax (film): 3284, 1668, 1596, 1581, 1425, 1039 cm
-
1
; δH: 7.62 (2H, m, ArH), 7.88 (2H, m, ArH), 8.83 (1H, bs, OH); δC: 129.3 [ArC(Br)], 
131.7 and 132.1 (2 x ArCH), 133.4 (ipso C of Ar), 139.4 [C(Cl)=NOH], 182.6 (C=O). m/z 
= no identifiable ions. 
4.4 Synthesis of other hydroximoyl halides 
4.4.1 Glycine ethyl ester hydrochloride[24a] 294 
HCl gas was bubbled through a mechanically stirred suspension of 
glycine (75.1 g, 1.0 mol) in 96% ethanol (300 mL). A further 
portion of 96% ethanol (200 mL) was added to aid stirring of the 
mixture. The mixture was heated under reflux overnight (19 h). The mixture was cooled 
and the solvent was evaporated in vacuo to yield glycine ethyl ester hydrochloride (131 g, 
94%) as a white solid, m.p. 120-122 
o
C (Lit. 144 
o
C). νmax (KBr): 2977, 1745, 1508, 1413, 
1248 cm
-1
; δH(D2O): 1.19 (3H, t, J = 7.20, CH3CH2O), 3.81 (2H, s, COCH2NH2.HCl), 4.20 
(2H, q, J = 7.00, CH3CH2O); δC: 13.5 (CH3CH2O), 40.5 (COCH2NH2.HCl), 63.5 
(CH3CH2O), 168.5 [OC(O)CH2]. 
4.4.2 Ethylchloroglyoxalate oxime[157] 295 
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Concentrated hydrochloric acid (20.75 mL, 0.21 mol) was added 
dropwise to a cooled (<0 
o
C, salt/ice-bath), stirring solution of 
glycine ethyl ester hydrochloride (35.04 g, 0.25 mol) in water (47.5 
mL). The mixture was cooled (<0 
o
C, salt/ice bath) and sodium 
nitrite (17.5 g, 0.3 mol) in water (25 mL) was added dropwise over 1 h. The solution 
turned from yellow to green and evolution of gas was observed. Further conc. hydrochloric 
acid (20.75 mL, 0.2 mol) was added followed by additional sodium nitrite (17.5 g, 0.3 mol) 
in water (25 mL) dropwise over 1 h. The reaction colour went from pale green through 
blue/green, brown/orange and finally to orange. A brown gas evolved on addition of 
sodium nitrite. The reaction was stirred for 69 h. Saturated sodium chloride solution (50 
mL) was added to the cloudy mixture. The product was extracted into dichloromethane (4 
x 50 mL), the organic extracts were combined, dried and the solvent evaporated in vacuo. 
The resulting residue was recrystallised from chloroform/hexane to yield the hydroximoyl 
chloride (9.0 g, 24%) as a colourless crystalline solid, m.p. 80-81 
o
C (Lit. 80 
o
C). νmax 
(KBr): 3310, 1751, 1618, 1457, 1307 cm
-1
; δH: 1.39 (3H, t, J = 7.15, CH3CH2O), 4.40 (2H, 
q, J = 7.14, CH3CH2O), 9.66 (1H, bs, OH). δC: 14.4 (CH3CH2O), 64.1 (CH3CH2O), 133.4 
(C=NOH), 159.0 (C=O). 
4.4.3 p-Toluenesulfonylnitromethane 297 
Sodium metal (4.14 g, 0.18 mol) was reacted with dry methanol 
(75 mL) and the excess methanol was evaporated in vacuo. DMF 
(180 mL) was added and the resulting solution was cooled in an 
icebath (<10 
o
C, water/icebath). Nitromethane (10 mL, 0.19 mol) was added and a cloudy 
white mixture resulted. Following 40 min of stirring the cooled reaction mixture, sodium 
p-toluenesulfinate (16.04 g, 0.09 mol), followed by iodine (20.31 g, 0.08 mol) were added 
to the stirring solution. The resulting bright orange solution was stirred overnight at room 
temperature. The reaction mixture was poured onto icewater (~600 g) and the solution was 
stirred until the ice had melted. Solid sodium sulphite was added until the mixture became 
lighter in colour. The excess solid sodium sulphite was removed by filtration. The filtrate 
was then acidified to pH 1-3 with 2.4 M HCl. A precipitate formed which was isolated by 
vacuum filtration. Recrystallisation from 95% ethanol yielded p-







). νmax (KBr): 3018, 2952, 1551, 1385, 1327, 1153 cm
-1
; δH: 2.50 (3H, s, 
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ArCH3), 5.57 (2H, s, CH2NO2), 7.44 (2H, d, J = 7.96, o-ArH), 7.84 (2H, m, m-ArH); δC: 
21.9 [ArC(CH3)], 90.4 (SO2CH2NO2), 128.4 and 130.4 (2 x ArCH), 132.6 [p-ArC(CH3)], 
147.2 (ipso C of Ar). m/z = 214 (M-H
+
, 100%). 
4.4.4 1-p-Toluenesulfonyl-1-bromoformaldoxime[51b] 299 
A solution of bromine (1.1 mL, 20 mmol) in dry dichloromethane 
(35 mL) was added dropwise via pressure-equalising addition 
funnel to a cooled (<10 
o
C, water/icebath), stirring solution of 
sodium acetate (7.4 g, 90 mmol) and p-
toluenesulfonylnitromethane (4.31 g, 20 mmol) in 
dichloromethane (70 mL, dry). A white solid precipitated from the solution. The reaction 
mixture was washed with water (1 x 30 mL), the phases were separated and the organic 
phase was dried, filtered and concentrated. 
1
H NMR spectroscopic analysis conducted at 
this point to ascertain the level of bromination - predominantly mono-bromo product 
isolated. A cold (<0 
o
C, salt/icebath), stirring solution of the crude bromination product in 
ether (62.5 mL) was treated with ethereal diazomethane (~1.0 g, 24.5 mmol, added in 3 
portions). On addition, the solution changed from clear to yellow and effervescence was 
observed, then the solution became clear and the next portion was added. After 10 min, the 
solution was partially evaporated under reduced pressure (~20 mL solution) to remove 
excess diazomethane. The residue was dissolved in dichloromethane (37.5 mL, dry) and 
stirred, then heated at reflux for 15 min. The solvent was removed in vacuo and to the 
resulting orange oil was added dry dichloromethane (~5 mL) and distilled hexane (~5 mL). 
This solution was then transferred to a freezer. The hydroximoyl bromide (4.29 g, 77%) 







 νmax (film): 3088, 2971, 2912, 2866, 1588, 1571, 1344, 1326, 
1300, 1156 cm
-1
; δH: 2.48 (3H, s, Ar-CH3), 7.40 (2H, d, J = 8.01, o-ArH), 7.89 (2H, d, J = 
8.38, m-ArH), 9.47 (1H, bs, OH); δC: 21.8 [ArC(CH3)], 129.7 and 130.3 (2 x ArCH), 132.4 
[p-ArC(CH3)], 132.6 (ipso C of Ar), 146.6 [C(Br)=N].  
4.4.5 Diazomethane[161] 298 
Diazald
®
 (N-methyl-N-nitroso-p-toluenesulfonylamide) (7.51 g, 35 mmol) 
in ether (43.5 mL) was added dropwise over 1 h to a solution of potassium 
hydroxide (2.81 g, 50 mmol) in 96% ethanol (11.5 mL) and water (2.8 mL) 
while stirring at 70 
o
C. The rate of addition was regulated so that the addition of one drop 
of Diazald
® 
coincided with the distillation of one drop of diazomethane. Once the addition 
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was complete, further ether (20 mL) was added and the distillation was continued until 
most of the ether had distilled across, to give a solution of diazomethane in ether (~1.0 g, 
25 mmol) which was used directly in the next step. The solution was yellow in colour. 
Note/caution: Diazomethane is highly toxic and explosive. Its preparation should be 
carried out in a well-ventilated fume-hood with adequate shielding. Explosive 
decomposition of diazomethane can be initiated by sharp surfaces, thus only glassware 
with clear-seal
®
 joints should be used for the distillation. The distillation apparatus should 
not be exposed to strong sun or artificial light. 




A saturated solution of sodium carbonate (15.92 g, 0.15 mol) in 
water (60 mL) was added portionwise to a cooled (<0 
o
C, 
salt/icebath), stirring solution of hydroxylamine hydrochloride 
(20.91 g, 0.30 mol) in water (50 mL). A clear pink solution resulted and anhydrous chloral 
(14.73 g, 0.10 mol) was added dropwise via a Pasteur pipette to the cooled (<0 
o
C, 
salt/icebath) stirring solution. On addition of some of the chloral, effervescence was 
observed and a gloupy layer appeared on surface of the solution. This solution was not 
stirring successfully, so addition was stopped until the solution was stirring properly. This 
was done every time the solution became too gloopy and continued until chloral addition 
was complete. The resulting pale yellow cloudy mixture was stirred for 2 h. (The icebath 
was not in place during the stir time but the solution remained cold). The icebath (<0 
o
C, 
salt/icebath) was reinstated prior to NaOH addition. A saturated solution of sodium 
hydroxide (16.07 g, 0.4 mol) in water (50 mL) was then added portionwise to the freshly 
cooled stirring solution. The resulting yellow solution was stirred for 1.25 h. This stirring, 
cooled (<0 
o
C, salt/icebath) solution was neutralised with 10% (v/v) aq. H2SO4 to pH 7. At 
pH 7, a pale yellow solid precipitated from the mixture. This precipitate was isolated by 
vacuum filtration and dissolved in diethyl ether. This solution was then concentrated to a 
third of its original volume in vacuo. Hexane was added to precipitate the crude oxime 
(2.00 g, 16%). m.p. 156-158 
o




 νmax (KBr): 3288, 1678, 1618, 1471, 
1272, 982 cm
-1
; δH(DMSO-d6): 8.34 (1H, s, CH=N), 10.36 (1H, bs, OH), 12.31 (1H, bs, 
OH); δC(DMSO-d6): 137.1 (N=CH), 142.4 [N=C(Cl)].  




 did not contain a Lit. m.p. for chloroglyoxime 303. 
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Method 2  
Chloral oxime (8.95 g, 55 mmol), hydroxylamine hydrochloride (3.83 g, 55 mmol) and 
sodium acetate (9.03 g, 0.11 mol) were heated under reflux for 26 h in 95% ethanol (150 
mL). The mixture was cooled and the solvent was removed in vacuo. The resulting residue 
was dissolved in a mixture of 2 M NaOH (150 mL) and water (250 mL). The bright orange 
solution was then acidified to pH 3 with glacial acetic acid. No precipitate was isolated. 
The yellow solution was left to stir over the weekend. The pH was found to be pH 4 on 
checking. The solution was extracted with ether (500 mL first, then 2 x 200 mL). The 
combined organic extracts were dried, filtered and solvent evaporated in vacuo. (2.09 g, 
31%) unidentifiable mixture. 
Method 3 
A solution of sodium bicarbonate (15.88 g, 0.19 mol) in water (100 mL) was added 
portionwise to a stirring solution of hydroxylamine hydrochloride (20.87 g, 0.30 mol) in 
water (50 mL). Once effervescence had subsided, chloral hydrate (16.55 g, 0.10 mol) was 
added portionwise to the stirring clear solution and the solution was stirred overnight. The 
solution was concentrated to dryness and a further portion of water (75 mL) added. The 
solution was cooled (<0 
o
C, salt/icebath) and a solution of NaOH (16.00 g, 0.40 mol) in 
water (75 mL) was added portionwise, resulting in a yellow solution. The solution (pH 10) 
was acidified with 25% sulfuric acid solution. At pH 7, a solid precipitated from the 
solution and was isolated by vacuum filtration and the filtrate was further acidified to pH 3. 
Ether (200 mL) was added to the stirring solution and the solution was stirred overnight. 
The phases were separated and the aqueous phase was extracted with ether (200 mL). The 
combined organic extracts were dried, filtered and solvent evaporated in vacuo to yield a 
pale yellow solid (2.84 g). Both samples were analysed and the solid isolated at pH 7 was 
found to be the chloroglyoxime (4.20 g, 34%) as a white solid, m.p. 152-154 
o





. νmax (KBr): 3289, 1678, 1618, 1471, 1272, 983 cm
-1
; δH(DMSO-d6): 8.33 
(1H, s, N=CH), 12.37 (1H, bs, OH), 12.58 (1H, bs, OH); δC(DMSO-d6): 137.08 (N=CH), 




To a dried 1 L 3-necked rbf equipped with a thermometer, stirring pellet and dropping 
funnel protected under nitrogen was added water (60.6 g) and hydroxylamine 
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hydrochloride (31.51 g, 0.45 mol). The reaction mixture was stirred at 20-25 
o
C for 0.5 h 
until the solids were dissolved. To the solution was added dropwise, a clear solution of 
potassium carbonate (31.35 g, 0.23 mol) and water (280 mL) over 55 min at 20-25 
o
C, 
followed by chloral hydrate (25.02 g, 0.15 mol) in portions at 20-28 
o
C. After addition, the 
reaction mixture was stirred overnight and reaction deemed complete by TLC. The 
reaction mixture was cooled to 0-5 
o
C, 25% sodium hydroxide (96.74g, 0.63 mol) was 
added over 1 h at 0-5 
o
C. After addition, the stirring mixture was acidified with 25% 
sulphuric acid at 0-5 
o
C until pH 3.0. The resulting mixture was extracted with methyl-t-
butyl ether (2 x 37.5 ml). The combined organic layer was dried with sodium sulphate 
(10.01 g), filtered and then concentrated in vacuo to ~15 g, which was diluted with n-
heptane (26.70 g). The resulting mixture was concentrated in vacuo to ~15 g. To the 
resulting slurry, was added n-heptane (26.70 g), and then cooled to 0-5 
o
C and maintained 
at this temperature over 69 h. The sample was isolated by vacuum filtration and washed 
with n-heptane (2 x 3.65 ml). The sample was dried under high vacuum at 30-38 
o
C to 
yield the chloroglyoxime (3.69 g, 20%) as a white solid, m.p. 154 
o




 νmax (KBr): 3270, 1621, 1450, 1273, 1196, 1036, 959 cm
-1
; δH(DMSO-d6): 8.33 
(1H, s, HC=N), 12.31 (1H, bs, OH), 12.52 (1H, bs, OH); δC(DMSO-d6): 137.15 (N=CH), 
142.49 [N=C(Cl)]. m/z: 121 (M-H
+
).  
4.4.7 Chloral oxime[164] 305 
A solution of anhydrous chloral (306) (29.48 g, 0.20 mol), 
hydroxylamine hydrochloride (6.96 g, 0.10 mol) and calcium chloride 
(22.21 g, 0.20 mol) in water (20 mL) were stirred together for ~20 min 
at room temperature and then heated for 1 h at 50 
o
C. The solution 
was then distilled at water aspirator pressure and the fraction collected boiled at 41-44.5 
o
C 




) correlates with the product (31.11 g, 
32%). Anhydrous chloral 306 and chloral oxime 305 were obtained in a ratio of 3:1. νmax 
(film): 3395, 2175, 1715, 1633, 1402, 1300, 1096, 987, 833 cm
-1
; δH: 7.82 (1H, s, CH=N), 
8.37 (1H, bs, OH), 9.05 (3H, s, CHO 306); δC: 94.1 (CCl3 306), 103.4 (CH=N 305), 149.8 
(CCl3 305), 176.7 (CHO 306).  
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4.4.8 Cyanoformohydroximoyl chloride[157] 304 
Neat thionyl chloride (7.5 mL, 0.1 mol) was dropwise via pressure 
equalising addition funnel  to a stirring solution of chloroglyoxime (3.0 
g, 25 mmol) in ether (20mL) under a nitrogen atmosphere. The 
resulting clear yellow solution was stirred for 80 min at room temperature and the excess 
SOCl2 and ether were evaporated in vacuo. The resulting yellow oily residue was purified 
by distillation (b.p. 72 
o
C @ 15 mmHg) and the distillate solidified on standing. The 
distillate was recrystallised from hexane and placed in the freezer. The solvent was 
evaporated in vacuo as the hydroximoyl halide (0.8 g, 31%) was a white needle-like 
crystalline solid at -20 
o
C and a pale yellow oil at room temperature; νmax (film): 3234, 
2990, 2866, 2243, 1624, 1459, 1146, 1113, 1049cm
-1
; δC: 111.1 (C≡N) and 115.2 
[C(Cl)=N]. m/z: 103 (M-, 100%). 
5 Preparation of nitrile oxides 
5.1.1 p-Nitrobenzonitrile-N-oxide 265 
NMR Spectroscopy tube reaction  
A solution of p-nitrobenzohydroximoyl chloride (20.10 mg, 
0.105 mmol) in chloroform-d (1.5 mL) and a solution of 
triethylamine (15.00 mg, 0.148 mmol) also in chloroform-d (1.5 
mL) were combined. A 0.6 mL portion of this solution was 




C NMR spectroscopic 
analysis. δH: 7.73 (2H, m, ArH), 8.31 (2H, m, ArH); δC: 119.6 (C≡N), 123.4 and 132.1 (2 x 
ArCH). The sample was monitored over time to view the dimerisation of the nitrile oxide.  
δH: (t = 15 h): 7.90 (3H, m, ArH 312), 8.32 (5H, m, ArH 
312). Dimerisation of the nitrile oxide 265 to the furoxan 










Triethylamine (0.84 mL, 6.03 mmol) was added dropwise to a cooled (<0 
o
C, salt/icebath), 
stirring solution of p-nitrobenzohydroximoyl chloride (1.01 g, 5.04 mmol) in the minimum 
amount of ethanol. Cold water (~10 mL) was then added. The resulting solution was 
filtered by vacuum filtration and was washed with water (~5 mL). The nitrile oxide (0.75 
g, 91%)  was isolated as a pale yellow solid, m.p. 92-93 
o
C (Lit m.p. 95 
o
C). δH: Exp 10 
15:59 13.04.2010, 7.72 (2H, m, ArH 265), 8.31 (2H, m, ArH 265) shows nitrile oxide. Exp 
11 17:14 13.04.2010 7.73 (2H, m, ArH 265 & 312), 8.33 (2.22H, m, ArH 265 & 312) 
shows some dimer beginning to form, but predominantly nitrile oxide. Exp 12 09:44 
14.04.2010 shows the dimer-no nitrile oxide. 7.73 (4H, m, ArH 312), 8.34 (4H, m, ArH 
312).  
5.1.2 Mesitonitrile-N-oxide 7 
2,4,6-Trimethylbenzohydroximoyl chloride (304.80 mg, 1.54 
mmol) in ether (10 mL) was added dropwise (via Pasteur pipette) 
to a stirring solution of triethylamine (155.30 mg, 1.52 mmol) in 
ether (10 mL) at room temperature. The resulting white cloudy mixture was stirred at room 
temperature for 2 h and filtered. The solvent was removed in vacuo to yield the crude 
mesitonitrile-N-oxide (0.260 g, >100%
37







 νmax (film): 2948, 2919, 2288, 1332 cm
-1
; δH: 2.30 (3H, s, ArCH3), 2.42 
[6H, s, Ar(CH3)2], 6.91 (2H, s, ArH); δC: 20.8 [Ar(CH3)2], 21.4 (ArCH3), 111.0 
[ArC(CH3)2], 128.3 (ArCH), 141.0 (ipso C of Ar), 141.7 (C≡N).  
Complete dimerisation to furoxan 313 was observed (in CDCl3) within 15 days. δH: 2.25 
(3H, s, ArCH3), 2.28 [6H, s, Ar(CH3)2], 2.31 (3H, s, 
ArCH3), 2.42 [6H, s, Ar(CH3)2], 6.84 (2H, s, ArH), 6.90 
(2H, s, ArH); δC: 18.6 [Ar(CH3)2], 20.8 [Ar(CH3)2], 21.4  
(ArCH3), 128.3 (ArCH), 128.7 (ArCH), 132.7 (C=N), 
135.1 (C=N), 141.0 (ipso C of Ar), 141.7 (ipso C of Ar). 
313 
 
                                                 
37
 Contains ether. 
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5.1.3 Bromoformonitrile-N-oxide 13 
Method 1 
Dibromoformaldoxime (0.61 g, 3.01 mmol) in ether (5 mL) was added 
dropwise via Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring 
solution of triethylamine (0.31 g, 3.02 mmol) in ether (5 mL). Ether (10 mL) was used to 
rinse the flask and the solution was stirred for ~2 min. The mixture was filtered to remove 
the precipitate and the solvent was evaporated in vacuo to yield the nitrile oxide (0.187 g, 
51%) as a white solid. δC: 98.2 (Br-C≡N). 
Method 2: NMR Spectroscopy tube reaction  
Dibromoformaldoxime (14.2 mg, 0.07 mmol) was dissolved in 0.07 M triethylamine 
solution (1 mL, CDCl3) and the resulting mixture was monitored over time by 
13
C NMR 
spectroscopy. δC: Exp 10: 99.08 (C≡N, 13), 114.29. Exp 12: [7 days after addition] 98.92, 
99.02 (2 x C=N, 15). 
Method 3: NMR spectroscopy tube reaction 
Dibromoformaldoxime  (42.6 mg, 0.21 mmol) was dissolved in CDCl3 (0.7 mL) and 
13
C 
NMR spectroscopic analysis was carried out. Triethylamine (44 μl, 0.316 mmol) was 
added directly to the NMR spectroscopy tube and 
13
C NMR submitted. δC: 95.91 (C=N, 
41), 104.0, 111.4, 124.8.  
 
41 
5.1.4 p-Toluenesulfonylformonitrile-N-oxide 307 
Method 1: NMR spectroscopy tube reaction 
1-p-Toluenesulfonyl-1-bromoformaldoxime  (19.90 mg, 0.07 
mmol) was dissolved in CDCl3 (1.5 mL) and combined with 
triethylamine (8.90 mg, 0.09 mmol) and the resulting solution 
was shaken to ensure dissolution. 0.6 mL of this solution was 
transferred to an NMR spectroscopy tube and 
1
H NMR spectroscopic analysis was carried 
out. δH: 1.44 (15.6H, t, CH3 433), 2.47 (3.28H, s, ArCH3 309), 2.49 (3.83H, s, ArCH3 307), 
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2.52 (3.32H, s, ArCH3 309), 3.17 (23.4H, m, CH2 433), 7.38 (2.52H, d, J = 8.12, ArH 307), 
7.45 (4.5H, m, ArH 309), 7.85 (2.03H, d, J = 8.28, ArH 307), 8.04 (4H, dd, J = 8.9, 2.6, 
ArH 309). A mixture of triethylamine hydrobromide (433), nitrile oxide (307) and furoxan 
(309) was observed in a ratio of 2.6:1:1.  
Method 2 
1-p-Toluenesulfonyl-1-bromoformaldoxime  (834.60 mg, 3.00 mmol) in ether (10 mL) and 
triethylamine (308.80 mg, 3.05 mmol) in ether (5 mL) were combined at room 
temperature. A cloudy pale yellow mixture resulted which was stirred for ten minutes. The 
mixture was filtered and the solvent was evaporated in vacuo to yield a pale yellow solid 
(0.38 g, 64%). δH: 2.48 (6.91H, s, ArCH3 299), 2.49 (4.11H, s, ArCH3 309), 2.51 (2.99H, s, 
ArCH3 307), 2.54 (3.58H, s, ArCH3 309), 7.32 (1.32H, d, J = 7.97, ArH), 7.39 (5.26H, d, J 
= 7.97, ArH 299), 7.44 (4.88H, m, ArH 309), 7.51 (2.14H, d, J = 8.02, ArH), 7.81 (1.44H, 
m, ArH), 7.88 (4.38H, m, ArH 299), 7.96 (2.48H, d, J = 8.48, ArH), 8.04 (4.04H, dd, J = 




Solid potassium hydrogencarbonate (0.107 g, 1.069 mmol) was added to a stirring solution 
of 1-p-toluenesulfonyl-1-bromoformaldoxime (0.280 g, 1.01 mmol) in chloroform (10 mL) 
at room temperature. The resulting solution was stirred for 5 min and water (5 mL) was 
added. The phases were separated and organic phase dried, filtered and solvent removed in 
vacuo to yield a grey solid (0.241 g). δH: Predominantly 299 was isolated with a trace of 
307/309. Dehydrohalogenation using potassium hydrogencarbonate was not successful 
with this reaction time. 
Method 4 
Solid potassium carbonate (0.141 g, 1.02 mmol) was added to a stirring solution of 1-p-
toluenesulfonyl-1-bromoformaldoxime (0.280 g, 1.01 mmol) in chloroform (10 mL) at 
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room temperature. The resulting solution was stirred for 5 min and water (5 mL) was 
added. The phases were separated and organic phase dried, filtered and solvent removed in 
vacuo to yield a clear oil (0.12 g). δH: 2.46 (2.91H, s, ArCH3 309), 2.49 (3.36H, s, ArCH3 
307), 2.51 (3.01H, s, ArCH3 309), 7.38 (2.02H, d, J = 8.04, ArH 307), 7.44 (4.14H, m, 
ArH 309), 7.88 (2H, d, J = 8.37, ArH 307), 8.04 (3.77H, m, ArH 309). 
Method 5 
1,8-Diazabicyclo-[5.4.0]-undec-7-ene (0.15 mL, 1.0 mmol) was added to a stirring solution 
of 1-p-Toluenesulfonyl-1-bromoformaldoxime (0.3 g, 1.0 mmol) in chloroform (10 mL) at 
room temperature. The resulting solution was stirred for 5 min and water (5 mL) was 
added. The phases were separated and organic phase dried, filtered and solvent removed in 
vacuo to yield a yellow oil (0.112 g). δH: Contains an unidentifiable mixture of products. 
Method 6 
Triethylamine (0.14 mL, 1.00 mmol) was added to a stirring solution of 1-p-
toluenesulfonyl-1-bromoformaldoxime (0.28 g, 1.01 mmol) in chloroform (10 mL) at room 
temperature. The resulting solution was stirred for 5 min. Water (5 mL) was added. The 
phases were separated and organic phase dried, filtered and solvent removed in vacuo to 
yield a pale orange oil (2.9 g). δH: Contains mostly 309 with a trace of 307. 
Method 7 
Potassium t-butoxide (0.1 g, 1.0 mmol) was added to a stirring solution of 1-p-
toluenesulfonyl-1-bromoformaldoxime (0.3 g, 1.0 mmol) in chloroform (10 mL) at room 
temperature. The resulting mixture was stirred for 5 min. Water (5 mL) was added and the 
phases were separated. The organic phase was dried, filtered and solvent removed in vacuo 
to yield a clear oil (0.101 g). δH: Contains 299 and a trace of 309.  
5.2 Preparation of furoxans 
5.2.1 3,4-Dibenzoylfuroxan 314 
Triethylamine (0.46 mL, 3.3 mmol) was added to a 
stirring solution of 1-benzoyl-1-chloroformaldoxime (0.6 
g, 3.3 mmol) in ether (20 mL) at room temperature. The 
resulting cloudy (precipitate formed immediately) pale 
yellow solution was stirred overnight. The solution was filtered and solvent removed in 
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vacuo. Any residual solvent or triethylamine was removed under vacuum to yield the 
furoxan (0.746 g, 78%) as a yellow crystalline solid. m.p. 77.5-80.5 
o





νmax (film): 3066, 3007, 1682, 1614, 1470, 1452, 1329, 1238, 1180, 1035, 923, 846 cm
-1
; 
δH: 7.55 (4H, m, ArH), 7.70 (2H, m, ArH), 7.86 (2H, m, ArH), 8.20 (2H, m, ArH); δC: 
129.1, 129.2, 129.7 and 130.6 (4 x ArCH), 128.5 and 130.2 (2 x p-ArCH), 135.2 and 135.5 
(2 x i-ArC), 154.3 and 170.7 (2 x C=N), 180.4 and 181.8 (2 x C=O). m/z = 295 [M+H]
+
. 
5.2.2 3,4-Diethoxycarbonylfuroxan 315 
Ethylchloroglyoxalate oxime (0.276 g, 1.82 mmol) and 
triethylamine (0.200 g, 1.98 mmol) in ether (10 mL) were stirred 
together for 1 h. The solution was filtered and the solvent was 
removed in vacuo. As evaporation of the solvent did not yield the 
product, the solid isolated on the filter paper was dissolved in dichloromethane (10 mL) 
and was washed with water (10 mL). The layers were separated, the organic extract was 





 νmax (film): 2987, 2943, 1750, 1626, 1247, 1198, 1024 cm
-1
; 
δH: 1.42 (6H, m, 2 x CH3), 4.48 (4H, two overlapping q (showing 6 of 8 possible lines), J = 
7.15, 7.10, 2 x CH2); δC: 8.6 and 13.9 (2 x CH3), 43.8 and 63.6 (2 x CH2), 106.7 and 148.4 
(2 x C=N), 155.1 and 156.7 (2 x C=O). HRMS (ESI
+
) exact mass calculated for 
C8H11N2O6 [(M+H)
+
], 231.0617, found 231.0621.  
5.2.3 3,4-bis-(p-Toluenesulfonyl)-furoxan 309 
Triethylamine (0.46 mL, 3.3 mmol) was added to a stirring 
solution of 1-toluenesulfonyl-1-bromoformaldoxime (0.91 g, 
3.3 mmol) in ether (20 mL) at room temperature. The 
resulting orange mixture (precipitate formed immediately) 
was stirred overnight. The solution was filtered and the filtrate 
was concentrated in vacuo to yield the product (0.37 g, 29%) 
as a yellow oil. The sample was placed under high vacuum to remove any residual 
solvent/triethylamine residues and an orange solid was isolated, m.p. 155-158 
o





 νmax (film): 3067, 2983, 2926, 2185, 1783, 1619, 1594, 1492, 1449, 1376, 
1351, 1164, 955 cm
-1
; δH: 2.49 (6H, m, 2 x ArCH3), 7.42 (4H, m, ArH), 7.80 (2H, m, 
ArH), 7.96 (1H, m, ArH), 8.04 (1H, m, ArH); δC: 21.4, 21.5 and 22.0 (3 x ArCH3 
309/316), 126.0, 126.5, 129.1, 129.3, 129.7, 130.2, 130.3, 130.5 (8 x ArCH), 147.5 (C=N). 
m/z = 198 [M
+
 of nitrile oxide] furoxan (309) not observed in mass spectral analysis. 
275 
8 x ArH signals suggest that two products are present. The p-substituted aromatic rings 
should only give 4 signals in the furoxan structure. Therefore the asymmetrical 1,2,4-
oxadiazole-4-oxide 316 could be present also. The 
13
C NMR spectroscopy was taken a 
long time after synthesis, therefore the nitrile oxide should not be present and would not 
account for the second set of signals. 
 
       316 
6 Reference compounds 
6.1 Reference material for amidine degradation 
6.1.1 N-Benzylformamide 319 
Benzylamine (5.54 g, 51.68 mmol) was heated at reflux with ethyl 
formate (11.50 g, 155.29 mmol) for 24 h. The by-product (ethanol) was 
evaporated in vacuo to yield the amide as clear oil which solidified on 
standing. Recrystallisation from toluene gave the formamide (5.77 g, 83%) as a white solid 
as a 1:5 mixture of rotamers, m.p. 65 
o




 νmax (KBr): 3271, 3056, 
3031, 1639, 1534, 1389 cm
-1
; δH: 4.40 (0.33H, d, J = 6.52, CH2 minor), 4.47 (1.61H, d, J = 
5.92, CH2 major), 5.96 (1H, bs, NH), 7.32 (5H, m, ArH), 8.17 (0.16H, d, J = 11.94, 
NHCHO, minor), 8.25 (0.79H, s, NHCHO major); δC: 42.2 (CH2 major), 45.6 (CH2 
minor), 127.0 (ArCH minor), 127.7 (ArCH major), 127.8 (ArCH major), 128.0 (ArCH 
minor), 128.8 (ArCH major), 129.0 (ArCH minor), 137.6 (ipso C of Ar), 161.0 (CHO 








6.2 Reference material for bromo nitrileoxide cycloadditions 
6.2.1 N-Benzoylmorpholine 322 
 Benzoyl chloride (7.03 g, 0.05 mol) in ether (30 mL) was added 
dropwise via a pressure-equalising addition funnel to a stirring 
solution of morpholine (4.38 g, 0.05 mol) and triethylamine (5.06 
g, 0.05 mol) in the same solvent (50 mL). The resulting white 
solution was stirred overnight. Ether (~80 mL) was added to the solution as some ether had 
evaporated off overnight. The solution was filtered and solvent removed in vacuo to yield 
the crude product as a white crystalline solid. The crude product was dissolved in 
dichloromethane (distilled, ~60 mL) and was washed with water (3 x 40 mL). The 
dichloromethane extract was dried, filtered and solvent removed in vacuo to yield a clear 
oil. This was diluted in hexane (distilled, ~80 mL) and stored in a freezer for 2 h and left to 
stand over the weekend. The amide (4.03 g, 42%) was isolated as a white crystalline solid, 
m.p. 67-69 
o




 νmax (KBr): 3080, 3064, 1626, 1426, 1271, 1254, 
1111 cm
-1
; δH: 3.60 [8H, m, N(CH2)4O], 7.41 (5H, m, ArH); δC: 42.5 [N(CH2)2], 66.9 
[O(CH2)2], 127.1 (m-ArCH), 128.6 (o-ArCH), 129.9 (p-ArCH), 135.3 (ipso C of Ar), 170.5 





6.2.2 N-Benzoylpiperidine 324 
 A solution of benzoyl chloride (7.03 g, 0.05 mol) in ether (30 mL) 
was added dropwise via pressure-equalising addition funnel to a 
stirring solution of piperidine (4.26 g, 0.05 mol) and triethylamine 
(5.06 g, 0.05 mol) in ether (50 mL). The resulting white cloudy 
mixture was left to stir overnight. The solution was filtered and solvent removed in vacuo 




 νmax (film): 3058, 
1713, 1627, 1577, 1443, 1275 cm
-1
; δH: 1.51 (2H, bs, CH2), 1.68 (4H, bs, CH2), 3.34 (2H, 
bs, CH2), 3.71 (2H, bs, CH2), 7.39 (5H, bs, ArH); δC: 24.6, 25.6, 26.6, 43.1 and 48.8 (5 x 
CH2 of piperidine ring), 126.8 and 128.4 (2 x ArCH), 129.4 (p-ArCH), 136.5 (ipso C of 
Ar), 170.4 (C=O). 
6.2.3 N-(p-Chlorobenzoyl)-morpholine 327 
 A solution of p-chlorobenzoyl chloride (6.86 g, ~0.04 mol) in 
ether (50 mL) was added to a stirring solution of triethylamine 
(5.58 mL, 0.04 mol) and morpholine (3.51 g, 0.04 mmol) in 
277 
ether (150 mL). A slight exotherm occurred. The resulting white cloudy mixture was 
stirred over the weekend. Dichloromethane (200 mL) added as the solution had dried out. 
The solution was washed with water (3 x 200 mL). The combined organic extracts were 
dried, filtered and the solvent was removed in vacuo to yield the amide (6.8 g, 77% two 
steps) as a white solid, m.p. 73-74 
o




 νmax (KBr): 3028, 1626, 1593, 
1436, 1112 cm
-1
; δH: 3.69 [8H, bm, N(CH2)4O], 7.40 (4H, m, ArH); δC: 42.8 [N(CH2)], 
48.1 [N(CH2)], 66.8 [O(CH2)2], 128.7 and 128.9 (2 x ArCH), 133.6 (ipso C of Ar), 136.0 









6.2.4 N-Phenylthiourea[176] 329 
Phenylisothiocyanate (13.82 g, 0.10 mol) was added dropwise via 
Pasteur pipette to a stirring solution of ammonia (6 mL, 0.10 mol) in 
dichloromethane (300 mL, distilled) at room temperature and the 
resulting clear solution was stirred at room temperature for 18 h. Water (1000 mL) was 
added. The solution was transferred to a separating funnel. The phases were separated and 
the aqueous phase was extracted with distilled dichloromethane (3 x 100 mL). A white 
emulsion was present. The organic extracts were combined and washed with brine (100 
mL). Note: some of the emulsion cleared and distilled dichloromethane (100 mL) was 
added to clear the remaining emulsion-which disappeared after addition. The combined 
organic extracts were dried, filtered and the solvent was evaporated in vacuo to yield a 
white crystalline solid. The resulting residue was recrystallised from dichloromethane : 
hexane (distilled). The thiourea (9.65 g, 63%) was isolated by vacuum filtration as a white 
crystalline solid, m.p. 154-155 
o
C (Lit. m.p. 155 
o
C). νmax (KBr): 3423, 3276, 1609, 1519, 
1444, 1260, 1230 cm
-1
; δH: 6.16 (2H, bs, NH2), 7.24 (2H, m, o-ArH), 7.35 (1H, m, p-ArH), 
7.45 (2H, m, m-ArH), 8.18 (1H, bs, NH). 
6.2.5 Methyl-N-phenylcarbamidothioate hydroiodide[178] 330 
Iodomethane (5 mL, 0.08 mol) was added to a stirring solution of N-
phenylthiourea (12.18 g, 0.08 mol) in the minimum quantity of acetone 
and the mixture was stirred overnight at room temperature. The solvent 
was evaporated in vacuo and ether was used to transfer the sample. The sample was then 
washed with ether. The product (22.4 g, 95%) was isolated as a pale cream solid, m.p. 145-
145.5 
o
C(Lit. m.p. 140 
o
C), νmax (KBr): 3079, 1624, 1591, 1569, 1433 cm
-1
; δH: 2.78 (3H, s, 
SCH3), 7.35 (2H, m, ArH), 7.44 (3H, m, ArH). 
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6.2.6 N-Phenyl-S-methylisothiourea[178] 331 
Conc. ammonia (aqueous) solution was added dropwise via Pasteur 
pipette to a cooled (<10 
o
C, water/icebath), stirring solution of S-
methyl-N-phenylcarbamidothioate hydroiodide (7.51 g, 25.5 mmol) in 
water (200 mL). N-Phenyl-S-methylisothiourea (3.49 g, 82%) precipitated as a white solid 
which was isolated by vacuum filtration, m.p. 63-65 
o




). νmax (KBr): 
3431, 3092, 1619, 1571, 1483, 1275 cm
-1
; δH: 2.46 (3H, s, SCH3), 4.42 (2H, bs, NH2), 6.92 
(2H, m, o-ArH), 7.04 (1H, m, p-ArH), 7.31 (2H, m, m-ArH). 
6.2.7 Potassium phenylcyanamide[177] 332 
A solution of potassium hydroxide (0.66 g, 11.84 mmol) in water (2 
mL) was added dropwise via Pasteur pipette to a stirring solution of N-
phenyl-S-methylisothiourea (1.96 g, 11.7 mmol) in iso-propyl alcohol 
(6 mL) at room temperature. The resulting clear solution was heated under reflux for ten 
min. The flask was cooled to room temperature and the solvent was removed in vacuo to 
yield a white solid. The crude product was recrystallised from acetone and left to stand in 
the fumehood overnight. Potassium phenylcyanamide (0.78 g, 42%) was isolated by 
vacuum filtration as a white solid, m.p. 328 
o
C decomp. (Lit. m.p. 345 
o
C). νmax (KBr): 
3075, 3015, 2077, 1596, 1495, 1323, 1313 cm
-1
; δH(DMSO-d6): 6.32 (1H, tt, J = 1.15, 7.16, 
p-ArH), 6.58 (2H, m, o-ArH), 6.89 (2H, m, m-ArH); δC(DMSO-d6): 113.8 (C≡N), 118.0, 
126.1 and 128.3 (3 x ArCH), 155.4 (ipso C of Ar).  
6.2.8 Phenylcyanamide[177] 333 
A solution of potassium phenylcyanamide (0.40 g, 2.56 mmol) in iso-
propyl alcohol (3.75 mL) and water (0.75 mL) was neutralised (to pH 7) 
with 2 M HCl (aq.) solution. The solvent was evaporated in vacuo to yield 
a pale cream solid. This was dissolved in distilled dichloromethane (30 mL) and was 
filtered to remove any remaining solids. The solvent was removed in vacuo to yield the 
crude phenylcyanamide (0.29 g, 96%) as a pale yellow oil. νmax (film): 3171, 3100, 2987, 
2914, 2229, 1601, 1501, 1435, 1302, 1249, 1176 cm
-1
; δH: 5.94 (1H, bs, NH), 7.05 (3H, m, 
ArH), 7.33 (2H, m, m-ArH); δC: 111.6 (C≡N), 115.4, 123.6 and 129.8 (3 x ArCH), 137.3 




6.3 Decomposition reference products 
6.3.1 Ureas 
6.3.1.1 1-Benzyl-3-(N,N-dimethyl)-urea 335 
A solution of benzylisocyanate (1 mL, 8.10 mmol) in dry toluene 
(20 mL) was added dropwise via a pressure equalising addition 
funnel to a stirring solution of N,N-dimethylamine (1.45 mL, 
8.12 mmol, 33% in abs ethanol) in dry toluene (20 mL) at 70-80 
o
C. Following addition, the solution was stirred at 70-80 
o
C for 10 min and was then cooled 
to room temperature. The solvent was removed in vacuo to yield a pale yellow oil, which 
solidified on standing. The sample was recrystallised from methanol to yield the urea (1.23 
g, 85%) as a white solid, m.p. 64-65 
o




), νmax (KBr) 3312, 3031, 1631, 
1536, 1453, 1349, 1234 cm
-1
; δH(DMSO-d6): 2.92 [6H, s, N(CH3)2], 4.42 (2H, d, J = 5.55, 
PhCH2), 4.65 (1H, bs, NH), 7.30 (5H, m, ArH); δC(DMSO-d6): 36.3 [N(CH3)2], 45.1 
(PhCH2), 127.3 (p-ArCH), 127.8 and 128.6 (2 x ArCH), 139.7 (ipso C of Ar); m/z = 179 
([M+H]
+
, 100%).  
6.3.1.2 N-Benzylmorpholine-4-carboxamide 
336 
A solution of benzylisocyanate (1.0 mL, 8.10 mmol) in dry 
toluene (20 mL) was added dropwise via pressure equalising 
addition funnel to a stirring solution of morpholine (0.71 mL, 8.12 mmol) in dry toluene 
(20 mL) at 70-80 
o
C. On completion of addition, the solution was stirred at 70-80 °C for 10 
min. The solution was cooled and a solid precipitated out of solution which was isolated by 
vacuum filtration. The urea (1.50 g, 84%) was isolated as a white crystalline solid, m.p. 
129-130 °C (Lit. m.p. 123-124 °C).
[213]
 νmax (KBr): 3337, 3076, 3029, 1626, 1543, 1267, 
1115 cm
-1
; δH: 3.36 [4H, t, J = 4.92, N(CH2)2], 3.68 [4H, t, J = 4.91, O(CH2)2], 4.43 (2H, d, 
J = 5.46, PhCH2], 4.73 (1H, bs, NH), 7.31 (5H, m, ArH); δC: 44.1 [N(CH2)2], 45.0 
(PhCH2), 66.5 [O(CH2)2], 127.4 (p-ArCH), 127.8 and 128.7 (2 x ArCH), 139.2 (ipso C of 
Ar), 157.7 (C=O). m/z = 221 ([M+H]
+




6.3.1.3 N-Phenyl-1-piperidine carboxamide 337 
A solution of phenylisocyanate (5.43 mL, 50 mmol) in distilled 
toluene (50 mL) was added dropwise via pressure-equalising addition 
funnel to a stirring solution of piperidine (4.9 mL, 50 mmol) in 
distilled toluene (50 mL) at 70-80 
o
C. A white solid precipitated from 
solution. The solution was cooled and the urea (9.16 g, 90%) was isolated by vacuum 
filtration as a white solid, m.p. 166-168 
o




 νmax (KBr): 3287, 3054, 
1629, 1536, 1449, 1242 cm
-1
; δH: 1.61 [6H, m, (CH2)3], 3.42 [4H, m, N(CH2)2], 6.47 (1H, 
bs, NH), 7.00 (1H, m, p-ArH), 7.26 (2H, m, m-ArH), 7.36 (2H, m, o-ArH); δC: 24.4 
(CH2CH2CH2), 25.7 [N(CH2)2(CH2)2], 45.3 [N(CH2)2], 119.8, 122.8 and 128.9 (3 x ArCH), 
139.4 (ipso C of Ar), 155.0 (C=O). m/z = 205 (M+H)
+
, 100%. 
7 Preparation of dipolarophiles 
7.1 Formamidines 
7.1.1 N,N-Dimethyl-N´-benzylformamidine 339 
Method 1 
N,N-Dimethylformamide dimethyl acetal (17.0 g, 0.1 mol) was 
added dropwise via a Pasteur pipette to a stirring solution of 
benzylamine (12.40 g, 0.12 mol) in dry methanol (40 mL). Once 
addition was complete, the solution was heated under reflux 
overnight. The reaction mixture was cooled and the solvent was evaporated in vacuo. 
Purification by distillation gave the amidine (17.38 g, 93%) as a clear yellow oil, b.p. 132-
136 °C @15 mmHg (Lit. b.p. 70-71 
o
C @ 0.005 torr).
[214]
 νmax (film): 3084, 3060, 3026, 
2911, 1643, 1346, 1106 cm
-1
; δH: 2.88 [6H, s, N(CH3)2], 4.45 (2H, s, PhCH2), 7.28 (5H, m, 
ArH),  7.38 (1H, s, N=CHN); δC: 37.5 [N(CH3)2], 59.9 (PhCH2), 126.2 (p-ArCH), 127.8 
(o-ArCH), 128.6 (m-ArCH), 143.7 (ipso C of Ar), 156.3 (N=CHN).  
Method 2 
N,N-Dimethylformamide dimethyl acetal (18.6 mL, 140 mmol) in dry methanol (20 mL) 
was added dropwise via pressure-equalising addition funnel to a stirring solution of 
benzylamine (12.67 mL, 116 mmol) in methanol (20 mL, distilled). The resulting solution 
was stirred overnight at room temperature and solvent evaporated in vacuo to yield a clear 
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oil. This was purified by kugelröhr distillation, (b.p. 128.5-130.5 
o
C @2 mmHg (Lit. b.p. 
70-71 
o
C @ 0.005 torr)) to give the amidine as a clear oil (16.32 g, 87%).
[214]
 νmax (film): 
3060, 3026, 2912, 1950, 1650, 1346, 1106 cm
-1
; δH: 2.84 [6H, s, N(CH3)2], 4.43 (2H, s, 
PhCH2), 7.23 (5H, m, ArH), 7.35 (1H, s, N=CHN). 
Method 3  
Benzylamine (12.67 mL, 116 mmol) and N,N-dimethylformamide dimethyl acetal (18.6 
mL, 140 mmol) were stirred together at room temperature overnight in chloroform (40 
mL). The solvent was evaporated in vacuo. The amidine was purified by kugelröhr 
distillation, b.p. 90-110 
o
C @ 2 mmHg (Lit. b.p. 70-71 
o
C @ 0.005 torr) and isolated as a 
clear oil (17.32 g, 92%).
[214]
 νmax (film): 3084, 3060, 3026, 2910, 2285, 1656, 1346, 1105 
cm
-1
; δH: 2.83 [6H, s, N(CH3)2], 4.44 (2H, s, PhCH2), 7.23 (5H, m, ArH), 7.34 (1H, s, 
N=CHN). 
7.1.2 N-Formylmorpholine 340 
98-100% Formic acid (82.96 g, 1.8 mol) was added dropwise via a 
pressure-equalising addition funnel to a cooled (<10 
o
C, water/ice bath), 
stirring solution of morpholine (156.84 g, 1.8 mol) in toluene (250 mL). 
On completion of addition, the solution was heated at reflux until 34.5 
mL water was collected in a Dean-Stark trap. Solid sodium hydrogen carbonate (6.0 g, 0.1 
mol) was added to the cooled solution. This solution was stirred for 30 min, filtered and the 
solvent was removed in vacuo. Purification by vacuum distillation, b.p. 112-114 
o
C @25 
mmHg (Lit. b.p. 120-122 
o
C @ 19-20 mmHg) yielded N-formylmorpholine (189.61 g, 
91%) as a clear oil.
[215]
 νmax (film): 3103, 1660, 1435, 1399, 1069 cm
-1
; δH: 3.41 [2H, m, 
N(CHax)2], 3.57 [2H, m, N(CHeq)2], 3.68 [4H, m, O(CH2)2], 8.06 (1H, s, CHO). 
7.1.3 N-Benzylformimidoylmorpholine 318 
Phosphorous oxychloride (2.76 g, 18 mmol) in benzene (20 
mL) was added dropwise to a mechanically stirring solution 
of N-formylmorpholine (1.85 g, 16.1 mmol) in the same 
solvent (20 mL). The resulting solution was stirred at room 
temperature for 30 min. A solution of benzylamine (1.7 g, 16.1 mmol) in benzene (20 mL) 
was then added dropwise to the stirring, biphasic solution over 25 min. The solution was 
then heated under reflux for 22 h. The stirring reaction mixture was cooled and 6 M NaOH 
(10 mL) was added. The biphasic solution was transferred to a separating funnel and the 
282 
phases were separated. The aqueous layer was washed with ether (2 x 100 mL). The 
organic extracts were combined, dried and the solvent evaporated in vacuo to give pale 
yellow oil. The oil was purified by kugelröhr distillation (b.p 140-163 
o
C @0.8 mmHg) to 
yield the amidine (1.54 g, 47%) as a clear yellow oil. νmax (film): 3060, 3025, 2852, 1650, 
1453, 1115 cm
-1
; δH: 3.34 [4H, m, N(CH2)2], 3.68 [4H, m, O(CH2)2], 4.45 (2H, s, PhCH2), 
7.30 (6H, m, N=CHN and ArH); δC: 46.1 [N(CH2)2], 59.5 (PhCH2), 66.7 [O(CH2)2], 126.5, 
127.5 and 128.3 (3 x ArCH), 141.6 (ipso C of Ar), 155.0 (N=CHN). 
7.1.4 N-Phenylformimidoylmorpholine 341 
Phosphorous oxychloride (8.97 mL, 98 mmol) in benzene (30 
mL) was added dropwise via a pressure equalizing addition 
funnel to a vigorously stirring solution of aniline (7.97 mL, 87 
mmol) and N-formylmorpholine (9.65 mL, 96 mmol) in benzene 
(100 mL) at room temperature. The solution was heated under reflux for 4 h. The reaction 
mixture was cooled, poured onto ice (~100 g) and rendered pH 10-12 (with universal 
indicator paper) with 6 M NaOH (aq.) solution. The biphasic solution was transferred to a 
separating funnel and the phases were separated. The aqueous phase was extracted with 
ether (2 x 100 mL). The combined organic extracts were dried, filtered and solvent 
removed in vacuo to yield the crude amidine as a yellow crystalline solid. Recrystallisation 
from ether:hexane yielded the amidine (8.4 g, 51%) as a pale yellow crystalline solid, m.p. 
63-67 
o
C(Lit. b.p. 120 
o
C @0.05 mmHg) on isolation by vacuum filtration.
[102]
 νmax (KBr): 
2965, 1628, 1586, 1169, 1151, 1110 cm
-1
; δH: 3.52 [4H, bs, N(CH2)2], 3.75 [4H, m, 
O(CH2)2], 6.96 (2H, m, o-ArH), 7.03 (1H, m, p-ArH), 7.27 (2H, m, m-ArH), 7.52 (1H, s, 
N=CH). 
7.1.5 N-Formylpiperidine 342 
98-100% Formic acid (7.6 mL, 0.2 mol) was added dropwise to a cooled 
(<10 
o
C, water/icebath), stirring solution of piperidine (19.8 mL, 0.2 mol) 
in toluene (55 mL, distilled). The solution was heated at reflux until a 
total of 3.6 mL of water was collected (1.5 h) in a Dean-Stark trap. The 
solution was cooled, solid sodium carbonate (5 g) added and the solution was stirred for 5 
min (neutralise excess acid). The solution was filtered and solvent removed in vacuo to 
yield the crude formamide as a pale yellow oil. Vacuum distillation yielded the amide 
(15.88 g, 70%) as a clear oil, b.p. 74-99 
o





(film): 2938, 2858, 1664, 1439, 1399, 1279, 1257, 1210, 1118 cm
-1
; δH: 1.56  [4H, m, 
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N(CH2)2-(CH2)2], 1.69 [2H, m, N(CH2)2(CH2)2CH2], 3.31 [2H, t, J = 5.6, N(CHax)2], 3.48 
[2H, t, J = 5.7, N(CHeq)2], 8.00 (1H, s, CHO). 
7.1.6 N-Phenylformimidoylpiperidine 343 
Phosphorous oxychloride (8.97 mL, 98 mmol) in benzene (30 
mL) was added dropwise via a pressure-equalising addition 
funnel to a vigorously stirring solution of aniline (7.93 mL, 87 
mmol, freshly distilled just prior to use) and N-formylpiperidine 
(10.66 mL, 96 mmol) in benzene (100 mL). The resulting pale yellow solution was heated 
under reflux for 4 h. The solution was cooled, poured onto ice (~100 g), brought to pH 10 
with 6 M NaOH solution and phases were separated. The aqueous phase was extracted 
with ether (2 x 100 mL). A cream coloured emulsion formed which was kept with the 
aqueous phase during extraction with ether. Chloroform (~400 mL) added to aqueous 
phase containing emulsion and emulsion dissipated. The phases were separated 
(chloroform and ether extracts were kept separate) and aqueous phase extracted with 
chloroform (1 x 400 mL). The ether/benzene extracts were dried, filtered and left to stand 
overnight
38
. The chloroform extracts were combined, dried, filtered and the solvent was 
removed in vacuo. The residue was recrystallised from chloroform:hexane, and the 
amidine was isolated as a pale yellow solid (3.2 g, 19%), m.p. 169-170.5 
o
C (Lit. b.p. 134-
136 
o
C @ 0.5 mmHg).
[189]
 νmax (KBr): 3129, 1690, 1598, 1478, 1341 cm
-1
; δH: 1.69 [6H, m, 
(CH2)3], 3.83 [2H, m, N(CH2)], 4.06 [2H, m, N(CH2)], 7.17 (1H, m, p-ArH), 7.28 (2H, m, 
m-ArH), 7.70 (2H, m, o-ArH), 8.74 (1H, s, N=CHN); δC: 23.2, 25.1 and 26.3 [3 x 
N(CH2)(CH2)3], 48.2 [N(CH2)], 54.0 [N(CH2)], 119.7 (m-ArCH), 126.3 (p-ArCH), 129.5 
(o-ArCH), 137.3 (ipso C of Ar), 150.4 (N=CHN). m/z = 188 [M
+
, 100%]. 
7.1.7 N-(N´-p-Chlorophenylformimidoyl)-morpholine 345 
Phosphorous oxychloride (8.97 mL, 98 mmol) in benzene 
(30 mL) was added dropwise via a pressure-equalising 
addition funnel to a stirring solution of p-chloroaniline 
(11.11 g, 87 mmol) and N-formylmorpholine (9.65 mL, 96 
mmol) in benzene (100 mL) at room temperature. The solution was heated under reflux for 
4 h. The cooled reaction mixture was poured onto ice (~100 g), stirred overnight and then 
neutralised with 6 M NaOH and the phases were separated. The aqueous phase was 
                                                 
38
 Ether/ benzene extracts contained starting material. 
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extracted with ether (2 x 100 mL). The organic phases were combined, dried, filtered and 
solvent evaporated in vacuo to yield silver/brown solid. The amidine was recrystallised 
from chloroform:hexane and isolated by vacuum filtration as a grey crystalline solid (12.4 
g, 63%), m.p. 66-67 
o
C. νmax (KBr): 2965, 2865, 1632, 1582, 1489, 1435, 1357, 1106 cm
-1
; 
δH: 3.52 [4H, bs, N(CH2)2], 3.74 [4H, m, O(CH2)2], 6.88 (2H, m, o-ArCH), 7.21 (2H, m, 
m-ArCH), 7.49 (1H, s, N=CH); δC: 45.8 [N(CH2)2], 66.7 [O(CH2)2], 122.2 and 129.1 (2 x 





) exact mass calculated for C11H13N2OCl [M+H]
+
 225.0795, found 225.785. 
7.2 Imines 




Benzaldehyde (5.31 g, 0.05 mol) in distilled dichloromethane 
(100 mL) was added dropwise via a pressure equalising addition 
funnel to a stirring solution of aniline (4.66 g, 0.05 mol) in 
distilled dichloromethane (100 mL). MgSO4 was then added to 
the stirring solution to remove water as it formed. The solution was stirred for 2.5 h. The 
resulting dark yellow/orange solution was filtered and the solvent was removed in vacuo to 
yield a pale orange/yellow solid. Recrystallisation from 1:3 ethyl acetate:hexane afforded 




C). νmax (KBr): 
3059, 1626, 1589, 1493, 748, 698 cm
-1
; δH: 7.22 (3H, m, ArH), 7.39 (2H, m, ArH), 7.48 




Benzaldehyde (31.84 g, 0.3 mol) was added to neat aniline (27.94 g, 0.3 mol). Toluene 
(200 mL) was added and the solution was stirred and Dean Stark trap was fitted. The 
solution was heated at reflux until 5.3 mL water was collected (3 h). Solvent evaporated in 
vacuo to yield imine (53.62 g, 99%) as a brown solid, m.p. 48-51 
o
C (Lit. 50-51 
o
C). δH: 
7.22 (3H, m, ArH), 7.39 (2H, m, ArH), 7.48 (3H, m, ArH), 7.90 (2H, m, ArH), 8.46 (1H, s, 
N=CHN); δC: 120.9, 125.9, 128.8, 128.8, 129.2 and 131.4 (6 x ArCH), 136.3 (ipso C of 
Ar), 152.1 (ipso C of Ar), 160.4 (N=CH). 
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7.3 Benzamidines 
7.3.1 N-Benzoylaniline 347 
Benzoylchloride (19.7 g, 0.1 mol) in THF (25 mL, distilled) was 
added dropwise via pressure-equalising addition funnel to a 
cooled (<10 
o
C, water/ice bath), stirring solution of aniline (13.0 
g, 0.1 mol) and pyridine (75 mL) in THF (25 mL, distilled). The 
reaction was stirred overnight. The resulting solution was poured carefully onto 6 M HCl 
(1L). The resulting solid was isolated by vacuum filtration and washed with water (4 x 300 
mL). The resulting grey solid was recrystallised from 96% ethanol and left to stand 
overnight. The amide (23.6 g, 85%) was isolated by vacuum filtration as a grey crystalline 
solid, m.p. 166-168 
o




 νmax (KBr): 3343, 3051, 1655, 1599, 
1529, 1437, 1321 cm
-1
; δH: 7.16 (1H, m, ArH), 7.38 (2H, m, ArH), 7.52 (3H, m, ArH), 
7.66 (2H, m, ArH), 7.79 (1H, bs, NH), 7.87 (2H, m, ArH); δC: 120.2, 124.6, 127.0, 128.9, 
129.2, 131.9 (6 x ArCH), 135.0 (ipso C of Ar), 137.9 (ipso C of Ar), 165.7 (C=O). 
7.3.2 N-Phenylbenzimidoyl chloride[218] 348 
N-Benzoylaniline (10.79 g, 0.055 mol) and phosphorous 
pentachloride (10.45 g, 0.050 mol) were heated under reflux in 
toluene (150 mL) for 17 h. The reaction mixture was then cooled 
to room temperature and solvent removed in vacuo. Benzene (2 x 
20 mL) was added (to remove POCl3) and evaporated each time. The remaining residue 
was heated to ~60 
o
C on rotary evaporator for 1 h to remove any residual POCl3. The crude 
imidoyl chloride was used directly in the next step. 
7.3.3 N-(N´-Phenylbenzimidoyl)-morpholine 349 
Morpholine (8.71 g, 0.1 mol) in ether (50 mL) was added 
dropwise via pressure-equalising addition funnel to a cooled 
(<10 
o
C, water/icebath), stirring solution of crude N-
phenylbenzimidoyl chloride (~0.05 mol) in ether (100 mL). The 
reaction mixture was then stirred overnight at room temperature 
(21 h). The solvent was removed in vacuo and the resulting residue was acidified with 6 M 
HCl (aq) (100 mL). The solid was isolated by vacuum filtration and the filtrate was 
basified with 6 M NaOH (aq.) solution. The solution became lighter in colour and cloudier 
as the base was added. At pH 14, the solution was completely cloudy and pale yellow in 
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colour. This solution was then extracted with ether (3 x 70 mL). The organic phases were 
combined, dried, filtered and solvent removed in vacuo to yield a pale yellow residue. 
Recrystallisation from hexane gave the amidine (7.1 g, 53% over two steps) as pale orange 
crystalline solid, m.p. 92-93 
o




 νmax (film): 3046, 3024, 1613, 1590, 
1372, 1278, 1129 cm
-1
; δH: 3.41 [4H, bs, N(CH2)2], 3.75 [4H, m, O(CH2)2], 6.56 (2H, m, 
ArH), 6.75 (1H, m, p-ArH), 7.00 (2H, m, ArH), 7.11 (2H, m, ArH), 7.23 (3H, m, ArH); δC: 
46.7 [N(CH2)2], 66.8 [O(CH2)2], 121.3, 122.7, 128.2, 128.3, 128.8 and 129.1 (6 x ArCH), 
133.1 (ipso C of Ar), 150.8 (ipso C of Ar), 160.7 (N=C). m/z = 267 ([M+H]
+
, 100%).  
7.3.4 N-(N´-Phenylbenzimidoyl)-piperidine 350 
Piperidine (7.4 mL, 75 mmol) in ether (50 mL) was added 
dropwise via Pasteur pipette to a cooled (<10 
o
C, water/icebath), 
stirring solution of crude N-phenylbenzimidoyl chloride (~0.05 
mol) in ether (100 mL) and the resulting solution was stirred 
overnight at room temperature. The bright orange/red solution 
was acidified with 6 M HCl (aq) (100 mL). The solution was filtered by gravity filtration 
and the filtrate was basified with aqueous 6 M sodium hydroxide solution to pH 8 when the 
solution became cloudy and pale cream in colour. The solution was extracted with ether (3 
x 70 mL). The organic extracts were combined, dried, filtered and solvent evaporated in 




 νmax (film): 3074, 3056, 1589, 1272, 1249, 1109 cm
-1
; δH: 1.64 [6H, m, (CH2)3], 
3.37 [4H, bs, N(CH2)2], 6.54 (2H, m, ArH), 6.69 (1H, m, p-ArH), 6.97 (2H, m, ArH), 7.09 
(2H, m, ArH), 7.18 (3H, m, ArH); δC: 24.9 and 25.9 (2 x CH2), 47.0 [N(CH2)2], 120.7, 
122.9, 126.8, 128.0, 128.3 and 129.0 (6 x ArCH), 134.1 (ipso C of Ar), 151.4 (ipso C of 
Ar), 160.7 (N=C). m/z = 265 [M+H]
+
. 
7.3.5 N-Benzoyl-p-chloroaniline 351 
Benzoyl chloride (19.69 g, 0.14 mol) in dry THF (25 mL) 
was added dropwise to a cooled (<10 
o
C, water/ice bath), 
stirring solution of p-chloroaniline (17.86 g, 0.14 mol) and 
pyridine (75 mL) in dry THF (25 mL). The resulting dark 
grey solution was stirred overnight (17.25 h) and was poured slowly onto 6 M HCl (1 L). 
The solid precipitate was isolated by vacuum filtration and washed with water (3 x 400 
mL). The resulting dark grey solid was recrystallised from 96% ethanol and left to stand 
for 6 h. The amide (26.43 g, 82%) was isolated by vacuum filtration as a grey crystalline 
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solid, m.p. 190-191.5 
o




 νmax (KBr): 3349, 1654, 1595, 1518, 
1493, 718 cm
-1
; δH: 7.35 (2H, m, ArH), 7.51 (3H, m, ArH), 7.60 (2H, m, ArH), 7.80 (1H, 
bs, NH), 7.86 (2H, m, ArH); δC: 121.4, 127.0, 128.9, 129.2 and 132.1 (5 x ArCH), 129.6 
(ipso C of Ar), 134.6 [ArC(Cl)], 136.5 (ipso C of Ar), 165.7 (C=O). HRMS (ESI
+
) exact 
mass calculated for C13H10NOCl [(M+H)
+
], 232.0529, found 232.0520. 
7.3.6 N-p-Chlorophenylbenzimidoyl chloride[218] 352 
A mixture of N-benzoyl-(p-chloroaniline) (12.51 g, 0.05 
mol) and phosphorous pentachloride (10.42 g, 0.05 mmol) 
was heated under reflux in toluene (150 mL) for 17.5 h. A 
CaCl2 guard tube was fitted to the condenser. The reaction 
mixture was cooled to room temperature and the solvent removed in vacuo. Benzene (2 x 
20 mL) was added twice and evaporated each time (to remove excess POCl3). The 
remaining residue was heated to ~60 
o
C on rovac to remove any residual POCl3. The crude 
imidoyl chloride was used directly in the step. 
7.3.7 N-(p-Chlorophenyl)-benzimidoylmorpholine 353 
Morpholine (8.72 g, 0.1 mol) in ether (50 mL) was added 
dropwise via a pressure-equalising addition funnel to a 
cooled (<10 
o
C, water/icebath), stirring solution of the crude 
N-p-chlorophenylbenzimidoyl chloride (~0.05 mol) in ether 
(100 mL). The resulting solution was stirred overnight at 
room temperature. The solvent was removed in vacuo and the resulting residue was 
acidified with 6 M HCl (100 mL). The solid was collected by filtration and the filtrate was 
basified with 6 M aqueous sodium hydroxide solution to pH 14. At this point, the solution 
was cream coloured and cloudy with some brown solid. The solution was left to stand 
overnight. The solution was transferred to a separating funnel and extracted with ether (3 x 
70 mL). The organic phases were combined, dried, filtered and solvent evaporated in 
vacuo. The resulting residue was recrystallised from hexane and the amidine (7.33 g, 49% 
over two steps) isolated by vacuum filtration as a pale orange/yellow crystalline solid, m.p. 
98-99 
o




 νmax (film): 3047, 2853, 1627, 1597, 1394, 1252, 1111, 
770 cm
-1
; δH: 3.41 [4H, bs, N(CH2)2], 3.74 [4H, bs, O(CH2)2], 6.47 (2H, m, ArH of p-
substituted Ar), 6.96 (2H, m, ArH of p-substituted Ar), 7.09 (2H, m, ArH), 7.26 (3H, m, 
ArH); δC(500MHz): 46.6 [N(CH2)2], 66.8 [O(CH2)2], 123.9, 128.2, 128.5, 129.0 and 129.0 (5 
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7.3.8 p-Chlorobenzoyl chloride 354 
Method 1 
Neat thionyl chloride (11.61 mL, 0.16 mol) was added to a stirring 
solution of p-chlorobenzoic acid (6.27 g, 0.04 mol) in 
dichloromethane (35 mL, distilled) and the resulting solution was 
heated at reflux for 8.5 h. IR (1776 cm
-1
) confirmed formation of the 
acid chloride. Solvent removed in vacuo to yield the crude acid chloride (6.86 g, 98%) as a 
pale yellow solid which was used immediately without further purification. 
Method 2 
Oxalyl chloride (3.5 mL, 0.04 mol) was added dropwise via pressure-equalising addition 
funnel to a stirring suspension of 4-chlorobenzoic acid (6.27 g, 0.04 mol) in 
dichloromethane (50 mL) and the resulting solution was stirred at room temperature for 69 
h. IR (NaCl) confirmed acid chloride peak (1776 cm
-1
). Solvent removed in vacuo and 
crude product (~0.04 mol) used directly in next step.  
IR of the C=O of the acid shifted from 1677 cm
-1
 to 1662 cm
-1
 indicating conversion to the 
acid chloride. 
7.3.9 N-(p-Chlorobenzoyl)-aniline 355 
p-Chlorobenzoyl chloride (~0.04 mol) in dry THF (25 mL) 
was added dropwise via a pressure-equalising addition 
funnel to a cooled (<10 
o
C, water/icebath), stirring solution 
of pyridine (75 mL) and aniline (3.8 mL, 0.04 mol) in dry 
THF (25 mL). The reaction mixture was stirred overnight and poured slowly onto 6 M HCl 
(1 L). A pale orange solid precipitated which was collected by vacuum filtration and was 
washed thoroughly with water. Recrystallisation from 95% ethanol yielded the amide (7.14 
g, 77%) as a white crystalline solid, m.p. 198-199 
o





(film): 3351, 1653, 1598, 1529, 1439, 753 cm
-1
; δH: 7.17 (1H, m, p-ArH), 7.38 (2H, t, J = 
8.0, m-ArH), 7.47 (2H, m, m-ArH), 7.62 (2H, m, o-ArH), 7.75 (1H, bs, NH), 7.82 (2H, m, 
o-ArH of p-ClAr); δC: 120.2 (o-ArCH of ArN), 124.8 (p-ArCH of ArN), 128.5 (m-ArCH of 
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p-Cl-Ar), 129.1 (o-ArCH of p-Cl-Ar), 129.2 (m-ArCH of ArN), 133.3 [ArC(Cl)], 137.6 
(ipso C of p-Cl-Ar), 138.2 (ipso C of ArN), 164.6 (C=O). 
7.3.10  N-Phenyl-(p-chlorobenzimidoyl) chloride[218] 356 
N-(p-Chlorobenzoyl)-aniline (6.95 g, 0.03 mol) and 
phosphorous pentachloride (6.34 g, 0.03 mol) were heated 
under reflux in toluene (90 mL) overnight. The solvent was 
removed in vacuo at 60 
o
C for 2 h to ensure removal of 
excess POCl3. IR shows the formation of the imidoyl chloride peak (1654 cm
-1
). The crude 
reaction mixture (7.4 g, 98%) was used directly in next step.  
7.3.11 N-Phenyl-(p-chlorobenzimidoyl)-morpholine 357 
Morpholine (5.24 g, 0.06 mol) in ether (30 mL) was added 
dropwise via pressure-equalising addition funnel to a cooled 
(<10 
o
C, water/icebath), stirring solution of N-phenyl-(p-
chlorobenzimidoyl) chloride (~ 30 mmol) in ether (90 mL) 
and the resulting solution was stirred overnight at room 
temperature. The solvent was removed under vacuum and 
the remaining residue was acidified with 6 M HCl solution (60 mL). The solid which 
formed was collected by vacuum filtration and the filtrate was basified with 6 M NaOH. 
The product was extracted with ether (1 x 50 mL) and dichloromethane (2 x 75 mL, 
distilled). The organic extracts were combined, dried and the solvent evaporated in vacuo. 
A pale yellow solid was isolated. Recrystallisation from hexane afforded the pure amidine 
(4.74 g, 52% (2 steps)) as a pale yellow crystalline solid (m.p. 138-140 
o
C) which was 
isolated by vacuum filtration. νmax (film): 3071, 3011, 1587, 1485, 1417, 742 cm
-1
; δH: 3.38 
[4H, bs, N(CH2)2], 3.74 [4H, m, O(CH2)2], 6.53 (2H, m, ArH), 6.78 (1H, m, p-ArH), 7.03 
(4H, m, ArH), 7.21 (2H, m, ArH); δC: 46.7 [N(CH2)2], 66.8 [O(CH2)2], 121.5, 122.5, 128.4, 
128.7 and 130.5 (5 x ArCH), 131.4 [ipso C of Ar], 134.8 [ipso C of Ar], 150.4 [ArC(Cl)], 








Cl, 100%]; HRMS (ESI
+
) exact 
mass calculated for C17H18N2OCl [M+H]
+
 301.1108, found 301.1102. 
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8 Preparation of Δ2-1,2,4-oxadiazolines 
8.1 1,3-Dipolar cycloaddition reactions with formamidines 
8.1.1 Reactions with N,N-dimethyl-N´-benzylformamidine  
8.1.1.1 Attempted preparation of 3-phenyl-4-benzyl-5-(N´,N´-dimethyl)-
Δ2,1,2,4-oxadiazoline 366 with the formation of decomposition 
products benzonitrile 175 and 1-benzyl-3-(N,N-dimethyl)-urea 335 
Method 1 
Benzohydroximoyl chloride (0.162 g, 1.04 mmol) in ether (10 mL) 
was added dropwise to a cooled (<10 
o
C, water/icebath) stirring 
solution of N,N-dimethyl-N´-benzylformamidine (0.165 g, 1.01 
mmol) and triethylamine (0.1 g, 1.1 mmol) in ether (10 mL) over 5 
min. The white cloudy mixture was warmed to room temperature 
and allowed to stir overnight. Water (10 mL) was added to the 
stirring solution, the precipitate dissolved immediately on addition 
to yield a clear biphasic solution. The solution was transferred to a separating funnel and 
the phases were separated. The aqueous layer was washed with ether (1 x 10 mL) and 
separated. The organic extracts were combined, dried, filtered and the solvent was 
removed in vacuo. The sample was then placed under high vacuum to remove any residual 
solvent and isolated as a white solid. The product was a mixture of benzonitrile (175) and 
1-benzyl-3-(N,N-dimethyl)-urea (335) in a 1 : 1 ratio. δH: 2.91 [6H, s, N(CH2)2 335], 4.41 
(2H, d, J = 5.6, PhCH2 335), 4.80 (1H, bs, NH 335), 7.32 (4H, m, ArH 335 & 175), 7.47 
(2H, m, ArH 335 & 175), 7.63 (4H, m, ArH 335 & 175); δC: 36.3 [N(CH3)2 335], 45.0 
(PhCH2 335), 112.4 (ipso C of Ar 175), 118.9 (C≡N 175) 127.2, 127.7, 128.6, 129.2, 132.2 
and 132.8 (6 x ArCH 335 & 175), 139.8 (ipso C of Ar 335), 158.4 (C=O 335).  
Method 2  
Benzohydroximoyl chloride (1.03 g, 6.6 mmol) in ether (20 mL) was added dropwise via a 
pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath) stirring solution of 
N,N-dimethyl-N´-benzylformamidine (1.055 g, 6.5 mmol) and triethylamine (0.658 g, 6.5 
mmol) in ether (35 mL). Ether (10 mL) was added via the addition funnel to rinse the 
funnel and apparatus clear of any solid residue. The resulting white cloudy mixture was 
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warmed to room temperature and stirred for 1 h. The solution was then filtered to remove 
the solid precipitate and the solvent was evaporated in vacuo (without heat) to yield the 
crude oxadiazoline (0.92 g, 50%) as a pale orange liquid. The sample was placed under 
high vacuum to remove any residual solvent. However, the oxadiazoline had decomposed 




A solution of p-nitrobenzohydroximoyl chloride (0.840 g, 
4.19 mmol) in distilled dichloromethane (15 mL) was added 
dropwise to a cooled (<10 
o
C, water/icebath), stirring 
solution of N´-benzyl-N,N-dimethylformamidine (0.686 g, 
4.23 mmol) and triethylamine (0.428 g, 4.22 mmol) in 
dichloromethane (20 mL) over 20 min. The resulting bright 
orange solution was stirred at room temperature for ten 
minutes. Water (30 mL) added to dissolve the precipitate and the solution was stirred. The 
phases were separated and the aqueous phase was extracted with dichloromethane (20 
mL). The organic phases were combined, dried, filtered and solvent removed in vacuo 
(without heat) to yield the crude oxadiazoline (2.42 g, >100%
39
) as a brown oil. νmax (film): 
3055, 2955, 1706, 1525, 1348 cm
-1
; δH: 2.41 [1H, s, N(CH3)2 367], 2.89 [6H, s, N(CH3)2 
339], 4.40 (0.5H, m, PhCH2 367), 4.44 (2H, s, PhCH2 339), 6.14 (0.13H, s, NCHON 367), 
6.76 (0.83H, s), 7.29 (5.45H, m, ArH 367), 7.39 (1H, s, N=CH 339), 7.76 (2H, m, o-ArH), 
8.28 (2H, m, m-ArH). Ratio of N´-benzyl-N,N-dimethylformamidine (339) : oxadiazoline 
(367) was 1 : 0.13. 
Method 2  
p-Nitrobenzohydroximoyl chloride (1.306 g, 6.51 mmol) in ether (20 mL) was added 
dropwise via a pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath) 
stirring solution of N,N-dimethyl-N´-benzylformamidine (1.055 g, 6.50 mmol) and 
triethylamine (0.66 g, 6.51 mmol) in ether (35 mL). The yellow cloudy mixture which 
resulted was warmed to room temperature and stirred for 1 h. The solution was filtered to 
remove the insoluble solid. The solvent was evaporated in vacuo (without heat) to yield the 




H NMR spectrum shows dichloromethane is present in the sample.  
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crude oxadiazoline (0.4 g, 19%) as a bright yellow solid, m.p. 78-80 
o
C. The sample was 
placed under high vacuum for 20 min to remove any residual solvent. νmax (KBr): 3082, 
3063, 1568, 1520, 1441, 1354 cm
-1
; δH: 2.41 [6H, s, N(CH3)2], 4.40 (2H, q, J = 16.0, 
PhCH2), 6.14 (1H, s, NCHON), 7.15 (2H, m, ArH), 7.33 (3H, m, ArH), 7.75 (2H, m, o-
ArH of p-NO2-Ar), 8.28 (2H, m, m-ArH of p-NO2-Ar); δC: 36.7 [N(CH3)2], 48.3 (PhCH2), 
107.7 [NCHON], 124.1, 127.1, 128.0, 129.0 and 129.1 (5 x ArCH), 132.0 and 136.2 (2 x 
ipso C of Ar), 149.0 (p-NO2-CAr), 154.8 (C=N). m/z = 179 ([M+H]
+
, 1-benzyl-3-(N,N-
dimethyl)-urea (335)), 149 ([M+H]
+
 p-nitrobenzonitrile (378)). 
Method 3  
p-Nitrobenzohydroximoyl chloride (1.31 g, 6.51 mmol) in ether (20 mL) was added 
dropwise via Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring solution of N,N-
dimethyl-N´-benzylformamidine (1.06 g, 6.54 mmol) and triethylamine (0.66 g, 6.51 
mmol) in ether (35 mL). The bright yellow/orange cloudy mixture which resulted was 
warmed to room temperature and stirred for 10 min. The solution was filtered to give a 
bright yellow clear solution. The solvent was evaporated in vacuo to yield the crude 
oxadiazoline (1.02 g, 47%) as a yellow solid. νmax (film): 3107, 3031, 1634, 1531, 1349 
cm
-1
; δH: 2.41 [6H, s, N(CH3)2], 4.41 (2H, q, J = 16.1, PhCH2), 6.14 (1H, s, NCHON), 7.16 
(2H, m, ArH), 7.30 (3H, m, ArH), 7.75 (2H, m, o-ArH of p-NO2Ar), 8.28 (2H, m, m-ArH 
of p-NO2Ar). The method of producing the oxadiazoline is reproducible from method 2 to 
method 3. 
Method 4 NMR spectroscopy tube reaction 
Triethylamine (1 mL, 0.07 M solution in CDCl3) was added directly to p-
nitrobenzohydroximoyl chloride (14.10 mg, 0.07 mmol) and the solution was mixed 
briskly. A 0.6 mL quantity of solution was transferred to an NMR spectroscopy tube and a 
1
H NMR spectrum was run immediately. Once the NMR spectroscopic analysis was 
complete, the NMR spectroscopy tube contents were returned to the sample vial and were 
combined with neat N,N-dimethyl-N´-benzylformamidine (11.70 mg, 0.072 mmol). This 
solution was mixed briskly and 0.6 mL of this solution was placed in an NMR 
spectroscopy tube and sample submitted for 
1
H NMR spectroscopic analysis. Proton NMR 
spectra taken at intervals over a period of 27.5 h showed that the oxadiazoline had formed 
immediately and then converted into a mixture of the p-nitrobenzonitrile (378) and 1-





A solution of m-nitrobenzohydroximoyl chloride (0.849 g, 4.2 
mmol) in distilled dichloromethane (15 mL) was added dropwise to 
a stirring, cooled (<10 
o
C, ice/water bath) solution of N,N-
dimethyl-N´-benzylformamidine (0.699 g, 4.3 mmol) and 
triethylamine (0.439 g, 4.3 mmol), also in distilled 
dichloromethane (20 mL), over ten minutes. The solution was 
stirred (<10 
o
C, water/icebath) for ten minutes further, then 
warmed to room temperature and stirred for ten minutes. Water (30 
mL) was added to dissolve the precipitate and the resulting biphasic solution was stirred. 
The phases were separated and the aqueous phase was extracted with dichloromethane (15 
mL). The combined organic extracts were dried, filtered and solvent evaporated in vacuo 
to give the crude oxadiazoline with residual solvent (2.04 g, >100%
40
) as a yellow viscous 
liquid. νmax (film): 3088, 3050, 2875, 1635, 1534, 1355 cm
-1
; δH: 2.42 [6H, s, N(CH3)2], 
4.42 (2H, q, J = 16.6, PhCH2), 6.14 (1H, s, NCHON), 7.15 (2H, m, ArH), 7.33 (3H, m, 
ArH), 7.63 (1H, t, J = 8.0, m-ArH of m-NO2-Ar), 7.90 (1H, m, o-ArH of m-NO2-Ar), 8.32 
(1H, m,  p-ArH of m-NO2-Ar), 8.43 (1H, m, o-ArH of m-NO2-Ar); δC: 36.9 [N(CH3)2], 
48.2 (PhCH2), 107.4 (NCHON), 123.1, 125.2, 127.1, 128.0, 129.0, 130.2 and 134.0 (7 x 
ArCH), 127.5 (ipso C of Ar), 136.1 (ipso C of Ar), 148.4 (ArC-NO2), 154.6 (C=N). 
Method 2 
m-Nitrobenzohydroximoyl chloride (1.31 g, 6.52 mmol) in ether (20 mL) was added 
dropwise via a pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath), 
stirring solution of N,N-dimethyl-N´-benzylformamidine (1.06 g, 6.51 mmol)  and 
triethylamine (0.66 g, 6.57 mmol) in ether (35 mL). The cloudy pale yellow solution which 
resulted was warmed to room temperature and stirred for 1 h. The precipitate was removed 
by filtration and the solvent removed in vacuo without heat to yield the crude oxadiazoline 
as a pale yellow solid. The sample was placed under high vacuum to remove residual 
solvent and the oxadiazoline (0.478 g, 23%) was isolated as a yellow solid, m.p. 69-80 
o
C. 
νmax (film): 3107, 3082, 3062, 1591, 1535, 1527, 1347 cm
-1
; δH: 2.42 [6H, s, N(CH3)2], 
                                                 
40
Dichloromethane present in product. 
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4.41 (2H, q, J = 15.9, PhCH2), 6.14 (1H, s, NCHON), 7.15 (2H, m, ArH), 7.33 (3H, m, 
ArH), 7.62 (1H, t, J = 8.0, m-ArH of m-NO2-Ar), 7.89 (1H, m, o-ArH of m-NO2-Ar), 8.31 
(1H, m,  p-ArH of m-NO2-Ar), 8.42 (1H, m, o-ArH of m-NO2-Ar); δC: 36.7 [N(CH3)2], 
48.2 (PhCH2), 107.5 (NCHON), 123.1, 125.2, 127.2, 128.0, 129.0, 130.1 and 134.0 (7 x 










Repeating the reaction at the same scale, but employing a ten minute stir time rather than 1 
h yielded the crude oxadiazoline (0.217 g, 10%) as a pale yellow solid. δH: 2.42 [6H, s, 
N(CH3)2], 4.41 (2H, q, J = 16.1, PhCH2), 6.14 (1H, s, NCHON), 7.15 (2H, m, ArH), 7.31 
(3H, m, ArH), 7.63 (1H, t, J = 8.0, m-ArH of m-NO2-Ar), 7.89 (1H, m, o-ArH of m-NO2-
Ar), 8.31 (1H, m, p-ArH of m-NO2-Ar), 8.42 (1H, m, o-ArH of m-NO2-Ar). 
8.1.1.4 Attempted preparation of 3-(2,4,6-trimethylphenyl)-4-benzyl-5-(N´,N´-
dimethyl)-Δ2,1,2,4-oxadiazoline 369 
Method 1 
2,4,6-Trimethylbenzohydroximoyl chloride (0.198 g, 1.00 
mmol) in ether (10 mL) was added dropwise to a cooled (<10 
o
C, water/icebath), stirring solution of N,N-dimethyl-N´-
benzylformamidine (0.163 g, 1.01 mmol) and triethylamine 
(0.107 g, 1.05 mmol) in ether (10 mL) over 5 min. The resulting 
cream coloured solution was warmed to room temperature and 
stirred overnight. Water (15 mL) was added to the stirring 
mixture to dissolve the precipitate. The solution was transferred to a separating funnel and 
the phases were separated. The aqueous layer was washed with ether (1 x 10 mL) and 
separated. The organic extracts were combined, dried, filtered and concentrated. The 
resulting yellow oil was placed under high vacuum overnight to remove any residual 
solvents. 
1
H NMR spectroscopic analysis gave a mixture of unidentifiable products. 
                                                 
41
Other solvents were used to try to obtain a parent molecular ion peak without success, 
[Acetonitrile:methanol & acetonitrile:dimethylsulfoxide]. 
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Method 2  
2,4,6-Trimethlybenzohydroximoyl chloride (1.287 g, 6.51 mmol) in ether (20 mL) was 
added dropwise via Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring solution of 
N,N-dimethyl-N´-benzylformamidine (1.055 g, 6.5 mmol) and triethylamine (0.66 g, 6.5 
mmol) in ether (35 mL). The resulting pale cream solution was warmed to room 
temperature and stirred for 10 min. The mixture was filtered to remove the precipitate. The 
solvent was evaporated in vacuo to yield a pale yellow solid (1.08 g, 51%). νmax(film): 




H NMR spectroscopic analysis showed that 
dehydrohalogenation did occur as is evident by the formation of mesitonitrile-N-oxide (7) 
which has the characteristic signals at 2.30 and 2.42 ppm in the 
1
H NMR spectrum. 
However, the cycloaddition did not take place within 10 min as the N,N-dimethyl-N´-
benzylformamidine (339) (7.38 ppm) and mesitonitrile-N-oxide (7) were observed.  
Method 3 NMR spectroscopy tube reaction 
N,N-Dimethyl-N´-benzylformamidine (33.00 mg, 0.2 mmol) in CDCl3 (0.5 mL) was added 
to mesitonitrile-N-oxide (34.00 mg, 0.2 mmol) in CDCl3-d1 (0.5 mL). Half of the sample 
volume was transferred to an NMR spectroscopy tube and topped up to 0.6 mL with 
CDCl3. The sample in the NMR spectroscopy tube was immediately submitted for 
1
H 
NMR spectroscopic analysis. The sample was also monitored over intervals for 17 h by 
NMR spectroscopy. It showed that the cycloaddition reaction did not take place within 17 
h of combining the reactants as indicated by the presence of mesitonitrile-N-oxide (7) (2.30 
& 2.42 ppm) and N,N-dimethyl-N´-benzylformamidine (339) (7.38 ppm) 
Method 4 NMR spectroscopy tube reaction 
Mesitonitrile-N-oxide (11.00 mg, 0.07 mmol) was dissolved in CDCl3 (1 mL). 
1
H NMR of 
the entire solution was carried out. The CDCl3 solution was then transferred to a sample of 
N,N-dimethyl-N´-benzylformamidine (12.00 mg, 0.07 mmol). The solution was then mixed 
and transferred to the NMR spectroscopy tube and submitted for 
1
H NMR spectroscopic 
analysis. 
1
H NMR spectroscopic analysis suggests that the mesitonitrile-N-oxide and N,N-
dimethyl-N´-benzylformamidine (339) did not undergo cycloaddition reaction as only the 
3,4-dimesitylfuroxan (313) was observed after 65 h of analysis. N,N-dimethyl-N´-
benzylformamidine (339) appears to have degraded over this time. 
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8.1.1.5 Attempted preparation of 3-bromo-4-benzyl-5-(N´,N´-dimethyl)-
Δ2,1,2,4-oxadiazoline 370 
Method 1  
Dibromoformaldoxime (1.32 g, 6.51 mmol) in ether (20 mL) was 
added dropwise via a pressure equalising addition funnel to a cooled 
(<10 
o
C, water/icebath), stirring suspension of N,N-dimethyl-N´-
benzylformamidine (1.06g, 6.51 mmol) and potassium t-butoxide (0.73 
g, 6.51 mmol) in ether (35 mL). The yellow cloudy mixture which 
resulted was warmed to room temperature and stirred for 1 h. The 
mixture was filtered to remove the solid triethylamine hydrobromide precipitate. The 
solvent was removed in vacuo (without heat) to yield a yellow/orange oil (0.608 g, 33%). 
The crude sample was placed under high vacuum to remove any residual solvent, however, 
dimethylformamide (371) was the product observed.. νmax (film): 3187, 3066, 3032, 2218, 
1666, 1454, 1388, 1098 cm
-1
; δH: 1.25 (2H, s), 2.83 (3H, s, NCH3 371), 2.92 (3H, s, NCH3 
371), 4.15 (1.3H, d, J = 5.6), 5.64 (0.6H, bs), 7.33 (5H, m), 7.53 (0.55H, m), 7.91 (1H, s, 




Dibromoformaldoxime (1.32 g, 6.51 mmol) in ether (20 mL) was added dropwise via 
Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring solution of N,N-dimethyl-N´-
benzylformamidine (1.06 g, 6.50 mmol) and triethylamine (0.66 g, 6.54 mmol) in ether (35 
mL). A yellow cloudy mixture resulted which was warmed to room temperature and stirred 
for ten minutes. The solution was then filtered to remove the precipitate and the solvent 
was evaporated in vacuo to yield a pale yellow oil (0.351 g, 19%). νmax (film): 3207, 2217, 
1660, 1496, 1454, 1412, 1358, 1254, 1099 cm
-1
; δH: 1.16 (1.72H, m), 1.37 (1H, m), 2.88 
(3H, s, NCH3 371), 2.96 (3H, s, NCH3 371), 3.02 (1H, m), 4.15 (1.20H, bs), 4.42 (0.93H, 




8.1.1.6 3-Benzoyl-4-benzyl-5-(N´,N´-dimethyl)-Δ2,1,2,4-oxadiazoline 373 
Method 1 
1-Benzoyl-1-chloroformaldoxime (1.19 g, 6.50 mmol) in ether 
(20 mL) was added dropwise via a pressure-equalising addition 
funnel to a cooled (<10 
o
C, water/icebath), stirring solution of 
N,N-dimethyl-N´-benzylformamidine (1.06 g, 6.51 mmol) and 
triethylamine (0.66 g, 6.50 mmol) in ether (35 mL). The pale 
orange cloudy mixture which resulted was warmed to room 
temperature and stirred for 1 h. The precipitate was removed by gravity filtration. The 
solvent was evaporated in vacuo (without heat) to yield the crude oxadiazoline (0.89 g, 
44%) as pale yellow oil. The sample was placed under high vacuum for 20 min to remove 
any excess solvent. νmax (film): 3062, 3031, 1657, 1545, 1453, 1292, 1045 cm
-1
; δH: 2.38 
[6H, s, N(CH3)2], 4.29 (1H, d, J = 15.6Hz, PhCH2), 5.08 (1H, d, J = 15.6Hz, PhCH2), 6.12 
(1H, s, NCHON), 7.29 (5H, m, ArH), 7.46 (2H, t, J = 8.1Hz, m-ArH), 7.60 (1H, m, p-
ArH), 8.12 (2H, m, o-ArH); δC: 36.4 [N(CH3)2], 46.5 (PhCH2), 107.7 (NCHON), 127.7, 
127.8, 128.4, 128.7, 130.5 and 134.1 (6 x ArCH), 136.0 (ipso C of Ar), 136.7 (ipso C of 
Ar), 151.4 (C=N), 183.6 (C=O). m/z = 342 [(M+H+MeOH)
+
 oxadiazoline (373)]. 
Method 2  
1-Benzoyl-1-chloroformaldoxime (1.19 g, 6.50 mmol) in ether (20 mL) was added 
dropwise via Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring solution of N,N-
dimethyl-N´-benzylformamidine (1.06 g, 6.54 mmol) and triethylamine (0.66 g, 6.53 
mmol) in ether (35 mL). The yellow cloudy mixture which resulted was stirred at room 
temperature for ten min, then filtered and the solvent was evaporated in vacuo to yield the 
crude oxadiazoline (1.034 g, 51%) as a yellow/orange oil. νmax (film): 3063, 3031, 1663, 
1614, 1549, 1453, 1236 cm
-1
; δH: 2.38 [6H, s, N(CH3)2], 4.29 (1H, d, J = 15.8, PhCH2), 
5.07 (1H, d, J = 15.8, PhCH2), 6.12 (1H, s, NCHON), 7.28 (5H, m, ArH), 7.46 (2H, m, m-
ArH), 7.60 (1H, m, p-ArH), 8.12 (2H, m, o-ArH).  
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8.1.1.7 Attempted preparation of 3-ethoxy-4-benzyl-5-(N´,N´-dimethyl)-
Δ2,1,2,4-oxadiazoline 374 
Method 1  
A solution of ethylchloroglyoxalate oxime (0.99 g, 6.55 mmol) 
in dry ether (24 mL) was added dropwise to a cooled solution 
(<10 
o
C, water/icebath), stirring solution of N´-benzyl-N,N-
dimethylformamidine (1.07 g, 6.6 mmol) and triethylamine 
(0.68 g, 6.69 mmol) in dry ether (26 mL) over 45 min. A white 
precipitate formed on addition and the resulting solution was 
stirred overnight. Water (30 mL) was added to dissolve the precipitate and the phases were 
separated. The aqueous phase was extracted with ether (30 mL). The combined organic 
extracts were dried, filtered and the solvent was removed in vacuo (without heat). 
Attempted recrystallization of the residue from cold ethyl acetate and hexane was 
unsuccessful and evaporation of the solvent gave the oxadiazoline as an enriched sample 
together with furoxan 315 as a yellow oil. νmax (film): 3062, 3029, 1749, 1697, 1635, 1535, 
1232 cm
-1
; δH: 1.36 (3H, t, J = 7.3, CH2CH3), 2.34 [6H, s, N(CH3)2], 4.26 (1H, d, J = 15.7, 
PhCH2), 4.35 (2H, qd, J = 7.2, 7.3, CH2CH3), 5.14 (1H, d, J = 15.8, PhCH2), 6.08 (1H, s, 
NCHON), 7.29 (5H, m, ArH); δC: 13.9 (CH3CH2O), 36.4 [N(CH3)2], 46.5 (PhCH2), 62.5 
(CH3CH2O), 108.2 (NCHON), 127.6, 127.7 and 128.7 (3 x ArCH), 136.5 (ipso C of Ar), 
146.8 (C3 of oxadiazoline), 157.9 (C=O). 
1
H NMR spectroscopy shows the presence (15%) 
of 3,4-diethoxycarbonylfuroxan (315) as illustrated by the characteristic signals at 1.42 & 
4.48 ppm. 
Method 2 
Ethylchloroglyoxalate oxime (0.99 g, 6.5 mmol) in ether (20 mL) was added dropwise via 
a pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring solution 
of N,N-dimethyl-N´-benzylformamidine (1.06 g, 6.51 mmol) and triethylamine (0.66 g, 
6.51 mmol) in ether (35 mL). The yellow cloudy mixture which resulted was warmed to 
room temperature and stirred for 1 h. The mixture was filtered to remove the triethylamine 
hydrochloride precipitate. The solvent was removed in vacuo (without heat) and the crude 
oxadiazoline (0.6 g. 35%) was isolated as yellow oil together with the furoxan 315. The 
sample was placed under high vacuum to ensure the removal of any residual solvent. νmax 
(film): 3088, 3063, 3031, 1730, 1567, 1454, 1304, 1216, 1034 cm
-1
; δH: 1.36 (3H, t, J = 
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7.1, CH2CH3), 2.33 [6H, s, N(CH3)2], 4.27 (1H, d, J = 15.7, PhCH2), 4.35 (2H, qd, J = 7.2, 
7.1, CH2CH3), 5.12 (1H, d, J = 15.7, Ph-CH2), 6.08 (1H, s, NCHON), 7.28 (5H, m, ArH); 
δC: 13.9 (CH3CH2O), 36.4 [N(CH3)2], 46.6 (PhCH2), 62.5 (CH3CH2O), 108.3 (NCHON), 
127.6, 127.6 and 128.7 (3 x ArCH), 136.5 (ipso C of Ar), 146.9 (C3 of oxadiazoline), 158.0 




H NMR spectroscopy shows the presence (22%) of 3,4-
diethoxycarbonylfuroxan (315) as illustrated by the characteristic signals at 1.42 & 4.48 
ppm  
Method 3  
Ethylchloroglyoxalate oxime (0.99 g, 6.5 mmol) in ether (20 mL) was added dropwise via 
Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring solution of N,N-dimethyl-N´-
benzylformamidine (1.07 g, 6.54 mmol) and triethylamine (0.66 g, 6.51 mmol) in ether (35 
mL). The white cloudy mixture which resulted was warmed to room temperature and 
stirred for 10 min. The mixture was filtered to remove the precipitate and the solvent was 
evaporated in vacuo to yield the crude oxadiazoline (0.866 g, 48%) as a pale yellow oil. 
νmax (film): 3088, 3064, 3031, 1731, 1681, 1626, 1567, 1454, 1301, 1233, 1032 cm
-1
; δH: 
1.36 (3H, t, J = 7.5, CH2CH3), 2.34 [6H, s, N(CH3)2], 4.26 (1H, d, J = 15.7, PhCH2), 4.35 
(2H, qd, J = 7.2, 7.3, CH2CH3), 5.13 (1H, d, J = 15.7, PhCH2), 6.08 (1H, s, NCHON), 7.28 
(5H, m, ArH). 
1
H NMR spectroscopy shows the presence (68%) of 3,4-




1-p-Toluenesulfonyl-1-bromoformaldoxime (1.808 g, 6.50 
mmol) in ether (20 mL) was added dropwise via a Pasteur 
pipette to a cooled (<10 
o
C, water/icebath), stirring solution 
of N,N-dimethyl-N´-benzylformamidine (1.06 g, 6.52 mmol) 
and triethylamine (0.66 g, 6.52 mmol) in ether (35 mL). The 
pale yellow cloudy mixture which resulted was warmed to 
room temperature and stirred for 10 min. The mixture was 
filtered to remove the precipitate and the solvent was removed in vacuo to yield the crude 
oxadiazoline (1.1 g, 47%) as an orange oil. Comparison of the 
1
H NMR spectrum of an 
authentic sample of the urea and literature data of the nitrile indicates that the oxadiazoline 
300 
has been isolated along with tosylcyanide (377) and 1-benzyl-3-(N,N-dimethyl)-urea (335) 
in a ratio of 4:1:1.
[199]
 νmax (film): 3294, 3031, 2949, 2876, 2796, 2691, 2192 (C≡N), 1675, 
1622, 1556, 1456, 1339, 1231, 1160, 1120, 1086, 1051, 1031, 962 cm
-1
; δH: 2.23 [6H, s, 
N(CH3)2], 2.46 (3H, s, ArCH3), 4.27 (1H, d, J = 15.5, PhCH2), 5.13 (1H, d, J = 15.5, 
PhCH2), 5.94 (1H, s, NCHON), 7.30 (7H, m, ArH), 7.88 (2H, d, J = 8.4, o-ArH). Other 
peaks: 2.35 (1.3H, s), 2.45 (0.7H, s), 2.50 (0.6H, s), 2.87 (0.5H, s), 2.89 (0.6H, s), 4.46 
(0.7H, d, J = 6.0), 6.32 (0.3H, bs), 7.18 (0.8H, m), 7.44 (1.1H, t, J = 8.8), 7.57 (0.3H, d, J = 




8.1.2 Reactions with N-benzylformimidoylmorpholine 
8.1.2.1 Attempted preparation of 3-phenyl-4-benzyl-5-(4’-morpholino)-Δ2-
1,2,4-oxadiazoline 380 
Benzohydroximoyl chloride (0.156 g, 1.0 mmol) in ether (5 mL) 
was added dropwise to a cooled (<10 
o
C, water/icebath), stirring 
solution of N-benzylformimidoylmorpholine (0.206 g, 1.01 
mmol) and triethylamine (0.115 g, 1.14 mmol) in ether (5 mL) 
over 5 min. The white cloudy mixture was warmed to room 
temperature and stirred overnight. Water (10 mL) was added to 
the stirring mixture to dissolve the precipitate. The precipitate dissolved immediately on 
addition to yield a cloudy biphasic solution. The phases were separated and the aqueous 
layer was extracted with ether (2 x 20 mL). The organic extracts were combined, dried, 
filtered and the solvent was removed in vacuo. The sample was then placed under high 
vacuum overnight to remove any residual solvent. (0.1381g, 42.7%) Benzonitrile (175) and 
N-benzylmorpholine-4-carboxamide (336) in a 1:1 ratio were observed. δH: 3.36 [4H, t, J = 
4.9, N(CH2)2 336], 3.68 [4H, t, J = 4.9, O(CH2)2 336], 4.43 (2H, d, J = 5.5, PhCH2 336), 







p-Nitrobenzohydroximoyl chloride (0.204 g, 1.02 mmol) 
in ether (5 mL) was added dropwise to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-
benzylformimidoylmorpholine (0.208 g, 1.02 mmol) and 
triethylamine (0.101 g, 1.00 mmol) in ether (10 mL) over 
5 min. The solution was warmed to room temperature and 
stirred overnight. Water (15 mL) was added to the stirring 
mixture to dissolve the precipitate. The phases were separated and the aqueous layer was 
washed with ether (2 x 20 mL). The organic extracts were combined, dried, the solvent 
evaporated and the resulting residue was placed under high vacuum overnight. The crude 
weight isolated was 0.1873g and the 
1
H NMR spectroscopic analysis of this shows a small 
quantity of oxadiazoline, but the sample isolated was predominantly N-benzylmorpholine-
4-carboxamide (336) and p-nitrobenzonitrile (378). The residue was recrystallised from 
ethyl acetate/hexane to yield dark yellow solid (177.00 mg, 5%), (Found: C, 61.73; H, 
5.87; N, 13.37 C19H20N4O4 requires C, 61.95; H, 5.47; N, 15.21%). 
1
H NMR spectroscopic 
analysis of the recrystallized product showed that N-benzylmorpholine-4-carboxamide 
(336) had been isolated.δH: 3.37 [4H, m, N(CH2)2 336], 3.69 [4H, m, O(CH2)2 336], 4.44 
(2H, d, J = 5.5, PhCH2 336), 4.71 (1H, bs, NH 336), 7.31 (5H, m, ArH 336).  
Method 2 
p-Nitrobenzohydroximoyl chloride (0.202 g, 1.01 mmol) in ether (10 mL) was added 
dropwise via a pressure equalizing addition funnel to a cooled (<10 
o
C, water/icebath), 
stirring solution of N-benzylformimidoylmorpholine (0.204 g, 1.00 mmol) and 
triethylamine (0.102 g, 1.01 mmol) in ether (10 mL). Following addition, the icebath was 
removed and the solution was stirred at room temperature for ten minutes. Water (15 mL) 
was added to the stirring mixture to dissolve the precipitate. The phases were separated and 
the organic layer was washed with water (2 x 10 mL). A slight emulsion appeared on the 
first addition of water to the organic phase, so ether (15 mL) was added in an attempt to 
break it up (fairly successful). The organic extracts were combined dried and the solvent 
302 
was evaporated to yield a pale yellow solid (0.2 g, 6%). δH: p-Nitrobenzonitrile-N-oxide 
(265) isolated. 
Method 3 
p-Nitrobenzohydroximoyl chloride (1.307 g, 6.51 mmol) in ether (20 mL) was added 
dropwise via a Pasteur pipette, to a cooled (<10 
o
C, water/icebath), stirring solution of N-
benzylformimidoylmorpholine (1.33 g, 6.53 mmol) and triethylamine (0.66 g, 6.53 mmol) 
in ether (35 mL). The cloudy yellow mixture which resulted was warmed to room 
temperature and stirred for ten min. The mixture was filtered to remove the precipitate and 
a yellow solution resulted. The solvent was evaporated in vacuo without heat to yield a 
yellow solid (1.1 g, 45%). Comparison of 
1
H NMR spectroscopic data with authentic 
samples of N-benzylmorpholine-4-carboxamide (336), p-nitrobenzonitrile-N-oxide (265), 
p-Nitrobenzohydroximoyl chloride (275), N-benzylformimidoylmorpholine (318) and 
oxadiazoline (381) show that N-benzylmorpholine-4-carboxamide (336) was isolated.νmax 
(film): 3296, 3062, 3032, 1667, 1523, 1453, 1386, 1348, 1113 cm
-1
; δH: 3.39 [1.88H, m, 
N(CH2)2 336], 3.56 (1.54H, m), 3.65 (1.57H, m), 3.69 [1.85H, m, O(CH2)2 336], 4.22 
(0.23H, d, J = 6.8), 4.39 (0.51H, d, J = 6.5), 4.48 (2H, d, J = 5.9, PhCH2 336), 6.08 (1H, bs, 
NH 336), 7.30 (7.79H, m, ArH), 7.62 (0.59H, m), 8.04 (0.92H, bs, ArH), 8.17 (0.72H, m), 
8.26 (1.1H, bs, ArH) m/z = no diagnostic ions.  
Method 4 NMR spectroscopy tube reaction 
0.07 M Triethylamine solution in CDCl3 (1 mL) was added to a sample vial containing p-
nitrobenzohydroximoyl chloride (14.00 mg, 0.07 mmol) and that solution was mixed 
briskly. 0.7 mL of the solution was transferred to an NMR spectroscopy tube and 
1
H NMR 
spectroscopic analysis carried out. Once completed, the NMR spectroscopy tube contents 
were poured into a sample vial and solution (1 mL) was transferred to a sample vial 
containing N-benzylformimidoylmorpholine (14.30 mg, 0.07 mmol) and that solution was 
mixed briskly. A 0.7 mL portion of the solution was transferred to an NMR spectroscopy 
tube and 
1
H NMR spectroscopy run. The sample was analysed by 
1
H NMR spectroscopy 
over time. δH: 2.68 [2H, m, N(CHeq)2], 2.84 [2H, m, N(CHeq)2], 3.71 [4H, t, J = 4.8, 
O(CH2)2], 4.43 (2H, d, J = 5.3, PhCH2), 6.08 (1H, s, NCHON), 7.18 (2H, m, ArH), 7.34 
(3H, m, ArH), 7.77 (2H, m, ArH), 8.30 (2H, m, ArH). The oxadiazoline formed 
quantitatively on mixing of reactants. Cycloreversion began to occur within 4.75 h to form 
the p-nitrobenzonitrile (378) and N-benzylmorpholine-4-carboxamide (336) in a 1:1 ratio. 
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Cycloreversion was complete in 128 h. Comparison with an authentic sample of the urea 





 m-Nitrobenzohydroximoyl chloride (1.304 g, 6.5 mmol) in 
ether (30 mL) was added dropwise via a Pasteur pipette, to a 
cooled (<10 
o
C, water/icebath), stirring solution of N-
benzylformimidoylmorpholine (1.33 g, 6.52 mmol) and 
triethylamine (0.66 g, 6.53 mmol) in ether (25 mL). The white 
cloudy mixture which resulted was warmed to room 
temperature and stirred for ten min. The mixture was then 
filtered to remove the precipitate and a clear solution resulted. 
The solvent was evaporated in vacuo and a yellow solid (1.68 g, 70%) was isolated. νmax 




H NMR spectroscopy shows a 
mixture of N-benzylmorpholine-4-carboxamide (336) and other unidentifiable peaks.; δH: 
3.39 (1.90H, m), 3.57 [1.81H, m, N(CH2)2 336], 3.64 (1.46H, m), 3.69 (1.65H, m, O(CH2)2 
336], 3.75 (0.84H, m), 4.40 (0.45H, d, J = 6.5), 4.48 (2H, d, J = 5.9, PhCH2 336), 6.02 (1H, 
bs, NH 336), 7.30 (8H, m, ArH 336), 7.82 (1H, m, ArH), 8.04 (0.81H, bs), 8.30 (2.44H, 
m), 8.53 (0.62H, m), 8.90 (0.3H, m), 9.05 (0.3H, m), 9.49 (0.42H, m). m/z = no diagnostic 
ions observed.  
8.1.2.4 Attempted synthesis of 3-(2,4,6-trimethylphenyl)-4-benzyl-5-(4’-
morpholino)-Δ2-1,2,4-oxadiazoline 384 
Method 1 
2,4,6-Trimethylbenzohydroximoyl chloride (0.20 g, 1.01 
mmol) in ether (5 mL) was added dropwise to a cooled (<10 
o
C, water/icebath) stirring solution of N-
benzylformimidoylmorpholine (0.21 g, 1.02 mmol) and 
triethylamine (0.10 g, 1.03 mmol) in ether (10 mL). The pale 
yellow solution which resulted was warmed to room 
temperature and stirred overnight. Water (25 mL) was added 
to the stirring mixture to dissolve the precipitate. The phases were separated and the 
aqueous layer was washed with ether (2 x 20 mL). The organic extracts were combined, 
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dried, filtered and the solvent was removed in vacuo. The sample (0.1847g) was then 
placed under high vacuum overnight to remove any residual solvent. Recrystallisation from 
ethyl acetate/hexane yielded a white solid (0.05 mg, 0.01%) which was identified as N-
benzylmorpholine-4-carboxamide (336). δH: 3.37 [4H, t, J = 4.9, N(CH2)2 336], 3.69 [4H, 
t, J = 4.9, O(CH2)2 336], 4.44 (2H, d, J = 5.5,  PhCH2 336), 4.68 (1H, bs, NH 336), 7.33 
(5H, m, ArH 336).  
Method 2 
2,4,6-Trimethylbenzohydroximoyl chloride (1.29 g, 6.52 mmol) in ether (20 mL) was 
added dropwise via a Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring solution 
of N-benzylformimidoylmorpholine (1.33 g, 6.53 mmol) and triethylamine (0.66 g, 6.52 
mmol) in ether (35 mL). The white cloudy mixture which resulted was warmed to room 
temperature and stirred for ten min. The solution was filtered and the solvent was 
evaporated in vacuo to yield a pale yellow solid (1.8 g, 77%). Comparison of literature data 
for the nitrile and with an authentic sample of the urea, the 
1
H NMR spectroscopic data 
shows that a mixture of N-benzylmorpholine-4-carboxamide (336) and 2,4,6-
trimethylbenzonitrile (379) was isolated in a ratio of 33 : 67.
[201]
 νmax (film): 3296 NH of 
urea?, 3031, 2291, 1671 C=O of urea?, 1436, 1384, 1271, 1113 cm
-1
; δH: 2.30 (3H, bs, 
ArCH3 379), 2.40 [6H, s, Ar(CH3)2 379], 3.32 (0.72H, t, J = 4.7), 3.37 [1.18H, t, J = 3.0, 
N(CH2)2 336], 3.56 (1.19H, m), 3.65 [3.30H, m, O(CH2)2 336 & ?], 4.43 (1H, d, J = 5.9, 
PhCH2 336), 6.54 (0.38H, bs, NH 336), 6.90 (2H, bs, ArH 379), 7.29 (3.24H, m, ArH 336  
& ?), 8.02 (0.58H, bs), 8.20 (0.50H, bs).  
Method 3 NMR spectroscopy tube reaction 
Mesitonitrile-N-oxide (10.00 mg, 0.06 mmol) was dissolved in CDCl3 (1 mL) and 
submitted for 
1
H NMR spectroscopic analysis. The solution was transferred from the NMR 
spectroscopy tube to a sample vial containing N-benzylformimidoylmorpholine (16.00 mg, 
0.08 mmol) and the resulting solution was mixed and transferred to an NMR spectroscopy 
tube. The sample was submitted for 
1
H NMR spectroscopic analysis. The sample was 
analysed by 
1
H NMR spectroscopy periodically over 360.8 h. These spectra (expt 10-21) 
were compared to amidine and mesitonitrile-N-oxide. On comparison, it appears that the 
oxadiazoline does not form and the nitrile oxide dimerised even in the presence of the 
amidine.  
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8.1.2.5 3-Bromo-4-benzyl-5-(4’-morpholino)-Δ2-1,2,4-oxadiazoline 385 
Method 1  
Dibromoformaldoxime (1.32 g, 6.51 mmol) in ether (20 mL) was 
added dropwise via Pasteur pipette to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-
benzylformimidoylmorpholine (1.34 g, 6.54 mmol) and 
triethylamine (0.66 g, 6.52 mmol) in ether (35 mL). The cloudy 
yellow solution which resulted was warmed to room temperature and stirred for ten min. 
The sample was filtered to remove the precipitate. The solvent was evaporated in vacuo 
and a pale yellow oil (1.17 g, 73%) was isolated. The comparison of 
1
H NMR spectrum 
with authentic samples of N-formylmorpholine (340) & N-benzylmorpholine-4-
carboxamide (336) show that both compounds have been isolated in a 50 : 50 ratio. νmax 
(film): 2864, 2217, 1661, 1528, 1496, 1452, 1446, 1111 cm
-1
; δH: 3.37 [2H, m, N(CH)2 336 
& 340], 3.52 [2H, m, N(CH)2 340], 3.65 [4.1H, m, O(CH2)2 336 & 340], 4.37 (0.5H, d, J = 
6.7), 4.43 (2H, d, J = 6.7, PhCH2 336), 4.49 (0.15H, s), 6.64 (1H, bs, NH 336), 7.29 (8H, 
m, ArH 336), 7.98 (0.89H, s, CHO 340), 8.19 (1.20H, m); m/z = no diagnostic ions.  
Method 2 
Dibromoformaldoxime (1.32 g, 6.50 mmol) in ether (20 mL) was added dropwise via 
Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring suspension of N-
benzylformimidoylmorpholine (1.33 g, 6.51 mmol) and potassium tert-butoxide (0.73 g, 
6.50 mmol) in ether (35 mL). This mixture was warmed to room temperature and stirred 
for ten min. The mixture was filtered to remove the precipitate. The solvent was removed 
in vacuo to yield a pale orange oil (1.57 g, >100%
42
). The comparison of 
1
H NMR 
spectrum with authentic samples of N-formylmorpholine (340) & N-benzylmorpholine-4-
carboxamide (336) show that both compounds were present in a 50 : 50 ratio. νmax (film): 
3231, 2216, 1652, 1453, 1391, 1271, 1113 cm
-1
; δH: 1.28 (8H, s, 
t
BuOH), 3.38 [3.3H, m, 
N(CH2) 336 & 340], 3.53 [3H, m, N(CH2) 340], 3.66 [7.7H, m, O(CH2)2 336 & 340], 4.43 
(2H, d, J = 6.0, PhCH2 336), 6.78 (1H, bs, NH 336), 7.29 (8.2H, m, ArH 336), 8.00 (1.2H, 
s, CHO 340), 8.20 (0.96H, bs), 9.99 (0.66H, s), 11.78 (0.04H, s).  
                                                 
42
 Sample contains t-butanol. 
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8.1.2.6 Attempted preparation of 3-benzoyl-4-benzyl-5-(4’-morpholino)-Δ2-
1,2,4-oxadiazoline 386 
1-Benzoyl-1-chloroformaldoxime (1.20 g, 6.55 mmol) in 
ether (20 mL) was added dropwise via Pasteur pipette to a 
cooled (<10 
o
C, water/icebath), stirring solution of N-
benzylformimidoylmorpholine (1.33 g, 6.50 mmol) and 
triethylamine (0.66 g, 6.52 mmol) in ether (35 mL). The pale 
yellow cloudy mixture which resulted was warmed to room 
temperature and stirred for ten min. The mixture was filtered 
to remove the precipitate which had formed and the solvent was removed from the 
resulting clear yellow solution in vacuo (without heat) to yield a bright yellow/orange oil 
(1.88 g, 82%). The comparison of 
1
H NMR spectrum with an authentic sample of N-
benzylmorpholine-4-carboxamide (336) and comparison with literature data of benzoyl 
cyanide (387) show that both compounds have been isolated.
[202]
 The ratio of products is 
difficult to decipher as the characteristic peaks are overlapping. νmax (film): 3285, 3061, 
2285, 1660, 1530, 1450 cm
-1
; δH: 3.37 [1.24H, m, N(CH)2 336], 3.55 [1.23H, m], 3.65 
[2.29H, m, O(CH2)2 336 & ?], 3.74 (0.50H, m), 4.32 (0.42H, d, J = 6.5), 4.46 (2H, d, J = 
5.9, PhCH2 336), 6.12 (1H, bs, NH 336), 7.31 (7H, m, ArH 336 & ?), 7.51 (4.16H, m, ArH 
387), 7.70 (0.89H, m, ArH 387), 7.85 (0.98H, m, ArH 387), 8.18 (2.37H, m, ArH 387); 
m/z = no diagnostic ions observed.  
8.1.2.7 Attempted preparation of 3-ethoxy-4-benzyl-5-(4’-morpholino)-Δ2-
1,2,4-oxadiazoline 388 
Method 1  
Ethylchloroglyoxalate oxime (0.15 g, 1.01 mmol) in ether (5 
mL) was added dropwise to a cooled (<10 
o
C, water/icebath), 
stirring solution of N-benzylformimidoylmorpholine (0.21 g, 
1.01 mmol) and triethylamine (0.11 g, 1.06 mmol) in ether 
(10 mL) over 5 min. The white solution which resulted was 
warmed to room temperature and stirred overnight. Water 
(25 mL) was added to the stirring mixture to dissolve the precipitate. The phases were 
separated and the aqueous layer was washed with ether (2 x 20 mL) and separated. The 
organic extracts were combined, dried, filtered and concentrated to yield a yellow oil 




spectrum. δH: 3.37 [4H, m, N(CH2)2 336], 3.69 [4H, m, O(CH2)2 336], 4.44 (2H, d, J = 5.4, 
PhCH2 336), 4.70 (1H, bs, NH 336), 7.32 (5H, m, ArH 336) and ether. 
Method 2 
Ethylchloroglyoxalate oxime (0.99 g, 6.5 mmol) in ether (20 mL) was added dropwise via 
Pasteur pipette, to a cooled (<10 
o
C, water/icebath), stirring solution of N-
benzylformimidoylmorpholine (1.33 g, 6.5 mmol) and triethylamine (0.66 g, 6.5 mmol) in 
ether (35 mL). A white cloudy mixture resulted, which was warmed to room temperature 
and stirred for ten min, then filtered to remove the precipitate. The solvent was removed in 
vacuo to yield a yellow oil (1.5 g, 74%). Comparison of 
1
H NMR spectrum with authentic 
samples showed that N-benzylformimidoylmorpholine (318), 3,4-diethoxycarbonylfuroxan 
(315), ether and triethylammonium chloride were isolated in a ratio of 37.5 : 50 : 8.3 : 4.2. 
The amidine (318) showed characteristic signal at 3.37 ppm and the furoxan (315) showed 
a characteristic signal at 1.42 ppm. νmax (film): 3287, 3062, 3031, 1744, 1662, 1453, 1386, 
1112, 1067, 1021 cm
-1
; δH:; m/z = no diagnostic ions. 
8.1.2.8 3-(p-Toluenesulfonyl)-4-benzyl-5-(4’-morpholino)-Δ2-1,2,4-
oxadiazoline 389 
1-p-Toluenesulfonyl-1-bromoformaldoxime (1.82 g, 6.53 mmol) 
in ether (20 mL) was added dropwise via Pasteur pipette to a 
cooled (<10 
o
C, water/icebath), stirring solution of N-
benzylformimidoylmorpholine (1.32 g, 6.5 mmol) and 
triethylamine (0.66 g, 6.5 mmol) in ether (35 mL). The pale cream 
cloudy mixture which resulted was warmed to room temperature 
and stirred for ten min. The mixture was filtered to remove the 
precipitate and the solvent was removed from the resulting clear 
solution in vacuo (without heat) to yield a pale yellow oil (1.8 g, 68%). The comparison of 
1
H NMR spectrum with authentic samples of N-benzylmorpholine-4-carboxamide (336), p-
toluenesulfonylformonitrile-N-oxide (307), 3,4-bis-(p-toluenesulfonyl)-furoxan (309) and 
with the literature data of tosylcyanide (377) shows that a mixture of these products were 
isolated.
[199]
  νmax (film): 3285, 2219, 1655, 1496, 1453, 1147 cm
-1
; δH: 2.42 (2.92H, m, 
307/377), 2.50 (0.97H, m, 309/377), 3.36 (2.92H, m, N(CH2)2 336), 3.53 (1.37H, m), 3.64 
(4.3H, m, O(CH2)2 336), 4.41 (0.33H, d, J = 7.0), 4.44 (1H, d, J = 5.9, PhCH2 336), 4.70 
(0.6H, d, J = 6.3), 5.36 (0.28H, t, J = 6.5), 6.46 (0.46H, bs, NH 336), 7.32 (8H, m, ArH 336 
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& 307/377), 7.79 (2.35H, m, ArH 307/377), 8.02 (0.93H, m), 8.12 (0.18H, m), 8.21 
(0.49H, bs); m/z = no diagnostic ions.  
8.1.2.9 3-Cyano-4-benzyl-5-(4’-morpholine)-Δ2-1,2,4-oxadiazoline 390 
Cyanoformhydroximoyl chloride (0.21 g, 2.00 mmol) in ether (10 
mL) was added dropwise via a pressure equalising addition funnel 
to a cooled (<10 
o
C, water/icebath), stirring solution of N-
benzylformimidoylmorpholine (0.41 g, 2.00 mmol) and 
triethylamine (0.28 mL, 2.01 mmol) in ether (15 mL). The solution 
became yellow and cloudy. Following addition, the solution was 
warmed to room temperature and stirred for 30 min. Water (20 mL) was added and the 
phases were separated. The organic phase was dried, filtered and solvent evaporated in 
vacuo (without heat) to yield the crude reaction mixture as a yellow oil (0.2686g). NMR 
spectroscopic analysis shows that N-benzylformimidoylmorpholine (318), N-
benzylmorpholine-4-carboxamide (336) and oxadiazoline (390) were observed. δH: 2.60 
[2H, m, N(CHax)2 oxadiazoline?), 2.69 (2H, m, N(CHeq)2 oxadiazoline?), 3.34 (m, O(CH2) 
oxadiazoline?), 3.63 (m, O(CH2) oxadiazoline?), 4.36 (1H, d, J = 15.6 Hz, PhCH 
oxadiazoline), 4.45 (d/m, PhCH2 urea?), 4.51 (1H, d, J = 15.6 Hz, PhCH oxadiazoline), 
6.06 (1H, s, NCHON), 6.37 (0.7H, bs, NH urea?), 7.30 (11H, m, ArH), 8.21 (0.77H, s, ?); 
δC: 15.26 (Ether), 42.09 (CH2), 45.64 (CH2), 46.16 (CH2), 47.76 (CH2), 59.15 (CH2), 65.83 
(CH2 ether), 66.45 (CH2), 66.60 (CH2), 107.40 (CN), 107.50 (NCHON), 126.61 (ArCH), 
127.50 (ArCH), 127.60 (ArCH), 127.76 (ArCH), 128.15 (ArCH), 128.33 (ArCH), 128.66 
(ArCH), 128.72 (ArCH), 129.11 (ArCH), 134.14 (CH2/4
o
 C), 135.13 (CH2/4
o
 C), 137.71 
(CH2/4
o
 C), 141.35 (CH2/4
o
 C), 155.10 (CH), 161.16 (CH), 164.75 (CH).  
8.1.3 Reactions with N-phenylformimidoylmorpholine 
8.1.3.1 3-Phenyl-4-phenyl-5-(4’-morpholino)-Δ2-1,2,4-oxadiazoline 267 
Method 1  
Benzohydroximoyl chloride (0.99 g, 6.36 mmol) in ether (30 
mL) was added dropwise to a cooled (<10 
o
C, water/icebath), 
stirring solution of N-(N´-phenylformimidoyl)-morpholine 
(1.22 g, 6.44 mmol) and triethylamine (0.67 g, 6.58 mmol) in 
ether (30 mL) over five min. On addition, a white cloudy 
mixture resulted, which was warmed to room temperature and stirred for ten minutes. 
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Water (30 mL) was added to the stirring solution to dissolve the triethylamine 
hydrochloride and a biphasic solution resulted. The organic extract was washed with water 
(3 x 20 mL). The resulting aqueous phase contained an emulsion/solid, so dichloromethane 
(50 mL, distilled) was added to try to dissolve it (successfully). The ether extracts and 
dichloromethane extracts were kept separately and each were dried, filtered and the solvent 
removed in vacuo. The resulting residue was dissolved in ethyl acetate:hexane and placed 
in a freezer overnight. The recrystallised oxadiazoline (0.515 g, 26%) was isolated as a 
white solid by vacuum filtration. δH: 2.79 [2H, m, N(CH ax)2], 2.98 [2H, m, N(CHeq)2], 3.79 
[4H, t, J = 4.77Hz, O(CH2)2], 6.13 (1H, s, NCHON), 7.10 (3H, m, ArH), 7.23 (2H, m, 
ArH), 7.35 (3H, m, ArH), 7.51 (2H, m, ArH); δC: 45.0 [N(CH2)2], 67.0 [O(CH2)2], 108.4 
(NCHON), 123.0, 125.2, 127.8, 128.7, 129.0 and 130.5 (6 x ArCH), 132.8 and 139.8 (ipso 
C’s of Ar), 158.2 (NC=N). 
Method 2  
Benzohydroximoyl chloride (1.01 g, 6.50 mmol) in ether (20 mL) was added dropwise via 
a pressure equalizing addition funnel to a cooled (<10 
o
C, water/ice bath), stirring solution 
of N-(N´-phenylformimidoyl)-morpholine (1.24 g, 6.50 mmol) and triethylamine (0.66 g, 
6.49 mmol) in ether (35 mL). The white cloudy mixture which resulted was warmed to 
room temperature and stirred for 1 h. The solid precipitate was removed by filtration and 
the solvent was evaporated in vacuo (without heat). A pale cream solid residue was 
isolated. The sample was placed under high vacuum for 1.5 h. Examination of the proton 
NMR spectroscopic analysis shows that a morpholine group is present in a 1:1 ratio with 
the oxadiazoline. The aromatic peaks are also too numerous to correlate to just the 
oxadiazoline. However, comparison with N-phenylmorpholine-4-carboxamide (395), N-
(N´-phenylformimidoyl)-morpholine (341) and N-formylmorpholine (340) show that none 
of these are present. δH: 2.78 [2H, m, N(CHax)2], 3.01 [2H, m, N(CHeq)2], 3.53 (4H, bs, ?), 







p-Nitrobenzohydroximoyl chloride (1.28 g, 6.38 mmol) in 
ether (30 mL) was added dropwise to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-(N´-
phenylformimidoyl)-morpholine (1.22 g, 6.39 mmol) and 
triethylamine (0.66 g, 6.56 mmol) in ether (30 mL) over 
15 min. The solution was stirred for 1.25 h. Water (50 
mL) was added to the stirring mixture to dissolve the precipitate. A pale yellow emulsion 
formed so water (50 mL) and ether (50 mL) were added alternatively to see if the emulsion 
would dissolve/break-up. The solution was transferred to a separating funnel and the 
phases were separated. The aqueous layer was washed with ether (3 x 50 mL). The organic 
extracts were combined dried and the solvent was evaporated in vacuo. The resulting pale 
yellow solid was recrystallised from ethyl acetate/hexane and stored in a freezer overnight. 
The oxadiazoline (0.922 g, 41%) was isolated as a pale yellow crystalline solid. δH: 2.79 
[2H, m, N(CHax)2], 2.98 [2H, m, N(CHeq)2], 3.81 [4H, t, J = 4.74, O(CH2)2], 6.19 (1H, s, 
NCHON), 7.05 (2H, m, ArH), 7.19 (1H, m, ArH), 7.28 (2H, m, ArH), 7.70 (2H, m, o-
ArH), 8.19 (2H, m, m-ArH); δC: 45.0 [N(CH2)2], 66.9 [O(CH2)2], 109.9 (NCHON), 123.3, 
123.9, 126.1, 128.6 and 129.4 (5x ArCH), 131.5 and 139.3 (ipso C’s of Ar), 148.7 
(ArCNO2), 151.7 [NC(Ar)=N].  
Method 2 
p-Nitrobenzohydroximoyl chloride (1.29 g, 6.41 mmol) in ether (30 mL) was added 
dropwise to a cooled (<10 
o
C, water/icebath), stirring solution of N-(N´-
phenylformimidoyl)-morpholine (1.24 g, 6.51 mmol) and triethylamine (0.66 g, 6.5 mmol) 
in ether (30 mL) over 5 min. The yellow cloudy mixture which resulted was warmed to 
room temperature and stirred for 10 min. Water (30 mL) was added to dissolve the 
precipitate. An emulsion formed so organic extract was washed with water (3 x 20 mL). 
Emulsion/solid present in aqueous layer, therefore dichloromethane (1 x 50 mL) added and 
the phases separated. The emulsion dispersed and the phases were separated. Each fraction 
(Ether and dichloromethane) was isolated separately. The organic extracts were combined, 
dried and the solvent was evaporated in vacuo. Both extracts contained the oxadiazoline. 
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Recrystallisation of the residue from ethyl acetate/hexane afforded the oxadiazoline (0.6 g, 
29%) as a yellow solid. δH: 2.79 [2H, m, N(CHax)2], 2.98 [2H, m, N(CHeq)2], 3.80 [4H, t, J 
= 4.75, O(CH2)2], 6.19 (1H, s, NCHON), 7.05 (2H, m, o-ArH), 7.24 (3H, m, ArH), 7.70 
(2H, m, o-ArH), 8.18 (2H, m, m-ArH); δC: 45.0 [N(CH2)2], 66.9 [O(CH2)2], 109.3 
(NCHON), 123.3, 123.9, 126.1, 128.6 and 129.4 (5 x ArCH), 131.5 (ipso C of Ar), 139.3 
(ipso C of Ar), 148.7 [ArC(NO2)], 151.8 (NC=N).  
Method 3 
p-Nitrobenzohydroximoyl chloride (1.31 g, 6.52 mmol) in ether (20 mL) was added 
dropwise via a pressure equalizing addition funnel to a cooled (<10 
o
C, water/ice bath), 
stirring solution of N-(N´-phenylformimidoyl)-morpholine (1.24 g, 6.51 mmol) and 
triethylamine (0.66 g, 6.51 mmol) in ether (35 mL). The yellow cloudy mixture which 
resulted was warmed to room temperature and stirred for 1 h. The mixture was filtered to 
remove the precipitate and the solvent was evaporated in vacuo (without heat). An orange 
solid was isolated. The sample was placed under high vacuum for 1.5 h. The crude sample 
was recrystallised from chloroform:hexane to yield the oxadiazoline (0.502 g, 22%) as a 
yellow solid. δH: 2.79 [2H, m, N(CHax)2] 2.98 [2H, m, N(CHeq)2], 3.80 [4H, t, J = 4.77, 
O(CH2)2], 6.19 (1H, s, NCHON), 7.05 (2H, m, o-ArH), 7.24 (3H, m, ArH), 7.70 (2H, m, o-
ArH), 8.18 (2H, m, m-ArH). 
Method 4: NMR spectroscopy tube reaction 
Triethylamine (1 mL of 0.07 M solution in CDCl3) was added to p-nitrobenzohydroximoyl 
chloride (14.10 mg, 0.07 mmol) and the resulting solution was briskly stirred. A 0.6 mL 
portion of the solution was submitted for 
1
H NMR spectroscopic analysis. Following 
1
H 
NMR spectroscopic analysis, the sample in the NMR spectroscopy tube was returned to the 
sample vial and the entire solution was mixed immediately with N-(N´-
phenylformimidoyl)-morpholine (13.30 mg, 0.07 mmol). Once homogenous, a 0.6 mL 
portion was transferred to an NMR spectroscopy tube and 
1
H NMR spectroscopic analysis 
carried out immediately. δH: initial spectrum showed 100% conversion to nitrile oxide, 
subsequent spectra show some amidine still present, but all of the nitrile oxide has been 
consumed (within 7 min).  
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Method 5: NMR spectroscopy tube reaction 
p-Nitrobenzonitrile-N-oxide (11.60 mg, 0.07 mmol) was dissolved in CDCl3 (1 mL) and a 
0.7 mL sample was transferred to an NMR spectroscopy tube and 
1
H NMR spectroscopic 
analysis carried out immediately. The entire solution was then combined with N-(N´-
phenylformimidoyl)-morpholine (13.40 mg, 0.07 mmol) and mixed briskly until 
homogenous. A 0.7 mL sample of this yellow solution was transferred to NMR 
spectroscopy tube and 
1
H NMR spectroscopic analysis was carried out immediately. The 
sample was monitored by 
1
H NMR spectroscopy over time to establish its decomposition 
rate. δH: reaction monitored over 1055 h for decomposition-no decomposition observed.  
8.1.3.3 3-(m-Nitrophenyl)-4-phenyl-5-(4’-morpholino)-Δ2-1,2,4-oxadiazoline 
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m-Nitrobenzohydroximoyl chloride (1.31 g, 6.51 mmol) in ether 
(20 mL) was added dropwise via a pressure equalizing addition 
funnel to a cooled (<10 
o
C, water/ice bath), stirring solution of 
N-(N´-phenylformimidoyl)-morpholine (1.24 g, 6.51 mmol) and 
triethylamine (0.66 g, 6.54 mmol) in ether (35 mL). The pale 
cream cloudy mixture which resulted was warmed to room 
temperature and stirred for 1 h. The mixture was filtered to 
remove the precipitate and the solvent was evaporated in vacuo without heat. The crude 
oxadiazoline (1.35 g, 59%) was isolated as a pale yellow solid. The sample was placed 
under high vacuum for 1.5 h. δH: 2.79 [2H, m, N(CHax)2], 2.97 [2H, m, N(CHeq)2], 3.81 
[4H, t, J = 4.77, O(CH2)2], 6.19 (1H, s, NCHON), 7.05 (2H, m, ArH), 7.21 (1H, m, ArH), 
7.27 (2H, m, ArH), 7.53 (1H, t, J = 8.02, ArH) 7.84 (1H, m, ArH), 8.24 (1H, m, ArH), 8.35 




2,4,6-Trimethylbenzohydroximoyl chloride (1.27 g, 6.42 
mmol) in dry dichloromethane (30 mL) was added dropwise 
to a cooled (<10 
o
C, water/ice bath), stirring solution of N-
(N-phenylformimidoyl)-morpholine (1.22 g, 6.39 mmol) and 
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triethylamine (0.66 g, 6.49 mmol) in dry dichloromethane (30 mL) over ten minutes. The 
resulting solution was stirred for 1 h with the icebath (<10 
o
C, water/ice bath) maintained. 
Water (30 mL) was added to the stirring solution. The phases were separated and the 
aqueous layer was washed with dichloromethane (3 x 30 mL, dry). The organic extracts 
were combined, dried, filtered and the solvent was removed in vacuo. The sample isolated 
was pale pink in colour (0.1 g, 5%). 
1
H NMR spectroscopic analysis indicated that the 
amidine starting material was still present. This, along with the absence of the oxadiazoline 
peak implies that the mesitonitrile-N-oxide may not react at <10 
o
C (water/ ice bath). 
Method 2 
2,4,6-Trimethylbenzohydroximoyl chloride (1.29 g, 6.41 mmol) in ether (20 mL) was 
added dropwise via pressure-equalising addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-(N´-phenylformimidoyl)-morpholine (1.24 g, 6.51 
mmol) and triethylamine (0.66 g, 6.52 mmol) in ether (35 mL). The pale cream cloudy 
mixture which resulted was warmed to room temperature and stirred for 1 h. The solution 
was filtered and the solvent was evaporated in vacuo (without heat). The crude reaction 
mixture (2.1 g, 94%) was isolated as a white solid. δH: shows N-(N´-phenylformimidoyl)-
morpholine (341) (7.51 ppm) and 2,4,6-trimethylbenzonitrile oxide (7) (2.30, 2.42 and 6.91 
ppm) starting materials. m/z = 191 (100%, 341). 
Method 3 
2,4,6-Trimethylbenzohydroximoyl chloride (1.28 g, 6.46 mmol) in dry dichloromethane 
(30 mL) was added dropwise to a stirring solution of N-(N-phenylformimidoyl)-
morpholine (1.22 g, 6.41 mmol) and triethylamine (0.65 g, 6.46 mmol) in dry 
dichloromethane (30 mL) at room temperature over ten minutes. The resulting solution 
was stirred overnight. Water (30 mL) was added to the stirring solution. The phases were 
separated and the aqueous layer was washed with dichloromethane (30 mL). The organic 
extracts were combined, dried, filtered and the solvent was removed in vacuo to yield a 
pale orange residue. This residue was recrystallised from dichloromethane:hexane and the 
resulting solution placed in a freezer. The isolated sample was a pale yellow crystalline 
solid (0.2 g, 7%). 
1
H NMR spectroscopy indicated that N-(N´-phenylformimidoyl)-
morpholine (341) (7.51 ppm) is still present. This, along with the absence of the 
oxadiazoline peak implies that the mesitonitrile-N-oxide (7) may not react at room 
temperature. 
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Method 4: NMR spectroscopy tube reaction 
Mesitonitrile-N-oxide (11.00 mg, 0.068 mmol) was dissolved in CDCl3 (1 mL) and sample 
submitted for 
1
H NMR spectroscopy analysis. The sample was then transferred from the 
NMR spectroscopy tube to a sample vial containing N-(N´-phenylformimidoyl)-
morpholine (13.00 mg, 0.068 mmol) and solution was transferred back to the NMR 
spectroscopy tube and shaken. Sample submitted for 
1
H NMR spectroscopic analysis and 
was analysed over 360 h (15 days). The spectra showed that the sample contained the N-
(N´-phenylformimidoyl)-morpholine (341) (7.51 ppm) and mesitonitrile-N-oxide (7) (2.30, 
2.42 and 6.91 ppm) starting materials after this time. 
8.1.3.5 3-Bromo-4-phenyl-5-(4’-morpholino)-Δ2-1,2,4-oxadiazoline 396 
Method 1 
Dibromoformaldoxime (1.32 g, 6.53 mmol) in doubly distilled 
dichloromethane (50 mL) was added dropwise to a cooled (<10 
o
C, water/ice bath), stirring solution of N-(N´-
phenylformimidoyl)-morpholine (1.24 g, 6.54 mmol) and 
triethylamine (0.66 g, 6.51 mmol) in doubly distilled 
dichloromethane (50 mL) over 15 min. The ice bath was removed and the resulting orange 
solution was stirred at room temperature for ten min. Water (30 mL) was added to dissolve 
the precipitate. The biphasic solution was transferred to a separating funnel and the phases 
were separated. The organic phase was further extracted with water (1 x 50 mL). The 
organic phase was dried, filtered and the solvent removed in vacuo (without heat) to yield a 
brown oil. The attempted crystallisation of the residue from ethyl acetate-hexane yielded a 
brown sticky solid (0.242 g, 18%
43
). Examination of the proton NMR spectrum indicated 
that neither N-phenylmorpholine-4-carboxamide (395) nor N-formylmorpholine (340) 
were present. δH: 1.24 (4H, m), 3.39 (2H, m), 3.57 (2.8H, m), 3.68 (7.2H, m), 3.76 (6H, 
m), 7.11 (1.3H, t, J = 7.28), 7.18 (2.5H, m), 7.30 (3.6H, m), 7.81 (1.9H, s), 8.06 (1.2H, s).  
Method 2 
Dibromoformaldoxime (1.59 g, 7.82 mmol) in ether (20 mL) was added dropwise via a 
pressure-equalising addition funnel to a cooled (<10 
o
C, water/ice bath), stirring 
suspension of N-(N´-phenylformimidoyl)-morpholine (1.25 g, 6.57 mmol) and potassium t-
                                                 
43
 Contains ethyl acetate and hexane. 
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butoxide (0.73 g, 6.51 mmol) in ether (35 mL). The resulting pink/brown mixture was 
warmed to room temperature and stirred overnight. The mixture was filtered to remove the 
solid residue and solvent evaporated in vacuo to yield a brown solid. Spiking the proton 
NMR spectroscopic sample with N-formylmorpholine (340) aided the confirmation of its 
presence. νmax (film): 3099, 2240, 1658, 1600, 1491, 1441, 1272 cm
-1
; δH: 3.41 [1.92H, t, J 
= 4.86, N(CHax)2], 3.58 [2H, m, N(CHeq)2], 3.97 [4H, m, O(CH2)2], 7.36 ( 4.24H, m), 8.06 
(1H, s, NCHO).  
Method 3 
Dibromoformaldoxime (1.32 g, 6.50 mmol) in ether (20 mL) was added dropwise via a 
pressure-equalising addition funnel to a cooled (<10 
o
C, water/ice bath), stirring 
suspension of N-(N´-phenylformimidoyl)-morpholine (1.24 g, 6.51 mmol) and potassium t-
butoxide (0.73 g, 6.50 mmol) in ether (35 mL). The pale brown mixture which resulted 
was warmed to room temperature and stirred for 1 h. The mixture was filtered to remove 
the solid residue and the solvent was evaporated in vacuo (without heat). The sample was 
dried under high vacuum for 1 h. The residue was recrystallised from chloroform:hexane 
and isolated as a pale brown solid (0.691 g, 34%). Comparison of the proton NMR data 
with an authentic sample of N-formylmorpholine (340) indicated its presence. δH: 3.41 
[2H, m, N(CHax)2], 3.58 [2H, m, N(CHeq)2], 3.69 [4H, m, O(CH2)2],  7.03 (2H, m, ArH), 
7.43 (4H, m, ArH), 8.06 (1H, s, CHO).  
Method 4 
A solution of dibromoformaldoxime (0.66 g, 3.25 mmol) in ether (10 mL) was added 
dropwise via a pressure-equalising addition funnel to a cooled (<10 
o
C, water/ice bath), 
stirring solution of N-(N´-phenylformimidoyl)-morpholine (0.62 g, 3.25 mmol) and 
triethylamine (0.46 mL, 3.3 mmol) in ether (15 mL). The resulting green/brown mixture 
was warmed to room temperature and stirred for 10 min. The reaction mixture was filtered 
to remove the solid residue and the solvent was evaporated in vacuo to yield a brown/green 
solid, (0.434 g, 43%). The presence of N-formylmorpholine (340) was confirmed by 
spiking with a reference sample. δH: 3.40 [1.87H, t, J = 4.86, N(CHax)2 of 340], 3.64 
[9.67H, m, incl. N(CHeq)2 of 340], 3.76 [6.48H, m, incl. O(CH2)2 of 340], 7.07 (5.1H, m), 
7.29 (5H, m), 7.64 (1.86H, s), 8.06 (1H, s, NCHO of 340).. 
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8.1.3.6 3-Chloro-4-phenyl-5-(4’-morpholino)-Δ2-1,2,4-oxadiazoline 397 
Method 1 
A solution of dichloroformaldoxime (~5.2 mmol [100% yield]) 
in 1,2-dimethoxyethane (5 mL) and ether (10 mL) was added 
dropwise via pressure-equalising addition funnel to a cooled 
(<10 
o
C, water/icebath), stirring solution of N-(N´-
phenylformimidoyl)-morpholine (0.99 g, 5.21 mmol) and 
triethylamine (0.73 mL, 5.24 mmol) in ether (25 mL). The cloudy brown/red solution was 
washed through the pressure-equalising addition funnel with ether (~5 mL). The resulting 
cloudy pale orange/yellow solution was warmed to room temperature and stirred for ten 
minutes. The mixture was filtered to remove the precipitate and the solvent was removed 
in vacuo to yield a red/brown liquid. νmax (film): 2966, 1710, 1629, 1588, 1492, 1433, 




H NMR spectroscopic analysis indicated that N-(N´-
phenylformimidoyl)-morpholine (341) and 1,2-dimethoxyethane were the products of this 
reaction. δH: 2.70 (3.3H, s), 3.39 (16.7H, s, 1,2-dimethoxyethane), 3.53 [14H, s and bs 
overlapping, N(CH2)2 341 and 1,2-dimethoxyethane], 3.74 [4H, t, J = 4.88, O(CH2)2 341], 
6.96 (2H, m, ArH 341), 7.02 (1H, m, ArH 341), 7.26 (2H, m, ArH 341), 7.52 (1H, s, 
N=CH 341). 
Method 2 
A solution of dichloroformaldoxime (1.67 g, 14.64 mmol) in ether (16 mL) was added 
dropwise via Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring solution of N-(N´-
phenylformimidoyl)-morpholine (0.99 g, 5.19 mmol) and triethylamine (0.73 mL, 5.24 
mmol) in ether (24 mL). The resulting orange solution was stirred at room temperature for 
20 min, filtered, solvent removed in vacuo to yield a brown oil (1.49 g). 
1
H NMR 
spectroscopic analysis indicated that N-(N´-phenylformimidoyl)-morpholine (341) was the 
product of this reaction. δH: 1.21 [4.3H, t, J = 7.11, CH2 ether], 2.70 (1.86H, s, ?), 2.84 
(1.85H, q, J = 7.27, ? ), 3.48 [4.69H, overlapping bs &  m, N(CH2)2 341 and ether], 3.74 
[4H, m, O(CH2)2 341], 6.96 (2H, m, ArH 341), 7.02 (1H, m, ArH 341), 7.26 (2H, m, ArH 
341), 7.51 (1H, s, N=CH 341). m/z = 191 (M+H)
+
 341.  
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8.1.3.7 3-Benzoyl-4-phenyl-5-(4’-morpholino)-Δ2-1,2,4-oxadiazoline 398 
Method 1 
1-Benzoyl-1-chloroformaldoxime (1.18 g, 6.43 mmol) in ether 
(50 mL) was added dropwise via a pressure equalizing addition 
funnel to a cooled (<0 
o
C, salt/ice bath), stirring solution of N-
(N´-phenylformimidoyl)-morpholine (1.22 g, 6.41 mmol) and 
triethylamine (0.65 g, 6.39 mmol) in ether (40 mL) over 1.5 h. 
The resulting mixture was stirred for 10 min. Water (50 mL) was 
added and the layers were separated. The aqueous layer was 
further extracted with ether (30 mL) and the combined organic extracts were dried and the 
solvent removed in vacuo. The residue was recrystallised from ethyl acetate/hexane. The 
pale yellow solid oxadiazoline (0.842 g, 39%) was isolated by vacuum filtration, m.p. 94-
95.5 
o
C. νmax (film): 3321, 3061, 2966, 2919, 1679, 1637, 1598, 1537, 1444, 1248, 1115 
cm
-1
; δH: 2.75 [2H, m, N(CHax)2], 3.00 [2H, m, N(CHeq)2], 3.77 [4H, t, J = 4.76, O(CH2)2], 
6.26 (1H, s, NCHNO), 7.09 (2H, m, ArH), 7.17 (1H, m, ArH), 7.31 (2H, m, ArH), 7.53 
(2H, m, ArH), 7.69 (1H, m, ArH), 8.22 (2H, m, ArH); δC: 44.6 [N(CH2)2], 66.8 [O(CH2)2], 
108.4 (NCHON), 121.4, 125.6, 128.7, 129.2, 130.6 and 134.7 (6 x ArCH), 135.2 and 138.3 
(2 x ipso C of Ar), 150.8 (C=N), 181.6 (C=O). HRMS (ESI
+
) exact mass calculated for 
C11H14N2O2 [(M+H)
+
], 207.1134, found 207.1134 for N-phenylmorpholine-4-carboxamide 
(395). 
Method 2 
1-Benzoyl-1-chloroformaldoxime (1.19 g, 6.51 mmol) in ether (20 mL) was added 
dropwise via a pressure equalizing addition funnel to a cooled (<0 
o
C, salt/ice bath), 
stirring solution of N-(N´-phenylformimidoyl)-morpholine (1.24 g, 6.50 mmol) and 
triethylamine (0.66 g, 6.50 mmol) in ether (35 mL). The pale yellow/cream mixture which 
resulted was warmed to room temperature and stirred for 1 h. The reaction mixture was 
filtered to remove the precipitate and the solvent was removed in vacuo (without heat) to 
yield the crude oxadiazoline as a yellow solid. The sample was dried further under high 
vacuum for 1 h. The crude residue was recrystallised from chloroform-hexane. The 
oxadiazoline (0.540 g, 25%) was isolated as a yellow solid, m.p. 95-95.5 
o
C. νmax (film): 
1663, 1549, 1496, 1220, 1115 cm
-1
; δH: 2.75 [2H, m, N(CHax)2], 3.00 [2H, m, N(CHeq)2], 
3.76 [4H, m, O(CH2)2], 6.25 (1H, s, NCHNO), 7.11 (2H, m, ArH), 7.26 (3H, m, ArH), 7.52 
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(2H, m, ArH), 7.67 (1H, m, ArH), 8.22 (2H, m, ArH). HRMS (ESI
+
) exact mass calculated 
for C19H19N3O3 [(M+H)
+
], 338.1505, found 338.1499. 
Method 3 
A solution of 1-benzoyl-1-chloroformaldoxime (0.60 g, 3.25 mmol) in ether (10 mL) was 
added dropwise via a pressure equalizing addition funnel to a cooled (<10 
o
C, water/ice 
bath), stirring solution of N-(N´-phenylformimidoyl)-morpholine (0.62 g, 3.25 mmol) and 
triethylamine (0.46 mL, 3.30 mmol) in ether (15 mL). The resulting cloudy yellow solution 
was warmed to room temperature and stirred for 10 min. The mixture was filtered to 
remove the precipitate and the solvent removed in vacuo (without heat) to yield the crude 
oxadiazoline (0.945g) as a yellow solid. The crude residue was recrystallised from cold 
chloroform/hexane and placed in the freezer overnight. The oxadiazoline (128.00 mg, 
12%) isolated as a solid, m.p. 116-122 
o
C. νmax (film): 2964, 2853, 1664, 1599, 1550, 1496, 
1220, 1116 cm
-1
; δH: 2.76 [2H, m, N(CHax)2], 3.00 [2H, m, N(CHeq)2], 3.77 [4H, t, J = 
4.77, O(CH2)2], 6.26 (1H, s, NCHNO), 7.08 (2H, m, N-ArH), 7.17 (1H, m, N-ArH), 7.29 
(2H, m, N-ArH), 7.53 (2H, m, ArH), 7.68 (1H, m, ArH), 8.23 (2H, m, ArH);  δC: 44.7 
[N(CH2)2], 66.8 [O(CH2)2], 108.4 (NCHON), 121.4, 125.6 and 129.2 (3 x N-ArCH), 128.7, 
130.6 and 134.7 (3 x ArCH), 135.2 and 138.3 (2 x ipso C of Ar), 150.8 (C=N), 181.7 
(C=O); m/z = 338 [M+H]
+
. 
Method 4: NMR spectroscopy tube reaction 
1-Benzoyl-1-chloroformaldoxime (12.90 mg, 0.07 mmol) was combined with 0.07 M 
triethylamine solution in CDCl3 (1 mL) and the solution was mixed briskly. A 0.6 mL 
sample of this solution was transferred to an NMR spectroscopy tube and a 
1
H NMR 
spectrum run immediately (1:1 ratio of nitrile oxide : furoxan). The contents of NMR 
spectroscopy tube were returned to the sample vial and the resulting solution (1 mL) was 
combined with N-(N´-phenylformimidoyl)-morpholine (13.40 mg, 0.07 mmol) and was 
mixed briskly. A 0.6 mL sample of this solution was transferred to an NMR spectroscopy 
tube and 
1
H NMR spectroscopy run immediately. The NMR spectroscopy tube was then 
spiked with a solution of freshly synthesised oxadiazoline in CDCl3. δH: 2.68 [2H, m, 
N(CHax)2 398], 2.92 [2H, m, N(CHeq)2 398], 3.45 [12.18H, bs, N(CH2)2 341], 3.68 [17.94H, 
m, O(CH2)2 341 and O(CH2)2 398], 6.18 (1H, s, NCHON 398), 6.89 (6.34H, m, ArH 341), 
6.96 (3.27H, m, ArH 341), 7.03 (2H, m, ArH 398), 7.10 (1H, m, ArH 398), 7.19 (9.20H, 
m, ArH 341 and ArH 398) 7.47 (10.90H, m, ArH 314, ArH 398 and CH=N 341), 7.63 
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(3.87H, m, ArH 398 and ArH 314), 7.79 (2.48H, m, ArH 314), 8.14 (4.89H, m, ArH 314 
and ArH 398). Ratio of 3,4-dibenzoylfuroxan (314) : oxadiazoline (398) : N-(N´-




A solution of 1-(p-bromobenzoyl)-1-chloroformaldoxime (0.86 g, 
3.26 mmol) in ether (10 mL) was added dropwise via a pressure 
equalizing addition funnel to a cooled (<10 
o
C, water/ice bath), 
stirring solution of N-(N´-phenylformimidoyl)-morpholine (0.62 g, 
3.25 mmol) and triethylamine (0.46 mL, 3.30 mmol) in ether (15 
mL). The resulting mixture was warmed to room temperature and 
stirred for 10 min. The mixture was filtered to remove the 
precipitate with the aid of additional ether (10 mL) and the solvent 
was removed in vacuo (without heat) to yield a yellow/pale orange solid, (1.287 g). The 
oxadiazoline (677.00 mg, 50%) was recrystallised from chloroform:hexane and isolated by 
vacuum filtration as a pale orange/yellow solid, m.p. 90-92 
o
C. νmax (film): 3097, 3061, 
1673, 1597, 1546, 1499, 1427, 1323, 1259, 1160, 1117, 1099, 1029, 1010 cm
-1
; δH(DMSO-d6): 
2.72 [4H, m, N(CH2)2], 3.62 [4H, bs, O(CH2)2], 6.58 (1H, s, NCHON), 7.16 (3H, m, N-
ArH), 7.33 (2H, m, N-ArH), 7.83 (2H, m, o-ArH), 8.05 (2H, m, m-ArH); δC(DMSO-d6): 44.2 
[N(CH2)2], 65.9 [O(CH2)2], 107.5 (NCHON), 121.7, 125.3 and 129.0 (3 x ArCH of N-Ph), 
129.3 (ArCBr), 131.9 and 132.1 (2 x ArCH), 133.8 and 137.7 (2 x ipso C of Ar), 150.3 






) exact mass 
calculated for C19H18N3O3Br [M+H]
+




Method 2: NMR spectroscopy tube reaction 
0.07 M Triethylamine solution in CDCl3 (1 mL) was added to a sample vial containing 1-
(p-bromobenzoyl)-1-chloroformaldoxime (18.40 mg, 0.07 mmol) and a 0.7 mL quantity of 
the solution was transferred to an NMR spectroscopy tube and 
1
H NMR spectroscopic 
analysis was carried out. The contents of this NMR spectroscopy tube were returned to the 
original solution and the entire solution was transferred to sample vial containing N-(N´-
phenylformimidoyl)-morpholine (13.30 mg, 0.07 mmol). A 0.7 mL portion of the resulting 
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solution was transferred to an NMR spectroscopy tube and 
1
H NMR spectroscopic analysis 
was carried out immediately. δH: 1.40 (32H, t, CH3 triethylammonium chloride), 3.10 
(21H, q, CH2 triethylammonium chloride), 7.49 (0.76H, m, ?), 7.72 (7H, m, 430/431), 7.91 
(2H, m, 431), 8.09 (2H, m, 430). The first proton NMR spectrum shows complete 
conversion to p-bromobenzoylnitrile-N-oxide (430) or 3,4-bis-(p-bromobenzoyl)-furoxan 
(431) or a mixture of both. The next proton NMR spectrum taken directly after the mixing 
of the 1,3-dipole and dipolarophile illustrates that a mixture of N-(N´-phenylformimidoyl)-
morpholine (341) and 3,4-bis-(p-bromobenzoyl)-furoxan (431) were observed in a 1 : 1 
ratio. δH: 1.39 (9.4H, t, CH3 triethylammonium chloride), 3.09 (6.3H, q, CH2 
triethylammonium chloride), 3.53 [3.3H, m, N(CH2)2 341], 3.75 [4.2H, m, O(CH2)2 341], 
7.01 (3H, m, ArH 341), 7.27 (2.4H, m, ArH 341), 7.55 (1H, s, N=CH 341), 7.71 (2H, m, 
431), 7.92 (0.27H, m, 431), 8.09 (0.87H, m, 431).  
8.1.3.9 3-Ethoxy-4-phenyl-5-(4’-morpholino)-Δ2-1,2,4-oxadiazoline 400 
Method 1  
Ethylchloroglyoxalate oxime (0.97 g, 6.42 mmol) in ether 
(30 mL) was added dropwise to a cooled (<10 
o
C water/ice 
bath), stirring solution of N-(N-phenylformimidoyl)-
morpholine (1.24 g, 6.54 mmol) and triethylamine (0.66 g, 
6.48 mmol) in ether (30 mL) over 5 min. The cloudy white 
solution which resulted was warmed to room temperature and stirred for 10 min. Water (30 
mL) was added to dissolve the precipitate. The phases were separated and the organic 
extract was washed with water (3 x 20 mL). The organic extracts were combined, dried 
and the solvent was evaporated in vacuo. The residue was dissolved in ethyl acetate/hexane 
and the recrystallised oxadiazoline (0.192 g, 10%) was isolated as a white crystalline solid, 
m.p. 105-105.5 
o
C. νmax (film): 3454, 2963, 2853, 1739, 1568, 1500, 1431, 1318, 1261, 
1207, 1117 cm
-1
; δH: 1.30 (3H, t, J = 7.14, OCH2CH3), 2.74 [2H, m, N(CHax)2], 2.96 [2H, 
m, N(CHeq)2], 3.76 [4H, t, J = 4.78, O(CH2)2], 4.32 (2H, q, J = 7.13, OCH2CH3), 6.17 (1H, 
s, NCHON), 7.15 (2H, m, ArH), 7.24 (1H, m, ArH), 7.35 (2H, m, ArH). δC: 13.9 
(OCH2CH3), 44.8 [N(CH2)2], 62.8 (OCH2CH3), 66.8 [O(CH2)2], 109.6 (NCHON), 122.7 
and 129.2 (2 x ArCH), 126.3 (p-ArC), 138.6 (ipso C of Ar), 146.7 (C3 of oxadiazoline), 
157.2 (C=O). HRMS (ESI
+






Ethylchloroglyoxalate oxime (0.99 g, 6.51 mmol) in ether (20 mL) was added dropwise via 
a pressure-equalising addition funnel to a cooled (<10 
o
C water/ice bath), stirring solution 
of N-(N-phenylformimidoyl)-morpholine (1.24 g, 6.51 mmol) and triethylamine (0.66 g, 
6.52 mmol) in ether (35 mL). The white cloudy mixture which resulted was warmed to 
room temperature and stirred for 1 h. The mixture was filtered to remove the precipitate 
and the solvent was removed in vacuo (without heat) to yield a white solid. The sample 
was dried under high vacuum for 1 h. Recrystallisation from chloroform and hexane 
yielded the oxadiazoline (0.1 g, 56%) as a white crystalline solid, m.p. 105-106 
o
C. δH: 
1.30 (3H, t, J = 7.14, OCH2CH3), 2.73 [2H, m, N(CHax)2], 2.96 [2H, m, N(CHeq)2], 3.76 
[4H, t, J = 4.77, O(CH2)2], 4.32 [2H, q, J = 7.13, OCH2CH3], 6.17 (NCHON), 7.14 (2H, m, 
ArH), 7.25 (1H, m, ArH), 7.36 (2H, m, ArH); δC: 13.9 (OCH2CH3), 44.7 [N(CH2)2], 62.8 
(OCH2CH3), 66.8 [O(CH2)2], 109.6 (NCHON), 122.7, 126.3 and 129.2 (3 x ArCH), 138.5 





exact mass calculated for C15H19N3O4 [(M+H)
+
], 306.1454, found 306.1449. 
Method 3: NMR spectroscopy tube reaction 
Ethylchloroglyoxalate oxime (10.70 mg, 0.07 mmol) was combined with 0.07 M 
triethylamine solution (1 mL, CDCl3) and the solution was mixed briskly. A 0.6 mL 
portion of this solution was transferred to an NMR spectroscopy tube and 
1
H NMR 
spectroscopic analysis was carried out. The contents of the NMR spectroscopy tube poured 
into the sample vial and its entire contents were combined with N-(N-phenylformimidoyl)-
morpholine (13.40 mg, 0.07 mmol). The resulting solution was mixed briskly, a 0.6 mL 
portion of this solution was transferred to an NMR spectroscopy tube and the 
1
H NMR 
analysed immediately. Subsequent NMR spectroscopic analysis was carried out to monitor 
the reaction over time. The 
1
H NMR spectroscopic data showed that the nitrile oxide 
dimerised prior to the addition of the amidine. The subsequent NMR spectra showed that 
3,4-diethoxycarbonylfuroxan (315) and N-(N-phenylformimidoyl)-morpholine (341) were 





1-p-Toluenesulfonyl-1-bromoformaldoxime (1.81 g, 6.50 mmol) 
in ether (50 mL) was added dropwise via a pressure equalizing 
addition funnel to a cooled (<10 
o
C, water/icebath), stirring 
solution of N-(N´-phenylformimidoyl)-morpholine (1.24 g, 6.52 
mmol) and triethylamine (0.66 g, 6.49 mmol) in ether (50 mL). 
On addition, a pale yellow precipitate formed and the mixture 
was stirred for 5 min. Water (50 mL) was added to dissolve the 
precipitate. The biphasic solution was separated and the organic phase was washed with 
water (3 x 50 mL). The combined aqueous phase was washed with ether (1 x 50 mL). The 
combined organic extracts were dried, filtered and the solvent removed in vacuo to yield 
the crude oxadiazoline (2.08 g, 83%) as a pale yellow solid. δH: 2.43 (3H, s, ArCH3), 2.56 
[2H, m, N(CHax)2], 2.68 [2H, m, N(CHeq)2], 3.62 [4H, t, J = 4.77, O(CH2)2], 6.15 (1H, s, 




Method 2: NMR spectroscopy tube reaction 
1-p-Toluenesulfonyl-1-bromoformaldoxime (19.50 mg, 0.07 mmol) combined with 0.07 M 
triethylamine solution (1 mL, CDCl3) and 0.6 mL of solution transferred to an NMR 
spectroscopy tube and 
1
H NMR spectroscopic analysis was carried out. δH: 2.50 (3.15H, m, 
ArCH3 309 & 307), 7.18 (0.16H, m, ArH 307 & 309), 7.44 (1.36H, m, ArH 307 & 309), 
7.51 (0.18H, m, ArH 307 & 309), 7.76 (0.21H, m, ArH 307 & 309), 7.88 (0.48H, m, ArH 
307 & 309), 7.96 (0.17H, m, ArH 307 & 309), 8.03 (1H, m, ArH 307 & 309). The NMR 
spectroscopy tube contents were combined with the remainder of the original sample and 
then in turn combined with N-(N´-phenylformimidoyl)-morpholine (13.60 mg, 0.07 mmol). 
The solution was mixed briskly and a 0.6 mL portion was transferred to and NMR 
spectroscopy tube and 
1
H NMR spectroscopic analysis was carried out. δH: 2.50 (2.40H, m, 
2 x ArCH3 309), 3.54 [4H, bs, N(CH2)2 341], 3.75 [4.22H, m, O(CH2)2 341], 6.98 (2H, m, 
ArH 341), 7.03 (1H, m, ArH 341), 7.18 (0.225H, m, ArH 309), 7.27 (2.35H, m, ArH 309 
& 341), 7.44 (1.383H, m, ArH 309), 7.51 (0.16H, m, 309), 7.56 (1H, s, CH=N 341), 7.76 
(0.238H, m, 309), 7.88 (0.43H, m, 309), 7.96 (0.167H, m, 309), 8.03 (0.954H, m, 309). 
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Ratio of 3,4-bis-(p-toluenesulfonyl)-furoxan (309) : N-(N´-phenylformimidoyl)-
morpholine (341) (29 : 71).  
Method 3 
A solution of 1-p-toluenesulfonyl-1-bromoformaldoxime (0.90 g, 3.25 mmol) in ether (10 
mL) was added dropwise via a pressure equalizing addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-(N´-phenylformimidoyl)-morpholine (0.62 g, 3.25 
mmol) and triethylamine (0.46 mL, 3.30 mmol) in ether (15 mL). Following addition, the 
solution was warmed to room temperature and stirred for 1 h. The solution was filtered and 
the solvent was removed in vacuo (without heat) to yield crude oxadiazoline as a yellow 
oil, (0.705 g). The residue was dissolved in chloroform and hexane was added. The 
solution was placed in a freezer and a mixture containing the oxadiazoline (55 mg, 4%) 
was isolated by vacuum filtration as an orange solid. δH: 2.43 (3.45H, s, ArCH3 401), 2.55 
[2H, m, N(CHax)2 401], 2.67 [2H, m, N(CHeq)2 401], 3.54 [4.9H, m, N(CH2)2 341], 3.61 
[4.9H, m, O(CH2)2 401], 3.72 [7.27H, m, O(CH2)2 341], 6.14 (1H, s, NCHON 401), 7.03 
(5.25H, m, ArH 341), 7.26 (8H, m, ArH 341 & 401), 7.36 (3.8H, m, ArH 401), 7.60 (1.8H, 
s, N=CH 341), 7.65 (2H, m, ArH 401). Ratio oxadiazoline (401) : N-(N´-





A solution of 1-p-toluenesulfonyl-1-bromoformaldoxime (0.90 g, 3.25 mmol) in ether (20 
mL) was added dropwise via a pressure equalizing addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-(N´-phenylformimidoyl)-morpholine (0.62 g, 3.25 
mmol) and triethylamine (0.46 mL, 3.30 mmol) in ether (15 mL). The pale yellow cloudy 
mixture which resulted was warmed to room temperature and stirred for 32 min. The 
solution was filtered and the solvent was removed in vacuo (without heat). The residue was 
recrystallised from cold ethyl acetate:hexane and a mixture containing the oxadiazoline 
(528.00 mg, 42%) was isolated by vacuum filtration as a pale yellow solid, m.p. 70-72 
o
C, 
νmax (KBr): 3067, 2966, 2916, 1734, 1595, 1553, 1496, 1376, 1327, 1154, 1116, 1039 cm
-1
; 
δH: 2.46 (3H, s, PhCH3), 2.58 [2H, m, N(CHax)2], 2.71 [2H, m, N(CHeq)2], 3.64 [4H, t, J = 
4.78, O(CH2)2], 6.16 (1H, s, NCHON), 7.35 (7H, m, ArH), 7.69 (2H, m, ArH); δC: 21.9 
(ArCH3), 44.7 [N(CH2)2], 66.6 [O(CH2)2], 111.1 (NCHON), 126.3, 128.1, 129.2, 129.3 and 
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129.9 (5 x ArCH), 129.4 [p-ArC(CH3)], 135.1 and 136.6 (2 x ipso C of Ar), 146.4 (C=N). 
m/z = 388 (M+H)
+
 401. 
8.1.3.11 3-Cyano-4-phenyl-5-(4’-morpholino)-Δ2-1,2,4-oxadiazoline 402 
A solution of cyanoformohydroximoyl chloride (0.21 g, 2.00 
mmol) in ether (6 ml) was added dropwise via a pressure 
equalizing addition funnel to a cooled (<10
o
C, water/ice bath), 
stirring solution of N-(N´-phenylformimidoyl)-morpholine (0.38 
g, 2.00 mmol) and triethylamine (0.28 ml, 2.01 mmol) in ether 
(11 mL). The resulting orange cloudy mixture was warmed to room temperature and stirred 
for 10 min. The mixture was filtered to remove the precipitate and the solvent was 
evaporated in vacuo (without heat) to yield the crude oxadiazoline as a pale orange oil. 
Recrystallisation from cold ether-hexane afforded a mixture of the oxadiazoline and 
amidine as a yellow solid. m.p. 59-63 
o
C. νmax (film): 3059, 2964, 2916, 2855, 2248 
(weak), 1694, 1630, 1587, 1550, 1500, 1421, 1164, 1115cm
-1
; δH: 2.76 [2H, m, N(CHax)2], 
2.89 [2H, m, N(CHeq)2], 3.52 (4H, bs, N(CH2)2 341), 3.74 [8H, m, O(CH2)2 402 and 341], 
6.38 (1H, s, NCHON), 6.96 (1.86H, m, ArH 341), 7.03 (1H, m, ArH 341), 7.30 (5.88H, m, 
ArH inc. 2H, m, 341), 7.43 (2.16H, m, ArH 341), 7.52 (1.1H, s, N=CH 341); δC: 44.79 
[N(CH2)2], 45.98 [N(CH2)2 341], 66.49 [O(CH2)2], 66.70 [O(CH2)2 341],  107.55 (CN), 
108.83 (NCHON), 121.09, 122.92 and 129.05 (3 x ArCH 341), 121.58 and 129.84 (2 x 
ArCH), 127.01 (p-ArCH), 132.17 (ipso C of Ar 341), 135.7 (ipso C of Ar), 151.45 (C=N), 
152.3 (N=CH 341). HRMS (ESI
+
) exact mass calculated for C13H14N4O2 [(M+H)
+
], 
259.1195, found 259.1189. 
8.1.4 Reactions of N-phenylformimidoylpiperidine with p-
nitrobenzohydroximoyl chloride  
8.1.4.1 Attempted preparation of 3-(p-nitrophenyl)-4-phenyl-5-piperidino-Δ2-
1,2,4-oxadiazoline 404 
Method 1 
A solution of p-nitrobenzohydroximoyl chloride (0.65 g, 
3.25 mmol) in ether (10 mL) was added dropwise via a 
pressure equalizing addition funnel to a cooled (<10 
o
C, 
water/ice bath), stirring solution of N-(N´-
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phenylformimidoyl)-piperidine (0.61 g, 3.25 mmol) and triethylamine (0.46 mL, 3.30 
mmol) in ether (15 mL). The resulting cloudy mixture was warmed to room temperature 
and stirred for 10 min. The mixture was filtered with the aid of ether (10 mL) and the 
solvent was evaporated in vacuo (without heat) to yield a bright yellow solid/oil, (0.71 g, 
62%). An attempt at crystallisation on the compound from chloroform and hexane was 
unsuccessful at room temperature so the mixture was transferred to a freezer. The 
recrystallised oxadiazoline (84.00 mg, 7%) was isolated by vacuum filtration as a yellow 
solid. The compound was dried under high vacuum, but had decomposed prior to full 
characterization being carried out. Decomposition products purified by column 
chromatography: Gradient eluent used, Ethyl acetate:hexane (10-80%).  
F14-20: pale yellow solid isolated, 9 mg, δH: 3.48 (5H, m, piperidine ring), 3.74 (5H, m, 
piperidine ring), 6.37 (1H, bs, NH), 7.07 (1H, m, ArH), 7.34 (4H, m, ArH).  MS = no 
diagnostic molecular ions. 
F26-28: yellow solid isolated, 5.6 mg, δH: 8.01 (2H, d, J = 8.95, ArH), 8.32 (2H, d, J = 
8.94, ArH). m/z = no diagnostic molecular ions. 
Method 2 
A solution of p-nitrobenzohydroximoyl chloride (1.00 g, 5.00 mmol) in ether (15.5 mL) 
was added dropwise via a pressure equalizing addition funnel to a cooled (<10 
o
C, 
water/ice bath), stirring solution of N-(N´-phenylformimidoyl)-piperidine (0.94 g, 5.00 
mmol) and triethylamine (0.7 mL, 5.02 mmol) in ether (23 mL). The resulting yellow 
cloudy mixture was warmed to room temperature and stirred for 1 h. The mixture was 
filtered and the solution was evaporated in vacuo (without heat) to yield a pale yellow 
solid. δH: 1.57 (9.64H, m, CH2 404 & 337], 1.83 [3.10H, m, CH2 404], 2.72 [2.03H, m, 
CH2 404], 2.93 [1.97H, m, CH2 404], 3.12 [2.20H, m, CH2 404], 3.50 [1.75H, m, CH2 
337], 6.20 (1H, s, NCHON 404), 6.45 (0.40H, bs, NH 337), 7.03 (2.40H, m, ArH 404 & 
337), 7.18 (1.54H, m, ArH 404), 7.26 (3.54H, m, ArH 404 & 337), 7.38 (2.18H, m, ArH 
404 & 337), 7.54 (1.30H, m, ArH 404), 7.71 (2.89H, m, ArH 404 & 265), 7.90 (1.92H, m, 
ArH 337), 8.02 (1.73H, m, ArH 404), 8.21 (4.33H, m, ArH 404), 8.31 (1.54H, m, ArH 
265), 8.37 (1.86H, m, ArH 378). The compound was recrystallised from ethyl acetate: cold 
distilled hexane and recrystallisation was aided by placing the solution in a freezer 
overnight. A mixture was isolated by vacuum filtration as a yellow solid (131.00 mg, 7%). 
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The recrystallisation product showed a mixture of p-nitrobenzonitrile (378) and N-phenyl-
1-piperidine carboxamide (337) only, the oxadiazoline (404) was not isolated.  
Method 3: NMR spectroscopy tube reaction  
0.07 M Triethylamine solution (1 mL, CDCl3) was added to a sample vial containing p-
nitrobenzohydroximoyl chloride (14.00 mg, 0.07 mmol) and the solution mixed. A 0.7 mL 
portion of this solution was transferred to an NMR spectroscopy tube and 
1
H NMR 
spectroscopic analysis was carried out. Once complete, the mixture was recombined with 
the remaining solution and the entire contents were transferred to a sample vial containing 
N-(N´-phenylformimidoyl)-piperidine (13.20 mg, 0.07 mmol) and solution mixed briskly 
until homogenous and a 0.7 mL portion of this solution was transferred to an NMR 
spectroscopy tube and 
1
H NMR spectroscopic analysis was carried out immediately. The 
1
H NMR spectrum obtained immediately after the addition of amidine to nitrile oxide 
showed that the oxadiazoline formed. Subsequent 
1
H NMR spectroscopic data illustrates 
that decomposition had occurred 20 h later.  
8.1.5 Reactions of N-p-chlorophenylformimidoylmorpholine with p-




p-Nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) in 
ether (10 mL) was added dropwise via pressure-equalising 
addition funnel to a cooled (<10 
o
C, water/icebath), stirring 
solution of N-(N´-p-chlorophenylformimidoyl)-morpholine 
(0.73 g, 3.25 mmol) and triethylamine (0.46 mL, 3.30 
mmol) in ether (15 mL). The resulting solution was warmed 
to room temperature and stirred for 10 min. The solution was filtered and the solvent was 
removed in vacuo (without heat) to yield a yellow solid with a yellow liquid, (0.35 g). An 
attempt to crystallise the compound from chloroform:hexane was unsuccessful, so the 
compound was placed in a freezer. The oxadiazoline (41.00 mg, 3%) was isolated by 
vacuum filtration as a pale yellow crystalline solid, m.p. 123-147 
o
C, (Found: C, 54.74; H, 
4.41; N, 14.09 C18H17ClN4O4 requires C, 55.60; H,4.41; N,14.41%), νmax (KBr): 3072, 
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1582, 1566, 1519, 1489, 1349, 1256, 1120, 786 cm
-1
; δH : 2.78 [2H, m, N(CHax)2], 2.95 
[2H, m, N(CHeq)2], 3.79 [4H, t, J = 4.62, O(CH2)2], 6.15 (1H, s, NCHON), 6.99 (2H, d, J = 
8.52, m-ArH on C3), 7.24 (2H, d, J = 8.46, o-ArH on C3), 7.68 (2H, d, J = 8.58, m-ArH on 
N4), 8.20 (2H, d, J = 8.58, o-ArH on N4); δC: 44.98 [N(CH2)2], 66.80 [O(CH2)2], 109.32 
(NCHON), 124.07 (o-ArCH on C3), 124.36 (m-ArCH on N4), 128.52 (m-ArCH on C3), 
129.55 (o-ArCH on N4), 131.14 [p-ArC(NO2)], 131.78 [p-ArC(Cl)], 148.86 (ipso C of Ar 




) exact mass 
calculated for C18H17N4O4Cl [M+H]
+
 389.1017, found 389.1003. 
Method 2 
p-Nitrobenzohydroximoyl chloride (1.30 g, 6.50 mmol) in ether (20 mL) was added 
dropwise via pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath), 
stirring solution of N-(N´-p-chlorophenylformimidoyl)-morpholine (1.46 g, 6.50 mmol) 
and triethylamine (0.91 mL, 6.53 mmol) in ether (30 mL). Following addition, the solution 
was warmed to room temperature and stirred for 2 h 10 min. The mixture was filtered to 
remove the precipitate and the solvent was removed in vacuo to yield an orange oil. The 
oxadiazoline (0.10 g, 4%) was recrystallised from chloroform:hexane and isolated by 
vacuum filtration as an orange crystalline solid. δH: 2.78 [2H, m, N(CHax)2], 2.95 [2H, m, 
N(CHeq)2], 3.79 [4H, t, J = 4.75, O(CH2)2], 6.15 (1H, s, NCHON), 6.99 (2H, m, ArH), 7.24 
(2H, m, ArH), 7.68 (2H, m, ArH), 8.20 (2H, m, ArH). m/z = 241 (M+H)
+
 4-(4-




Method 3: NMR spectroscopy tube reaction 
Triethylamine solution (1 mL, 0.07 M solution in CDCl3) was added to p-
nitrobenzohydroximoyl chloride (14.00 mg, 0.07 mmol) and the solution was briskly 
mixed and a 0.6 mL portion was transferred to an NMR spectroscopy tube and 
1
H NMR 
spectroscopic analysis carried out immediately. The contents of the NMR spectroscopy 
tube were combined with the remaining 0.4 mL of solution and the entire (1 mL) of 
solution was transferred to sample vial containing N-(N´-p-chlorophenylformimidoyl)-
morpholine (15.70 mg, 0.07 mmol). This solution was mixed briskly and a 0.6 mL portion 
was transferred to an NMR spectroscopy tube and 
1
H NMR spectroscopic analysis was 
carried out immediately. Exp 11 took place 9 min after nitrile oxide check: δH: 2.78 [2H, 
bm, N(CHax)2 405], 2.95 [2H, bm, O(CHeq)2 405], 3.51 [1.26H, bs, N(CH2)2 345], 3.75 
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[1.58H, m, O(CH2)2 345], 3.80 [4H, t, J = 4.73, O(CH2)2 405], 6.16 (1H, s, NCHON 405), 
6.89 (0.65H, m, ArH 345), 6.99 (2H, m, ArH 405), 7.24 (3H, m, ArH 405 & 345), 7.51 
(0.41H, s, N=CH 345), 7.71 (2.48H, m, ArH 405, 265 & 345), 8.21 (2H, m, ArH 405), 
8.30 (0.61H, m, ArH 265). 
Exp 12 took place 1 h 6 min after exp 11: δH: 2.78 [2H, bm, N(CHax)2 405], 2.95 [2.11H, 
m, N(CHeq)2 405], 3.51 [0.50H, bs, N(CH2)2 345], 3.75 [0.75H, m, O(CH2)2 345], 3.83 
[3.91H, t, J = 4.73, O(CH2)2 405], 6.16 (1H, s, NCHON 405), 6.88 (0.25H, m, ArH 345), 
6.99 (2H, m, ArH 405), 7.24 (2.55H, m, ArH 405 & 345), 7.51 (0.17H, s, N=CH 345), 
7.69 (2H, m, ArH 405), 8.21 (2H, m, ArH 405). 
Exp 13 took place 4 h 36 min after exp 11: δH: 2.78 [2H, bm, N(CHax)2 405], 2.95 [2.11H, 
m, N(CHeq)2 405], 3.51 [0.50H, bs, N(CH2)2 345], 3.74 [0.68H, m, O(CH2)2 345], 3.80 
[4H, t, J = 4.73, O(CH2)2 405], 6.16 (1H, s, NCHON 405), 6.88 (0.25H, m, ArH 345), 6.99 
(2H, m, ArH 405), 7.24 (2.54H, m, ArH 405 & 345), 7.51 (0.15H, s, N=CH 345), 7.69 
(2H, m, ArH 405), 8.20 (2.19H, m, ArH 405). 
8.2 1,3-Dipolar cycloaddition reactions with benzamidines 




A solution of p-nitrobenzohydroximoyl chloride (0.65 
g, 3.25 mmol) in ether (10 mL) was added dropwise 
via pressure-equalising addition funnel to a cooled 
(<10 
o
C, water/icebath), stirring solution of N-(N´-
phenylbenzimidoyl)-morpholine (0.87 g, 3.25 mmol) 
and triethylamine (0.46 mL, 3.30 mmol) in ether (15 
mL). Following addition, the solution was warmed to room temperature and stirred for 1 h. 
The resulting solution was filtered and the solvent was removed in vacuo (without heat) to 
yield the crude oxadiazoline as a pale orange solid (0.266 g). This sample was 
recrystallised from chloroform:hexane and the resulting solution was placed in a freezer to 
aid crystallisation. The oxadiazoline (96.00 mg, 7%) was isolated by vacuum filtration as a 
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bright yellow crystalline solid, m.p. 180-181 
o
C, (Found: C, 63.60; H, 4.94; N, 10.94 
C24H22N4O4 requires C, 66.97; H, 5.15; N, 13.02 %), νmax (KBr): 3064, 1598, 1572, 1522, 
1494, 1350 cm
-1
; δH: 2.85 [2H, m, N(CHax)2], 3.17 [2H, m, N(CHeq)2], 3.86 [4H, m, 
O(CH2)2], 6.73 (2H, m, o-ArH on C5), 7.07 (3H, m, m-ArH and p-ArH on C5), 7.15 (3H, 
m, m-ArH and p-ArH on N4), 7.38 (2H, m, o-ArH on N4), 7.56 (2H, m, o-ArH on C3), 8.08 
(2H, m, m-ArH on C3); δC: 45.87 [N(CH2)2], 67.01 [O(CH2)2], 115.09 (C5 of oxadiazoline 
ring), 123.59 (m-ArCH at C3), 127.16 (p-ArCH at C5), 127.58 (o-ArCH at C5), 127.73 (o-
ArCH at N4), 127.89 (p-ArCH on N4), 128.72 (o-ArCH on C3), 128.95 (p-ArCH at N4 and 
m-ArCH at C5), 131.97 [ArC(NO2)], 135.11 (ipso C of Ar at N4), 136.94 (ipso C of Ar at 





) exact mass calculated for C24H22N4O4 [M+H]
+
 431.1719, found 
431.1722. 
Method 2: NMR spectroscopy tube reaction 
1 mL of 0.07 M triethylamine solution in CDCl3 was added to solid p-
nitrobenzohydroximoyl chloride (14.10 mg, 0.07 mmol) and a 0.6 mL portion of this 
solution was transferred to an NMR spectroscopy tube and 
1
H NMR spectroscopic analysis 
was carried out. The NMR spectroscopy tube contents were returned to the sample vial and 
were combined with N-(N´-phenylbenzimidoyl)-morpholine (349) (18.90 mg, 0.07 mmol). 
A 0.6 mL portion of this solution was transferred to an NMR spectroscopy tube and 
1
H 
NMR spectroscopic analysis was carried out. This sample was monitored over time by 
1
H 
NMR spectroscopy. δH: 2.85 [2H, m, N(CHax)2 406], 3.17 [2H, m, N(CHeq)2 406], 3.41 
[0.73H, bs, N(CH2)2 349], 3.74 [0.88H, m, O(CH2)2 349], 3.86 [4H, m, O(CH2)2 406], 6.56 
(2H, m, ArH 349) 6.72 (2.1H, m, ArH 406 & 349), 7.00 (0.4H, m, ArH 349), 7.09 (3H, m, 
ArH 406), 7.14 (3.17H, m, ArH 406 & 349), 7.23 (0.67H, m, ArH 349), 7.38 (2H, m, ArH 





8.2.1.2 Attempted preparation of 3-bromo-4,5-diphenyl-5’-(4’-morpholino)-Δ2-
1,2,4-oxadiazoline 407 
Method 1 
Dibromoformaldoxime (0.20 g, 1.01 mmol) in ether (5 mL) 
was added dropwise via Pasteur pipette to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-(N´-phenylbenzimidoyl)-
morpholine (0.27 g, 1.01 mmol) and triethylamine (0.11 g, 
1.06 mmol) in ether (10 mL). The clear solution became 
yellow and then orange during addition. The solution was warmed to room temperature, 
stirred for 10 min and was filtered. The solvent was removed in vacuo (without heat) to 
yield an orange/brown oil with solid (0.233 g, 56%). νmax (film): 3060, 2221, 1614, 1494, 
1434, 1278, 1258, 1115, 1068, 1020 cm
-1
; δH: 3.76 (8H, bm, N(CH2)2 and O(CH2)2 322 & 
?), 6.91 (1.89H, m, ArH), 7.05 (2.05H, m, ArH), 7.33 (7.16H, m, ArH 322 & ?). m/z = 267 
(100%, (M+H)
+
 349), 192 (M+H)
+
 322. The crude reaction product was purified by 
column chromatography on silica gel using ethyl acetate: hexane as eluents. Initially, 20 : 
80 ethyl acetate : hexane used, which was gradually increased as separation continued to 
60:40 ethyl acetate : hexane. Two separate fractions were isolated. The first of which 
correlated to a mixture of predominantly N-(N´-phenylbenzimidoyl)-morpholine (349) and 
a small quantity of N-benzoylmorpholine (322). This sample was analysed by 
1
H NMR 
spectroscopy, δH: 3.42 (4.47H, bs, N(CH2)2 349 & 322), 3.75 (5.13H, bt, J = 4.70, O(CH2)2 
349 & 322), 6.42 (0.31H, m, ArH), 6.56 (1.92H, m, ArH 349), 6.75 (1H, m, ArH 349), 
7.00 (2.14H, m, ArH 349), 7.12 (2.67H, m, ArH 349), 7.23 (3.29 H, m, ArH 349), 7.42 
(1.87H, m, ArH 322). The ratio of N-(N´-phenylbenzimidoyl)-morpholine (349) : N-
benzoylmorpholine (322) was 73 : 27. m/z = 347, 345, 267 (M+H)
+
 100% 349. The second 
fraction which was analysed by 
1
H NMR spectroscopy, δH: 3.59 [74.96H, bm, N(CH2)2 and 
O(CH2)2 322 & 349], 6.42 (0.60H, m, ArH), 6.56 (1.88H, m, ArH 349), 6.75 (1H, m, ArH 
349), 7.00 (2.07H, m, ArH 349), 7.11 (3.40H, m, ArH 349), 7.23 (3.50H, m, ArH 349), 
7.41 (33.36H, m, ArH 322). The ratio of N-(N´-phenylbenzimidoyl)-morpholine (349) : N-
benzoylmorpholine (322) was 13 : 87. m/z = 383 (2M+H)
+
 N-benzoylmorpholine (322), 
347, 345, 267 (M+H)
+
 (100%) N-(N´-phenylbenzimidoyl)-morpholine (349). 
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Method 2 
Dibromoformaldoxime (0.21 g, 1.03 mmol) in ether (5 mL) was added dropwise via 
Pasteur pipette to a cooled (<10 
o
C, water/icebath), stirring suspension of N-(N´-
phenylbenzimidoyl)-morpholine (0.27 g, 0.99 mmol) and potassium t-butoxide (0.12 g, 
1.03 mmol) in ether (10 mL). The mixture became orange in colour during addition. The 
mixture was warmed to room temperature, stirred for 10 min and filtered. The solvent was 
removed in vacuo (without heat). An orange solid residue and pale brown oily residue 
resulted (0.2388 g), νmax (film): 3061, 2238, 1614, 1488, 1434, 1276, 1115 cm
-1
; δH: 3.79 
[10.44H, bm, N(CH2)2 and O(CH2)2 322 & ?], 6.94 (0.34H, m, ArH), 7.10 (4,25H, m, 
ArH), 7.31 (2.51H, m, ArH), 7.37 (1.26H, m, ArH), 7.41 (5H, m, ArH 322). m/z = 192 
[M+H]
+
 322. The crude reaction product was purified by column chromatography on silica 
gel using ethyl acetate and hexane as eluents. Initially, 10:90 ethyl acetate : hexane used, 
which was gradually increased as separation continued to 100% ethyl acetate. The 
fractions correlating to N-benzoylmorpholine (322) (F25-32) were combined. νmax (film): 
3059, 1629, 1431, 1278, 1259, 1114 cm
-1
; δH: 3.59 [8H, m, N(CH2)2 and O(CH2)2 ], 7.50 
(5H, m, ArH); δC: 42.5 [N(CH2)2], 66.9 [O(CH2)2], 127.1, 128.6 and 129.9 (3 x ArCH), 
135.4 (ipso C of Ar), 170.4 (C=O). m/z = 383 [(2M+H)
+
 100% N-benzoylmorpholine 
(322)].  
Method 3 
Dibromoformaldoxime (1.32 g, 6.50 mmol) in ether (20 mL) was added dropwise via 
pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring solution of 
N-(N’-phenylbenzimidoyl)-morpholine (1.73g, 6.50 mmol) and triethylamine (0.66 g, 6.51 
mmol) in ether (30 mL). The solution was filtered and solvent removed in vacuo (without 
heat) (1.79 g, 71%). νmax (film): 3060, 2221, 1621, 1589, 1445, 1434, 1278, 1257, 1114 cm
-
1
; δH: 3.65 [12.11H, bm, N(CH2)2 and O(CH2)2 322 & ?], 6.75 (2H, m, ArH ?), 6.85 
(1.05H, m, ArH ?), 6.91  (0.21H, m, ArH ?), 7.03 (2.93H, m, ArH ?), 7.18 (2.15H, m, ArH 
?), 7.28 (4.08H, m, ArH ?), 7.36 (0.34H, m, ArH ?), 7.42 (3.29H, m, ArH 322). m/z = 383 
[(2M+H)
+
 N-benzoylmorpholine (322)] 
Method 4 
Dibromoformaldoxime (1.32 g, 6.50 mmol) in ether (20 mL) was added dropwise via 
pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring suspension 
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of N-(N’-phenylbenzimidoyl)-morpholine (1.74 g, 6.51 mmol) and potassium t-butoxide 
(0.73 g, 6.51 mmol) in ether (30 mL). The mixture was filtered and the solvent was 
removed in vacuo (without heat) (1.88 g, 74%). νmax (film): 3061, 2237, 1614, 1494, 1445, 
1276, 1116 cm
-1
; δH: 3.72 [11.10H, bm, N(CH2)2 and O(CH2)2 322 & ?], 7.05 (5.39H, m, 




8.2.2 Reactions with N-(N’-phenylbenzimidoyl)-piperidine  
8.2.2.1 Attempted preparation of 3-bromo-4,5-diphenyl-5’-(N-piperidino)-Δ2-
1,2,4-oxadiazoline 416 
Method 1 
Dibromoformaldoxime (1.32 g, 6.51 mmol) in ether (20 mL) 
was added dropwise via pressure-equalising addition funnel to 
a cooled (<10 
o
C, water/icebath), stirring solution of N-(N’-
phenylbenzimidoyl)-piperidine (1.73 g, 6.54 mmol) and 
triethylamine (0.66 g, 6.50 mmol) in ether (30 mL). The 
solution was warmed to room temperature and stirred for ten min. The cloudy mixture was 
filtered and the solvent was removed in vacuo (without heat) to yield a brown oil (0.48 g, 




H NMR spectroscopicc 
analysis indicated that N-benzoylpiperidine (324) was isolated. δH: 1.52 (2.03H, bs, CH2 
324), 1.68 (3.89H, bs, CH2 324 & ?), 1.79 (1.73H, bs, ?), 3.35(1.91H, bs, CH2 324), 3.72 
(1.97H, bs, CH2 324), 6.91 (0.28H, m, ArH ?), 7.04 (2.77H, m, ArH ?), 7.31 (2.99H, m, 





Dibromoformaldoxime (1.3 g, 6.48 mmol) in ether (20 mL) was added dropwise via 
pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring suspension 
of N-(N’-phenylbenzimidoyl)-piperidine (1.73 g, 6.53 mmol) and potassium t-butoxide 
(0.73 g, 6.50 mmol) in ether (30 mL). On completion of addition, the brown/orange cloudy 
mixture was warmed to room temperature, stirred for ten min and was filtered. The solvent 
was removed in vacuo (without heat) to yield a brown oil (0.46 g, 18%). νmax (film): 3060, 




H NMR spectroscopicc analysis indicated that 
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N-benzoylpiperidine (324) was isolated. δH: 1.52 (2.35H, bs, CH2 324), 1.68 (3.96H, CH2 
324 & ?), 1.79 (1.33H, bs, ?), 3.34 (1.96H, bs, CH2 324), 6.90 (0.36H, m, ArH ?), 7.04 
(2.79H, m, ArH ?), 7.30 (1.38H, m, ArH ?), 7.38 (5H, m, ArH 324); m/z = 265 (M+H)
+
 
(100%) N-(N’-phenylbenzimidoyl)-piperidine (350). 
8.2.3 Reactions with N-(p-chlorophenyl)-benzimidoylmorpholine  
8.2.3.1 Attempted preparation of 3-bromo-4-(p-chlorophenyl)-5-phenyl-5’-(N-
morpholino)-Δ2-1,2,4-oxadiazoline 417 
Method 1 
Dibromoformaldoxime (1.32 g, 6.52 mmol) in ether (20 
mL) was added dropwise via pressure-equalising 
addition funnel to a cooled (<10 
o
C, water/icebath), 
stirring solution of N-(N’-p-chlorophenyl)-
benzimidoylmorpholine (1.96 g, 6.5 mmol) and 
triethylamine (0.66 g, 6.50 mmol) in ether (30 mL). On completion of addition, the 
solution was warmed to room temperature and stirred for ten min. The cloudy mixture was 
filtered and the solvent was removed in vacuo (without heat) (2.10 g, 76%), νmax (film): 




H NMR spectroscopicc analysis 
indicated that N-benzoylmorpholine (322) was isolated. δH: 3.65 (19.28H, m, ArH 322 & 
?), 6.71 (3.93H, m, ArH), 6.98 (4.63H, m, ArH), 7.21 (4.81H, m, ArH), 7.33 (6.01H, m, 





Dibromoformaldoxime (1.32 g, 6.51 mmol) in ether (20 mL) was added dropwise via 
pressure-equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring suspension 
of N-(N’-p-chlorophenyl)-benzimidoylmorpholine (1.96 g, 6.51 mmol) and potassium t-
butoxide (0.73 g, 6.50 mmol) in ether (30 mL). On completion of addition, the mixture was 
warmed to room temperature, stirred for ten min and was filtered. The solvent was 
removed in vacuo (without heat) (1.47 g, 53%). νmax (film): 3061, 2237, 1615, 1492, 1363, 




H NMR spectroscopicc analysis indicated that N-
benzoylmorpholine (322) was isolated δH: 3.74 [13.56H, bm, N(CH2)2 and O(CH2)2 322 & 
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?], 6.86 (2H, m, ArH), 6.96 (0.79H, m, ArH), 7.03 (2.06H, m, ArH), 7.23 (2.81H, m, ArH), 
7.38 (8.26H, m, ArH 322 & ?). m/z = 383 (2M+H)
+
 322, 301 (M+H)
+ 
100% 353. 
8.2.4 Reactions with N-phenyl-(p-chlorobenzimidoyl)-morpholine  
8.2.4.1 Attempted preparation of 3-bromo-4-phenyl-5-(p-chlorophenyl)-5’-(N-
morpholino)-Δ2-1,2,4-oxadiazoline 418 
Dibromoformaldoxime (1.32 g, 6.50 mmol) in ether (20 
mL) was added dropwise via pressure-equalising addition 
funnel to a cooled (<10 
o
C, water/icebath), stirring solution 
of N-phenyl-(p-chlorobenzimidoyl)-morpholine (1.96 g, 
6.51 mmol) and triethylamine (0.67 g, 6.58 mmol) in ether 
(30 mL). A precipitate formed immediately. This precipitate was isolated by gravity 
filtration and the solvent evaporated in vacuo from the resulting filtrate (without heat). νmax 




H NMR spectroscopicc analysis indicated that 
N-(p-chlorobenzoyl)-morpholine (327) was isolated δH: 3.45 (1.80H, bs), 3.72 [5.34H, bm, 
N(CH2)2 and O(CH2)2 327 and ?], 4.28 (0.68H, bs), 6.95 (0.26H, m, ArH), 7.04 (0.60H, m, 
ArH), 7.15 (1.94H, m, ArH), 7.28 (0.57H, m, ArH), 7.38 (4H, m, ArH 327).  
8.3 1,3-Dipolar cycloaddition reactions with other dipolarophiles 
8.3.1 1,3-Dipolar cycloaddition reactions with imines  
8.3.1.1 3-Phenyl-4-phenyl-5-phenyl-Δ2-1,2,4-oxadiazoline 419 
Benzohydroximoyl chloride (1.01 g, 6.52 mmol) in ether  (20 
mL) was added dropwise via a pressure equalising addition 
funnel to a cooled (<10 
o
C, water/icebath), stirring solution of 
N-benzylideneaniline (1.18 g, 6.51 mmol) and triethylamine 
(0.66 g, 6.55 mmol) in ether (20 mL). The resulting mixture 
was warmed to room temperature and stirred overnight. The mixture was filtered to 
remove the precipitate. Additional ether (10 mL) was used to rinse the flask. The solvent 
was removed in vacuo (without heat) and any residual solvent was removed under high 
vacuum. A mixture of the crude oxadiazoline (1.74 g, 89%) and N-benzylideneaniline 




, νmax (film): 3062, 3035, 
1701, 1669, 1593, 1497, 1457, 1446, 1395 cm
-1
; δH: 6.54 (1H, s, NCHON 419), 6.79 (2H, 
m, ArH 419), 7.16 (4.3H, m, ArH 419 & 346), 7.35 (3.6H, m, ArH 419 & 346), 7.45 
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(4.4H, ArH 419 & 346), 7.61 (4.3H, m, ArH 419 & 346), 7.91 (0.6H, m, ArH 346), 8.46 
(0.25H, m, N=CH 346). 
8.3.1.2 3-(p-Nitrophenyl)-4-phenyl-5-phenyl-Δ2-1,2,4-oxadiazoline 420 
Method 1 
p-Nitrobenzohydroximoyl chloride (1.31 g, 6.51 mmol) in 
ether (30 mL) was added dropwise via a pressure 
equalising addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-benzylideneaniline 
(1.18 g, 6.50 mmol) and triethylamine (0.66 g, 6.52 
mmol) in ether (40 mL). The mixture was warmed to 
room temperature and stirred for ten minutes. Water (30 mL) was added to dissolve the 
precipitate. The resulting biphasic solution was transferred to a separating funnel. As an 
emulsion was present, a further portion of ether (50 mL) was added to no avail. Water (120 
mL) was then added. A slight dissipation of emulsion occurred. The phases were separated 
with the emulsion being transferred to aqueous phase. The organic layer was washed with 
water (2 x 30 mL). The combined aqueous phases were washed with distilled 
dichloromethane (50 mL). The dichloromethane layer was combined with the ether layer 
and the overall combined organic extracts were dried, filtered and solvent was evaporated 
in vacuo. Recrystallisation from ethyl acetate:hexane (2:5) yielded the oxadiazoline (1.34 
g, 60%) as a green crystalline solid, m.p. 143-144 
o





(KBr): 3082, 1597, 1562, 1514, 1494, 1413, 1340 cm
-1
; δH: 6.55 (1H, s, NCHON), 6.81 
(2H, m, ArH), 7.18 (3H, m, ArH), 7.46 (3H, m, ArH), 7.58 (2H, m, ArH), 7.77 [2H, m, o-
ArH of p-NO2(Ar)], 8.19 [2H, m, m-ArH of p-NO2(Ar)]; δC: 101.4 (NCHON), 123.9, 
124.6, 126.5, 127.2, 128.8, 128.9, 129.6 and 130.1 (8 x ArCH), 131.8 [ArC(NO2)], 138.4 
(ipso C of Ar at C5 of oxadiazoline), 140.7 (ipso C of Ar at N4 of oxadiazoline), 148.9 
(ipso C of Ar at C3 of oxadiazoline), 153.8 [NC(p-NO2Ar)=N]; m/z = 346 (M+H)
+
, 100%. 
Method 2: NMR spectroscopy tube reaction 
0.07 M Triethylamine solution (1 mL) was added to p-nitrobenzohydroximoyl chloride 
(14.50 mg, 0.07 mmol) and 0.6 mL was analysed by proton NMR spectroscopic analysis. 
The contents of the NMR spectroscopy tube were returned to the sample vial. The entire (1 
mL) of solution was added to N-benzylidene aniline (12.70 mg, 0.07 mmol) and 0.6 mL of 
this solution was transferred to NMR spectroscopy tube and 
1
H NMR spectroscopy used to 
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monitor the reaction. A mixture of products resulted and N-benzylidene aniline (346), p-
nitrobenzonitrile-N-oxide (265) and oxadiazoline (420) were observed in a ratio of 42 : 38 : 
20. δH: 6.55 (1H, s, NCHON 420), 6.80 (2H, m, ArH 420), 7.22 (10H, ArH 420 & 346), 
7.40 (4.8H, m, ArH 346), 7.48 (9.6H, m, ArH 346 & 420), 7.58 (2H, m, ArH 346), 7.72 
(4H, m, ArH 265), 7.78 (2H, m, ArH 420), 7.91 (4H, m, ArH 346), 8.18 (2H, m, ArH 420), 
8.30 (4H, m, ArH 265), 8.47 (2.2H, s, N=CH 346).  
8.3.1.3 3-(m-Nitrophenyl)-4-phenyl-5-phenyl-Δ2-1,2,4-oxadiazoline 421 
Method 1 
m-Nitrobenzohydroximoyl chloride (1.31 g, 6.51 mmol) in ether 
(20 mL) was added dropwise via a pressure equalising addition 
funnel to a cooled (<10 
o
C, water/icebath), stirring solution of 
N-benzylideneaniline (1.18 g, 6.51 mmol) and triethylamine 
(0.66 g, 6.57 mmol) in ether (20 mL). A solid precipitated from 
the solution. On completion of addition, the solution was stirred 
overnight (16.25 h). The sample was filtered to remove the 
precipitate with the aid of ether (10 mL). The solvent was removed in vacuo and sample 
placed under high vacuum to remove any residual solvent. Recrystallisation from 
chloroform:hexane was unsuccessful and a mixture of products yielded a brown oil (0.89 
g, 40%). A mixture of products resulted and N-benzylidene aniline (346) and oxadiazoline 
(421) were observed in a ratio of 22 : 78. νmax (film): 3062, 1594, 1533, 1493, 1350 cm
-1
; 
δH: 6.56 (1H, s, NCHON 421), 6.83 (2H, m, ArH 421), 7.19 (4H, m, ArH 421 & 346), 7.39 
(0.58H, m, ArH 346), 7.46 (3.6H, m, ArH 421 & 346), 7.53 (1.44H, t, J = 8.05, ArH 421), 
7.59 (2.21H, m, ArH 421), 7.92 (1.63H, m, ArH 421 & 346), 8.24 (1.14H, m, ArH 421), 
8.45 (1H, m, ArH 421), 8.46 (0.28H, s, N=CH 346).  
Method 2 
A solution of m-nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) in distilled 
dichloromethane (10 mL) was added dropwise via a pressure equalising addition funnel to 
a cooled (<10 
o
C, water/icebath), stirring solution of N-benzylideneaniline (0.59 g, 3.27 
mmol) and triethylamine (0.46 mL, 3.30 mmol) in distilled dichloromethane (15 mL). The 
solution was warmed to room temperature and stirred for 10 min. Water (30 mL) was 
added and phases separated. Organic phase washed with water (1 x 20 mL). Organic phase 
dried, filtered and solvent evaporated in vacuo (without heat) to yield oxadiazoline (0.95 g, 
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85%) as a yellow liquid. νmax (film): 3385, 3087, 3064, 1670, 1594, 1530, 1494, 1392, 
1350, 1308 cm
-1
; δH: 6.56 (1H, s, NCHON), 6.83 (2H, m, ArH), 7.15 (1H, m, ArH), 7.20 
(2H, m, ArH), 7.45 (3H, m, ArH), 7.51 (1H, m, ArH), 7.58 (2H, m, ArH), 7.90 (1H, m, 
ArH), 8.21 (1H, m, ArH), 8.45 (1H, m, ArH). δC: 101.3 (NCHON), 122.9, 124.8, 125.1, 
126.6, 127.4, 128.9, 129.6, 129.8, 130.1 and 133.5 (10 x ArCH), 127.2 [ArC(NO2)], 138.3, 
140.4 and 148.2 (3 x ipso C of Ar), 153.7 (C3 of oxadiazoline ring). HRMS (ESI
+
) exact 
mass calculated for C20H15N3O3 [(M+H)
+
], 346.1192, found 346.1180. 
Method 3 
A solution of m-nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) in distilled 
dichloromethane (10 mL) was added dropwise via a pressure equalising addition funnel to 
a cooled (<10 
o
C, water/icebath), stirring solution of N-benzylideneaniline (0.59 g, 3.27 
mmol) and triethylamine (0.46 mL, 3.30 mmol) in distilled dichloromethane (15 mL). 
Following addition, the solution was warmed to room temperature and stirred for 1 h. 
Water (30 mL) was added and phases separated. The organic phase was washed with water 
(1 x 20 mL). The organic phase was dried, filtered and the solvent was evaporated in vacuo 
(without heat) to yield oxadiazoline (0.54 g, 48%) as brown oil. Recrystallisation from 
chloroform : hexane was attempted without success. δH: 6.56 (1H, s, NCHON), 6.83 (2H, 
m, ArH), 7.16 (1H, m, ArH), 7.21 (2H, m, ArH), 7.46 (3H, m, ArH), 7.52 (1H, m, ArH), 
7.59 (2H, m, ArH), 7.90 (1H, m, ArH), 8.23 (1H, m, ArH), 8.45 (1H, m, ArH). 
Method 4 
A solution of m-nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) in distilled 
dichloromethane (10 mL) was added dropwise via a pressure equalising addition funnel to 
a cooled (<10 
o
C, water/icebath), stirring solution of N-benzylideneaniline (0.59 g, 3.27 
mmol) and triethylamine (0.46 mL, 3.30 mmol) in distilled dichloromethane (15 mL). The 
resulting clear yellow solution was warmed to room temperature and stirred for 6 h. Water 
(30 mL) was added and the phases were separated. The organic phase was washed with 
water (1 x 20 mL). The organic phase was dried, filtered and the solvent was evaporated in 
vacuo (without heat) to yield the oxadiazoline (0.75 g, 67%) as a brown oil. δH: 6.56 (1H, 
s, NCHON), 6.83 (2H, m, ArH), 7.15 (1H, m, ArH), 7.20 (2H, m, ArH), 7.45 (3H, m, 
ArH), 7.51 (1H, m, ArH), 7.58 (2H, m, ArH), 7.90 (1H, m, ArH), 8.21 (1H, m, ArH), 8.45 
(1H, m, ArH). 
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Method 5 
A solution of m-nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) in ether (10 mL) was 
added dropwise via a pressure equalising addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-benzylideneaniline (0.59 g, 3.26 mmol) and 
triethylamine (0.46 mL, 3.30 mmol) in ether (15 mL). The mixture was warmed to room 
temperature and stirred for 10 min. The mixture was filtered and the solvent was removed 
in vacuo to yield the crude oxadiazoline (940.00 mg, 84%) as a yellow oil. δH: 6.56 (1H, s, 
NCHON), 6.83 (2H, m, ArH), 7.15 (1H, m, ArH), 7.20 (2H, m, ArH), 7.45 (3H, m, ArH), 
7.51 (1H, m, ArH), 7.58 (2H, m, ArH), 7.90 (1H, m, ArH), 8.21 (1H, m, ArH), 8.45 (1H, 
m, ArH). 
Method 6 
A solution of m-nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) in ether (10 mL) was 
added dropwise via a pressure equalising addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-benzylideneaniline (0.59 g, 3.27 mmol) and 
triethylamine (0.46 mL, 3.30 mmol) in ether (15 mL). The solution was warmed to room 
temperature and stirred for 1 h. The resulting solution was filtered and the solvent was 
removed in vacuo (without heat) to yield the crude oxadiazoline (0.82 g, 73%) as a brown 
oil. δH: 6.56 (1H, s, NCHON), 6.83 (2H, m, ArH), 7.15 (1H, m, ArH), 7.20 (2H, m, ArH), 
7.45 (3H, m, ArH), 7.51 (1H, m, ArH), 7.58 (2H, m, ArH), 7.90 (1H, m, ArH), 8.21 (1H, 
m, ArH), 8.45 (1H, m, ArH). 
Method 7 
A solution of m-nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) in ether (10 mL) was 
added dropwise via a pressure equalising addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-benzylideneaniline (0.59 g, 3.26 mmol) and 
triethylamine (0.46 mL, 3.30 mmol) in ether (15 mL). The solution was warmed to room 
temperature and stirred for 6 h. The resulting solution was filtered and the solvent was 
removed in vacuo (without heat) to yield the crude oxadiazoline (0.30 g, 27%) as a brown 
oil. δH: 6.56 (1H, s, NCHON), 6.83 (2H, m, ArH), 7.15 (1H, m, ArH), 7.20 (2H, m, ArH), 
7.45 (3H, m, ArH), 7.51 (1H, m, ArH), 7.58 (2H, m, ArH), 7.90 (1H, m, ArH), 8.21 (1H, 




NMR spectroscopy tube reaction 
Mesitonitrile-N-oxide (12.40 mg, 0.07 mmol) was dissolved 
in CDCl3 (1.5 mL). This solution was mixed with N-
benzylideneaniline (13.10 mg, 0.07 mmol) and mixed 
briskly. A 0.6 mL aliquot of this solution was transferred to 
an NMR spectroscopy tube and 
1
H NMR spectroscopic 
analysis was carried out immediately, however starting 
materials (N-benzylideneaniline (346) and mesitonitrile-N-oxide (7)) were observed. δH: 
2.30 (3H, s, ArCH3 7), 2.41 [6H, s, Ar(CH3)2 7], 6.90 (2H, s, ArH 7), 7.23 (3H, m, ArH 
346), 7.40 (2H, m, ArH 346), 7.48 (3H, m, ArH 346), 7.91 (2H, m, ArH 346), 8.46 (1H, s, 
N=CH 346). 
8.3.1.5 Attempted preparation of 3-bromo-4-phenyl-5-phenyl-Δ2-1,2,4-
oxadiazoline 424 
Method 1 
Dibromoformaldoxime (1.32 g, 6.49 mmol) in ether (20 mL) was 
added dropwise via a pressure equalising addition funnel to a 
cooled (<10 
o
C, water/icebath) stirring suspension of N-
benzylideneaniline (1.18 g, 6.50 mmol) and potassium tert-
butoxide (0.73 g, 6.51 mmol) in ether (20 mL). On completion of 
addition, the mixture was warmed to room temperature and was stirred overnight (15 h). 
The mixture was filtered to remove the precipitate and the solvent was removed in vacuo. 
The resulting sample was placed under high vacuum to remove any residual solvent, 
yielding a pale orange oil (1.26 g, 64%). A mixture of oxadiazoline (424), N-
benzylideneaniline (346) and benzaldehyde (270) were observed ina ration of 14 : 69 : 17. 
νmax (film): 3061, 1697, 1656, 1597, 1558, 1495 cm
-1
; δH: 6.51 (0.2H, s, NCHON 424), 
6.89 (0.8H, m, ArH 424), 7.44 (10.8H, m, ArH 424, 346 & 270), 7.90 (2.5H, m, ArH  424, 














Dibromoformaldoxime (2.03 g, 0.01 mol) in ether (30 mL) was added dropwise via a 
pressure equalising addition funnel to a cooled (<10 
o
C, water/icebath) stirring solution of 
N-benzylideneaniline (1.81 g, 0.01 mmol) and triethylamine (1.01 g, 0.01 mol) in ether (30 
mL). A cloudy, pale orange mixture resulted. On completion of addition, the solution was 
immediately filtered and the solvent was evaporated in vacuo to yield the crude 
oxadiazoline (1.92 g, 63%) as a pale orange oil. The sample was placed under high vacuum 
to remove any residual solvent. A mixture of oxadiazoline (424), N-benzylideneaniline 
(346) and benzaldehyde (270)  were observed in a ratio of 4 : 88 : 8. νmax (film): 3061, 
3028, 1701, 1591, 1578, 1486, 1451, 1190 cm
-1
; δH: 6.49 (0.04H, s, NCHON 424), 6.91 
(0.3H, m, ArH 424), 7.24 (3H, m, ArH 346), 7.38 (2.2H, m, ArH 346 & 270), 7.47 (3.2H, 
m, ArH 424, 346 & 270), 7.59 (0.2H, m, ArH 424 & 270), 7.86 (2.2H, m, ArH 424, 346 & 
270), 8.43 (1H, s, N=CH 346), 9.97 (0.1H, s, CHO 270). m/z = no assignable peaks.  
Method 3 
Dibromoformaldoxime (2.03 g, 10.00 mmol) in ether (30 mL) was added dropwise via a 
pressure equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring solution of 
N-benzylideneaniline (1.82 g, 10.03 mmol) and triethylamine (1.01 g, 9.99 mmol) in ether 
(30 mL). The solution was warmed to room temperature and stirred for 10 min. The 
precipitate was removed by filtration and solvent evaporated in vacuo (without heat) to 
yield a yellow oil (1.57 g, 52%). A mixture of oxadiazoline (424), N-benzylideneaniline 
(346) and benzaldehyde (270)  were observed in a ratio of 3 : 91 : 6. δH: 6.50 (0.03H, s, 
NCHON 424), 6.73 (0.05H, m, ArH 424), 6.99 (0.06H, m, ArH 424), 7.25 (3H, m, ArH 
346 & 424), 7.39 (2H, m, ArH 346), 7.49 (5.2H, m, ArH 424, 346 & 270), 7.89 (2H, m, 
ArH 346), 8.45 (1H, s, CH=N 346), 10.00 (0.07H, s, CHO 270).  
Method 4 
Dibromoformaldoxime (2.03 g, 10.00 mmol) in ether (30 mL) was added dropwise via a 
pressure equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring solution of 
N-benzylideneaniline (1.82 g, 10.03 mmol) and triethylamine (1.01 g, 10.02 mmol) in ether 
(30 mL). On completion of addition, the solution was warmed to room temperature and 
stirred for 1 h. The precipitate was removed by filtration and the solvent was evaporated in 
vacuo (without heat) to yield a yellow oil (2.68 g, 89%). A mixture of oxadiazoline (424), 
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N-benzylideneaniline (346) and benzaldehyde (270) were observed in a ratio of 2 : 93 : 
5.δH: 6.49 (0.02H, s, NCHON 424), 6.72 (0.08H, m, ArH 424), 7.01 (0.06H, m, ArH 424), 
7.19 (3.1H, m, ArH 424, 346 & 270), 7.48 (5.3H, m, ArH 424, 346 & 270), 7.87 (2.1H, m, 
ArH 346 & 270), 8.43 (1H, s, N=CH 346), 9.98 (0.06H, s, CHO 270).  
Method 5 
Dibromoformaldoxime (2.0 g, 10.0 mmol) in ether (30 mL) was added dropwise via a 
pressure equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring solution of 
N-benzylidene aniline (1.8 g, 10.0 mmol) and triethylamine (1.0 g, 10.0 mmol) in ether (30 
mL). On completion of addition, the solution was warmed to room temperature and stirred 
for 6 h. The precipitate was removed by filtration and solvent evaporated in vacuo (without 
heat) to yield a mixture of oxadiazoline (424), N-benzylideneaniline (346) and 
benzaldehyde (270)  in a ratio of 2 : 84 : 14 as a brown oil.. νmax (film): 3062, 3029, 1701, 
1625, 1591, 1578, 1486, 1452, 1190 cm
-1
; δH: 6.51 (0.02H, s, NCHON 424), 6.75 (0.2H, 
m, ArH 424), 7.10 (0.16H, m, ArH 424), 7.24 (3H, m, ArH 346), 7.40 (2H, m, ArH 346), 
7.50 (3.2H, m, ArH 424, 346 & 270), 7.63 (0.2H, m, ArH 270), 7.90 (2.3H, m, ArH 346 & 
270), 8.46 (1H, s, N=CH 346), 10.01 (0.17H, s, CHO 270).  
Method 6 
Dibromoformaldoxime (2.03 g, 9.98 mmol) in ether (30 mL) was added dropwise via a 
pressure equalising addition funnel to a cooled (<10 
o
C, water/icebath) stirring solution of 
N-benzylideneaniline (1.82 g, 10.03 mmol) and triethylamine (1.01 g, 10.00 mmol) in ether 
(30 mL). On completion of addition, the solution was warmed to room temperature and 
stirred for 19.5 h. The precipitate was removed by filtration and solvent evaporated in 
vacuo (without heat) to yield a mixture of oxadiazoline (424), N-benzylideneaniline (346) 
and benzaldehyde (270) in a ratio of 2 : 75 : 23 as a.dark yellow/light green oil (1.62 g). δH: 
6.50 (0.03H, s, NCHON 424), 6.95 (0.34H, m, ArH 424), 7.22 (3H, m, ArH 346), 7.38 
(2H, m, ArH 346), 7.48 (3.7H, m, ArH 424, 346 & 270), 7.60 (0.4H, m, ArH 270), 7.87 
(2.4H, m, ArH 346 & 270), 8.44 (1H, s, N=CH 346), 9.98 (0.3H, s, CHO 270).  
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8.3.1.6 3-Benzoyl-4-phenyl-5-phenyl-Δ2-1,2,4-oxadiazoline 425 
Method 1 
A solution of 1-benzoyl-1-chloroformaldoxime (1.20 g, 6.53 
mmol) in ether (30 mL) was added dropwise via a pressure-
equalising addition funnel to a cooled (<10 
o
C, water/icebath), 
stirring solution of N-benzylideneaniline (1.18 g, 6.50 mmol) and 
triethylamine (0.66 g, 6.50 mmol) in ether (40 mL). The resulting 
cloudy mixture was stirred for 3 h at room temperature. Water 
(30 mL) was added to dissolve the precipitate. The resulting 
biphasic solution was transferred to a separating funnel and phases were separated. The 
organic phase was washed with water (2 x 30 mL). The combined aqueous layer was then 
washed with ether (1 x 30 mL). The combined ethereal extracts were dried, filtered and 
solvent removed in vacuo. The resulting residue of the crude oxadiazoline was dried 
further under high vacuum overnight. Recrystallisation from ethyl acetate: hexane yielded 
a mixture of the oxadiazoline (425) and N-benzoylaniline (347) in a 1 : 1 ratio as a pale 
orange solid (0.3 g). δH: 6.61 (1H, s, NCHON 425), 6.72 (0.37H, s, ? another form of the 
oxadiazoline?), 6.81 (1.9H, m, ArH 425), 6.94 (0.74H, m, ArH ?), 7.13 (4.6H, m, ArH 425 
& 347), 7.47 (11.8H, m, ArH 425 & 347), 7.66 (3H, m, ArH 425 & 347), 7.79 (0.7H, bs, 
NH 347), 7.87 (1.9H, m, ArH 347), 8.27 (2H, m, ArH 425). 
Method 2 
A solution of 1-benzoyl-1-chloroformaldoxime (1.19 g, 6.50 mmol) in ether (20 mL) was 
added dropwise via a pressure-equalising addition funnel to a cooled (<10 
o
C, 
water/icebath) stirring solution of N-benzylideneaniline (1.18 g, 6.50 mmol) and 
triethylamine (0.66 g, 6.55 mmol) in ether (20 mL). On completion of addition, the 
resulting mixture was warmed to room temperature and stirred overnight (15 h). The 
sample was filtered to remove the precipitate and the solvent was removed in vacuo 
(without heat). The sample was placed under high vacuum to remove any residual solvent 
(1.57 g, 74%). A mixture of oxadiazoline (425), N-benzylideneaniline (346), N-
benzoylaniline (347) and benzaldehyde (270) (38 : 48 : ? : 14).δH: 6.61 (1H, s, NCHON 
425), 6.80 (2H, m, ArH 425), 6.92 (1.1H, m, ArH 425), 7.17 (9.4H, m, ArH 425, 346 & 
347), 7.46 (20H, m, ArH 425, 346, 347 & 270), 7.68 (3H, m, ArH 425, 347 & 270), 7.89 
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(5.7H, m, ArH 425, 346, 347 & 270), 8.05 (0.3H, m, ArH 425 ?), 8.19 (1.45H, m, ArH 
425), 8.27 (1.6H, m, ArH 425), 8.46 (1.28H, s, N=CH 346), 10.01 (0.36H, s, CHO 270).  
8.3.1.7 3-Ethoxy-4-phenyl-5-phenyl-Δ2-1,2,4-oxadiazoline 426 
Method 1 
Ethylchloroglyoxalate oxime (0.99 g, 6.51 mmol) in ether (30 
mL) was added dropwise via a pressure equalising addition 
funnel to a cooled (<10 
o
C, water/icebath), stirring solution 
of N-benzylideneaniline (1.18 g, 6.50 mmol) and 
triethylamine (0.66 g, 6.50 mmol) in ether (40 mL). Once 
addition was complete, the solution was warmed to room temperature and stirred for ten 
minutes. Water (30 mL) was added to dissolve the precipitate and the resulting biphasic 
mixture was transferred to a separating funnel and the phases were separated. The organic 
phase was washed with water (3 x 30 mL). The combined aqueous phases were washed 
with ether (1 x 30 mL).The combined organic phases were dried, filtered and solvent 
evaporated in vacuo (without heat) and dried under high vacuum to yield the oxadiazoline 
(1.53 g, 79%) as yellow/orange oil. Recrystallisation from ether:hexane (1:5) was 
attempted. A clear crystalline solid was isolated which contained a mixture of 3,4-
diethoxycarbonylfuroxan (315), N-benzylideneaniline (346) and oxadiazoline (426) in a 
ratio of 31 : 63 : 6. δH: 1.39 [3H, m, (CH3CH2O)2 315], 4.45 [2H, two overlapping q, J = 
7.15, 7.16, (CH3CH2O)2 315], 6.50 (0.1H, s, NCHON 426), 6.72 (0.5H, m, ArH 426), 6.90 
(0.4H, m, ArH 426), 7.21 (4.05H, m, ArH 426 & 346), 7.47 (6.15H, m, ArH 426 & 346), 
7.90 (2.3H, m, ArH 426 & 346), 8.45 (1H, s, N=CH 346).  
Method 2 
Ethylchloroglyoxalate oxime (0.99 g, 6.50 mmol) in ether (30 mL) was added dropwise  
via a pressure equalising addition funnel to a cooled (<10 
o
C, water/icebath), stirring 
solution of N-benzylideneaniline (1.18 g, 6.50 mmol) and triethylamine (0.66 g, 6.57 
mmol) in ether (40 mL). The resulting cloudy mixture was stirred at room temperature for 
3 h. Water (30 mL) was added to the stirring mixture to dissolve the precipitate and the 
resulting biphasic solution was transferred to a separating funnel and the phases were 
separated. The organic phase was washed with water (2 x 30 mL) and the combined 
aqueous phases were washed with ether (1 x 30 mL).The combined organic phases were 
dried, filtered and solvent evaporated in vacuo. The resulting residue of crude oxadiazoline 
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was dried further under high vacuum overnight. The residue was recrystallised from ethyl 
acetate : hexane and a mixture of 3,4-diethoxycarbonylfuroxan (315), N-
benzylideneaniline (346) and oxadiazoline (426) was isolated by vacuum filtration as a 
dark green solid (20.20 mg). δH: 1.38 [3H, m, (CH3CH2O)2 315], 4.44 [2H, two 
overlapping q, J = 7.15, 7.16, (CH3CH2O)2 315], 6.49 (0.1H, s, NCHON 426), 6.79 (0.6H, 
m, ArH 426), 7.22 (3.5H, m, ArH 426 & 346), 7.48 (6.2H, m, ArH 426 & 346), 7.88 
(2.3H, m, ArH 426 & 346), 8.44 (1H, s, N=CH 346).  
Method 3 
Ethylchloroglyoxalate oxime (0.49 g, 3.26 mmol) in ether (10 mL) was added at a rate of 
0.793 mL/min using a syringe pump, to a cooled (<10 
o
C, water/icebath), stirring solution 
of N-benzylideneaniline (0.59 g, 3.25 mmol) and triethylamine (0.33 g, 3.29 mmol) in 
ether (15 mL). This addition took 12 h 30 min. The solution was maintained at <10 
o
C for 
the first seven hours and then addition continued at room temperature. The mixture was 
filtered to remove the precipitate and the solvent was removed in vacuo (without heat) to 
yield the oxadiazoline (0.79 g, 82%). The residue was washed with water and 
recrystallisation from chloroform: hexane was attempted. A dark green solid containing a 
mixture of 3,4-diethoxycarbonylfuroxan (315), N-benzylideneaniline (346) and 
oxadiazoline (426) was isolated in a ratio of 28 : 63 : 9. δH: 1.40 [3H, m, (CH3CH2O)2 
315], 4.46 [1.5H, m, (CH3CH2O)2 315], 6.51 (0.3H, s, NCHON 426), 6.89 (1.2H, m, ArH 
426 & 346), 7.25 (4.3H, m, ArH 426 & 346), 7.50 (7.3H, m, ArH 426 & 346), 7.89 (2.3H, 
m, ArH 426 & 346), 8.46 (1H, s, N=CH 346).  
Method 4 
Triethylamine (0.33 g, 3.25 mmol) in ether (10 mL) was added at a rate of 0.793 mL/h via 
syringe pump to a cooled (<10 
o
C, water/icebath), stirring solution of 
ethylchloroglyoxalate oxime (0.50 g, 3.28 mmol) and N-benzylideneaniline (0.59 g, 3.25 
mmol) in ether (20 mL). The solution was maintained (<10 
o
C, water/icebath) for 2.5 h, 
then warmed to room temperature and stirred overnight. The sample was filtered to remove 
the precipitate. The solvent was evaporated in vacuo and any residual solvent was 
evaporated under high vacuum to yield a mixture of 3,4-diethoxycarbonylfuroxan (315), 
N-benzylideneaniline (346) and oxadiazoline (426) (25 : 50 : 25) as a dark green oil.(0.427 
g, 44%) νmax (film): 1742, 1626, 1496, 1194 cm
-1
; δH: 1.38 [3H, m, (CH3CH2O)2 315], 4.44 
[1.5H, m, (CH3CH3O)2 315], 6.50 (0.5H, s, NCHON), 6.82 (1.5H, m, ArH 426 & 346), 
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7.22 (4.7H, m, ArH 426 & 346), 7.48 (8.5H, m, ArH 426 & 346), 7.89 (2.3H, m, ArH 426 
& 346), 8.45 (1H, s, N=CH 346).  
8.3.1.8 3-(p-Toluenesulfonyl)-4-phenyl-5-phenyl-Δ2-1,2,4-oxadiazoline 427 
A suspension of 1-p-toluenesulfonyl-1-bromoformaldoxime (0.91 
g, 3.27 mmol) in ether (10 mL) was added dropwise via a 
pressure equalising addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-benzylideneaniline (0.59 g, 
3.26 mmol) and triethylamine (0.34 g, 3.33 mmol) in ether (15 
mL). The solution was warmed to room temperature and stirred 
overnight (14.5 h). The sample was filtered to remove the 
precipitate. The solvent was removed in vacuo and residual solvent removed under high 
vacuum to yield oxadiazoline (0.87 g, 73%) as a brown oil. Recrystallisation from 
chloroform:hexane was attempted without success and the crude product mixture was 
analysed. A mixture of oxadiazoline (427), N-benzylideneaniline (346), N-benzoylaniline 
(347), benzaldehyde (270) and 3,4-bis-(p-toluenesulfonyl)-furoxan (309) (4 : 29 : ? : 44 : 
23) were observed. δH: 2.43 (5.7H, m, 309), 6.56 (0.13H, s, NCHON 427), 6.94 (3.2H, m, 
ArH 427 & 347), 7.31 (13.7H, m, ArH 427, 346 & 309), 7.51 (6.2H, m, ArH 427?, 346, 
347 & 270), 7.65 (2H, m, ArH 347 & 270), 7.77 (1.3H, m, ArH 427 & 309), 7.90 (5.14H, 
m, ArH 427, 346, 347, 270 & 309), 8.04 (0.81H, m, ArH 427 & 309), 8.47 (1H, s, N=CH 
346), 10.03 (1.53H, s, CHO 270).  
8.3.2 1,3-Dipolar cycloaddition reactions with an alkene 
8.3.2.1 Trans-3-(p-nitrophenyl)-4,5-diphenyl-1,2-isoxazoline 429 
Method 1 NMR spectroscopy tube reaction 
Triethylamine (1 mL, 0.07 M solution in CDCl3) was added to a 
sample vial containing p-nitrobenzohydroximoyl chloride 
(14.60 mg, 0.07 mmol) and a 0.6 mL portion of the resulting 
yellow solution was submitted for 
1
H NMR spectroscopic 
analysis (Exp 10). Once the spectrum was recorded, the 
contents of the NMR spectroscopy tube were returned to the sample vial. This solution was 
then transferred to a sample vial containing trans-stillbene (12.60 mg, 0.07 mmol) and a 
0.6 mL portion of the resulting yellow solution was transferred to an NMR spectroscopy 
tube and 
1




spectroscopic analysis was used to monitor the reaction. p-Nitrobenzonitrile-N-oxide (265) 
and trans-stillbene (428) were the products in the initial 
1
H NMR spectrum. Exp 11 δH: 
7.11 (2H, bs, HC=CH 428), 7.26 (2.27H, m, ArH 428), 7.36 (3.97H, m, ArH 428), 7.51 
(3.86H, m, ArH 428), 7.70 (1.70H, m, ArH 265), 8.28 (1.77H, m, ArH 265).  
Exp 12 was submitted for NMR spectroscopic analysis immediately after the 
1
H NMR 
spectrum for Exp 11 was recorded. δH: 4.71 (0.04H, d, J = 6.08, CH 429), 5.61 (0.04H, d, J 
= 6.08, CH 429), 7.11 (2H, bs, HC=CH 428), 7.26 (2.36H, m, ArH 428), 7.36 (4.20H, m, 
ArH 429 & 428), 7.52 (3.84H, m, ArH 428), 7.71 (1.74H, m, ArH 429 & 265), 8.09 
(0.22H, m, ArH 429), 8.29 (1.87H, m, ArH 265). 
Exp 13 indicates that the 3,4-bis-(p-nitrophenyl)-furoxan (312) began to form: 4.71 
(0.30H, d, J = 6.08, CH 429), 5.61 (0.30H, d, J = 6.08, CH 429), 7.11 (2H, bs, HC=CH 
428), 7.26 (2.93H, m, ArH 428), 7.36 (6.37H, m, ArH 429 & 428), 7.52 (3.85H, m, ArH 
428), 7.72 (1.81H, m, ArH 265 & 429), 8.05 (0.14H, m, ArH 312), 8.11 (0.66H, m, ArH 
429), 8.21 (0.28H, m, ArH 312), 8.29 (1.04H, m, ArH 265 & 312), 8.38 (0.66H, m, ArH 
312). 
Exp 19: 4.71 (0.61H, d, J= 6.08, CH 429), 5.61 (0.61H, d, J = 6.08, CH 429), 7.11 (2H, bs, 
HC=CH 428), 7.26 (3.91H, m, ArH 428), 7.37 (8.97H, m, ArH 429 & 428), 7.74 (1.82H, 
m, ArH 429), 7.85 (0.21H, m, ArH 312), 8.09 (1.52H, m, ArH 429 & 312), 8.27 (2.41H, 
m, ArH 429 & 312). 
Method 2 
A solution of p-nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) in ether (10 mL) was 
added dropwise via pressure-equalising addition funnel to a cooled (<10 
o
C, 
water/icebath),  stirring solution of trans-stillbene (0.59 g, 3.25 mmol) and triethylamine 
(0.46 mL, 3.30 mmol) in ether (15 mL). The resulting solution was warmed to room 
temperature and stirred overnight (20 h), filtered and solvent evaporated in vacuo (without 
heat) to yield crude isoxazoline. δH: 4.66 (1H, d, J = 6.11, CH 429), 5.54 (1H, d, J = 6.10, 
CH 429), 7.01 (3H, m, ArH), 7.17 (5.28H, m, ArH), 7.29 (14.04H, m, ArH), 7.43 (5.91H, 
m, ArH), 7.54 (0.72H, m, ArH), 7.64 (2.10H, m, ArH), 7.94 (2.35H, m, ArH), 8.16 (3.03H, 
m, ArH). m/z = no diagnostic molecular ions. Recrystallisation from chloroform : hexane 
yielded the isoxazoline (0.14 g, 13%) as an orange solid. The recrystallised product was 
purified by column chromatography [gradient eluent, 10-60% Ethyl acetate : hexane]. F1-6 
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combined and solvent evaporated in vacuo to yield a pale yellow solid, 49 mg. δH: 4.71 
(1H, d, J = 6.09, HC), 5.61 (1H, d, J = 6.17, HC), 7.26 (1.89H, m, ArH), 7.37 (6.41H, m, 
ArH), 7.75 (1.64H, m, ArH of p-NO2Ar), 8.13 (1.72H, m, ArH of p-NO2Ar), 8.40 (2H, bs, 
ArH), 8.45 (2H, bs, ArH). F7-10 combined and solvent evaporated in vacuo to yield a 
white solid, 73 mg. Unknown product: δH: 7.74 (4H, m, ArH), 8.33 (1H, m, ArH), 8.36 
(2H, m, ArH), 8.39 (2.67H, m, ArH), 8.54 (1.75H, bs, ArH). m/z = no diagnostic 
molecular ions. 
8.4 Competition reactions 
To investigate which dipolarophile was more reactive towards the nitrile oxide, the 
hydroximoyl halide solution was added to a mixture of the two formamidines to be 
screened. The ratio of oxadiazolines formed was measured using proton NMR 
spectroscopic analysis 
8.4.1 Competition reaction to investigate if N,N-dimethyl-N-
benzylformamidine 339 or N-benzylformimidoylmorpholine 318 is more 
reactive to p-nitrobenzonitrile-N-oxide 265 
p-Nitrobenzohydroximoyl chloride (0.60 g, 3.00 mmol) in dichloromethane (20 mL) was 
added dropwise via a pressure equalizing addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N,N-dimethyl-N-benzylformamidine (0.24 g, 1.50 
mmol) and N-benzylformimidoylmorpholine (0.31 g, 1.50 mmol) in dichloromethane (10 
mL) and triethylamine (0.30 g, 3.01 mmol) in dichloromethane (10 mL). The resulting 
yellow mixture was stirred. Water (15 mL) was added to the stirring mixture to dissolve 
the precipitate. The phases were separated & the organic layer was extracted with water (3 
x 15 mL). The aqueous layer was washed with dichloromethane (1 x 15 mL). The organic 
extracts were combined, filtered, dried and the solvent was evaporated in vacuo (without 
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8.4.2 Competition reaction to investigate if N-benzylformimidoylmorpholine 
318 or N-(N’-phenylformimidoyl)-morpholine 341 is more reactive to p-
nitrobenzonitrile-N-oxide 265 
p-Nitrobenzohydroximoyl chloride (0.42 g, 2.11 mmol) in dichloromethane (50 mL) was 
added dropwise to a cooled (<10 
o
C, water/icebath), stirring solution of N-(N’-
phenylformimidoyl)-morpholine (0.20 g, 1.06 mmol), N-benzylformimidoylmorpholine 
(0.22 g, 1.05 mmol) and triethylamine (0.21 g, 2.11 mmol) in dichoromethane (20 mL). 
Following the addition, the solution was warmed to room temperature and stirred for 10 
min. Water (20 mL) was added to the stirring mixture to dissolve the precipitate and the 
phases were separated. The organic layer was extracted with water (3 x 20 mL). The 
organic extracts were combined, dried and the solvent was evaporated on the high vacuum 
line. (0.47 g) bright yellow solid isolated. δH: 1.65 (2.1H, bs, ?), 2.48 (0.39H, bs, ?), 2.79 
[2H, m, N(CHax)2 392], 2.97 [2H, m, N(CHeq)2 392], 3.57 [1.53H, m, N(CH2)2 & O(CH2)2 
336], 3.80 [4H, t, J = 4.76, O(CH2)2 392], 4.43 (0.19H, d, J = 6.46, PhCH2 336), 4.50 
(0.46H, d, J = 5.87, PhCH2 ?), 6.19 (1H, s, NCHON 392), 7.05 (2H, m, ArH 392), 7.21 
(1.04H, m, ArH ?), 7.26 (4.70H, m, ArH 392 & 336), 7.69 (2H, m, ArH 392), 8.18 (2H, m, 
ArH 392), 8.34 (1.40H, m, ArH ?), 8.48 (0.94H, m, ArH ?), 8.70 (0.48H, m, ArH ?), 8.90 
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8.4.3 Competition reaction to investigate if N-benzylformimidoylmorpholine 
318 or N-(N’-phenylformimidoyl)-morpholine 341 is more reactive to 
cyanoformonitrile-N-oxide 435 
A solution of cyanoformhydroximoyl chloride (0.21 g, 2.00 mmol) in ether (10 mL) was 
added dropwise via a pressure equalising addition funnel to a cooled (<10 
o
C, 
water/icebath), stirring solution of N-(N’-phenylformimidoyl)-morpholine (0.19 g, 1.00 
mmol), N-benzylformimidoylmorpholine (0.20 g, 1.00 mmol) and triethylamine (0.28 mL, 
2.01 mmol) in ether (20 mL). Following addition, the solution was warmed to room 
temperature and stirred for 10 min. Water (20mL) was added to dissolve the precipitate. 
The phrases were separated and the organic phase was dried, filtered and solvent 
evaporated in vacuo (without heat) to yield a yellow oil (0.245 g). Proton NMR 
spectroscopic analysis showed that oxadiazolines 390 and 402 were obtained in a ratio of 
68 : 32 by comparison of the characteristic oxadiazoline CH peak at 6.06 and 6.38 ppm 
respectively. 
 
        390    402 
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8.4.4 Competition reaction to investigate if benzonitrile-N-oxide 27 or 
ethoxycarbonylnitrile-N-oxide 376 is more reactive to N-(N’-
phenylformimidoyl)-morpholine 341  
Benzohydroximoyl chloride (0.51 g, 3.26 mmol) and ethylchloroglyoxalate oxime (0.49 g, 
3.25 mmol) in ether (30 mL) was added dropwise via a pressure equalizing addition funnel 
to a cooled (<10 
o
C, water/icebath), stirring solution of N-(N’-phenylformimidoyl)-
morpholine (1.23 g, 6.48 mmol)  and triethylamine (0.66 g, 6.51 mmol) in ether (40 mL). 
Following the addition, the solution was warmed to room temperature and the solution was 
stirred for 10 min. Water (30 mL) was added to dissolve the precipitate and a clear 
biphasic solution resulted. The solution was transferred to a separating funnel and the 
phases were separated. The organic layer was extracted with water (3 x 30 mL). The 
combined aqueous extracts were washed with ether (1 x 30 mL). The organic extracts were 
combined, dried, filtered and the solvent was evaporated in vacuo to yield the crude 
oxadiazolines (1.52 g) as a pale cream solid. Proton NMR spectroscopic analysis shows 
that oxadiazolines 267 and 400 were observed in a ratio of 59 : 41 by comparison of the 
characteristic oxadiazoline CH resonances at 6.13 and 6.17 ppm respectively. 
 
          267    400 
8.4.5 Competition reaction to investigate if p-nitrobenzonitrile-N-oxide 265 or 
ethoxycarbonylnitrile-N-oxide 376 is more reactive to N-(N’-
phenylformimidoyl)-morpholine 341  
p-Nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) and ethylchloroglyoxalate oxime 
(0.49 g, 3.26 mmol) in ether (30 mL) was added dropwise via a pressure equalizing 
addition funnel to a cooled (<10 
o
C, water/icebath), stirring solution of N-(N’-
phenylformimidoyl)-morpholine (1.24 g, 6.51 mmol) and triethylamine (0.66 g, 6.51 
mmol) in ether (40 mL). Once addition was complete, the ice bath was removed and the 
solution was stirred for 10 min. Water (30 mL) was added to dissolve the precipitate. The 
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yellow biphasic solution was then transferred to a separating funnel and the phases were 
separated. The organic layer was extracted with water (3 x 30 mL). The combined aqueous 
extracts were washed with ether (1 x 30 mL). The organic extracts were combined, dried, 
filtered and the solvent was evaporated in vacuo (without heat) to yield a yellow oily 
residue (1.85 g). Proton NMR spectroscopic analysis showed that oxadiazolines 392 and 
400 were observed in a ratio of 63 : 37 by comparison of the characteristic oxadiazoline 
CH resonances at 6.19 and 6.17 ppm respectively. 
 
     392     400 
8.4.6 Competition reaction to investigate if benzoylnitrile-N-oxide 10 or 
ethoxycarbonylnitrile-N-oxide 376 is more reactive to N-(N’-
phenylformimidoyl)-morpholine 341  
1-Benzoyl-1-chloroformaldoxime (0.60 g, 3.25 mmol) and ethylchloroglyoxalate oxime 
(0.49 g, 3.25 mmol) in ether (30 mL) was added dropwise via a pressure equalizing 
addition funnel to a cooled (<10 
o
C, water/ice bath) stirring solution of N-(N’-
phenylformimidoyl)-morpholine (1.24 g, 6.51 mmol) and triethylamine (0.66 g, 6.50 
mmol) in ether (40 mL). Once addition was complete, the solution was warmed to room 
temperature and stirred for 10 min. Water (30 mL) was added to the resulting pale cream 
solution to dissolve the precipitate and the biphasic solution was transferred to a separating 
funnel. The phases were separated and the organic phase was extracted with water (3 x 30 
mL). The combined aqueous extracts were washed with ether (1 x 30 mL). The organic 
extracts were combined, dried, filtered and the solvent was evaporated in vacuo (without 
heat) to yield a pale yellow residue (1.66 g). Proton NMR spectroscopic analysis showed 
that oxadiazolines 400 and 398 were observed in a ratio of 40 : 60 by comparison of the 
characteristic oxadiazoline CH resonances at 6.17 and 6.25 ppm respectively. 
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   400         398 
8.4.7 Competition reaction to investigate if benzoylnitrile-N-oxide 10 or p-
nitrobenzonitrile-N-oxide 265 is more reactive to N-(N’-
phenylformimidoyl)-morpholine 341  
1-Benzoyl-1-chloroformaldoxime (0.60 g, 3.26 mmol) and p-nitrobenzohydroximoyl 
chloride (0.62 g, 3.11 mmol) in ether (30 mL) was added dropwise via a pressure 
equalizing addition funnel to a cooled (<10 
o
C, water/icebath), stirring solution of N-(N’-
phenylformimidoyl)-morpholine (1.23 g, 6.47 mmol) and triethylamine (0.66 g, 6.50 
mmol) in ether (40 mL). Once addition was complete, the solution was warmed to room 
temperature and stirred for 10 min. Water (30 mL) was added to dissolve the precipitate. 
The clear yellow biphasic solution was transferred to a separating funnel and the phases 
were separated. The organic layer was extracted with water (3 x 30 mL). The combined 
aqueous extracts were washed with ether (1 x 30 mL). The organic extracts were 
combined, dried, filtered and the solvent was evaporated in vacuo (without heat) to yield a 
yellow solid (0.80 g). Proton NMR spectroscopic analysis showed that oxadiazolines 392 
and 398 were observed in a ratio of 46 : 54 by comparison of the characteristic 
oxadiazoline peaks at 6.18 and 6.25 ppm respectively. 
 
392         398 
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8.4.8 Competition reaction to investigate if p-nitrobenzonitrile-N-oxide 265 or 
ethoxycarbonylnitrile-N-oxide 376 is more reactive to N-
benzylideneaniline 346 
A solution of p-nitrobenzohydroximoyl chloride (0.65 g, 3.25 mmol) and 
ethylchloroglyoxalate oxime (0.49 g, 3.25 mmol)  in ether (30 mL) was added dropwise 
via a pressure equalizing addition funnel to a cooled (<10 
o
C, water/icebath), stirring 
solution of N-benzylideneaniline (1.18 g, 6.50 mmol) and triethylamine (0.66 g, 6.50 
mmol) in ether (40 mL). Once addition was complete, the solution was warmed to room 
temperature and stirred for 10 min. Water (30 mL) was added to dissolve the precipitate. 
The biphasic solution was transferred to a separating funnel and the phases were separated. 
The organic phase was washed with water (2 x 30 mL). The combined aqueous phases 
were washed with ether (1 x 30 mL) and dichloromethane (1 x 50 mL, distilled). Phases 
were separated and combined organic phases were dried, filtered and the solvent was 
evaporated in vacuo to yield a pale yellow solid (1.85 g). Proton NMR spectroscopic 
analysis showed that oxadiazolines 420 and 426 were observed in a ratio of 8:1 by 
comparison of the characteristic oxadiazoline peaks at 6.55 and 6.50 ppm respectively. 
 









H NMR spectra reaction of oxadiazoline 267 (CDCl3, 300MHz) over a 46 d period showing gradual conversion into nitrile 175 and urea 395 as 
illustrated graphically in Figure 72 
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Table 44 shows the calculations used to determine the relative rate constant in the formation of oxadiazoline 267 (CDCl3, 300MHz). The conversion of 
oxadiazoline 267 into urea 395 is illustrated graphically in Figure 72. Figure 74 outlines the determination of relative rate constant, krel, by plotting 
ln[Oxadiazoline 267]rel vs time (d). Figure 75 outlines the determination of relative rate constant, krel, by plotting ln[Urea 395]rel vs time (d). Figure 76 portrays the 
second order rate check by plotting 1/[Oxadiazoline 267]rel vs time (d). Figure 77 portrays the second order rate check by plotting 1/[Urea 395]rel vs time (d). 
Day 
no 
A B C D E  First order Second order 
Oxadiazoline 
integration 
(δH = 6.13 
ppm) 
Urea integration 

















(A+B) (A/C*100) (B/C*100) ln(D) ln(E) 1/D 1/E 
1 1 0 1.00 100.00 0.00 8.64E+04 4.61 - 0.01 - 
2 1 0.0594 1.06 94.39 5.61 1.73E+05 4.55 1.72 0.01 0.18 
3 1 0.1323 1.13 88.32 11.68 2.59E+05 4.48 2.46 0.01 0.09 
4 1 0.2162 1.22 82.22 17.78 3.46E+05 4.41 2.88 0.01 0.06 
5 1 0.2886 1.29 77.60 22.40 4.32E+05 4.35 3.11 0.01 0.04 
8 1 0.5278 1.53 65.45 34.55 6.91E+05 4.18 3.54 0.02 0.03 
9 1 0.6494 1.65 60.63 39.37 7.78E+05 4.10 3.67 0.02 0.03 
10 1 0.7506 1.75 57.12 42.88 8.64E+05 4.05 3.76 0.02 0.02 
11 1 0.8783 1.88 53.24 46.76 9.50E+05 3.97 3.85 0.02 0.02 
12 1 0.9845 1.98 50.39 49.61 1.04E+06 3.92 3.90 0.02 0.02 
16 1 1.6728 2.67 37.41 62.59 1.38E+06 3.62 4.14 0.03 0.02 
18 1 1.9615 2.96 33.77 66.23 1.56E+06 3.52 4.19 0.03 0.02 
19 1 2.207 3.21 31.18 68.82 1.64E+06 3.44 4.23 0.03 0.01 
22 1 3.1066 4.11 24.35 75.65 1.90E+06 3.19 4.33 0.04 0.01 
23 1 3.3134 4.31 23.18 76.82 1.99E+06 3.14 4.34 0.04 0.01 
357 
24 1 3.4189 4.42 22.63 77.37 2.07E+06 3.12 4.35 0.04 0.01 
25 1 3.9088 4.91 20.37 79.63 2.16E+06 3.01 4.38 0.05 0.01 
26 1 4.4409 5.44 18.38 81.62 2.25E+06 2.91 4.40 0.05 0.01 
29 1 5.9718 6.97 14.34 85.66 2.51E+06 2.66 4.45 0.07 0.01 
30 1 6.4248 7.42 13.47 86.53 2.59E+06 2.60 4.46 0.07 0.01 
31 1 7.1085 8.11 12.33 87.67 2.68E+06 2.51 4.47 0.08 0.01 
32 1 7.7623 8.76 11.41 88.59 2.76E+06 2.43 4.48 0.09 0.01 
33 1 8.5628 9.56 10.46 89.54 2.85E+06 2.35 4.49 0.10 0.01 
36 1 11.6177 12.62 7.93 92.07 3.11E+06 2.07 4.52 0.13 0.01 
37 1 13.4117 14.41 6.94 93.06 3.20E+06 1.94 4.53 0.14 0.01 
38 1 15.0782 16.08 6.22 93.78 3.28E+06 1.83 4.54 0.16 0.01 
40 1 19.2247 20.22 4.94 95.06 3.46E+06 1.60 4.55 0.20 0.01 
43 1 31.6809 32.68 3.06 96.94 3.72E+06 1.12 4.57 0.33 0.01 
44 1 36.2682 37.27 2.68 97.32 3.80E+06 0.99 4.58 0.37 0.01 
46 1 50.0522 51.05 1.96 98.04 3.97E+06 0.67 4.59 0.51 0.01 
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Table 45 shows the calculations used to determine the relative rate constant in the formation of oxadiazoline 392 (CDCl3, 300MHz). The conversion of 
oxadiazoline 392 into urea 395 is illustrated graphically in Figure 78. Figure 79 outlines the determination of relative rate constant, krel, by plotting 
ln[Oxadiazoline 392]rel vs time (d). Figure 80 outlines the determination of relative rate constant, krel, by plotting ln[Urea 395]rel vs time (d). Figure 81 portrays the 
second order rate check by plotting 1/[Oxadiazoline 392]rel vs time (d). Figure 82 portrays the second order rate check by plotting 1/[Urea 395]rel vs time (d). 
Day 
no 
A B C D E  First order Second order 
Oxadiazoline 
integration 
(δH = 6.19 
ppm) 
Urea integration 


















(A+B) (A/C*100) (B/C*100) ln(D) ln(E) 1/D 1/E 
1 1 0 1.00 100.00 0.00 0.00E+00 4.61 - 0.01 - 
2 1 0 1.00 100.00 0.00 1.73E+05 4.61 - 0.01 - 
3 1 0 1.00 100.00 0.00 2.59E+05 4.61 - 0.01 - 
4 1 0 1.00 100.00 0.00 3.46E+05 4.61 - 0.01 - 
5 1 0 1.00 100.00 0.00 4.32E+05 4.61 - 0.01 - 
8 1 0.0351 1.04 96.61 3.39 6.91E+05 4.57 1.22 0.01 0.29 
9 1 0.0462 1.05 95.58 4.42 7.78E+05 4.56 1.49 0.01 0.23 
10 1 0.081 1.08 92.51 7.49 8.64E+05 4.53 2.01 0.01 0.13 
11 1 0.1077 1.11 90.28 9.72 9.50E+05 4.50 2.27 0.01 0.10 
12 1 0.1296 1.13 88.53 11.47 1.04E+06 4.48 2.44 0.01 0.09 
12 1 0.1302 1.13 88.48 11.52 1.04E+06 4.48 2.44 0.01 0.09 
15 1 0.2545 1.25 79.71 20.29 1.30E+06 4.38 3.01 0.01 0.05 
17 1 0.3151 1.32 76.04 23.96 1.47E+06 4.33 3.18 0.01 0.04 
18 1 0.3501 1.35 74.07 25.93 1.56E+06 4.30 3.26 0.01 0.04 
21 1 0.4874 1.49 67.23 32.77 1.81E+06 4.21 3.49 0.01 0.03 
22 1 0.5089 1.51 66.27 33.73 1.90E+06 4.19 3.52 0.02 0.03 
23 1 0.5479 1.55 64.60 35.40 1.99E+06 4.17 3.57 0.02 0.03 
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24 1 0.6061 1.61 62.26 37.74 2.07E+06 4.13 3.63 0.02 0.03 
25 1 0.6565 1.66 60.37 39.63 2.16E+06 4.10 3.68 0.02 0.03 
28 1 0.8524 1.85 53.98 46.02 2.42E+06 3.99 3.83 0.02 0.02 
29 1 0.9801 1.98 50.50 49.50 2.51E+06 3.92 3.90 0.02 0.02 
30 1 0.9954 2.00 50.12 49.88 2.59E+06 3.91 3.91 0.02 0.02 
31 1 1.1161 2.12 47.26 52.74 2.68E+06 3.86 3.97 0.02 0.02 
32 1 1.1367 2.14 46.80 53.20 2.76E+06 3.85 3.97 0.02 0.02 
35 1 1.3684 2.37 42.22 57.78 3.02E+06 3.74 4.06 0.02 0.02 
36 1 1.479 2.48 40.34 59.66 3.11E+06 3.70 4.09 0.02 0.02 
37 1 1.5761 2.58 38.82 61.18 3.20E+06 3.66 4.11 0.03 0.02 
39 1 1.8131 2.81 35.55 64.45 3.37E+06 3.57 4.17 0.03 0.02 
42 1 2.1607 3.16 31.64 68.36 3.63E+06 3.45 4.22 0.03 0.01 
43 1 2.2704 3.27 30.58 69.42 3.72E+06 3.42 4.24 0.03 0.01 
45 1 2.5343 3.53 28.29 71.71 3.89E+06 3.34 4.27 0.04 0.01 
49 1 3.2091 4.21 23.76 76.24 4.23E+06 3.17 4.33 0.04 0.01 
50 1 3.3501 4.35 22.99 77.01 4.32E+06 3.13 4.34 0.04 0.01 
59 1 5.1871 6.19 16.16 83.84 5.10E+06 2.78 4.43 0.06 0.01 
63 1 6.67769 7.68 13.02 86.98 5.44E+06 2.57 4.47 0.08 0.01 
64 1 6.9572 7.96 12.57 87.43 5.53E+06 2.53 4.47 0.08 0.01 
67 1 8.1285 9.13 10.95 89.05 5.79E+06 2.39 4.49 0.09 0.01 
72 1 10.6569 11.66 8.58 91.42 6.22E+06 2.15 4.52 0.12 0.01 
79 1 13.88622 14.89 6.72 93.28 6.83E+06 1.90 4.54 0.15 0.01 
81 1 15.0643 16.06 6.22 93.78 7.00E+06 1.83 4.54 0.16 0.01 
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Table 46 shows the calculations used to determine the relative rate constant in the formation of oxadiazoline 398 (CDCl3, 300MHz). The conversion of 
oxadiazoline 398 into urea 395 is illustrated graphically in Figure 86. Figure 87 outlines the determination of relative rate constant, krel, by plotting 
ln[Oxadiazoline 398]rel vs time (d). Figure 88 outlines the determination of relative rate constant, krel, by plotting ln[Urea 395]rel vs time (d). Figure 89 portrays the 
second order rate check by plotting 1/[Oxadiazoline 398]rel vs time (d). Figure 90 portrays the second order rate check by plotting 1/[Urea 395]rel vs time (d). 
Day 
no 
A B C D E  First order Second order 
Oxadiazoline 
integration 
(δH = 6.26 ppm) 
Urea integration 


















(A+B) (A/C*100) (B/C*100) ln(D) ln(E) 1/D 1/E 
0 1 0 1.00 100.00 0.00 0.00E+00 4.61 #NUM! 0.01 #DIV/0! 
1 1 0.0042 1.00 99.58 0.42 8.64E+04 4.60 -0.87 0.01 2.39 
2 1 0.0045 1.00 99.55 0.45 1.73E+05 4.60 -0.80 0.01 2.23 
3 1 0.0047 1.00 99.53 0.47 2.59E+05 4.60 -0.76 0.01 2.14 
4 1 0.0047 1.00 99.53 0.47 3.46E+05 4.60 -0.76 0.01 2.14 
5 1 0.0048 1.00 99.52 0.48 4.32E+05 4.60 -0.74 0.01 2.09 
8 1 0.0048 1.00 99.52 0.48 6.91E+05 4.60 -0.74 0.01 2.09 
9 1 0.0049 1.00 99.51 0.49 7.78E+05 4.60 -0.72 0.01 2.05 
10 1 0.007 1.01 99.30 0.70 8.64E+05 4.60 -0.36 0.01 1.44 
11 1 0.008 1.01 99.21 0.79 9.50E+05 4.60 -0.23 0.01 1.26 
12 1 0.0085 1.01 99.16 0.84 1.04E+06 4.60 -0.17 0.01 1.19 
16 1 0.01 1.01 99.01 0.99 1.38E+06 4.60 -0.01 0.01 1.01 
18 1 0.01 1.01 99.01 0.99 1.56E+06 4.60 -0.01 0.01 1.01 
19 1 0.0102 1.01 98.99 1.01 1.64E+06 4.60 0.01 0.01 0.99 
23 1 0.0115 1.01 98.86 1.14 1.99E+06 4.59 0.13 0.01 0.88 
24 1 0.0128 1.01 98.74 1.26 2.07E+06 4.59 0.23 0.01 0.79 
25 1 0.0144 1.01 98.58 1.42 2.16E+06 4.59 0.35 0.01 0.70 
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26 1 0.0148 1.01 98.54 1.46 2.25E+06 4.59 0.38 0.01 0.69 
29 1 0.0156 1.02 98.46 1.54 2.51E+06 4.59 0.43 0.01 0.65 
30 1 0.0178 1.02 98.25 1.75 2.59E+06 4.59 0.56 0.01 0.57 
31 1 0.0171 1.02 98.32 1.68 2.68E+06 4.59 0.52 0.01 0.59 
32 1 0.0196 1.02 98.08 1.92 2.76E+06 4.59 0.65 0.01 0.52 
33 1 0.0197 1.02 98.07 1.93 2.85E+06 4.59 0.66 0.01 0.52 
36 1 0.0227 1.02 97.78 2.22 3.11E+06 4.58 0.80 0.01 0.45 
37 1 0.0232 1.02 97.73 2.27 3.20E+06 4.58 0.82 0.01 0.44 
38 1 0.0239 1.02 97.67 2.33 3.28E+06 4.58 0.85 0.01 0.43 
40 1 0.0249 1.02 97.57 2.43 3.46E+06 4.58 0.89 0.01 0.41 
43 1 0.0276 1.03 97.31 2.69 3.72E+06 4.58 0.99 0.01 0.37 
44 1 0.0293 1.03 97.15 2.85 3.80E+06 4.58 1.05 0.01 0.35 
46 1 0.032 1.03 96.90 3.10 3.97E+06 4.57 1.13 0.01 0.32 
50 1 0.0365 1.04 96.48 3.52 4.32E+06 4.57 1.26 0.01 0.28 
51 1 0.0399 1.04 96.16 3.84 4.41E+06 4.57 1.34 0.01 0.26 
60 1 0.0532 1.05 94.95 5.05 5.18E+06 4.55 1.62 0.01 0.20 
64 1 0.0596 1.06 94.38 5.62 5.53E+06 4.55 1.73 0.01 0.18 
65 1 0.0611 1.06 94.24 5.76 5.62E+06 4.55 1.75 0.01 0.17 
68 1 0.0661 1.07 93.80 6.20 5.88E+06 4.54 1.82 0.01 0.16 
73 1 0.075 1.08 93.02 6.98 6.31E+06 4.53 1.94 0.01 0.14 
80 1 0.0882 1.09 91.89 8.11 6.91E+06 4.52 2.09 0.01 0.12 
82 1 0.0953 1.10 91.30 8.70 7.08E+06 4.51 2.16 0.01 0.11 
85 1 0.0966 1.10 91.19 8.81 7.34E+06 4.51 2.18 0.01 0.11 
87 1 0.0995 1.10 90.95 9.05 7.52E+06 4.51 2.20 0.01 0.11 
99 1 0.1286 1.13 88.61 11.39 8.55E+06 4.48 2.43 0.01 0.09 
108 1 0.1413 1.14 87.62 12.38 9.33E+06 4.47 2.52 0.01 0.08 
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124 1 0.1824 1.18 84.57 15.43 1.07E+07 4.44 2.74 0.01 0.06 
136 1 1.2095 2.21 45.26 54.74 1.18E+07 3.81 4.00 0.02 0.02 
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Table 47 shows the calculations used to determine the relative rate constant in the formation of oxadiazoline 400 (CDCl3, 300MHz). The conversion of 
oxadiazoline 400 into urea 395 is illustrated graphically in Figure 92. Figure 93 outlines the determination of relative rate constant, krel, by plotting 
ln[Oxadiazoline 400]rel vs time (d). Figure 94 outlines the determination of relative rate constant, krel, by plotting ln[Urea 395]rel vs time (d). Figure 95 portrays the 
second order rate check by plotting 1/[Oxadiazoline 400]rel vs time (d). Figure 96 portrays the second order rate check by plotting 1/[Urea 395] vs time (d). 
Day no 
A B C D E  First order Second order 
Oxadiazoline 
integration 
(δH = 6.17 
ppm) 
Urea integration 
(δH = 6.48 ppm,  



















ln(D) ln(E) 1/D 1/E 
0.0000 1 0 1.00 100.00 0 0.00E+00 4.61 #NUM! 0.01 #DIV/0! 
0.6240 1 0 1.00 100.00 0 5.39E+04 4.61 #NUM! 0.01 #DIV/0! 
0.9965 1 0.09 1.09 91.74 8.257 8.61E+04 4.52 2.11 0.01 0.12 
4.2979 1 0.31 1.31 76.34 23.66 3.71E+05 4.34 3.16 0.01 0.04 
5.0417 1 0.35 1.35 74.07 25.93 4.36E+05 4.31 3.26 0.01 0.04 
6.0132 1 0.38 1.38 72.46 27.54 5.20E+05 4.28 3.32 0.01 0.04 
7.0430 1 0.44 1.44 69.44 30.56 6.09E+05 4.24 3.42 0.01 0.03 
8.0229 1 0.55 1.55 64.52 35.48 6.93E+05 4.17 3.57 0.02 0.03 
11.1063 1 0.86 1.86 53.76 46.24 9.60E+05 3.98 3.83 0.02 0.02 
11.5882 1 0.96 1.96 51.02 48.98 1.00E+06 3.93 3.89 0.02 0.02 
12.6660 1 1.14 2.14 46.73 53.27 1.09E+06 3.84 3.98 0.02 0.02 
13.6625 1 1.23 2.23 44.84 55.16 1.18E+06 3.80 4.01 0.02 0.02 
14.6660 1 1.43 2.43 41.15 58.85 1.27E+06 3.72 4.07 0.02 0.02 
17.6389 1 1.78 2.78 35.97 64.03 1.52E+06 3.58 4.16 0.03 0.02 
18.7556 1 2.15 3.15 31.75 68.25 1.62E+06 3.46 4.22 0.03 0.01 
19.6625 1 2.4 3.40 29.41 70.59 1.70E+06 3.38 4.26 0.03 0.01 
21.6174 1 2.75 3.75 26.67 73.33 1.87E+06 3.28 4.30 0.04 0.01 
24.8354 1 3.61 4.61 21.69 78.31 2.15E+06 3.08 4.36 0.05 0.01 
25.6868 1 4.38 5.38 18.59 81.41 2.22E+06 2.92 4.40 0.05 0.01 
27.6514 1 4.81 5.81 17.21 82.79 2.39E+06 2.85 4.42 0.06 0.01 
31.8840 1 7.7 8.70 11.49 88.51 2.75E+06 2.44 4.48 0.09 0.01 
32.7833 1 8.82 9.82 10.18 89.82 2.83E+06 2.32 4.50 0.10 0.01 
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Figure 117 HSQC spectrum of oxadiazoline 420 (CDCl3, 600MHz) 
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